PT J
AU Chang, CH
   Chang, YT
   Tseng, TH
   Wang, CJ
AF Chang, Chun-Hua
   Chang, Yu-Tzu
   Tseng, Tsui-Hwa
   Wang, Chau-Jong
TI Mulberry leaf extract inhibit hepatocellular carcinoma cell proliferation via depressing IL-6 and TNF-α derived from adipocyte
SO JOURNAL OF FOOD AND DRUG ANALYSIS
LA English
DT Article
DE Hepatocellular carcinoma (HCC); Obesity; Proinflammatory cytokines; Mulberry leaf extract (MLE); Proliferation
ID tumor-necrosis-factor; fatty liver-disease; inflammatory cytokines; cancer; obesity; lipogenesis; polyphenols; growth; leaves
AB Epidemiological studies have revealed that obesity and being overweight are associated with increased cancer risk. Adipose tissue is regarded as an endocrine organ that secretes proinflammatory cytokines such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6), which are related to the progression of hepatocellular carcinoma (HCC). In this study, adipocytes from 3T3-L1 cells were induced and stained with Oil Red O, which revealed marked intracellular lipid accumulation. Adding 15% conditioned medium (CM) from adipogenic -differentiated 3T3-L1 cells, which contained adipocyte-derived factors, to a culture medium of HepG2 cells was discovered to promote cell proliferation by a factor of up to 1.3 compared with the control. Mulberry leaf extract (MLE), with major components including chlorogenic acid and neochlorogenic acid, was revealed to inhibit CM-promoted HepG2 cell proliferation. The inhibitory effect of MLE on the proliferation of the signal network was evaluated. Expression of the CM-activated I kappa B/NF kappa B, STAT3, and Akt/mTOR pathways were reduced when MLE was administered. Although adipocyte-derived factors are complex, administrating anti-TNF-alpha and anti-IL-6 revealed that MLE blocks signal activation promoted by TNF-a and IL-6. Taken together, these results demonstrated that MLE targets the proliferation signal pathway of the inflammatory response of adipocytes in HCC and could be to prevent obesity-mediated liver cancer. Copyright (C) 2018, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
C1 [Chang, Chun-Hua; Chang, Yu-Tzu; Wang, Chau-Jong] Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.
   [Wang, Chau-Jong] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan.
   [Tseng, Tsui-Hwa] Chung Shan Med Univ, Dept Med Appl Chem, Taichung, Taiwan.
   [Tseng, Tsui-Hwa] Chung Shan Med Univ Hosp, Dept Med Educ, Taichung, Taiwan.
C3 Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital
RP Wang, CJ (corresponding author), Chung Shan Med Univ, Inst Biochem Microbiol & Immunol, Taichung, Taiwan.; Tseng, TH (corresponding author), Chung Shan Med Univ, 110 Sect 1,Jiankuo North Rd, Taichung 402, Taiwan.
EM tht@csmu.edu.tw; wcj@csmu.edu.tw
FU Ministry of Science and Technology Grant, Taiwan [MOST 104-2632-B-040-002]
CR Ann JY, 2015, GENES NUTR, V10, P0, DOI 10.1007/s12263-015-0495-x
   Bae MH, 1998, CANCER LETT, V128, P41, DOI 10.1016/S0304-3835(98)00044-5
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Chan KC, 2013, J AGR FOOD CHEM, V61, P2780, DOI 10.1021/jf305328d
   Chan KC, 2010, J AGR FOOD CHEM, V58, P2536, DOI 10.1021/jf904293p
   Coppack SW, 2001, P NUTR SOC, V60, P349, DOI 10.1079/PNS2001110
   Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359
   Devi KP, 2015, IND CROP PROD, V76, P582, DOI 10.1016/j.indcrop.2015.07.051
   Duan XF, 2013, INT J CANCER, V133, P1776, DOI 10.1002/ijc.28105
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Flores MBS, 2012, GASTROENTEROLOGY, V143, P741, DOI 10.1053/j.gastro.2012.05.045
   Grivennikov SI, 2011, ANN RHEUM DIS, V70, PI104, DOI 10.1136/ard.2010.140145
   Harvey AE, 2011, ANN NY ACAD SCI, V1229, P45, DOI 10.1111/j.1749-6632.2011.06096.x
   Hefetz-Sela S, 2013, PHARMACOL THERAPEUT, V138, P197, DOI 10.1016/j.pharmthera.2013.01.008
   Johnson Christopher, 2012, TRANSL GASTROINTEST CANCER, V1, P58
   Kobayashi Y, 2010, BIOSCI BIOTECH BIOCH, V74, P2385, DOI 10.1271/bbb.100392
   Korkina LG, 2009, CURR MED CHEM, V16, P3943, DOI 10.2174/092986709789352312
   Makki Kassem, 2013, ISRN INFLAMM, V2013, P139239, DOI 10.1155/2013/139239
   Malley CO, 2016, BBA CLIN, V5, P29, DOI 10.1016/j.bbacli.2015.11.003
   Noratto G, 2009, J AGR FOOD CHEM, V57, P5219, DOI 10.1021/jf900259m
   Ou TT, 2013, J SCI FOOD AGR, V93, P1880, DOI 10.1002/jsfa.5984
   Ou TT, 2011, J SCI FOOD AGR, V91, P2740, DOI 10.1002/jsfa.4489
   Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052
   Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787
   Rodriguez ML, 2013, J CARCINOG MUTAG S, V0, P6
   Russo M, 2016, FOOD CHEM, V196, P589, DOI 10.1016/j.foodchem.2015.09.085
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Stagos D, 2012, FOOD CHEM TOXICOL, V50, P2155, DOI 10.1016/j.fct.2012.04.002
   Starley BQ, 2010, HEPATOLOGY, V51, P1820, DOI 10.1002/hep.23594
   Tang CC, 2013, FOOD CHEM TOXICOL, V62, P786, DOI 10.1016/j.fct.2013.10.011
   Thurow T, 2012, EFFECT CHLOROGENIC A, V0, P0
   Yang MY, 2011, EUR J INTEGR MED, V3, PE153, DOI 10.1016/j.eujim.2011.08.008
NR 32
TC 23
Z9 26
U1 0
U2 20
PU DIGITAL COMMONS BEPRESS
PI BERKELEY
PA 2100 MILVIA ST, STE 300, BERKELEY, CA 94704 USA
SN 1021-9498
EI 
J9 J FOOD DRUG ANAL
JI J. Food Drug Anal.
PD JUL 15
PY 2018
VL 26
IS 3
BP 1024
EP 1032
DI 10.1016/j.jfda.2017.12.007
PG 9
WC Food Science & Technology; Pharmacology & Pharmacy
SC Food Science & Technology; Pharmacology & Pharmacy
GA GM1FH
UT WOS:000437809200009
PM 29976395
DA 2025-04-28
ER

PT J
AU Reis, CEG
   Paiva, CLRD
   Amato, AA
   Lofrano-Porto, A
   Wassell, S
   Bluck, LJC
   Dórea, JG
   da Costa, THM
AF Reis, Caio E. G.
   Paiva, Cicilia L. R. dos S.
   Amato, Angelica A.
   Lofrano-Porto, Adriana
   Wassell, Sara
   Bluck, Leslie J. C.
   Dorea, Jose G.
   da Costa, Teresa H. M.
TI Decaffeinated coffee improves insulin sensitivity in healthy men
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Glucose; Stable isotopes; Insulin sensitivity assessment; Intestinal cytokines
ID caffeinated coffee; glucose-tolerance; glycemic index; postprandial glucose; chlorogenic acid; body-mass; consumption; overweight; homeostasis; metabolism
AB Epidemiological studies have found coffee consumption is associated with a lower risk for type 2 diabetes mellitus, but the underlying mechanisms remain unclear. Thus, the aim of this randomised, cross-over single-blind study was to investigate the effects of regular coffee, regular coffee with sugar and decaffeinated coffee consumption on glucose metabolism and incretin hormones. Seventeen healthy men participated in five trials each, during which they consumed coffee (decaffeinated, regular (containing caffeine) or regular with sugar) or water (with or without sugar). After 1 h of each intervention, they received an oral glucose tolerance test with one intravenous dose of [1-C-13] glucose. The Oral Dose Intravenous Label Experiment was applied and glucose and insulin levels were interpreted using a stable isotope two-compartment minimal model. A mixed-model procedure (PROC MIXED), with subject as random effect and time as repeated measure, was used to compare the effects of the beverages on glucose metabolism and incretin parameters (glucose-dependent insulinotropic peptide (GIP)) and glucagon-like peptide-1 (GLP-1)). Insulin sensitivity was higher with decaffeinated coffee than with water (P<0.05). Regular coffee with sugar did not significantly affect glucose, insulin, C-peptide and incretin hormones, compared with water with sugar. Glucose, insulin, C-peptide, GLP-1 and GIP levels were not statistically different after regular and decaffeinated coffee compared with water. Our findings demonstrated that the consumption of decaffeinated coffee improves insulin sensitivity without changing incretin hormones levels. There was no short-term adverse effect on glucose homoeostasis, after an oral glucose challenge, attributable to the consumption of regular coffee with sugar.
C1 [Reis, Caio E. G.; Dorea, Jose G.; da Costa, Teresa H. M.] Univ Brasilia, Dept Nutr, BR-70910900 Brasilia, DF, Brazil.
   [Paiva, Cicilia L. R. dos S.] Univ Brasilia, Fac Hlth Sci, BR-70910900 Brasilia, DF, Brazil.
   [Amato, Angelica A.; Lofrano-Porto, Adriana] Univ Brasilia, Dept Pharmaceut Sci, BR-70910900 Brasilia, DF, Brazil.
   [Wassell, Sara; Bluck, Leslie J. C.] MRC, Elsie Widdowson Lab, Cambridge CB1 9NL, England.
C3 Universidade de Brasilia; Universidade de Brasilia; Universidade de Brasilia; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research
RP da Costa, THM (corresponding author), Univ Brasilia, Dept Nutr, BR-70910900 Brasilia, DF, Brazil.
EM thmdacosta@gmail.com
FU National Council for Scientific and Technological Development (CNPq, Brazil) [473074-2010-9]; MRC-Elsie Widdowson Laboratory [MC_UP_A090_1005, MC_U105960384]; MRC [MC_U105960384] Funding Source: UKRI
CR Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Aldughpassi A, 2009, BRIT J NUTR, V101, P1282, DOI 10.1017/S0007114508079610
   Unknown -, 2000, WHO TECHN REP SER, V0, P0
   Unknown -, 2013, ISRN PHARMACOLOGY, V0, P0
   Aston L, 2007, INT J OBESITY, V31, P0
   Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276
   Beaudoin MS, 2011, J NUTR, V141, P574, DOI 10.3945/jn.110.132761
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bluck L, 2013, ISRN ENDOCRINOL, V0, P0
   Bluck LJC, 2006, RAPID COMMUN MASS SP, V20, P493, DOI 10.1002/rcm.2326
   Bluck LJC, 2004, MEAS SCI TECHNOL, V15, PN21, DOI 10.1088/0957-0233/15/2/N02
   Buscemi S, 2010, EUR J CLIN NUTR, V64, P483, DOI 10.1038/ejcn.2010.9
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   Casal S, 2017, CURR MED CHEM, V24, P376, DOI 10.2174/0929867323666161003123717
   Clapperton AT, 2001, PROCEEDINGS OF THE NUTRITION SOCIETY, V60, P0
   Clapperton AT, 2002, RAPID COMMUN MASS SP, V16, P2009, DOI 10.1002/rcm.815
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   de Mejia EG, 2014, TRENDS ENDOCRIN MET, V25, P489, DOI 10.1016/j.tem.2014.07.003
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dórea JG, 2005, BRIT J NUTR, V93, P773, DOI 10.1079/BJN20051370
   Dotson CD, 2008, PLOS ONE, V3, P0, DOI 10.1371/journal.pone.0003974
   Dube S, 2015, CURR DIABETES REP, V15, P0, DOI 10.1007/s11892-015-0605-6
   Gavrieli A, 2013, METABOLISM, V62, P1099, DOI 10.1016/j.metabol.2013.02.003
   Gavrieli A, 2011, J NUTR, V141, P703, DOI 10.3945/jn.110.137323
   Greenberg JA, 2010, DIABETES CARE, V33, P278, DOI 10.2337/dc09-1539
   Gutch Manish, 2015, INDIAN J ENDOCRINOL METAB, V19, P160, DOI 10.4103/2230-8210.146874
   Hätönen KA, 2012, EUR J NUTR, V51, P801, DOI 10.1007/s00394-011-0258-4
   Jackson SJ, 2007, RAPID COMMUN MASS SP, V21, P3123, DOI 10.1002/rcm.3195
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Kim SD, 2015, J MICROBIOL BIOTECHN, V25, P174, DOI 10.4014/jmb.1411.11057
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180
   Littell RC, 1998, J ANIM SCI, V76, P1216
   Louie JCY, 2008, ASIA PAC J CLIN NUTR, V17, P657
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   LUKASKI HC, 1986, J APPL PHYSIOL, V60, P1327, DOI 10.1152/jappl.1986.60.4.1327
   Unknown -, 2010, ARQ. BRAS. CARDIOL., V95, PI, DOI 10.5935/abc.20160153, 10.5935/abc.20160152
   Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Moisey LL, 2008, AM J CLIN NUTR, V87, P1254, DOI 10.1093/ajcn/87.5.1254
   Moisey LL, 2010, BRIT J NUTR, V103, P833, DOI 10.1017/S0007114509992406
   Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Nuhu Abdulmumin A, 2014, ISRN NUTR, V2014, P384230, DOI 10.1155/2014/384230
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Sousa AG, 2015, BRIT J NUTR, V113, P1615, DOI 10.1017/S0007114515000835
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Wang Bin, 2009, JOURNAL OF AERONAUTICAL MATERIALS, V29, P1
NR 50
TC 23
Z9 23
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD MAY 14
PY 2018
VL 119
IS 9
BP 1029
EP 1038
DI 10.1017/S000711451800034X
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GN6IV
UT WOS:000439185100008
PM 29514721
DA 2025-04-28
ER

PT J
AU Lee, KW
   Shin, D
AF Lee, Kyung Won
   Shin, Dayeon
TI A Healthy Beverage Consumption Pattern Is Inversely Associated with the Risk of Obesity and Metabolic Abnormalities in Korean Adults
SO JOURNAL OF MEDICINAL FOOD
LA English
DT Article
DE beverage consumption pattern; factor analysis; healthy beverage; Korean adults; metabolic syndrome; obesity
ID sugar-sweetened beverages; soft drink consumption; national-health; coffee consumption; dietary patterns; caloric beverages; prevalence; children; mechanisms; components
AB As the use of beverages in diets is increasing, several studies have examined the effect of beverage consumption in human health. Thus, we aimed at identifying specific beverage patterns and determining their associations with obesity and metabolic syndrome (MetS) risk factors in Korean adults. Based on the Korea National Health and Nutrition Examination Survey (KNHANES) 2008-2012 data, 19,800 Korean adults (20 years) with a single 24-h dietary recall and health examination data were investigated. All beverage items consumed by participants were categorized into 15 beverage groups based on the KNHANES coding system. Three major beverage consumption patterns were identified according to factor analysis: (1) the healthy beverage (high intake of dairy products, 100% fruit/vegetable juices and low intake of alcoholic beverages); (2) the sugar-sweetened beverage (high intake of soda, sweetened coffee/tea, and fruit drink); and (3) the unsweetened beverage (high intake of unsweetened coffee) patterns. Multivariable logistic regression analyses were conducted to determine the odds of obesity (body mass index 25kg/m(2)) and MetS (defined by National Cholesterol Education Program III [NCEP III]) for each beverage pattern after controlling for covariates. Adjusted odds ratios (AORs) and 95% confidence intervals (CIs) for associations of the healthy beverage pattern with risks of obesity, abdominal obesity, and elevated triglycerides, fasting blood glucose (FBG), and blood pressure (BP) were 0.88 (0.79-0.98), 0.83 (0.74-0.92), 0.88 (0.78-0.99), 0.85 (0.79-0.98), and 0.81 (0.72-0.92), respectively. AORs (95% CIs) of associations of the sugar-sweetened beverage pattern with risks of abdominal obesity, elevated FBG and BP were 1.15 (1.03-1.30), 1.14 (1.01-1.29), and 1.18 (1.04-1.33), respectively. However, no associations were found between the unsweetened beverage pattern and any parameters examined. Intake of healthy beverages should be encouraged to reduce risks of obesity and metabolic abnormalities; however, individuals who consume sugar-sweetened beverages should be advised on the adverse effects of those beverages on the risk of obesity and MetS.
C1 [Lee, Kyung Won] Michigan State Univ, Dept Food Sci & Human Nutr, E Lansing, MI 48824 USA.
   [Lee, Kyung Won] Korea Ctr Dis Control & Prevent, Div Epidemiol & Hlth Index, Ctr Genome Sci, Korea Natl Inst Hlth, Cheongju, Chungcheongbuk, South Korea.
   [Shin, Dayeon] Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, 552 White Hall, Syracuse, NY 13244 USA.
C3 Michigan State University; Korea Disease Control & Prevention Agency (KDCA); Korea National Institute of Health (KNIH); Korea CDC Center for Genome Science; Syracuse University
RP Shin, D (corresponding author), Syracuse Univ, Dept Publ Hlth Food Studies & Nutr, 552 White Hall, Syracuse, NY 13244 USA.
EM dshin03@syr.edu
CR Aguilar M, 2015, JAMA-J AM MED ASSOC, V313, P1973, DOI 10.1001/jama.2015.4260
   Ahluwalia N, 2013, DIABETES METAB, V39, P99, DOI 10.1016/j.diabet.2012.08.007
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Unknown -, 2000, ASIA PACIFIC PERSPEC, V0, P0
   Baik I, 2008, AM J CLIN NUTR, V87, P1455, DOI 10.1093/ajcn/87.5.1455
   Barquera S, 2008, J NUTR, V138, P2454, DOI 10.3945/jn.108.092163
   Tran BT, 2017, BMC PUBLIC HEALTH, V17, P0, DOI 10.1186/s12889-016-3936-6
   Cho YA, 2011, NUTR METAB CARDIOVAS, V21, P893, DOI 10.1016/j.numecd.2010.02.018
   Chung S, 2015, METABOLISM, V64, P1477, DOI 10.1016/j.metabol.2015.07.012
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Danyliw AD, 2011, PUBLIC HEALTH NUTR, V14, P1961, DOI 10.1017/S1368980011001091
   Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008
   Drewnowski A, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-1068
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Duffey KJ, 2012, EUR J CLIN NUTR, V66, P244, DOI 10.1038/ejcn.2011.166
   Duffey KJ, 2006, J NUTR, V136, P2901, DOI 10.1093/jn/136.11.2901
   Duffey KJ, 2010, AM J CLIN NUTR, V92, P954, DOI 10.3945/ajcn.2010.29478
   Esmaillzadeh A, 2007, AM J CLIN NUTR, V85, P910, DOI 10.1093/ajcn/85.3.910
   Falahi E, 2016, INT DAIRY J, V61, P85, DOI 10.1016/j.idairyj.2016.04.008
   Ford ES, 2001, OBES RES, V9, P21, DOI 10.1038/oby.2001.4
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Han E, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-195
   Hostmark AT, 2010, APPL PHYSIOL NUTR ME, V35, P635, DOI 10.1139/H10-059
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   김경윤, 2017, JOURNAL OF THE KOREAN SOCIETY OF FOOD SCIENCE AND NUTRITION 한국식품영양과학회지, V46, P630
   Kang Y, 2017, BRIT J NUTR, V117, P315, DOI 10.1017/S0007114517000046
   Kim D, 2017, BRIT J NUTR, V117, P148, DOI 10.1017/S000711451600444X
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   *KOR CTR DIS CONTR, 2016, US GUID 4 KOR NAT HL, V0, P0, DOI DOI 10.1016/J.NIMB.2005.04.002
   *KOR HLTH IND DEV, 2014, FOOD IND AN REP 2014, V0, P0, DOI DOI 10.1186/1743-7075-8-65
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee JE, 2011, NUTRITION, V27, P26, DOI 10.1016/j.nut.2009.10.011
   LEE KW, 2016, NUTRIENTS, V8, P0, DOI 10.3390/NU8100617
   LEE KW, 2017, NUTRIENTS, V9, P0, DOI 10.3390/NU9060630
   Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Mesirow MSC, 2015, J ACAD NUTR DIET, V115, P559, DOI 10.1016/j.jand.2014.09.004
   Ministry of Health and Welfare, 2016, KOR HLTH STAT 2015 K, V0, P0
   Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, 2013, KOR HLTH STAT 2012 K, V0, P0
   *NAT HLTH INS SERV, 2015, SOC IMP HLTH RISK FA, V0, P0
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Pereira MA, 2010, J AM COLL NUTR, V29, P625, DOI 10.1080/07315724.2010.10719901
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Shin D, 2015, NUTRIENTS, V7, P9369, DOI 10.3390/nu7115472
   Song F, 2016, NFS JOURNAL, V4, P9
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
NR 52
TC 10
Z9 10
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1096-620X
EI 1557-7600
J9 J MED FOOD
JI J. Med. Food
PD SEP 15
PY 2018
VL 21
IS 9
BP 935
EP 945
DI 10.1089/jmf.2017.0119
EA MAR 2018
PG 11
WC Chemistry, Medicinal; Food Science & Technology; Nutrition & Dietetics
SC Pharmacology & Pharmacy; Food Science & Technology; Nutrition & Dietetics
GA GT7FT
UT WOS:000428437800001
PM 29569988
DA 2025-04-28
ER

PT J
AU Yamagata, K
AF Yamagata, Kazuo
TI Do Coffee Polyphenols Have a Preventive Action on Metabolic Syndrome Associated Endothelial Dysfunctions? An Assessment of the Current Evidence
SO ANTIOXIDANTS
LA English
DT Review
DE antioxidative effects; chlorogenic acid; endothelial dysfunction; metabolic syndrome
ID nonalcoholic fatty liver; dose-response metaanalysis; oxidative stress; chlorogenic acid; tea consumption; cardiovascular-disease; risk-factors; decaffeinated coffee; insulin-resistance; vascular-disease
AB Epidemiologic studies from several countries have found that mortality rates associated with the metabolic syndrome are inversely associated with coffee consumption. Metabolic syndrome can lead to arteriosclerosis by endothelial dysfunction, and increases the risk for myocardial and cerebral infarction. Accordingly, it is important to understand the possible protective effects of coffee against components of the metabolic syndrome, including vascular endothelial function impairment, obesity and diabetes. Coffee contains many components, including caffeine, chlorogenic acid, diterpenes and trigonelline. Studies have found that coffee polyphenols, such as chlorogenic acids, have many health-promoting properties, such as antioxidant, anti-inflammatory, anti-cancer, anti-diabetes, and antihypertensive properties. Chlorogenic acids may exert protective effects against metabolic syndrome risk through their antioxidant properties, in particular toward vascular endothelial cells, in which nitric oxide production may be enhanced, by promoting endothelial nitric oxide synthase expression. These effects indicate that coffee components may support the maintenance of normal endothelial function and play an important role in the prevention of metabolic syndrome. However, results related to coffee consumption and the metabolic syndrome are heterogeneous among studies, and the mechanisms of its functions and corresponding molecular targets remain largely elusive. This review describes the results of studies exploring the putative effects of coffee components, especially in protecting vascular endothelial function and preventing metabolic syndrome.
C1 [Yamagata, Kazuo] Nihon Univ, Coll Bioresource Sci NUBS, Dept Food Biosci & Biotechnol, Lab Mol Hlth Sci Food, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.
C3 Nihon University
RP Yamagata, K (corresponding author), Nihon Univ, Coll Bioresource Sci NUBS, Dept Food Biosci & Biotechnol, Lab Mol Hlth Sci Food, 1866 Kameino, Fujisawa, Kanagawa 2528510, Japan.
EM kyamagat@brs.nihon-u.ac.jp
FU Grants-in-Aid for Scientific Research [15K08321] Funding Source: KAKEN
CR Akerele OA, 2015, MED HYPOTHESES, V85, P754, DOI 10.1016/j.mehy.2015.10.013
   Andreasen MF, 2001, J AGR FOOD CHEM, V49, P4090, DOI 10.1021/jf0101758
   Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406
   Bakker R, 2010, AM J CLIN NUTR, V91, P1691, DOI 10.3945/ajcn.2009.28792
   Bakuradze T, 2011, MOL NUTR FOOD RES, V55, P793, DOI 10.1002/mnfr.201100093
   Baspinar B, 2017, FOOD FUNCT, V8, P2089, DOI 10.1039/c7fo00388a
   Bekedam EK, 2008, J AGR FOOD CHEM, V56, P7138, DOI 10.1021/jf800999a
   Bloomer RJ, 2013, NUTR METAB INSIGHTS, V6, P35, DOI 10.4137/NMI.S12215
   Bonita JS, 2007, PHARMACOL RES, V55, P187, DOI 10.1016/j.phrs.2007.01.006
   Brezová V, 2009, FOOD CHEM, V114, P859, DOI 10.1016/j.foodchem.2008.10.025
   Caprioli G, 2015, INT J FOOD SCI NUTR, V66, P505, DOI 10.3109/09637486.2015.1064871
   Chang CS, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038874
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013
   Davinelli S, 2016, HIGH BLOOD PRESS CAR, V23, P197, DOI 10.1007/s40292-016-0149-0
   Di Lorenzo A, 2017, CURR PHARM DESIGN, V23, P2474, DOI 10.2174/1381612823666170215145855
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dos Santos Poliana Rodrigues, 2015, CLIN NUTR RES, V4, P41, DOI 10.7762/cnr.2015.4.1.41
   Driessen MT, 2009, EUR J CLIN NUTR, V63, P536, DOI 10.1038/ejcn.2008.6
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Edeas M, 2010, PATHOL BIOL, V58, P220, DOI 10.1016/j.patbio.2009.09.011
   Fukushima Y, 2009, J AGR FOOD CHEM, V57, P1253, DOI 10.1021/jf802418j
   Fuster JJ, 2016, CIRC RES, V118, P1786, DOI 10.1161/CIRCRESAHA.115.306885
   García-Vilas JA, 2017, FOOD CHEM, V221, P1741, DOI 10.1016/j.foodchem.2016.10.111
   Godos J, 2014, INT J FOOD SCI NUTR, V65, P925, DOI 10.3109/09637486.2014.940287
   Goh GBB, 2014, HEPATOLOGY, V60, P661, DOI 10.1002/hep.27054
   Grassi D, 2011, CURR PHARM BIOTECHNO, V12, P1343, DOI 10.2174/138920111798281018
   Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494
   Grosso G, 2016, EUR J CLIN NUTR, V70, P109, DOI 10.1038/ejcn.2015.119
   Grosso G, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9080890
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Haidari F, 2017, ASIA PAC J CLIN NUTR, V26, P1048, DOI 10.6133/apjcn.022017.03
   Higashi Y, 2009, CIRC J, V73, P411, DOI 10.1253/circj.CJ-08-1102
   Hino A, 2007, DIABETES RES CLIN PR, V76, P383, DOI 10.1016/j.diabres.2006.09.033
   Hodge A, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9010056
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hu G, 2007, AM J CLIN NUTR, V86, P457, DOI 10.1093/ajcn/86.2.457
   Huang WY, 2017, J FOOD SCI, V82, P1239, DOI 10.1111/1750-3841.13706
   InterAct Consortium, 2016, DIABETOLOGIA, V59, P2613, DOI 10.1007/s00125-016-4090-5
   Jiang RJ, 2016, J NUTR BIOCHEM, V27, P53, DOI 10.1016/j.jnutbio.2015.08.017
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Jung HJ, 2017, BMB REP, V50, P323, DOI 10.5483/BMBRep.2017.50.6.182
   Kajikawa M, 2019, EUR J NUTR, V58, P989, DOI 10.1007/s00394-018-1611-7
   Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim K, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167007
   Kotyczka C, 2011, MOL NUTR FOOD RES, V55, P1582, DOI 10.1002/mnfr.201100248
   Kougias P, 2005, J SURG RES, V126, P121, DOI 10.1016/j.jss.2004.12.023
   Kumar SS, 2001, INT J RADIAT BIOL, V77, P617, DOI 10.1080/09553000110034649
   Kwok MK, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36500
   Landberg R, 2012, CURR OPIN LIPIDOL, V23, P147, DOI 10.1097/MOL.0b013e328351123a
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lee C, 2000, CLIN CHIM ACTA, V295, P141, DOI 10.1016/S0009-8981(00)00201-1
   Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x
   Low WY, 2015, INT J OCCUP MED ENV, V28, P20, DOI 10.2478/s13382-014-0326-0
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Martini D, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21080979
   Maruyama K, 2009, J STROKE CEREBROVASC, V18, P173, DOI 10.1016/j.jstrokecerebrovasdis.2008.03.008
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Micek A, 2018, INT J FOOD SCI NUTR, V69, P358, DOI 10.1080/09637486.2017.1362690
   Miller PE, 2017, AM J MED, V130, P188, DOI 10.1016/j.amjmed.2016.08.038
   Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034
   Natella F, 2002, J AGR FOOD CHEM, V50, P6211, DOI 10.1021/jf025768c
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Oboh Ganiyu, 2015, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V26, P165, DOI 10.1515/jbcpp-2013-0141
   Ochiai R, 2015, INT J FOOD SCI NUTR, V66, P350, DOI 10.3109/09637486.2015.1007453
   Ono M, 2010, CLIN J GASTROENTEROL, V3, P263, DOI 10.1007/s12328-010-0182-9
   Opitz SEW, 2014, FOODS, V3, P586, DOI 10.3390/foods3040586
   Palatini P, 2009, J HYPERTENS, V27, P1594, DOI 10.1097/HJH.0b013e32832ba850
   Paoletti R, 2006, VASC HEALTH RISK MAN, V2, P145, DOI 10.2147/vhrm.2006.2.2.145
   Patel YR, 2017, CLIN NUTR ESPEN, V17, P18, DOI 10.1016/j.clnesp.2016.12.003
   León-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y
   Reis JP, 2010, ARTERIOSCL THROM VAS, V30, P2059, DOI 10.1161/ATVBAHA.110.208280
   Saltiel AR, 2017, J CLIN INVEST, V127, P1, DOI 10.1172/JCI92035
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Serafini M, 2009, CLIN DERMATOL, V27, P225, DOI 10.1016/j.clindermatol.2008.04.007
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Sjöholm Å, 2005, LANCET, V365, P610, DOI 10.1016/S0140-6736(05)70804-7
   Stalmach Angélique, 2006, BRAZ. J. PLANT PHYSIOL., V18, P253, DOI 10.1590/S1677-04202006000100018
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Suliga E, 2017, INT J FOOD SCI NUTR, V68, P507, DOI 10.1080/09637486.2016.1256381
   Suzuki A, 2006, J HYPERTENS, V24, P1065, DOI 10.1097/01.hjh.0000226196.67052.c0
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Uemura H, 2013, EUR J CLIN NUTR, V67, P1109, DOI 10.1038/ejcn.2013.132
   van Dam RM, 2006, DIABETES CARE, V29, P398, DOI 10.2337/diacare.29.02.06.dc05-1512
   Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x
   Vykoukal D, 2012, VASCULAR, V20, P156, DOI 10.1258/vasc.2011.201201
   Walton HB, 2013, SCOT MED J, V58, P217, DOI 10.1177/0036933013507869
   Wang TG, 2017, BMC MED, V15, P0, DOI 10.1186/s12916-017-0862-0
   Wilsgaard T, 2007, DIABETES RES CLIN PR, V78, P217, DOI 10.1016/j.diabres.2007.03.006
   Yen AMF, 2006, AM J CLIN NUTR, V83, P1153, DOI 10.1093/ajcn/83.5.1153
   Yen GC, 1999, J AGR FOOD CHEM, V47, P1326, DOI 10.1021/jf9810618
   Yesil A, 2013, ALIMENT PHARM THER, V38, P1038, DOI 10.1111/apt.12489
   Yki-Järvinen H, 2014, LANCET DIABETES ENDO, V2, P901, DOI 10.1016/S2213-8587(14)70032-4
   Zelber-Sagi S, 2015, TRANSL RES, V165, P428, DOI 10.1016/j.trsl.2014.10.008
   Zhao YG, 2011, ADV DIFFER EQU-NY, V0, P0, DOI DOI 10.1186/1687-1847-2011-10
NR 100
TC 51
Z9 53
U1 1
U2 25
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-3921
EI 
J9 ANTIOXIDANTS-BASEL
JI Antioxidants
PD FEB 15
PY 2018
VL 7
IS 2
BP 
EP 
DI 10.3390/antiox7020026
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Food Science & Technology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Food Science & Technology
GA FZ3QR
UT WOS:000427505500005
PM 29401716
DA 2025-04-28
ER

PT J
AU Yang, CS
   Wang, H
   Sheridan, ZP
AF Yang, Chung Shu
   Wang, Hong
   Sheridan, Zachary Paul
TI Studies on prevention of obesity, metabolic syndrome, diabetes, cardiovascular diseases and cancer by tea
SO JOURNAL OF FOOD AND DRUG ANALYSIS
LA English
DT Review
DE Cancer; Diabetes; Metabolic syndrome; Obesity; Polyphenols
ID activated protein-kinase; green tea; epigallocatechin gallate; coffee consumption; insulin-resistance; polyphenon-e; energy-expenditure; prospective cohort; lipid-metabolism; controlled-trial
AB Tea, a popular beverage made from leaves of the plant Camellia sinensis, has been studied extensively in recent decades for its beneficial health effects in the prevention of obesity, metabolic syndrome, diabetes, cancer, and other diseases. Whereas these beneficial effects have been convincingly demonstrated in most laboratory studies, results from human studies have not been consistent. Some studies demonstrated that weight reduction, alleviation of metabolic syndrome and risk reduction in diabetes were only observed in individuals who consume 3-4 cups of tea (600-900 mg tea catechins) or more daily. This chapter reviews some of these studies, the possible mechanisms of actions of tea constituents, and the challenges in extrapolating laboratory studies to human situations. Copyright (C) 2017, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
C1 [Yang, Chung Shu; Wang, Hong; Sheridan, Zachary Paul] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA.
C3 Rutgers University System; Rutgers University New Brunswick
RP Yang, CS (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA.
EM csyang@pharmacy.rutgers.edu
FU NIH [CA120915, CA122474, CA133021]
CR Aggio A, 2013, EUR J NUTR, V52, P263, DOI 10.1007/s00394-012-0320-x
   Akiyama S, 2009, BIOSCI BIOTECH BIOCH, V73, P2779, DOI 10.1271/bbb.90576
   Arnaud MJ, 1900, V200, V0, P0
   Axling U, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-105
   Balentine DA, 1997, CRIT REV FOOD SCI, V37, P693, DOI 10.1080/10408399709527797
   Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005
   Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Byun JK, 2014, IMMUNOL LETT, V157, P51, DOI 10.1016/j.imlet.2013.11.006
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Chang CT, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0031808
   Chen HD, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0051001
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Chow HHS, 2011, PHARMACOL RES, V64, P105, DOI 10.1016/j.phrs.2011.05.007
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200
   Crew KD, 2012, CANCER PREV RES, V5, P1144, DOI 10.1158/1940-6207.CAPR-12-0117
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Di Castelnuovo A, 2012, EUR J INTERN MED, V23, P15, DOI 10.1016/j.ejim.2011.07.014
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Everard A, 2014, MBIO, V5, P0, DOI 10.1128/mBio.01011-14
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Ford ES, 2005, DIABETES CARE, V28, P2745, DOI 10.2337/diacare.28.11.2745
   Friedrich M, 2012, INT J OBESITY, V36, P735, DOI 10.1038/ijo.2011.136
   Gans JMD, 2010, ARTERIOSCL THROM VAS, V30, P1665, DOI 10.1161/ATVBAHA.109.201939
   GAO YT, 1994, JNCI-J NATL CANCER I, V86, P855, DOI 10.1093/jnci/86.11.855
   Grassi D, 2016, NUTRIENTS, V0, P8
   Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hartley L, 2013, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD009934.pub2
   Hodgson AB, 2013, J NUTR BIOCHEM, V24, P325, DOI 10.1016/j.jnutbio.2012.06.017
   Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480
   Huang YQ, 2016, NUTRITION, V32, P3, DOI 10.1016/j.nut.2015.05.021
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   James KD, 2015, FOOD CHEM TOXICOL, V76, P103, DOI 10.1016/j.fct.2014.12.009
   Janssens PLHR, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0153134
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jemnitz K, 2010, DRUG METAB REV, V42, P402, DOI 10.3109/03602530903491741
   Jensen GS, 2016, CLIN INTERV AGING, V11, P367, DOI 10.2147/CIA.S94881
   Jin JS, 2012, MICROBIOL IMMUNOL, V56, P729, DOI 10.1111/j.1348-0421.2012.00502.x
   Jochmann N, 2008, BRIT J NUTR, V99, P863, DOI 10.1017/S0007114507838992
   Joe AK, 2015, CANCER PREV RES, V8, P1131, DOI 10.1158/1940-6207.CAPR-14-0274-T
   Ju J, 2007, SEMIN CANCER BIOL, V17, P395, DOI 10.1016/j.semcancer.2007.06.013
   Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022
   Kokubo Y, 2013, STROKE, V44, P1369, DOI 10.1161/STROKEAHA.111.677500
   Kumar NB, 2015, CANCER PREV RES, V8, P879, DOI 10.1158/1940-6207.CAPR-14-0324
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Lambert JD, 2010, FOOD CHEM TOXICOL, V48, P409, DOI 10.1016/j.fct.2009.10.030
   Lee LS, 2015, MOL NUTR FOOD RES, V59, P784, DOI 10.1002/mnfr.201400470
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Li C, 2000, CHEM RES TOXICOL, V13, P177, DOI 10.1021/tx9901837
   Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039
   Li GW, 2015, J HYPERTENS, V33, P243, DOI 10.1097/HJH.0000000000000426
   Li M, 2016, CANCER EPIDEMIOL, V40, P73, DOI 10.1016/j.canep.2015.11.013
   Li X, 2017, HEART, V103, P783, DOI 10.1136/heartjnl-2016-310462
   Li YC, 2016, DIABETES-METAB RES, V32, P2, DOI 10.1002/dmrr.2641
   Li YR, 2009, J NUTR BIOCHEM, V20, P1021, DOI 10.1016/j.jnutbio.2008.12.001
   Liang WB, 2009, STROKE, V40, P2480, DOI 10.1161/STROKEAHA.109.548586
   Liu JX, 2016, EUR J EPIDEMIOL, V31, P853, DOI 10.1007/s10654-016-0173-3
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lorenz M, 2004, J BIOL CHEM, V279, P6190, DOI 10.1074/jbc.M309114200
   Lu YP, 2011, CANCER PREV RES, V4, P1118, DOI 10.1158/1940-6207.CAPR-11-0116
   Makiuchi T, 2016, CANCER SCI, V107, P76, DOI 10.1111/cas.12843
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Miller PE, 2017, AM J MED, V130, P188, DOI 10.1016/j.amjmed.2016.08.038
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Most J, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17896
   Muenzner M, 2016, INT J OBESITY, V40, P1850, DOI 10.1038/ijo.2016.172
   Mukamal KJ, 2006, J AM COLL NUTR, V25, P472, DOI 10.1080/07315724.2006.10719561
   Mulder TPJ, 2001, J CHROMATOGR B, V760, P271, DOI 10.1016/S0378-4347(01)00285-7
   Munir KM, 2013, AM J PHYSIOL-ENDOC M, V305, PE679, DOI 10.1152/ajpendo.00377.2013
   Murase T, 2009, BIOCHEM PHARMACOL, V78, P78, DOI 10.1016/j.bcp.2009.03.021
   Ng HLH, 2017, J NUTR BIOCHEM, V40, P23, DOI 10.1016/j.jnutbio.2016.10.005
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Ogunleye AA, 2010, BREAST CANCER RES TR, V119, P477, DOI 10.1007/s10549-009-0415-0
   Okuda MH, 2014, J NUTR BIOCHEM, V25, P1084, DOI 10.1016/j.jnutbio.2014.05.012
   Ortsäter H, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-11
   Pae MY, 2012, J NUTR BIOCHEM, V23, P526, DOI 10.1016/j.jnutbio.2011.02.006
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Pullikotil P, 2012, J NUTR BIOCHEM, V23, P1134, DOI 10.1016/j.jnutbio.2011.06.007
   Qin BL, 2010, MOL NUTR FOOD RES, V54, PS14, DOI 10.1002/mnfr.200900306
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Sae-Tan S, 2011, PHARMACOL RES, V64, P146, DOI 10.1016/j.phrs.2010.12.013
   Sang SM, 2011, PHARMACOL RES, V64, P87, DOI 10.1016/j.phrs.2011.02.007
   Sasazuki S, 2012, JPN J CLIN ONCOL, V42, P335, DOI 10.1093/jjco/hys009
   Schönthal AH, 2011, MOL NUTR FOOD RES, V55, P874, DOI 10.1002/mnfr.201000644
   Serisier S, 2008, BRIT J NUTR, V99, P1208, DOI 10.1017/S0007114507862386
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Sesso HD, 2003, AM J CLIN NUTR, V77, P1400, DOI 10.1093/ajcn/77.6.1400
   Shen GX, 2005, PHARM RES-DORDR, V22, P1805, DOI 10.1007/s11095-005-7546-8
   Shen L, 2012, J ZHEJIANG UNIV-SC B, V13, P652, DOI 10.1631/jzus.B1201001
   Shin CM, 2017, CLIN NUTR, V0, P0
   Song YQ, 2005, J AM COLL NUTR, V24, P376, DOI 10.1080/07315724.2005.10719488
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427
   Tian C, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep24353
   Valenti D, 2013, BBA-MOL BASIS DIS, V1832, P2085, DOI 10.1016/j.bbadis.2013.07.014
   van der Pijl PC, 2010, J FUNCT FOODS, V2, P239, DOI 10.1016/j.jff.2010.08.001
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Vuong QV, 2011, J SCI FOOD AGR, V91, P1931, DOI 10.1002/jsfa.4373
   Wang DX, 2015, TOXICOL APPL PHARM, V283, P65, DOI 10.1016/j.taap.2014.12.018
   Wang J, 2012, CANCER EPIDEMIOL, V36, PE354, DOI 10.1016/j.canep.2012.08.004
   Wang L, 2016, FOOD FUNCT, V7, P4956, DOI 10.1039/c6fo01150k
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang ZM, 2011, AM J CLIN NUTR, V93, P506, DOI 10.3945/ajcn.110.005363
   Wu AH, 2012, CANCER PREV RES, V5, P393, DOI 10.1158/1940-6207.CAPR-11-0407
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI 10.1039/c4fo00095a
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2013, ANNU REV NUTR, V33, P161, DOI 10.1146/annurev-nutr-071811-150717
   Yang CS, 2011, PHARMACOL RES, V64, P113, DOI 10.1016/j.phrs.2011.03.001
   Yang CS, 2009, NAT REV CANCER, V9, P429, DOI 10.1038/nrc2641
   Yang CS, 2008, MOL NUTR FOOD RES, V52, PS139, DOI 10.1002/mnfr.200700234
   Yang CS, 2016, MOLECULES, V0, P21
   Yarmolinsky J, 2015, NUTR REV, V73, P236, DOI 10.1093/nutrit/nuv001
   Yuan JM, 2011, PHARMACOL RES, V64, P123, DOI 10.1016/j.phrs.2011.03.002
   Zhao LG, 2017, J EPIDEMIOL, V27, P36, DOI 10.1016/j.je.2016.08.004
   Zhou J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087008
   Zhou Q, 2016, ARCH GYNECOL OBSTET, V293, P143, DOI 10.1007/s00404-015-3811-1
NR 124
TC 98
Z9 108
U1 1
U2 74
PU DIGITAL COMMONS BEPRESS
PI BERKELEY
PA 2100 MILVIA ST, STE 300, BERKELEY, CA 94704 USA
SN 1021-9498
EI 
J9 J FOOD DRUG ANAL
JI J. Food Drug Anal.
PD JAN 15
PY 2018
VL 26
IS 1
BP 1
EP 13
DI 10.1016/j.jfda.2017.10.010
PG 13
WC Food Science & Technology; Pharmacology & Pharmacy
SC Food Science & Technology; Pharmacology & Pharmacy
GA GD1FN
UT WOS:000430245600001
PM 29389543
DA 2025-04-28
ER

PT J
AU Hjelmesæth, J
   Åsberg, A
   Andersson, S
   Sandbu, R
   Robertsen, I
   Johnson, LK
   Angeles, PC
   Hertel, JK
   Skovlund, E
   Heijer, M
   Ek, AL
   Krogstad, V
   Karlsen, TI
   Christensen, H
   Andersson, TB
   Karlsson, C
AF Hjelmesaeth, Joran
   Asberg, Anders
   Andersson, Shalini
   Sandbu, Rune
   Robertsen, Ida
   Johnson, Line Kristin
   Angeles, Philip Carlo
   Hertel, Jens Kristoffer
   Skovlund, Eva
   Heijer, Maria
   Ek, Anna-Lena
   Krogstad, Veronica
   Karlsen, Tor-Ivar
   Christensen, Hege
   Andersson, Tommy B.
   Karlsson, Cecilia
TI Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for an open, non-randomised, three-armed single centre study (COCKTAIL)
SO BMJ OPEN
LA English
DT Article
ID beta-cell function; quality-of-life; bariatric surgery; systemic exposure; obesity; pharmacokinetics; inflammation; atorvastatin; disposition; enzymes
AB Introduction Roux-en-Y gastric bypass (GBP) is associated with changes in cardiometabolic risk factors and bioavailability of drugs, but whether these changes are induced by calorie restriction, the weight loss or surgery per se, remains uncertain. The COCKTAIL study was designed to disentangle the short-term (6 weeks) metabolic and pharmacokinetic effects of GBP and a very low energy diet (VLED) by inducing a similar weight loss in the two groups. Methods and analysis This open, non-randomised, three-armed, single-centre study is performed at a tertiary care centre in Norway. It aims to compare the short-term (6 weeks) and long-term (2 years) effects of GBP and VLED on, first, bioavailability and pharmacokinetics (24 hours) of probe drugs and biomarkers and, second, their effects on metabolism, cardiometabolic risk factors and biomarkers. The primary outcomes will be measured as changes in: (1) all six probe drugs by absolute bioavailability area under the curve (AUC(oral)/AUC(iv)) of midazolam (CYP3A4 probe), systemic exposure (AUC(oral)) of digoxin and rosuvastatin and drug:metabolite ratios for omeprazole, losartan and caffeine, levels of endogenous CYP3A biomarkers and genotypic variation, changes in the expression and activity data of the drug-metabolising, drug transport and drug regulatory proteins in biopsies from various organs and (2) body composition, cardiometabolic risk factors and metabolic biomarkers. Ethics and dissemination The COCKTAIL protocol was reviewed and approved by the Regional Committee for Medical and Health Research Ethics (Ref: 2013/2379/REK serest A). The results will be disseminated to academic and health professional audiences and the public via presentations at conferences, publications in peer-reviewed journals and press releases and provided to all participants.
C1 [Hjelmesaeth, Joran; Sandbu, Rune; Johnson, Line Kristin; Angeles, Philip Carlo; Hertel, Jens Kristoffer; Karlsen, Tor-Ivar] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway.
   [Hjelmesaeth, Joran] Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.
   [Asberg, Anders; Robertsen, Ida; Krogstad, Veronica; Christensen, Hege] Univ Oslo, Sch Pharm, Dept Pharmaceut Biosci, Oslo, Norway.
   [Asberg, Anders] Oslo Univ Hosp, Rikshosp, Dept Transplantat Med, Oslo, Norway.
   [Andersson, Shalini; Andersson, Tommy B.] AstraZeneca Gothenburg, IMED Biotech Unit, Drug Metab & Pharmacokinet, Cardiovasc Renal & Metab, Gothenburg, Sweden.
   [Skovlund, Eva] Norwegian Univ Sci & Technol, Dept Publ Hlth & Nursing, Trondheim, Norway.
   [Heijer, Maria; Ek, Anna-Lena] AstraZeneca Gothenburg, IMED Biotech Unit, Early Clin Dev, Study Operat, Gothenburg, Sweden.
   [Karlsen, Tor-Ivar] Univ Agder, Fac Hlth & Sports Sci, Kristiansand, Norway.
   [Andersson, Tommy B.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Pharmacogenet, Stockholm, Sweden.
   [Karlsson, Cecilia] AstraZeneca Gothenburg, IMED Biotech Unit, Cardiovasc Renal & Metab Translat Med Unit, Early Clin Dev, Gothenburg, Sweden.
   [Karlsson, Cecilia] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden.
C3 University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; AstraZeneca; Norwegian University of Science & Technology (NTNU); AstraZeneca; University of Agder; Karolinska Institutet; AstraZeneca; University of Gothenburg
RP Hjelmesæth, J (corresponding author), Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway.; Hjelmesæth, J (corresponding author), Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.
EM joran.hjelmeseth@siv.no
FU Vestfold Hospital Trust, Tonsberg, Norway; School of Pharmacy, University of Oslo, Oslo, Norway; AstraZeneca Gothenburg, Sweden; Vestfold Hospital Trust
CR Abdelaal M, 2017, ANN TRANSL MED, V5, P0, DOI 10.21037/atm.2017.03.107
   Abete I, 2010, NUTR REV, V68, P214, DOI 10.1111/j.1753-4887.2010.00280.x
   Barbarroja N, 2010, BIOCHEM J, V430, P141, DOI 10.1042/BJ20100285
   Bock KW, 2014, BIOCHEM PHARMACOL, V90, P1, DOI 10.1016/j.bcp.2014.04.009
   Boullata JI, 2010, P NUTR SOC, V69, P543, DOI 10.1017/S0029665110001990
   Bradley D, 2014, OBESITY, V22, P2026, DOI 10.1002/oby.20803
   Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3
   Brethauer SA, 2011, SURG ENDOSC, V25, P2650, DOI 10.1007/s00464-011-1620-6
   Brill MJE, 2014, CLIN PHARMACOKINET, V53, P931, DOI 10.1007/s40262-014-0166-x
   Brill MJE, 2012, CLIN PHARMACOKINET, V51, P277, DOI 10.2165/11599410-000000000-00000
   Brunes A, 2013, SOC PSYCH PSYCH EPID, V48, P745, DOI 10.1007/s00127-012-0594-6
   Buechler C, 2011, CURR DRUG METAB, V12, P24, DOI 10.2174/138920011794520035
   Cappelleri JC, 2009, INT J OBESITY, V33, P611, DOI 10.1038/ijo.2009.74
   Chan LN, 2015, PHARMACOTHERAPY, V35, P361, DOI 10.1002/phar.1560
   Cheng PY, 2001, CURR DRUG METAB, V2, P165, DOI 10.2174/1389200013338676
   Christensen M, 2003, CLIN PHARMACOL THER, V73, P517, DOI 10.1016/S0009-9236(03)00050-X
   Clarke JD, 2012, EXPERT OPIN DRUG MET, V8, P349, DOI 10.1517/17425255.2012.656087
   Darwich AS, 2013, CPT-PHARMACOMET SYST, V2, P0, DOI 10.1038/psp.2013.23
   Darwich AS, 2012, BRIT J CLIN PHARMACO, V74, P774, DOI 10.1111/j.1365-2125.2012.04284.x
   DeFronzo RA, 2011, DIABETES CARE, V34, P789, DOI 10.2337/dc11-0064
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Edwards A, 2012, ANN PHARMACOTHER, V46, P130, DOI 10.1345/aph.1Q414
   Ferrannini E, 2009, DIABETES CARE, V32, P514, DOI 10.2337/dc08-1762
   Foo J, 2011, OBES SURG, V21, P1914, DOI 10.1007/s11695-011-0527-6
   Gandhi A, 2012, CURR DRUG METAB, V13, P1327, DOI 10.2174/138920012803341302
   Garaulet M, 2013, INT J OBESITY, V37, P604, DOI 10.1038/ijo.2012.229
   Arno AG, 2017, OBES SURG, V27, P3194, DOI 10.1007/s11695-017-2745-z
   GREENBLATT DJ, 1984, ANESTHESIOLOGY, V61, P27, DOI 10.1097/00000542-198461010-00006
   Hachon L, 2017, OBES SURG, V27, P1076, DOI 10.1007/s11695-016-2535-z
   Hamad GG, 2012, AM J PSYCHIAT, V169, P256, DOI 10.1176/appi.ajp.2011.11050719
   Hamilton R, 2013, J ANTIMICROB CHEMOTH, V68, P666, DOI 10.1093/jac/dks431
   Hanley MJ, 2010, CLIN PHARMACOKINET, V49, P71, DOI 10.2165/11318100-000000000-00000
   Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4
   Illán-Gómez F, 2012, OBES SURG, V22, P950, DOI 10.1007/s11695-012-0643-y
   Jackness C, 2013, DIABETES, V62, P3027, DOI 10.2337/db12-1762
   Jakobsen GS, 2013, SURG ENDOSC, V27, P2094, DOI 10.1007/s00464-012-2716-3
   Jiao J, 2013, DIABETES, V62, P1074, DOI 10.2337/db12-0681
   Karlsson J, 2000, INT J OBESITY, V24, P1715, DOI 10.1038/sj.ijo.0801442
   Kasukawa T, 2012, P NATL ACAD SCI USA, V109, P15036, DOI 10.1073/pnas.1207768109
   Kissane NA, 2011, BEST PRACT RES-CLIN, V25, P11, DOI 10.1016/j.bpa.2011.01.001
   Kolotkin RL, 2001, OBES RES, V9, P102, DOI 10.1038/oby.2001.13
   Levi F, 1997, LANCET, V350, P681, DOI 10.1016/S0140-6736(97)03358-8
   Lingvay I, 2013, DIABETES CARE, V36, P2741, DOI 10.2337/dc12-2316
   Lloret-Linares C, 2017, EXPERT OPIN DRUG MET, V13, P493, DOI 10.1080/17425255.2017.1290796
   Lloret-Linares C, 2014, CLIN PHARMACOKINET, V53, P919, DOI 10.1007/s40262-014-0163-0
   Münzberg H, 2015, OBES REV, V16, P77, DOI 10.1111/obr.12258
   Nguyen NT, 2017, NAT REV GASTRO HEPAT, V14, P160, DOI 10.1038/nrgastro.2016.170
   Niero M, 2002, CLIN THER, V24, P690, DOI 10.1016/S0149-2918(02)85144-X
   Padwal RS, 2012, J ANTIMICROB CHEMOTH, V67, P2203, DOI 10.1093/jac/dks177
   Padwal RS, 2011, DIABETES CARE, V34, P1295, DOI 10.2337/dc10-2140
   Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552
   Patrick DL, 2004, OBES RES, V12, P48, DOI 10.1038/oby.2004.8
   Rendic S, 2010, CURR DRUG METAB, V11, P4, DOI 10.2174/138920010791110917
   Rogers CC, 2008, CLIN TRANSPLANT, V22, P281, DOI 10.1111/j.1399-0012.2007.00783.x
   Rubino F, 2006, ANN SURG, V244, P741, DOI 10.1097/01.sla.0000224726.61448.1b
   Shah RR, 2015, DRUG METAB DISPOS, V43, P400, DOI 10.1124/dmd.114.061093
   Skottheim IB, 2010, CLIN PHARMACOL THER, V87, P699, DOI 10.1038/clpt.2010.32
   Skottheim IB, 2009, CLIN PHARMACOL THER, V86, P311, DOI 10.1038/clpt.2009.82
   Spaggiari D, 2016, TOXICOL APPL PHARM, V302, P41, DOI 10.1016/j.taap.2016.04.013
   Stein J, 2014, ALIMENT PHARM THER, V40, P582, DOI 10.1111/apt.12872
   Summa KC, 2014, ADV NUTR, V5, P312S, DOI 10.3945/an.113.005132
   Tandra S, 2013, ANN SURG, V258, P262, DOI 10.1097/SLA.0b013e31827a0e82
   Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011
   Ulvestad M, 2013, CLIN PHARMACOL THER, V93, P275, DOI 10.1038/clpt.2012.261
   WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002
   Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008
   Zhou SF, 2008, CURR DRUG METAB, V9, P310, DOI 10.2174/138920008784220664
NR 67
TC 19
Z9 19
U1 0
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
EI 
J9 BMJ OPEN
JI BMJ Open
PD MAY 15
PY 2018
VL 8
IS 5
BP 
EP 
DI 10.1136/bmjopen-2018-021878
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA GJ7KZ
UT WOS:000435567200177
PM 29844102
DA 2025-04-28
ER

PT J
AU Ma, LY
   Sun, ZH
   Zeng, YW
   Luo, MC
   Yang, JZ
AF Ma, Luyao
   Sun, Zhenghai
   Zeng, Yawen
   Luo, Mingcan
   Yang, Jiazhen
TI Molecular Mechanism and Health Role of Functional Ingredients in Blueberry for Chronic Disease in Human Beings
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE blueberry; functional ingredients; chronic disease; functional food
ID induced oxidative stress; vaccinium-corymbosum l.; freeze-dried strawberry; killer-cell counts; antioxidant activity; insulin-resistance; bioactive compounds; arterial stiffness; alpha-glucosidase; gut microbiota
AB Functional ingredients in blueberry have the best health benefits. To obtain a better understanding of the health role of blueberry in chronic disease, we conducted systematic preventive strategies for functional ingredients in blueberry, based on comprehensive databases, especially PubMed, ISI Web of Science, and CNKI for the period 2008-2018. Blueberry is rich in flavonoids (mainly anthocyanidins), polyphenols (procyanidin), phenolic acids, pyruvic acid, chlorogenic acid, and others, which have anticancer, anti-obesity, prevent degenerative diseases, anti-inflammation, protective properties for vision and liver, prevent heart diseases, antidiabetes, improve brain function, protective lung properties, strong bones, enhance immunity, prevent cardiovascular diseases, and improve cognitive decline. The anthocyanins and polyphenols in blueberry are major functional ingredients for preventive chronic disease. These results support findings that blueberry may be one of the best functional fruits, and further reveals the mechanisms of anthocyanins and polyphenols in the health role of blueberry for chronic disease. This paper may be used as scientific evidence for developing functional foods, nutraceuticals, and novel drugs of blueberry for preventive chronic diseases.
C1 [Ma, Luyao; Sun, Zhenghai] Southwest Forestry Univ, Econ & Management Coll, Kunming 650224, Yunnan, Peoples R China.
   [Ma, Luyao; Sun, Zhenghai; Luo, Mingcan] Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilisat Sou, Minist Educ, Kunming 650224, Yunnan, Peoples R China.
   [Zeng, Yawen; Yang, Jiazhen] Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Kunming 650205, Yunnan, Peoples R China.
C3 Southwest Forestry University - China; Southwest Forestry University - China; Yunnan Academy of Agricultural Sciences
RP Sun, ZH (corresponding author), Southwest Forestry Univ, Econ & Management Coll, Kunming 650224, Yunnan, Peoples R China.; Sun, ZH (corresponding author), Southwest Forestry Univ, Key Lab Forest Resources Conservat & Utilisat Sou, Minist Educ, Kunming 650224, Yunnan, Peoples R China.; Zeng, YW (corresponding author), Yunnan Acad Agr Sci, Biotechnol & Germplasm Resources Inst, Kunming 650205, Yunnan, Peoples R China.
EM ma403294928@163.com; sunzhenghai1978@163.com; zengyw1967@126.com; lmc1961@sohu.com; yangjiazhen415@163.com
FU Science and Technology to Benefit the People from Yunnan Provincial Scientific and Technology Department [2014RA060]; scientific research foundation of Yunnan Provincial Department of Education [2017YJS091]; China Agriculture Research System [CARS-05]
CR Adams LS, 2010, CANCER RES, V70, P3594, DOI 10.1158/0008-5472.CAN-09-3565
   Ahrén IL, 2015, CLIN NUTR, V34, P719, DOI 10.1016/j.clnu.2014.08.009
   Unknown -, 2017, NUTR NEUROSCI, V0, P0
   Aranaz P, 2017, FOOD FUNCT, V8, P3999, DOI 10.1039/c7fo00996h
   Ayoub M, 2016, FOOD CHEM, V197, P221, DOI 10.1016/j.foodchem.2015.10.107
   Baba AB, 2017, FOOD CHEM TOXICOL, V109, P534, DOI 10.1016/j.fct.2017.09.054
   Bell L, 2017, FOOD FUNCT, V8, P3104, DOI 10.1039/c7fo00724h
   Ben Lagha A, 2018, BMC COMPLEM ALTERN M, V18, P0, DOI 10.1186/s12906-017-2072-x
   Ben Lagha A, 2015, J AGR FOOD CHEM, V63, P6999, DOI 10.1021/acs.jafc.5b01525
   Bensalem J, 2018, J NUTR SCI, V7, P0, DOI 10.1017/jns.2018.10
   Bobinaite R, 2015, J FOOD SCI TECH MYS, V52, P5898, DOI 10.1007/s13197-014-1668-0
   Bowtell JL, 2017, APPL PHYSIOL NUTR ME, V42, P773, DOI 10.1139/apnm-2016-0550
   Bunea A, 2013, PHYTOCHEMISTRY, V95, P436, DOI 10.1016/j.phytochem.2013.06.018
   Cásedas G, 2018, FOOD CHEM TOXICOL, V118, P572, DOI 10.1016/j.fct.2018.05.066
   Cásedas G, 2017, FOOD FUNCT, V8, P4187, DOI 10.1039/c7fo01205e
   Chen Chieh-fu, 2010, YAOXUE XUEBAO, V45, P422
   Chen GG, 2017, ONCOL REP, V38, P488, DOI 10.3892/or.2017.5675
   Chen Qi, 2014, YICHUAN, V36, P566, DOI 10.3724/SP.J.1005.2014.0566
   Chen YL, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/4196572
   Ciric A, 2018, BIOMED CHROMATOGR, V32, P0, DOI 10.1002/bmc.4150
   Çoban J, 2015, METAB BRAIN DIS, V30, P793, DOI 10.1007/s11011-014-9643-z
   Cocetta G, 2015, PHYSIOL PLANTARUM, V153, P269, DOI 10.1111/ppl.12243
   Correa-Betanzo J, 2014, FOOD CHEM, V165, P522, DOI 10.1016/j.foodchem.2014.05.135
   Cortez R, 2017, COMPR REV FOOD SCI F, V16, P180, DOI 10.1111/1541-4337.12244
   Cuevas A, 2013, NUTRIENTS, V5, P2314, DOI 10.3390/nu5072314
   Cutler BR, 2018, INT J CARDIOL, V261, P155, DOI 10.1016/j.ijcard.2018.03.027
   Davidson KT, 2018, PATHOL ONCOL RES, V24, P733, DOI 10.1007/s12253-017-0376-2
   DeFuria J, 2009, J NUTR, V139, P1510, DOI 10.3945/jn.109.105155
   Del Bo C, 2017, FOOD FUNCT, V8, P4108, DOI 10.1039/c7fo00861a
   Devareddy L, 2008, J NUTR BIOCHEM, V19, P694, DOI 10.1016/j.jnutbio.2007.09.004
   Diaconeasa Z, 2015, INT J MOL SCI, V16, P2352, DOI 10.3390/ijms16022352
   Elks CM, 2015, OBESITY, V23, P573, DOI 10.1002/oby.20926
   Faria A, 2010, PHYTOTHER RES, V24, P1862, DOI 10.1002/ptr.3213
   Ferlemi AV, 2015, NEUROCHEM RES, V40, P2280, DOI 10.1007/s11064-015-1718-7
   Fragua V, 2017, J NUTR SCI, V6, P0, DOI 10.1017/jns.2017.33
   Garcia-Diaz DF, 2015, J MED FOOD, V18, P489, DOI 10.1089/jmf.2014.0039
   Gong P, 2014, ENVIRON TOXICOL PHAR, V37, P1015, DOI 10.1016/j.etap.2014.03.017
   Håkansson Å, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0033510
   Hong SM, 2018, J AGR FOOD CHEM, V66, P99, DOI 10.1021/acs.jafc.7b03965
   Huang WF, 2018, DIABET METAB SYND OB, V11, P357, DOI 10.2147/DMSO.S166728
   Huang WY, 2018, J AGR FOOD CHEM, V66, P1638, DOI 10.1021/acs.jafc.7b06135
   Huang WY, 2014, MOLECULES, V19, P12827, DOI 10.3390/molecules190812827
   Huang WY, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/1862462
   Ishida Y, 2014, WORLD J HEPATOL, V6, P870, DOI 10.4254/wjh.v6.i12.870
   Jeong HR, 2013, J MED FOOD, V16, P968, DOI 10.1089/jmf.2013.2881
   Johnson MH, 2011, J AGR FOOD CHEM, V59, P8923, DOI 10.1021/jf201720z
   Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001
   Kalt W, 2014, J AGR FOOD CHEM, V62, P11180, DOI 10.1021/jf503689c
   Kang J, 2015, PLANT FOOD HUM NUTR, V70, P56, DOI 10.1007/s11130-014-0461-6
   Kausar H, 2012, CANCER LETT, V325, P54, DOI 10.1016/j.canlet.2012.05.029
   Khanal RC, 2009, J FOOD SCI, V74, PH52, DOI 10.1111/j.1750-3841.2009.01063.x
   Kim JG, 2013, J ZHEJIANG UNIV-SC B, V14, P793, DOI 10.1631/jzus.B1300012
   Kim M, 2017, J CANCER PREV, V22, P174, DOI 10.15430/JCP.2017.22.3.174
   Koupy D, 2015, CES SLOV FARM, V64, P3
   Kraujalyte V, 2015, FOOD CHEM, V188, P583, DOI 10.1016/j.foodchem.2015.05.031
   Krikorian R, 2010, J AGR FOOD CHEM, V58, P3996, DOI 10.1021/jf9029332
   Lasekan O, 2014, CURR OPIN CLIN NUTR, V17, P589, DOI 10.1097/MCO.0000000000000109
   Lee In-Chul, 2014, J CANCER PREV, V19, P209, DOI 10.15430/JCP.2014.19.3.209
   Lee SG, 2015, PLANT FOOD HUM NUTR, V70, P427, DOI 10.1007/s11130-015-0514-5
   Lee SG, 2015, J MED FOOD, V18, P476, DOI 10.1089/jmf.2013.0182
   Lee S, 2018, J NUTR, V148, P209, DOI 10.1093/jn/nxx027
   Lee YM, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9101089
   Lewis ED, 2018, BRIT J NUTR, V119, P1393, DOI 10.1017/S0007114518001034
   Li B, 2015, J FOOD SCI TECH MYS, V52, P5228, DOI 10.1007/s13197-014-1611-4
   Li CY, 2013, J AGR FOOD CHEM, V61, P523, DOI 10.1021/jf3046158
   Li HQ, 2020, NUTR NEUROSCI, V23, P75, DOI 10.1080/1028415X.2018.1471251
   Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021
   Lin WM, 2017, ONCOL LETT, V13, P4897, DOI 10.3892/ol.2017.6094
   Lin Z, 2016, FOOD CHEM, V194, P986, DOI 10.1016/j.foodchem.2015.08.113
   Liu FH, 2015, FOOD CHEM, V188, P399, DOI 10.1016/j.foodchem.2015.05.036
   Liu J, 2015, J FOOD SCI TECH MYS, V52, P3022, DOI 10.1007/s13197-014-1379-6
   Liu YX, 2015, J AGR FOOD CHEM, V63, P9295, DOI 10.1021/acs.jafc.5b04341
   Liu YX, 2011, J AGR FOOD CHEM, V59, P12254, DOI 10.1021/jf203136j
   Liu YX, 2011, J AGR FOOD CHEM, V59, P356, DOI 10.1021/jf103852s
   Liu YN, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0127813
   Louis XL, 2014, FOOD FUNCT, V5, P1785, DOI 10.1039/c3fo60588d
   Lu Shuang, 2012, ZHONGHUA GAN ZANG BING ZA ZHI, V20, P497, DOI 10.3760/cma.j.issn.1007-3418.2012.07.004
   Ma H, 2018, INT J MOL SCI, V19, P0, DOI 10.3390/ijms19020461
   Marhuenda J, 2016, J CHEM-NY, V2016, P0, DOI 10.1155/2016/5194901
   Maulik M, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-26905-4
   McAnulty LS, 2014, NUTR RES, V34, P577, DOI 10.1016/j.nutres.2014.07.002
   McAnulty LS, 2011, APPL PHYSIOL NUTR ME, V36, P976, DOI 10.1139/H11-120
   McGill CM, 2018, INT. J. BIOPHARM. SCI, V1, P0
   McNamara RK, 2018, NEUROBIOL AGING, V64, P147, DOI 10.1016/j.neurobiolaging.2017.12.003
   Milbury PE, 2010, J AGR FOOD CHEM, V58, P3950, DOI 10.1021/jf903529m
   Miller MG, 2018, EUR J NUTR, V57, P1169, DOI 10.1007/s00394-017-1400-8
   Minker C, 2015, OXID MED CELL LONGEV, V2015, P0, DOI 10.1155/2015/154164
   Moghe SS, 2012, J MED FOOD, V15, P448, DOI 10.1089/jmf.2011.0234
   Nair AR, 2017, FOOD FUNCT, V8, P4118, DOI 10.1039/C7FO00815E
   Nair AR, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0111976
   Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012
   Nemes-Nagy E, 2008, ACTA PHYSIOL HUNG, V95, P383, DOI 10.1556/APhysiol.95.2008.4.5
   Oh DR, 2018, AM J CHINESE MED, V46, P357, DOI 10.1142/S0192415X18500180
   Ozcelik E, 2014, PHARMACOGN MAG, V10, P217, DOI 10.4103/0973-1296.133234
   Pertuzatti PB, 2014, FOOD CHEM, V164, P81, DOI 10.1016/j.foodchem.2014.04.114
   Poulose SM, 2014, BRAIN RES, V1593, P9, DOI 10.1016/j.brainres.2014.10.028
   Rahal OM, 2013, CARCINOGENESIS, V34, P464, DOI 10.1093/carcin/bgs353
   Ravoori S, 2012, J AGR FOOD CHEM, V60, P5547, DOI 10.1021/jf205325p
   Ren TT, 2014, OXID MED CELL LONGEV, V2014, P0, DOI 10.1155/2014/469059
   Reyes-Farias M, 2015, J MED FOOD, V18, P601, DOI 10.1089/jmf.2014.0031
   Rowland LJ, 2012, BMC PLANT BIOL, V12, P0, DOI 10.1186/1471-2229-12-46
   Senevirathne M, 2010, NUTR RES PRACT, V4, P183, DOI 10.4162/nrp.2010.4.3.183
   Shi DZ, 2017, J IMMUNOL RES, V2017, P0, DOI 10.1155/2017/5476903
   Skrovankova S, 2015, INT J MOL SCI, V16, P24673, DOI 10.3390/ijms161024673
   Song Y, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069925
   Srovnalova A, 2014, J AGR FOOD CHEM, V62, P789, DOI 10.1021/jf404643w
   Sun JC, 2018, FOOD CHEM TOXICOL, V120, P491, DOI 10.1016/j.fct.2018.07.048
   Sun XY, 2015, MOLECULES, V20, P3841, DOI 10.3390/molecules20033841
   Tan L, 2014, BIOMED ENVIRON SCI, V27, P186, DOI 10.3967/bes2014.007
   Uysal U, 2013, CURR PHARM DESIGN, V19, P6094, DOI 10.2174/1381612811319340004
   Vendrame S, 2015, J MED FOOD, V18, P619, DOI 10.1089/jmf.2014.0065
   Vendrame S, 2014, BRIT J NUTR, V111, P194, DOI 10.1017/S0007114513002390
   Vendrame S, 2013, J NUTR BIOCHEM, V24, P1508, DOI 10.1016/j.jnutbio.2012.12.010
   Wang EL, 2017, FOOD NUTR RES, V61, P0, DOI 10.1080/16546628.2017.1325308
   Wang Y, 2015, J SCI FOOD AGR, V95, P936, DOI 10.1002/jsfa.6765
   Wang YP, 2010, HEPATOB PANCREAT DIS, V9, P164
   Whyte AR, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10060660
   Williams CM, 2008, FREE RADICAL BIO MED, V45, P295, DOI 10.1016/j.freeradbiomed.2008.04.008
   Wiseman W, 2011, CAN J PHYSIOL PHARM, V89, P67, DOI 10.1139/Y10-101
   Wu T, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/4051232
   Wu T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077585
   Wu Y, 2017, FOOD RES INT, V100, P312, DOI 10.1016/j.foodres.2017.07.004
   Xu N, 2017, FRONT PHARMACOL, V8, P0, DOI 10.3389/fphar.2017.00853
   Yan XR, 2015, J SURG RES, V199, P592, DOI 10.1016/j.jss.2015.06.013
   Zeng YW, 2018, OXID MED CELL LONGEV, V2018, P0, DOI 10.1155/2018/3232080
   Zeng YW, 2017, EVID-BASED COMPL ALT, V2017, P0, DOI 10.1155/2017/9402849
   Zeng YW, 2015, BIOMED RES INT, V2015, P0, DOI 10.1155/2015/497934
   Zhan W, 2017, ONCOTARGET, V8, P96761, DOI 10.18632/oncotarget.17842
   Zhang CY, 2017, J HORTIC SCI BIOTECH, V92, P57, DOI 10.1080/14620316.2016.1224604
   Zhang J, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0024486
   Zhao MY, 2015, FOOD FUNCT, V6, P3006, DOI 10.1039/c5fo00408j
   Zhao MY, 2015, J FOOD SCI, V80, PH869, DOI 10.1111/1750-3841.12815
   Zhou F, 2018, FOOD RES INT, V107, P509, DOI 10.1016/j.foodres.2018.02.071
   Zhu Juan-Juan, 2017, SICHUAN DA XUE XUE BAO YI XUE BAN, V48, P203
   Zu XY, 2010, CHINESE MED J-PEKING, V123, P2714, DOI 10.3760/cma.j.issn.0366-6999.2010.19.018
NR 139
TC 102
Z9 107
U1 15
U2 115
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD SEP 15
PY 2018
VL 19
IS 9
BP 
EP 
DI 10.3390/ijms19092785
PG 19
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HA1OU
UT WOS:000449988100321
PM 30223619
DA 2025-04-28
ER

PT J
AU Wong, THT
   Sui, ZX
   Rangan, A
   Louie, JCY
AF Wong, Tommy Hon Ting
   Sui, Zhixian
   Rangan, Anna
   Louie, Jimmy Chun Yu
TI Discrepancy in socioeconomic status does not fully explain the variation in diet quality between consumers of different coffee types
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee type; Diet quality; Sugar; Australia; Coffee additive; Coffee
ID dose-response metaanalysis; cardiovascular-disease; diabetes-mellitus; consumption; risk; adults; health; mortality; obesity; cancer
AB Purpose Habitual consumers of different coffee types may vary in socioeconomic status (SES), which is an important determinant of diet quality. Nonetheless, research on diet quality among coffee consumers was scarce. We aimed to compare the diet quality of coffee consumers with different preferences towards coffee type and additive usage. Methods In this cross-sectional analysis, intake data of food, coffee, and additive usage from the adult respondents of the 2011-2012 Australian Health Survey were used. Participants were grouped according to the type of coffee (espresso and ground coffee, E & G; coffee made from coffee mixes and instant coffee, M & I; non-consumers, NC) and additives (milk, sugar, and intense sweetener) consumed. Adjusted food group intake was compared between consumption groups using general linear model. Results E&G drinkers had better SES than M&I and NC. After adjusting for covariates, the mean dairy intake of E&G drinkers was 22.2% higher than M&I drinkers (p < 0.001) and 33.1% higher than NC (p < 0.001). Mean discretionary food intake of E&G drinkers was 12.1% lower than M&I (p = 0.003) and 12.3% lower than NC (p = 0.001). In terms of additive usage, non-users of coffee additive had the lowest dairy food intake and the highest discretionary food intake. Conclusions Coffee consumers' different preferences towards coffee type and additive usages reflected significant variations in their diet quality, even after adjustment of SES. Therefore, future epidemiological studies should consider separating coffee drinkers according to their habitual consumption of different types of coffee.
C1 [Wong, Tommy Hon Ting; Louie, Jimmy Chun Yu] Univ Hong Kong, Sch Biol Sci, Fac Sci, 5S-14 Kadoorie Biol Sci Bldg,1 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.
   [Sui, Zhixian; Rangan, Anna; Louie, Jimmy Chun Yu] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW, Australia.
C3 University of Hong Kong; University of Sydney
RP Louie, JCY (corresponding author), Univ Hong Kong, Sch Biol Sci, Fac Sci, 5S-14 Kadoorie Biol Sci Bldg,1 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.; Louie, JCY (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Camperdown, NSW, Australia.
EM jimmyl@hku.hk
CR Agriculture and Agri-Food Canada, 2013, 11965E AAFC INT MARK, V0, P0
   An RP, 2016, J ACAD NUTR DIET, V116, P28, DOI 10.1016/j.jand.2015.08.009
   Unknown -, 2013, AUSTR DIET GUID, V0, P0
   Unknown -, 2011, AUSTR STAND GEOGR CL, V0, P0
   Unknown -, 2011, CENSUS POPULATION HO, V0, P0
   Australian Bureau of Statistics, 2013, AUSTRALIAN HEALTH SURVEY: USERS GUIDE, V0, P0
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Crippa A, 2014, AM J EPIDEMIOL, V180, P763, DOI 10.1093/aje/kwu194
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Drewnowski A, 2004, AM J PREV MED, V27, P154, DOI 10.1016/j.amepre.2004.06.011
   Drewnowski A, 2014, NUTRIENTS, V6, P4389, DOI 10.3390/nu6104389
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Galobardes B, 2001, INT J EPIDEMIOL, V30, P334, DOI 10.1093/ije/30.2.334
   Grioni S, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0126550
   Gyntelberg F, 2009, INT J FOOD SCI NUTR, V60, P56, DOI 10.1080/09637480802668471
   Harttig U, 2011, EUR J CLIN NUTR, V65, PS87, DOI 10.1038/ejcn.2011.92
   Heuer T, 2015, BRIT J NUTR, V113, P1603, DOI 10.1017/S0007114515000744
   Jiang XB, 2014, EUR J NUTR, V53, P25, DOI 10.1007/s00394-013-0603-x
   Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   OConnor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1
   Pampel FC, 2010, ANNU REV SOCIOL, V36, P349, DOI 10.1146/annurev.soc.012809.102529
   Rayner M, 2005, J EPIDEMIOL COMMUN H, V59, P1054, DOI 10.1136/jech.2005.036491
   Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086
   SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373
   Thompson FE, 2015, J ACAD NUTR DIET, V115, P1986, DOI 10.1016/j.jand.2015.08.016
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
NR 29
TC 14
Z9 14
U1 0
U2 10
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD SEP 15
PY 2018
VL 57
IS 6
BP 2123
EP 2131
DI 10.1007/s00394-017-1488-x
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GQ7KL
UT WOS:000441919500009
PM 28638993
DA 2025-04-28
ER

PT J
AU Gebremariam, LW
   Aoyama, A
   Kahsay, AB
   Hirakawa, Y
   Chiang, CF
   Yatsuya, H
   Matsuyama, A
AF Gebremariam, Lemlem Weldegerima
   Aoyama, Atsuko
   Kahsay, Alemayehu Bayray
   Hirakawa, Yoshihisa
   Chiang, Chifa
   Yatsuya, Hiroshi
   Matsuyama, Akiko
TI Perception and practice of 'healthy' diet in relation to noncommunicable diseases among the urban and rural people in northern Ethiopia: a community-based qualitative study
SO NAGOYA JOURNAL OF MEDICAL SCIENCE
LA English
DT Article
DE noncornmunicable diseases; Northern Ethiopia; dietary habit; habitual practice; qualitative study
ID addis-ababa; consumption; nutrition; barriers; overweight; prevention; burden
AB Dietary habits are related to the risks of noncommunicable diseases (NCDs). such as cardiovascular disease and diabetes, of which burdens are increasing in low-income countries including Ethiopia. Although several epidemiological studies of NCD risk factors were conducted in Ethiopia, qualitative studies on people's dietary habit in relation to NCDs have not been conducted yet. This study aims to describe people's perception and practice of 'healthy' diet, and barriers to practice 'healthy' diet, paying attention to the dynamics between the perception and practice. We conducted 16 key informant interviews and eight focus group discussions in an urban and a rural areas in northern Ethiopia between November 2014 and January 2016. Audio-records in local language were transcribed word-for-word, and translated into English. English text data were analyzed qualitatively, through constant comparative analysis following the principles of the grounded theory. Three themes have emerged: (1) dietary habit perceived as 'good' or 'bad' for health; (2) reasons for continuing current 'unhealthy' dietary habit; and (3) current dietary habit perceived as 'traditional.' People's practice was mostly consistent with their perception, while they sometimes practiced contrary to the perception because of personal preference and physical or financial obstacles. People were often indifferent of health implications of their habitual dietary practice, such as drinking a lot of sweet coffee. We showed dynamics between perception and practice of 'healthy' diet among people in northern Ethiopia. It is needed to increase awareness of NCDs both among the urban and rural people and to improve the social environment for removing the obstacles.
C1 [Gebremariam, Lemlem Weldegerima; Aoyama, Atsuko; Hirakawa, Yoshihisa; Chiang, Chifa; Yatsuya, Hiroshi; Matsuyama, Akiko] Nagoya Univ, Sch Med, Dept Publ Hlth & Hlth Syst, Nagoya, Aichi, Japan.
   [Kahsay, Alemayehu Bayray] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia.
   [Yatsuya, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan.
C3 Nagoya University; Mekelle University; Fujita Health University
RP Aoyama, A (corresponding author), Nagoya Univ, Sch Med, Dept Publ Hlth & Hlth Syst, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.
EM atsukoa@med.nagoya-u.ac.jp
FU Tigray Provincial Health Bureau; Japan Society for the Promotion of Science [26293147]; Japan Agency for Medical Research and Development [16jk0110008h0102]; Mekelle University College of Health Sciences; Grants-in-Aid for Scientific Research [26293147] Funding Source: KAKEN
CR Abebe SM, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0125210
   Alemseged F, 2012, ETHIOP J HEALTH SCI, V22, P19
   Unknown -, 2013, NAT NUTR PROGR JUN 2, V0, P0
   Unknown -, 2008, SUMMARY AND STATISTICAL REPORT OF THE 2007 POPULATION AND HOUSING CENSUS-POPULATION SIZE BY AGE AND SEX, V0, P0
   Unknown -, 2017, WORLD DEVELOPMENT INDICATORS 2017, V0, P0, DOI DOI 10.1596/26447
   Unknown -, 2014, INT J INNOV PHARM SC, V0, P0
   Asgary R, 2014, AM J TROP MED HYG, V90, P153, DOI 10.4269/ajtmh.13-0215
   Barsness RE, 2018, CORE COMPETENCIES RE, V1st, P0
   Block JP, 2013, J ADOLESCENT HEALTH, V52, P702, DOI 10.1016/j.jadohealth.2012.11.017
   Boeije H, 2002, QUAL QUANT, V36, P391, DOI 10.1023/A:1020909529486
   Burton S, 2015, J BUS RES, V68, P2067, DOI 10.1016/j.jbusres.2015.03.004
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Daivadanam M, 2015, BMC PUBLIC HEALTH, V15, P0, DOI 10.1186/s12889-015-1880-5
   Dito BB, 2015, FEM ECON, V21, P168, DOI 10.1080/13545701.2015.1007073
   Ethiopian Public Health Institute, 2016, ETHIOPIA STEPS REPORT ON RISK FACTORS FOR NONCOMMUNICABLE DISEASES AND PREVALENCE OF SELECTED NCDS, V0, P0
   Farahmand M, 2015, APPETITE, V89, P291, DOI 10.1016/j.appet.2015.02.025
   Ferzacca S, 2013, APPETITE, V69, P156, DOI 10.1016/j.appet.2013.05.021
   Glaser BG, 2002, INT J QUAL METHODS, V1, P23, DOI 10.1177/160940690200100203
   Land MA, 2016, BMC PUBLIC HEALTH, V16, P0, DOI 10.1186/s12889-016-3064-3
   Langdon EJ, 2010, REV LAT-AM ENFERM, V18, P459, DOI 10.1590/S0104-11692010000300023
   Lazarou C, 2010, INT J FOOD SCI NUTR, V61, P739, DOI 10.3109/09637481003769782
   Maher D, 2012, GLOBALIZATION HEALTH, V8, P0, DOI 10.1186/1744-8603-8-14
   Matenge STP, 2012, AFRICAN JOURNAL OF AGRICULTURAL RESEARCH, V7, P2243
   Metta E, 2015, BMC PUBLIC HEALTH, V15, P0, DOI 10.1186/s12889-015-1504-0
   Mook K, 2016, PREV CHRONIC DIS, V13, P0, DOI 10.5888/pcd13.150402
   Morcos N Y, 2013, INTERNATIONAL JOURNAL OF NUTRITION, V0, P0
   Moser A, 2017, EUR J GEN PRACT, V24, P0, DOI 10.1080/13814788.2017.1375091
   Mukherjea A, 2013, FAM COMMUNITY HEALTH, V36, P311, DOI 10.1097/FCH.0b013e31829d2549
   Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61729-2
   Nakagawa Hideaki, 2004, ENVIRON HEALTH PREV MED, V9, P123, DOI 10.1007/BF02898090
   Ng SW, 2011, EUR J CLIN NUTR, V65, P1328, DOI 10.1038/ejcn.2011.135
   Oli N, 2014, GLOBAL HEALTH ACTION, V7, P0, DOI 10.3402/gha.v7.24023
   Persynaki A, 2017, NUTRITION, V35, P14, DOI 10.1016/j.nut.2016.10.005
   Reddy KS, 2004, PUBLIC HEALTH NUTR, V7, P167, DOI 10.1079/PHN2003587
   Scott A, 2013, HEALTH PROMOT INT, V28, P4, DOI 10.1093/heapro/das038
   Stead M, 2011, SOC SCI MED, V72, P1131, DOI 10.1016/j.socscimed.2010.12.029
   Tebekaw Y, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-1126
   Townsend N, 2017, HEALTH PROMOT INT, V32, P91, DOI 10.1093/heapro/dav056
   Trepanowski JF, 2010, NUTR J, V9, P0, DOI 10.1186/1475-2891-9-57
   Wagner MG, 2016, APPETITE, V100, P94, DOI 10.1016/j.appet.2016.02.002
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, V0, P1
   World Health Organization (WHO), 2014, UGANDA 2014 REPORT, V0, P0
   Yalew E, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-975
   Yilmaz B, 2017, JOURNAL OF ETHNIC FOODS, V4, P213, DOI 10.1016/j.jef.2017.11.003
   Zhang Y, 2016, NAGOYA J MED SCI, V78, P163
NR 48
TC 13
Z9 13
U1 0
U2 7
PU NAGOYA UNIV, SCH MED
PI NAGOYA
PA EDITORIAL OFF, NAGOYA UNIV MED LIB, SCH MED, 65 TSURUMAI-CHO SHOWA- KU, NAGOYA, 466-8550, JAPAN
SN 2186-3326
EI 0027-7622
J9 NAGOYA J MED SCI
JI Nagoya J. Med. Sci.
PD NOV 15
PY 2018
VL 80
IS 4
BP 451
EP 464
DI 10.18999/nagjms.80.4.451
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HC5QE
UT WOS:000451856700002
PM 30587860
DA 2025-04-28
ER

PT J
AU Björner, S
   Rosendahl, AH
   Tryggvadottir, H
   Simonsson, M
   Jirström, K
   Borgquist, S
   Rose, C
   Ingvar, C
   Jernström, H
AF Bjorner, Sofie
   Rosendahl, Ann H.
   Tryggvadottir, Helga
   Simonsson, Maria
   Jirstrom, Karin
   Borgquist, Signe
   Rose, Carsten
   Ingvar, Christian
   Jernstrom, Helena
TI Coffee Is Associated With Lower Breast Tumor Insulin-Like Growth Factor Receptor 1 Levels in Normal-Weight Patients and Improved Prognosis Following Tamoxifen or Radiotherapy Treatment
SO FRONTIERS IN ENDOCRINOLOGY
LA English
DT Article
DE coffee; insulin-like growth factor receptor 1; body mass index; breast cancer; prognosis
ID factor-i receptor; decaffeinated coffee; caffeinated coffee; estrogen-receptor; physical-activity; cancer patients; c-peptide; hormone; women; consumption
AB Coffee is associated with decreased breast cancer risk, but the impact of body mass index (BMI) in combination with coffee consumption on prognosis is unclear. The suppressive effect of coffee constituents on the insulin-like growth factor receptor 1 (IGF1R) levels in breast cancer cells may play a role. The aim was to investigate the prognostic impact of coffee consumption and possible associations with tumor specific IGF1R protein expression and BMI in a population-based cohort in Sweden, comprising 1,014 primary breast cancer patients without pretreatment enrolled 2002-2012 and followed for up to 13 years. Patients with higher coffee consumption had lower tumor IGF1R levels (P = 0.025), but only among the normal-weight patients (P = 0.005). Coffee did not impact the recurrence-risk overall. However, tamoxifen-treated patients with ER+ tumors drinking >= 2 cups of coffee/day had lower recurrence-risk [adjusted HR (HRadj,) 0.57, 95% Cl, 0.34-0.97] compared with patients with lower intake, although only among normal-weight patients (HRad, 0.37, 95% Cl: 0.17-0.78; P-interaction = 0.039). Similarly, coffee consumption >= 2 cups/day was associated with significantly lower recurrence-risk among the 640 radiotherapy-treated patients irrespective of BMI (HRad, 0.59, 95% Cl 0.36-0.98) and in the 296 normal-weight patients (HR,d, 0.36, 95% Cl 0.17-0.76) but not in the 329 overweight or obese patients (HRadj, 0.88, 95% Cl 0.42-1.82) although the interaction was not significant (P-interaction = 0.093). In conclusion, coffee consumption was negatively associated with tumor-specific IGF1R levels only among normal-weight patients. Though, IGF1R did not explain the association between coffee intake and improved prognosis among normal weight tamoxifen-or radiotherapy-treated patients. Studies of IGF1R-targeting therapies may benefit from taking BMI and coffee consumption into account.
C1 [Bjorner, Sofie; Rosendahl, Ann H.; Tryggvadottir, Helga; Simonsson, Maria; Jirstrom, Karin; Borgquist, Signe; Jernstrom, Helena] Lund Univ, Skane Univ Hosp, Fac Med, Dept Clin Sci Lund,Oncol & Pathol, Lund, Sweden.
   [Rose, Carsten] Lund Univ, Dept Immunotechnol, CREATE Hlth, Lund, Sweden.
   [Ingvar, Christian] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Surg, Lund, Sweden.
C3 Lund University; Skane University Hospital; Lund University; Lund University; Skane University Hospital
RP Jernström, H (corresponding author), Lund Univ, Skane Univ Hosp, Fac Med, Dept Clin Sci Lund,Oncol & Pathol, Lund, Sweden.
EM helena.jernstrom@med.lu.se
FU Swedish Cancer Society [CAN2014/465]; Mrs. Berta Kamprad Foundation [BKS19/2014, BKS27/2015]; Swedish Breast Cancer Group (BRO); South Swedish Health Care Region (Region Skane) [ALF 10622]; Lund Hospital Fund; RATHER consortium; Seventh Framework program
CR Bågeman E, 2008, CANCER EPIDEM BIOMAR, V17, P895, DOI 10.1158/1055-9965.EPI-07-0555
   Bertacca A, 2007, DIABETES RES CLIN PR, V78, P316, DOI 10.1016/j.diabres.2007.06.001
   Björner S, 2017, ONCOTARGET, V8, P9093, DOI 10.18632/oncotarget.14082
   Djordjevic Natasa, 2010, EUR J CLIN PHARMACOL, V66, P697, DOI 10.1007/s00228-010-0823-4
   Fan P, 2014, EUR J CANCER, V50, P2866, DOI 10.1016/j.ejca.2014.08.011
   Gapstur SM, 2017, CANCER EPIDEM BIOMAR, V26, P1477, DOI 10.1158/1055-9965.epi-17-0353
   Giri A, 2011, NUTRIENTS, V3, P937, DOI 10.3390/nu3110937
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Hawsawi Y, 2013, BBA-REV CANCER, V1836, P345, DOI 10.1016/j.bbcan.2013.10.005
   Iams WT, 2015, CLIN CANCER RES, V21, P4270, DOI 10.1158/1078-0432.CCR-14-2518
   Jernström H, 1999, J WOMEN HEALTH GEN-B, V8, P1265, DOI 10.1089/jwh.1.1999.8.1265
   Kakugawa Y, 2017, BREAST CANCER RES TR, V162, P115, DOI 10.1007/s10549-016-4094-3
   LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x
   Li XJ, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0052681
   Lipscombe LL, 2012, CANCER-AM CANCER SOC, V118, P2615, DOI 10.1002/cncr.26559
   Lodhia KA, 2015, FRONT ONCOL, V5, P0, DOI 10.3389/fonc.2015.00142
   McShane LM, 2005, NAT CLIN PRACT GASTR, V2, PA416, DOI 10.1038/ncponc0252
   Oh JK, 2015, INT J CANCER, V137, P1979, DOI 10.1002/ijc.29569
   Persson M, 2016, BRIT J CANCER, V115, P382, DOI 10.1038/bjc.2016.174
   Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215
   Rosendahl AH, 2015, CLIN CANCER RES, V21, P1877, DOI 10.1158/1078-0432.CCR-14-1748
   Simonsson M, 2013, CANCER CAUSE CONTROL, V24, P929, DOI 10.1007/s10552-013-0169-1
   Suga K, 2001, JPN J CANCER RES, V92, P127, DOI 10.1111/j.1349-7006.2001.tb01074.x
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yee D, 2000, J MAMMARY GLAND BIOL, V5, P107, DOI 10.1023/A:1009575518338
   Yee D, 2018, J MOL ENDOCRINOL, V61, PT61, DOI 10.1530/JME-17-0261
NR 26
TC 8
Z9 8
U1 1
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2392
EI 
J9 FRONT ENDOCRINOL
JI Front. Endocrinol.
PD JUN 6
PY 2018
VL 9
IS 
BP 
EP 
DI 10.3389/fendo.2018.00306
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA GI3JH
UT WOS:000434267100001
PM 29928262
DA 2025-04-28
ER

PT J
AU Furrer, AN
   Chegeni, M
   Ferruzzi, MG
AF Furrer, Amber N.
   Chegeni, Mohammad
   Ferruzzi, Mario G.
TI Impact of potato processing on nutrients, phytochemicals, and human health
SO CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
LA English
DT Review
DE Potatoes; nutritional quality; processing; phytochemicals
ID solanum-tuberosum l.; fleshed sweet-potato; in-vitro bioaccessibility; glycemic load values; resistant starch; beta-carotene; phenolic-compounds; chlorogenic acid; acrylamide formation; ipomoea-batatas
AB Potatoes (Solanum tuberosum) are an important global crop that can be transformed into many products impacting several health dimensions ranging from undernutrition, food security and disease prevention to issues of overnutrition including obesity, diabetes, heart disease. Processed potato products are typically categorized as high fat and sodium foods, as well as being classified as a significant source of carbohydrate, in the form of starch. Conversely, potato products are less known for their contribution of key micronutrients (vitamin C, potassium, magnesium), fiber, and phytochemicals (phenolics and carotenoids). More recent insight into the nutritional value of potatoes and the potential of potato phytochemicals to modulate oxidative and inflammatory stress as well as the potential to alter glycemic response has resulted in increased interest in strategies to improve and leverage the nutritional quality of processed potatoes. This review summarizes critical information on nutritional profiles of potatoes and their processed products and describes the state of the science relative to the influence of in-home and common commercial processing on nutritional quality and potential impacts on human health.
C1 [Furrer, Amber N.; Chegeni, Mohammad] Purdue Univ, Dept Food Sci, Smith Hall, W Lafayette, IN 47907 USA.
   [Ferruzzi, Mario G.] North Carolina State Univ, Plants Human Hlth Inst, Laureate Way, Kannapolis, NC 28081 USA.
C3 Purdue University System; Purdue University; North Carolina State University
RP Ferruzzi, MG (corresponding author), North Carolina State Univ, Plants Human Hlth Inst, 600 Laureate Way, Kannapolis, NC 28081 USA.
EM mferruz@ncsu.edu
FU PepsiCo Global RD
CR Aguilera JM, 2000, J FOOD SCI, V65, P476, DOI 10.1111/j.1365-2621.2000.tb16031.x
   Akash MSH, 2014, NUTRITION, V30, P755, DOI 10.1016/j.nut.2013.11.020
   Amrein TM, 2003, J AGR FOOD CHEM, V51, P5556, DOI 10.1021/jf034344v
   Andre CM, 2007, J AGR FOOD CHEM, V55, P10839, DOI 10.1021/jf0726583
   Andre CM, 2007, J AGR FOOD CHEM, V55, P366, DOI 10.1021/jf062740i
   Andrikopoulos NK, 2002, INT J FOOD SCI NUTR, V53, P351, DOI 10.1080/09637480220138098
   Antolovich M, 2000, ANALYST, V125, P989, DOI 10.1039/b000080i
   Arvanitoyannis IS, 2008, CRIT REV FOOD SCI, V48, P799, DOI 10.1080/10408390701691059
   Atkinson FS, 2008, DIABETES CARE, V31, P2281, DOI 10.2337/dc08-1239
   AUGUSTIN J, 1975, J FOOD SCI, V40, P1295, DOI 10.1111/j.1365-2621.1975.tb01076.x
   AUGUSTIN J, 1978, AM POTATO J, V55, P653, DOI 10.1007/BF02852138
   Barros F, 2012, J AGR FOOD CHEM, V60, P11609, DOI 10.1021/jf3034539
   Bassaganya-Riera J, 2011, J NUTR, V141, P1318, DOI 10.3945/jn.111.139022
   Beecher GR, 2003, J NUTR, V133, P0
   Bengtsson A, 2009, J AGR FOOD CHEM, V57, P9693, DOI 10.1021/jf901692r
   Berger KG, 2005, J AM OIL CHEM SOC, V82, P775, DOI 10.1007/s11746-005-1143-9
   Berni P, 2015, PLANT FOOD HUM NUTR, V70, P1, DOI 10.1007/s11130-014-0458-1
   Bertoft E, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, V0, PP83, DOI 10.1016/B978-0-12-374349-7.00004-0
   Blessington T, 2010, AM J POTATO RES, V87, P479, DOI 10.1007/s12230-010-9150-7
   Bogani P, 2007, ATHEROSCLEROSIS, V190, P181, DOI 10.1016/j.atherosclerosis.2006.01.011
   Bond J, 2013, VGS353 US DEP AGR, V0, P0
   Bordenave N, 2014, FOOD FUNCT, V5, P18, DOI 10.1039/c3fo60263j
   Bouchon P, 2003, J FOOD SCI, V68, P2711, DOI 10.1111/j.1365-2621.2003.tb05793.x
   Bouchon P, 2009, ADV FOOD NUTR RES, V57, P209, DOI 10.1016/S1043-4526(09)57005-2
   Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7
   Bradshaw JE, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, V0, PP1, DOI 10.1016/B978-0-12-374349-7.00001-5
   Bradshaw JE, 2010, HANDB PLANT BREED, V7, P1, DOI 10.1007/978-0-387-92765-7_1
   Bradshaw John E, 2007, P157, V0, P0
   BRAND JC, 1985, AM J CLIN NUTR, V42, P1192, DOI 10.1093/ajcn/42.6.1192
   Brat P, 2006, J NUTR, V136, P2368, DOI 10.1093/jn/136.9.2368
   Breithaupt DE, 2002, J AGR FOOD CHEM, V50, P7175, DOI 10.1021/jf0257953
   Brierley ER, 1996, J SCI FOOD AGR, V70, P515, DOI 10.1002/(SICI)1097-0010(199604)70:4<515::AID-JSFA529>3.0.CO;2-P
   Brown C, 2005, P WASH STAT POT C MO, V0, P0
   Brown CR, 2005, AM J POTATO RES, V82, P163, DOI 10.1007/BF02853654
   Brown CR, 2003, AM J POTATO RES, V80, P241, DOI 10.1007/BF02855360
   Burgos G, 2013, PLANT FOOD HUM NUTR, V68, P385, DOI 10.1007/s11130-013-0381-x
   Burton WG, 1989, THE POTATO, V3rd ed, P286
   BUSHWAY RJ, 1987, AM POTATO J, V64, P409, DOI 10.1007/BF02853703
   Camire ME, 2009, CRIT REV FOOD SCI, V49, P823, DOI 10.1080/10408390903041996
   Chen YY, 2013, J NUTR SCI VITAMINOL, V59, P272, DOI 10.3177/jnsv.59.272
   Chun J, 2006, J FOOD COMPOS ANAL, V19, P196, DOI 10.1016/j.jfca.2005.08.001
   Chun OK, 2005, J SCI FOOD AGR, V85, P1715, DOI 10.1002/jsfa.2176
   Cohen R, 2011, J AGR FOOD CHEM, V59, P7932, DOI 10.1021/jf2013277
   Cotton PA, 2004, J AM DIET ASSOC, V104, P921, DOI 10.1016/j.jada.2004.03.019
   Crowell EF, 2008, TRANSGENIC RES, V17, P205, DOI 10.1007/s11248-007-9091-1
   Crozier A, 2009, NAT PROD REP, V26, P1001, DOI 10.1039/b802662a
   Dale MFB, 2003, J AGR FOOD CHEM, V51, P244, DOI 10.1021/jf020547s
   Daniel DR, 2005, J AM DIET ASSOC, V105, P1927, DOI 10.1016/j.jada.2005.09.029
   DAO L, 1992, J AGR FOOD CHEM, V40, P2152, DOI 10.1021/jf00023a022
   De Wilde T, 2005, J AGR FOOD CHEM, V53, P6550, DOI 10.1021/jf050650s
   Decker EA, 2013, ADV NUTR, V4, P345S, DOI 10.3945/an.112.003574
   Del Rio D, 2010, BRIT J NUTR, V104, PS67, DOI 10.1017/S0007114510003958
   DESBOROUGH SL, 1981, QUAL PLANT, V31, P11, DOI 10.1007/BF01093884
   DESHPANDE SS, 1982, J FOOD SCI, V47, P2080, DOI 10.1111/j.1365-2621.1982.tb12956.x
   Deusser H, 2012, FOOD CHEM, V135, P2814, DOI 10.1016/j.foodchem.2012.07.028
   Dietary Guidelines Advisory Committee, 2010, SCI REP DIET GUID AD, V0, P0
   Dilworth LL, 2007, BIOMETALS, V20, P37, DOI 10.1007/s10534-006-9012-4
   Dörmann P, 2007, PLANTA, V225, P269, DOI 10.1007/s00425-006-0438-2
   Donado-Pestana CM, 2012, PLANT FOOD HUM NUTR, V67, P262, DOI 10.1007/s11130-012-0298-9
   Ducreux LJM, 2005, J EXP BOT, V56, P81, DOI 10.1093/jxb/eri016
   DuPont Andrew W, 2011, NAT REV GASTROENTEROL HEPATOL, V8, P523, DOI 10.1038/nrgastro.2011.133
   Eichhorn S, 2005, FOOD RES INT, V38, P943, DOI 10.1016/j.foodres.2005.03.011
   Ek KL, 2012, FOOD CHEM, V133, P1230, DOI 10.1016/j.foodchem.2011.09.004
   ENGLYST HN, 1992, EUR J CLIN NUTR, V46, P0
   ENGLYST HN, 1987, AM J CLIN NUTR, V45, P423, DOI 10.1093/ajcn/45.2.423
   Erdmann J, 2007, EUR J NUTR, V46, P196, DOI 10.1007/s00394-007-0649-8
   Ereifej KI, 1998, J FOOD SCI TECH MYS, V35, P55
   Erk T, 2012, MOL NUTR FOOD RES, V56, P1488, DOI 10.1002/mnfr.201200222
   Ezekiel R, 2013, FOOD RES INT, V50, P487, DOI 10.1016/j.foodres.2011.04.025
   Failla ML, 2014, FOOD FUNCT, V5, P1101, DOI 10.1039/c3fo60599j
   Failla ML, 2009, J AGR FOOD CHEM, V57, P10922, DOI 10.1021/jf900415g
   Falk J, 2010, J EXP BOT, V61, P1549, DOI 10.1093/jxb/erq030
   Fan MZ, 2012, J ANIM SCI, V90, P278, DOI 10.2527/jas.54006
   FAO Trade and Markets Division, 2008, INT YEAR POT EC INT, V0, P0
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farhoosh R, 2008, JAOCS, V86, P71
   Faria A, 2013, NATURAL PRODUCTS: PHYTOCHEMISTRY, V0, Phenolics and Terpenes
   Farrell TL, 2013, BIOFACTORS, V39, P448, DOI 10.1002/biof.1090
   Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192
   Fernandes G, 2005, J AM DIET ASSOC, V105, P557, DOI 10.1016/j.jada.2005.01.003
   Fillion L, 1998, INT J FOOD SCI NUTR, V49, P157, DOI 10.3109/09637489809089395
   Food and Agriculture Organization of the United Nations, 2008, INT YEAR POT POT WOR, V0, P0
   Food and Agriculture Organization of the United Nations, 2008, INT YEAR POT POT, V0, P0
   Foot RJ, 2007, FOOD ADDIT CONTAM A, V24, P37, DOI 10.1080/02652030701439543
   Foster-Powell K, 2002, AM J CLIN NUTR, V76, P5, DOI 10.1093/ajcn/76.1.5
   Friedman M, 1997, CRIT REV PLANT SCI, V16, P55, DOI 10.1080/713608144
   Friedman M, 2008, J AGR FOOD CHEM, V56, P6113, DOI 10.1021/jf0730486
   Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t
   Frossard E, 2000, J SCI FOOD AGR, V80, P861, DOI 10.1002/(SICI)1097-0010(20000515)80:7<861::AID-JSFA601>3.0.CO;2-P
   Gahlawat P, 1998, PLANT FOOD HUM NUTR, V52, P151, DOI 10.1023/A:1008045023304
   GALLIARD T, 1973, J SCI FOOD AGR, V24, P617, DOI 10.1002/jsfa.2740240515
   Garcia MA, 2002, INNOVATIVE FOOD SCIENCE & EMERGING TECHNOLOGIES, V3, P391, DOI 10.1016/S1466-8564(02)00050-4
   García-Alonso A, 2000, NAHRUNG, V44, P19, DOI 10.1002/(SICI)1521-3803(20000101)44:1<19::AID-FOOD19>3.3.CO;2-5
   Garrett DA, 2000, J NUTR BIOCHEM, V11, P574, DOI 10.1016/S0955-2863(00)00122-4
   Ghosh D, 2007, ASIA PAC J CLIN NUTR, V16, P200
   Giusti MM, 1996, J FOOD SCI, V61, P688, DOI 10.1111/j.1365-2621.1996.tb12182.x
   Giusti MM, 2003, BIOCHEM ENG J, V14, P217, DOI 10.1016/S1369-703X(02)00221-8
   Golaszewska B, 2001, POLISH J FOOD NUTR S, V10/51, P59
   Goltz SR, 2013, CAROTENOIDS AND HUMAN HEALTH, V0, P111
   Goni I, 1997, FOOD CHEM, V59, P269, DOI 10.1016/S0308-8146(96)00275-0
   Gonthier MP, 2006, BIOMED PHARMACOTHER, V60, P536, DOI 10.1016/j.biopha.2006.07.084
   GORDON MH, 1995, J SCI FOOD AGR, V68, P347, DOI 10.1002/jsfa.2740680314
   Govindakrishan PM, 2006, HANDBOOK OF POTATO PRODUCTION, V0, P0
   Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002
   Halton TL, 2006, AM J CLIN NUTR, V83, P284
   Han JS, 2004, J AGR FOOD CHEM, V52, P6516, DOI 10.1021/jf0493270
   Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365
   Harada K, 2004, BIOSCI BIOTECH BIOCH, V68, P1500, DOI 10.1271/bbb.68.1500
   He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754
   Hoover R, 2001, CARBOHYD POLYM, V45, P253, DOI 10.1016/S0144-8617(00)00260-5
   Huang CJ, 2000, J NUTR, V130, P534, DOI 10.1093/jn/130.3.534
   Huo T, 2007, J AGR FOOD CHEM, V55, P8950, DOI 10.1021/jf071687a
   Iablokov V, 2010, DIGEST DIS SCI, V55, P3078, DOI 10.1007/s10620-010-1158-9
   Im HW, 2008, J AGR FOOD CHEM, V56, P3341, DOI 10.1021/jf073476b
   Institute of Medicine (US), 2005, PAN MICR DIET REF IN, V0, P0
   Jansen G, 2006, GENET RESOUR CROP EV, V53, P1321, DOI 10.1007/s10722-005-3880-2
   Jansky S, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, V0, PP27, DOI 10.1016/B978-0-12-374349-7.00002-7
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   JENKINS DJA, 1981, AM J CLIN NUTR, V34, P362, DOI 10.1093/ajcn/34.3.362
   Jiao J, 2015, INT J FOOD SCI NUTR, V66, P114, DOI 10.3109/09637486.2014.959898
   Kanan W, 1998, INDIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, V42, P81
   Kärenlampi SO, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, V0, PP99, DOI 10.1016/B978-0-12-374349-7.00005-2
   Kaspar KL, 2011, J NUTR, V141, P108, DOI 10.3945/jn.110.128074
   Katan MB, 2006, ATHEROSCLEROSIS SUPP, V7, P63, DOI 10.1016/j.atherosclerosissup.2006.04.013
   Kean EG, 2008, J AGR FOOD CHEM, V56, P9918, DOI 10.1021/jf8018613
   Keijbets MJH, 2008, POTATO RES, V51, P271, DOI 10.1007/s11540-008-9104-3
   KELLER C, 1990, MITTEILUNGEN AUS DEM GEBIETE DER LEBENSMITTELUNTERSUCHUNG UND HYGIENE, V81, P68
   Kenny OM, 2013, LIFE SCI, V92, P775, DOI 10.1016/j.lfs.2013.02.006
   KEUKENS EAJ, 1992, BIOCHIM BIOPHYS ACTA, V1110, P127, DOI 10.1016/0005-2736(92)90349-Q
   KHANBARI OS, 1993, POTATO RES, V36, P359, DOI 10.1007/BF02361803
   Khosravi-Boroujeni H, 2012, INT J FOOD SCI NUTR, V63, P913, DOI 10.3109/09637486.2012.690024
   King JC, 2013, ADV NUTR, V4, P393S, DOI 10.3945/an.112.003525
   Kirkman Michael A, 2007, P27, V0, P0
   KOLASA KM, 1993, AM POTATO J, V70, P375, DOI 10.1007/BF02849118
   Kondo Y, 2014, J AGR FOOD CHEM, V62, P9286, DOI 10.1021/jf502587j
   Kondo Y, 2012, BRIT J NUTR, V107, P885, DOI 10.1017/S0007114511003643
   Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x
   Kurilich AC, 2005, J AGR FOOD CHEM, V53, P6537, DOI 10.1021/jf050570o
   Lachman J, 2005, PLANT SOIL ENVIRON, V51, P477, DOI 10.17221/3620-PSE
   Lachman J, 2013, FOOD CHEM, V138, P1189, DOI 10.1016/j.foodchem.2012.11.114
   Le Blay GM, 2003, J APPL MICROBIOL, V94, P312, DOI 10.1046/j.1365-2672.2003.01836.x
   Lee KR, 2004, J AGR FOOD CHEM, V52, P2832, DOI 10.1021/jf030526d
   Lee SJ, 2014, FOOD CHEM TOXICOL, V63, P53, DOI 10.1016/j.fct.2013.10.040
   Lee SK, 2000, POSTHARVEST BIOL TEC, V20, P207, DOI 10.1016/S0925-5214(00)00133-2
   Leeman AM, 2005, J SCI FOOD AGR, V85, P751, DOI 10.1002/jsfa.2035
   Leo L, 2008, J AGR FOOD CHEM, V56, P4154, DOI 10.1021/jf073322w
   Lewis CE, 1998, J SCI FOOD AGR, V77, P45, DOI 10.1002/(SICI)1097-0010(199805)77:1<45::AID-JSFA1>3.0.CO;2-S
   LINNEMANN AR, 1985, POTATO RES, V28, P271, DOI 10.1007/BF02357581
   Liu RH, 2013, ADV NUTR, V4, P384S, DOI 10.3945/an.112.003517
   Lloyd BJ, 2004, J FOOD PROCESS PRES, V28, P460, DOI 10.1111/j.1745-4549.2004.23075.x
   Love SL, 2004, HORTSCIENCE, V39, P156, DOI 10.21273/HORTSCI.39.1.156
   LUNETTA M, 1995, DIABETES NUTR METAB, V8, P49
   Mäder J, 2009, J AGR FOOD CHEM, V57, P6292, DOI 10.1021/jf901066k
   Maiani G, 2009, MOL NUTR FOOD RES, V53, PS194, DOI 10.1002/mnfr.200800053
   Man YBC, 1999, J FOOD LIPIDS, V6, P181, DOI 10.1111/j.1745-4522.1999.tb00142.x
   Manach C, 2005, AM J CLIN NUTR, V81, P230S, DOI 10.1093/ajcn/81.1.230S
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Manach C, 2005, CURR OPIN LIPIDOL, V16, P77, DOI 10.1097/00041433-200502000-00013
   Martinez-Puig D, 2003, J NUTR, V133, P134, DOI 10.1093/jn/133.1.134
   Matthäus B, 2006, EUR J LIPID SCI TECH, V108, P200, DOI 10.1002/ejlt.200500249
   Mattila P, 2007, J FOOD COMPOS ANAL, V20, P152, DOI 10.1016/j.jfca.2006.05.007
   MAZZA G, 1983, CAN I FOOD SC TECH J, V16, P39, DOI 10.1016/S0315-5463(83)72017-1
   McGhie TK, 2007, MOL NUTR FOOD RES, V51, P702, DOI 10.1002/mnfr.200700092
   McGill CR, 2013, ANN MED, V45, P467, DOI 10.3109/07853890.2013.813633
   Mehta U, 2001, CRIT REV FOOD SCI, V41, P133, DOI 10.1080/20014091091788
   Mellema M, 2003, TRENDS FOOD SCI TECH, V14, P364, DOI 10.1016/S0924-2244(03)00050-5
   Mendez CDV, 2004, J AGR FOOD CHEM, V52, P1323, DOI 10.1021/jf0345595
   Mercier C, 2013, POLYSACCHARIDES IN FOOD, V0, P153
   Miller PE, 2010, NUTR CANCER, V62, P413, DOI 10.1080/01635580903407114
   Mills CE, 2015, BRIT J NUTR, V113, P1220, DOI 10.1017/S0007114514003948
   Mills JP, 2009, J NUTR, V139, P44, DOI 10.3945/jn.108.098947
   Miranda L, 2013, FOOD FUNCT, V4, P1595, DOI 10.1039/c3fo60194c
   Miranda ML, 2006, FOOD REV INT, V22, P173, DOI 10.1080/87559120600574584
   Monro J, 2009, J FOOD COMPOS ANAL, V22, P539, DOI 10.1016/j.jfca.2008.11.008
   Monteleone E, 1997, APPETITE, V28, P255, DOI 10.1006/appe.1996.0081
   Morales F, 2008, ANN NY ACAD SCI, V1126, P89, DOI 10.1196/annals.1433.051
   Mori K, 2015, BREEDING SCI, V65, P3, DOI 10.1270/jsbbs.65.3
   Muttucumaru N, 2008, J AGR FOOD CHEM, V56, P6167, DOI 10.1021/jf800279d
   Navarre DA, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, V0, P395
   Navarre DA, 2013, PLANT PHYSIOL BIOCH, V65, P89, DOI 10.1016/j.plaphy.2013.01.007
   Navarre DA, 2011, FOOD CHEM, V127, P34, DOI 10.1016/j.foodchem.2010.12.080
   Navarre DA, 2010, AM J POTATO RES, V87, P350, DOI 10.1007/s12230-010-9141-8
   Nayak B, 2014, FOOD RES INT, V56, P35, DOI 10.1016/j.foodres.2013.12.020
   Neilson AP, 2010, J AGR FOOD CHEM, V58, P6685, DOI 10.1021/jf1005353
   Noda T, 2008, FOOD CHEM, V110, P465, DOI 10.1016/j.foodchem.2008.02.027
   Nugent AP, 2005, NUTR BULL, V30, P27, DOI 10.1111/j.1467-3010.2005.00481.x
   OConnor CJ, 2001, J FOOD SCI, V66, P903, DOI 10.1111/j.1365-2621.2001.tb15194.x
   Oakes ME, 2004, APPETITE, V42, P273, DOI 10.1016/j.appet.2003.10.004
   Oki T, 2006, BIOSCI BIOTECH BIOCH, V70, P2540, DOI 10.1271/bbb.60187
   Olthof MR, 2001, J NUTR, V131, P66, DOI 10.1093/jn/131.1.66
   Papathanasiou F, 1998, POTATO RES, V41, P117, DOI 10.1007/BF02358434
   Payyavula RS, 2015, PLANT BIOTECHNOL J, V13, P551, DOI 10.1111/pbi.12280
   Payyavula RS, 2013, J AGR FOOD CHEM, V61, P7357, DOI 10.1021/jf401522k
   Pedreschi F, 2008, J FOOD ENG, V87, P200, DOI 10.1016/j.jfoodeng.2007.11.031
   Pedreschi F, 2014, J SCI FOOD AGR, V94, P9, DOI 10.1002/jsfa.6349
   Peters CM, 2010, FOOD RES INT, V43, P95, DOI 10.1016/j.foodres.2009.08.016
   Raigond P, 2015, J SCI FOOD AGR, V95, P1968, DOI 10.1002/jsfa.6966
   Ramdath DD, 2014, FOOD FUNCT, V5, P909, DOI 10.1039/c3fo60395d
   Reboul E, 2006, J AGR FOOD CHEM, V54, P8749, DOI 10.1021/jf061818s
   Reddivari L, 2007, AM J POTATO RES, V84, P275, DOI 10.1007/BF02986239
   Reyes LF, 2004, AM J POTATO RES, V81, P187, DOI 10.1007/BF02871748
   Robert L, 2006, EUR J NUTR, V45, P267, DOI 10.1007/s00394-006-0594-y
   Robert L, 2008, J AM COLL NUTR, V27, P109, DOI 10.1080/07315724.2008.10719682
   Rodriguez-Saona LE, 1998, J FOOD SCI, V63, P458, DOI 10.1111/j.1365-2621.1998.tb15764.x
   Rommens CM, 2006, J AGR FOOD CHEM, V54, P9882, DOI 10.1021/jf062477l
   Rommens CM, 2008, PLANT BIOTECHNOL J, V6, P843, DOI 10.1111/j.1467-7652.2008.00363.x
   Rossi M, 2007, FOOD CHEM, V102, P812, DOI 10.1016/j.foodchem.2006.06.016
   Ruiz GM, 1999, J AM OIL CHEM SOC, V76, P421, DOI 10.1007/s11746-999-0019-1
   Rusinovci I, 2012, ACTA HORTIC, V960, P289, DOI 10.17660/ActaHortic.2012.960.41
   RYAN GB, 1977, AM J PATHOL, V86, P183
   Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x
   Salaman RN, 1926, POTATO VARIETIES, V0, P0
   Schramm DD, 2003, LIFE SCI, V73, P857, DOI 10.1016/S0024-3205(03)00373-4
   SHALLENBERGER RS, 1959, J AGR FOOD CHEM, V7, P274, DOI 10.1021/jf60098a010
   Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084
   Shikany JM, 2000, SOUTH MED J, V93, P1138, DOI 10.1097/00007611-200093120-00001
   Singh J, 2009, ADVANCES IN POTATO CHEMISTRY AND TECHNOLOGY, V0, PP273, DOI 10.1016/B978-0-12-374349-7.00010-6
   Slavin JL, 2013, ADV NUTR, V4, P351S, DOI 10.3945/an.112.003491
   Soh NL, 1999, EUR J CLIN NUTR, V53, P249, DOI 10.1038/sj.ejcn.1600713
   Sowokinos JR, 2001, AM J POTATO RES, V78, P221, DOI 10.1007/BF02883548
   SPYCHALLA JP, 1990, PLANT PHYSIOL, V94, P1214, DOI 10.1104/pp.94.3.1214
   Stalmach A, 2014, FOOD FUNCT, V5, P1727, DOI 10.1039/c4fo00316k
   STOCKIGT J, 1974, FEBS LETT, V42, P131, DOI 10.1016/0014-5793(74)80769-6
   Storey ML, 2013, ADV NUTR, V4, P335S, DOI 10.3945/an.112.003541
   Storey Michael, 2007, P441, V0, P0, DOI DOI 10.1016/B978-044451018-1/50063-4
   Stubenitsky K, 2000, BRIT J NUTR, V83, P277, DOI 10.1017/S0007114500000350
   Suda I, 2002, J AGR FOOD CHEM, V50, P1672, DOI 10.1021/jf011162x
   Tahvonen R, 2006, J FOOD COMPOS ANAL, V19, P372, DOI 10.1016/j.jfca.2005.10.008
   Tarazona-Díaz MP, 2013, FOOD SCI TECHNOL INT, V19, P439, DOI 10.1177/1082013212455346
   Tareke E, 2000, CHEM RES TOXICOL, V13, P517, DOI 10.1021/tx9901938
   THED ST, 1995, FOOD CHEM, V52, P301, DOI 10.1016/0308-8146(95)92828-8
   THOMPSON LU, 1984, AM J CLIN NUTR, V39, P745, DOI 10.1093/ajcn/39.5.745
   TOMA RB, 1979, J FOOD SCI, V44, P1403, DOI 10.1111/j.1365-2621.1979.tb06448.x
   TRUE RH, 1979, AM POTATO J, V56, P339, DOI 10.1007/BF02853849
   Tudela JA, 2002, POSTHARVEST BIOL TEC, V26, P75, DOI 10.1016/S0925-5214(02)00002-9
   Tudela JA, 2002, J AGR FOOD CHEM, V50, P5925, DOI 10.1021/jf020330y
   USDepartment of Agriculture Agricultural Research Service, 2014, USDA NAT NUTR DAT ST, V0, P0
   USFood and Drug Administration, 2015, 00141 US FDA, V0, P0
   United States Department of Agriculture, 2015, WHAT COUNTS CUP VEG, V0, P0
   United States Potato Board, 2007, CHIP STOCK POT, V0, P0
   United States Potato Board, 2007, TABL STOCK POT, V0, P0
   USDA Economic Research Service, 2014, USDA EC RES SERV POT, V0, P0
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Vaziri ND, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0114881
   Veitch NC, 2008, NAT PROD REP, V25, P555, DOI 10.1039/b718040n
   Vinha AF, 2015, FOOD FUNCT, V6, P1157, DOI 10.1039/C4FO01209G
   Vitaglione P, 2015, AM J CLIN NUTR, V101, P251, DOI 10.3945/ajcn.114.088120
   Vreugdenhil D, 2007, POTATO BIOL BIOTECHN, V0, P0, DOI DOI 10.1016/B978-044451018-1/50048-8
   Wang DJ, 2013, J SCI FOOD AGR, V93, P276, DOI 10.1002/jsfa.5753
   Watada AE, 1955, AMERICAN POTATO JOURNAL, V32, P132, DOI 10.1007/BF02851208
   Watanabe K, 2015, BREEDING SCI, V65, P53, DOI 10.1270/jsbbs.65.53
   White PJ, 2009, HORTSCIENCE, V44, P6, DOI 10.21273/HORTSCI.44.1.6
   WILSON AM, 1981, J FOOD SCI, V46, P300, DOI 10.1111/j.1365-2621.1981.tb14589.x
   Wszelaki AL, 2005, J SCI FOOD AGR, V85, P720, DOI 10.1002/jsfa.2051
   Xu XY, 2009, J AGR FOOD CHEM, V57, P10231, DOI 10.1021/jf902532q
   Zafra-Stone S, 2007, MOL NUTR FOOD RES, V51, P675, DOI 10.1002/mnfr.200700002
   Zaheer K, 2016, CRIT REV FOOD SCI, V56, P711, DOI 10.1080/10408398.2012.724479
   Zhang Y, 2007, CRIT REV FOOD SCI, V47, P521, DOI 10.1080/10408390600920070
   Zhu F, 2010, J SCI FOOD AGR, V90, P2254, DOI 10.1002/jsfa.4079
NR 260
TC 76
Z9 83
U1 8
U2 123
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1040-8398
EI 1549-7852
J9 CRIT REV FOOD SCI
JI Crit. Rev. Food Sci. Nutr.
PD JUN 15
PY 2018
VL 58
IS 1
BP 146
EP 168
DI 10.1080/10408398.2016.1139542
PG 23
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA FY5WF
UT WOS:000426907600009
PM 26852789
DA 2025-04-28
ER

PT J
AU Peng, SG
   Pang, YL
   Zhu, Q
   Kang, JH
   Liu, MX
   Wang, Z
AF Peng, Shu-guang
   Pang, Yi-lin
   Zhu, Qi
   Kang, Jing-he
   Liu, Ming-xin
   Wang, Zheng
TI Chlorogenic Acid Functions as a Novel Agonist of PPARγ2 during the Differentiation of Mouse 3T3-L1 Preadipocytes
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID proliferator-activated receptor; diet-induced obesity; ppar-gamma; transcription factors; fat accumulation; adipocyte differentiation; 5-caffeoylquinic acid; inhibit adipogenesis; gene-expression; c/ebp-alpha
AB Rosiglitazone (RG) is a well-known activator of peroxisome proliferator-activated receptor-gamma (PPAR) and used to treat hyperglycemia and type 2 diabetes; however, its clinical application has been confounded by adverse side effects. Here, we assessed the roles of chlorogenic acid (CGA), a phenolic secondary metabolite found in many fruits and vegetables, on the differentiation and lipolysis of mouse 3T3-L1 preadipocytes. The results showed that CGA promoted differentiation in vitro according to oil red O staining and quantitative polymerase chain reaction assays. As a potential molecular mechanism, CGA downregulated mRNA levels of the adipocyte differentiation-inhibitor gene Pref1 and upregulated those of major adipogenic transcriptional factors (Cebpb and Srebp1). Additionally, CGA upregulated the expression of the differentiation-related transcriptional factor PPAR2 at both the mRNA and protein levels. However, following CGA intervention, the accumulation of intracellular triacylglycerides following preadipocyte differentiation was significantly lower than that in the RG group. Consistent with this, our data indicated that CGA treatment significantly upregulated the expression of lipogenic pathway-related genes Plin and Srebp1 during the differentiation stage, although the influence of CGA was weaker than that of RG. Notably, CGA upregulated the expression of the lipolysis-related gene Hsl, whereas it did not increase the expression of the lipid synthesis-related gene Dgat1. These results demonstrated that CGA might function as a potential PPAR agonist similar to RG; however, the impact of CGA on lipolysis in 3T3-L1 preadipocytes differed from that of RG.
C1 [Peng, Shu-guang; Pang, Yi-lin; Zhu, Qi; Liu, Ming-xin; Wang, Zheng] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
   [Peng, Shu-guang] Res Inst Hunan Tobacco Sci, Changsha 410007, Hunan, Peoples R China.
   [Peng, Shu-guang] Hunan Agr Univ, Coll Plant Protect, Changsha 410128, Hunan, Peoples R China.
   [Kang, Jing-he] Chinese Acad Sci, Inst Subtrop Agr, Key Lab Agroecol Proc Subtrop, Changsha 410125, Hunan, Peoples R China.
C3 Hunan Agricultural University; China National Tobacco Corporation; Hunan Agricultural University; Chinese Academy of Sciences; Institute of Subtropical Agriculture, CAS
RP Wang, Z (corresponding author), Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha 410128, Hunan, Peoples R China.
EM zhengw@hunau.edu.cn
FU National Natural Science Foundation of China [31071531]; Foundation of the Research Institute of Hunan Tobacco Science [15-17Aa04]
CR Adedapo Adeolu Alex, 2015, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V26, P327, DOI 10.1515/jbcpp-2014-0051
   Agrawal R, 2012, MINI-REV MED CHEM, V12, P87, DOI 10.2174/138955712798995048
   Ahuja S, 2011, J PHARM PHARMACOL, V63, P1604, DOI 10.1111/j.2042-7158.2011.01363.x
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Sanchez MB, 2017, BIOMED PHARMACOTHER, V94, P169, DOI 10.1016/j.biopha.2017.07.086
   Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2
   Cheong LY, 2015, J CELL BIOCHEM, V116, P1361, DOI 10.1002/jcb.25093
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   CHRISTY RJ, 1991, P NATL ACAD SCI USA, V88, P2593, DOI 10.1073/pnas.88.6.2593
   Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1126, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1126::AID-JSFA604>3.0.CO;2-0
   De Souza Marinho Do Nascimento D, 2017, MOLECULES, V22, P0
   Deka SJ, 2017, CURR MOL MED, V17, P79, DOI 10.2174/1566524017666170209160619
   den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213
   Du WY, 2013, J ETHNOPHARMACOL, V147, P74, DOI 10.1016/j.jep.2013.01.042
   Fujimoto T, 2008, HISTOCHEM CELL BIOL, V130, P263, DOI 10.1007/s00418-008-0449-0
   Ghadieh HE, 2015, NUTR METAB, V12, P0, DOI 10.1186/s12986-015-0014-5
   Hakkou Z, 2017, BIOMED PHARMACOTHER, V93, P62, DOI 10.1016/j.biopha.2017.06.015
   HERRERA R, 1989, MOL CELL BIOL, V9, P5331, DOI 10.1128/MCB.9.12.5331
   HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Hudak CS, 2013, FRONTIERS IN ENDOCRINOLOGY VOL, V4, P0
   Hwang CS, 1996, P NATL ACAD SCI USA, V93, P873, DOI 10.1073/pnas.93.2.873
   Jang BC, 2016, BIOCHEM BIOPH RES CO, V474, P220, DOI 10.1016/j.bbrc.2016.04.109
   Jang J, 2018, J ETHNOPHARMACOL, V210, P10, DOI 10.1016/j.jep.2017.08.024
   Jiang RJ, 2016, J NUTR BIOCHEM, V27, P53, DOI 10.1016/j.jnutbio.2015.08.017
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P2518, DOI 10.1021/jf035407c
   Kowalska K, 2014, FOOD CHEM, V148, P246, DOI 10.1016/j.foodchem.2013.10.032
   Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1
   Lee H, 2000, CIRC RES, V87, P516
   Lee H, 2017, J GINSENG RES, V41, P257, DOI 10.1016/j.jgr.2016.04.004
   Li ZY, 2015, DIABETES, V64, P4011, DOI 10.2337/db15-0274
   Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056
   Liu SL, 2015, FOOD FUNCT, V6, P2779, DOI 10.1039/c5fo00626k
   Lu Y, 2015, J DIABETES INVEST, V6, P78, DOI 10.1111/jdi.12246
   Martínez G, 2017, PESTIC BIOCHEM PHYS, V140, P30, DOI 10.1016/j.pestbp.2017.05.012
   Mikami Y, 2015, LIFE SCI, V139, P69, DOI 10.1016/j.lfs.2015.08.005
   Mueller E, 2002, J BIOL CHEM, V277, P41925, DOI 10.1074/jbc.M206950200
   Nathan DM, 2015, JAMA-J AM MED ASSOC, V314, P1052, DOI 10.1001/jama.2015.9536
   Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761
   Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102
   Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024
   Orchard TJ, 2006, DIABETES CARE, V29, P746, DOI 10.2337/diacare.29.03.06.dc05-2181
   Palócz O, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0166642
   Park JJ, 2015, CELL ONCOL, V38, P111, DOI 10.1007/s13402-014-0216-2
   Rashid AM, 2016, FOOD FUNCT, V7, P881, DOI 10.1039/C5FO01208B
   Ren DL, 2002, GENE DEV, V16, P27, DOI 10.1101/gad.953802
   Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178
   Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702
   Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110
   Schreiber I, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-17595-5
   SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L
   Song X, 2015, SCI REPORTS, V5, P0
   Sprott KM, 2002, BIOCHEM J, V365, P181, DOI 10.1042/BJ20020215
   Sul HS, 2000, INT J OBESITY, V24, PS15, DOI 10.1038/sj.ijo.0801494
   Tajik N, 2017, EUR J NUTR, V56, P2215, DOI 10.1007/s00394-017-1379-1
   Toyota Y, 2017, BIOORG MED CHEM LETT, V27, P2776, DOI 10.1016/j.bmcl.2017.04.061
   Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879
   Wang G, 2005, METABOLISM, V54, P590, DOI 10.1016/j.metabol.2004.11.017
   Wang L, 2015, FRONTIERS MICROBIOLO, V6, P0
   Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015
   Wu DH, 2015, J PHARMACOL SCI, V129, P177, DOI 10.1016/j.jphs.2015.10.005
   WU ZD, 1995, GENE DEV, V9, P2350, DOI 10.1101/gad.9.19.2350
   Xue NN, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep39011
   Ye HY, 2017, INFLAMMATION, V40, P523, DOI 10.1007/s10753-016-0498-9
   Ye JP, 2011, ACTA PHARM SIN B, V1, P137, DOI 10.1016/j.apsb.2011.06.011
   Zhang KH, 2010, J CLIN PHARMACOL, V50, P1022, DOI 10.1177/0091270009355159
   Zhang ZZ, 2017, ADV ENERGY MATER, V7, P0, DOI 10.1002/aenm.201601196
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
   Zheng SQ, 2017, J GERONTOL A-BIOL, V72, P464, DOI 10.1093/gerona/glw105
NR 70
TC 25
Z9 26
U1 0
U2 15
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD JUN 15
PY 2018
VL 2018
IS 
BP 
EP 
DI 10.1155/2018/8594767
PG 14
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA HE8YN
UT WOS:000453734000001
PM 30627576
DA 2025-04-28
ER

PT J
AU Sanlier, N
   Gokcen, BB
   Altug, M
AF Sanlier, Nevin
   Gokcen, Busra Basar
   Altug, Mehmet
TI Tea consumption and disease correlations
SO TRENDS IN FOOD SCIENCE & TECHNOLOGY
LA English
DT Review
DE Black tea; Green tea; Oolong tea; White tea; Cancer; Obesity; Diabetes mellitus; Cardiovascular diseases; Other diseases
ID colorectal-cancer risk; green tea; black tea; breast-cancer; white tea; skin-cancer; lung-cancer; camellia-sinensis; dietary polyphenols; in-vitro
AB Tea is the most widely consumed beverage in the world next to water and is obtained from the leaves Camellia sinensis. In recent years, the potential health benefits and effect mechanisms of tea have attracted a lot of interest. The potential health benefits of tea have been attributed to its various phenolic compounds with unique biological properties found in tea. These phenolic compounds are especially catethins and their derivatives, which constitute at most 30% of the dry weight of the tea. Tea is a new and effective strategy for reducing the severity of neurological diseases and for protecting against obesity, cardiovascular disease, type 2 diabetes and certain types of cancer (ovaryum, lung, skin, breast, endometrial, prostate, bladder, oral and colorectal cancers). Overall, the study that supports the health benefits of tea is increasing. But, the amounts of and the frequency of tea consumption that is associated with potential health benefits vary greatly from work to work and this situation creates difficulty in determining the optimal consumption amount and frequency that tea can exhibit health benefits. For this reason, we aimed to examine the health effect of the tea and how much consumption is to investigate whether it meets the claimed health benefits. Within that frame, there is a need for more studies on the possible health effects of tea. While studying on that effect, the effects of various doses, forms (in synthetic or natural product matrix), exposure in different periods (short or long term) on health should be studied. However, currently the conducted studies are promising for tea is a bioactive component like polyphenol, theaflavins, thearubigins, caffeine and mineral. In addition, although the fact intake with diet proved to be reliable at the end of the conducted acute and chronic toxicity test is another positive part, safety of bioactive component in tea should be supported through further studies.
C1 [Sanlier, Nevin] Lokman Hekim Univ, Nutr & Dietet Dept, Fac Hlth Sci, Ankara, Turkey.
   [Gokcen, Busra Basar] Gazi Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.
   [Altug, Mehmet] Lokman Hekim Univ, Fac Med, Dept Med Biochem, Ankara, Turkey.
C3 Lokman Hekim University; Gazi University; Lokman Hekim University
RP Sanlier, N (corresponding author), Lokman Hekim Univ, Nutr & Dietet Dept, Fac Hlth Sci, Ankara, Turkey.
EM nevintekgul@gmail.com
CR Agostoni C, 2012, EFSA J, V10, P0, DOI 10.2903/j.efsa.2012.3000
   Agostoni C, 2011, EFSA J, V9, P0, DOI 10.2903/j.efsa.2011.2055
   Agostoni C, 2010, EFSA J, V8, P0, DOI 10.2903/j.efsa.2010.1463
   Almajano MP, 2011, NEUROTOX RES, V20, P372, DOI 10.1007/s12640-011-9252-0
   Alves MG, 2015, J FUNCT FOODS, V14, P102, DOI 10.1016/j.jff.2015.01.019
   Amin ARMR, 2013, TEA IN HEALTH AND DISEASE PREVENTION, V0, PP751, DOI 10.1016/B978-0-12-384937-3.00063-X
   Anderson RA, 2002, J AGR FOOD CHEM, V50, P7182, DOI 10.1021/jf020514c
   Arab L, 2013, AM J CLIN NUTR, V98, P1651S, DOI 10.3945/ajcn.113.059345
   Ardisson Korat Andres V, 2014, CURR NUTR REP, V3, P345
   Asgari MM, 2011, NUTR CANCER, V63, P314, DOI 10.1080/01635581.2011.523496
   Asif Mohammad, 2014, J EDUC HEALTH PROMOT, V3, P1, DOI 10.4103/2277-9531.127541
   Baker JA, 2007, INT J GYNECOL CANCER, V17, P50, DOI 10.1111/j.1525-1438.2006.00773.x
   Quintana JLB, 2009, J AM COLL NUTR, V28, P1
   Bhardwaj P, 2013, CHIN J NAT MEDICINES, V11, P345, DOI 10.1016/S1875-5364(13)60051-5
   Bhoo-Pathy N, 2013, EUR J CANCER, V49, P703, DOI 10.1016/j.ejca.2012.09.014
   Bombak A, 2014, J INFORM, V104, P0
   Bresson JL, 2015, EFSA J, V13, P0, DOI 10.2903/j.efsa.2015.4251
   Brown SB, 2015, STEROIDS, V99, P8, DOI 10.1016/j.steroids.2014.12.013
   Butler LM, 2011, MOL NUTR FOOD RES, V55, P931, DOI 10.1002/mnfr.201100058
   Butt MS, 2014, CRIT REV FOOD SCI, V54, P1002, DOI 10.1080/10408398.2011.623198
   Capellino S, 2014, ANN NY ACAD SCI, V1317, P24, DOI 10.1111/nyas.12398
   Cappelletti S, 2015, CURR NEUROPHARMACOL, V13, P71, DOI 10.2174/1570159X13666141210215655
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Caruana M, 2015, TEA POLYPHENOLS PARK, V0, P117
   Chacko Sabu M, 2010, CHIN MED, V5, P13, DOI 10.1186/1749-8546-5-13
   Chan EWC, 2011, PHARMACOGN RES, V3, P266, DOI 10.4103/0974-8490.89748
   Chan RSM, 2010, INT J ENV RES PUB HE, V7, P765, DOI 10.3390/ijerph7030765
   Chen S, 2015, BIOCHEM BIOPH RES CO, V461, P1, DOI 10.1016/j.bbrc.2015.03.158
   Chen ZM, 2015, J ZHEJIANG UNIV-SC B, V16, P87, DOI 10.1631/jzus.B1500001
   Cheng M, 2017, FOOD RES INT, V92, P9, DOI 10.1016/j.foodres.2016.12.008
   Chumsri S, 2011, J STEROID BIOCHEM, V125, P13, DOI 10.1016/j.jsbmb.2011.02.001
   Cole L, 2016, ALZHEIMERS DIS HUMAN, V0, P215
   Conney AH, 2012, INHIBITION UVB INDUC, V0, P61
   Cooper R, 2012, INT J FOOD SCI NUTR, V63, P90, DOI 10.3109/09637486.2011.629180
   Coppock RW, 2016, GREEN TEA EXTRACT A2, V0, P0
   Crews L, 2010, HUM MOL GENET, V19, PR12, DOI 10.1093/hmg/ddq160
   Dai Q, 2010, ANN EPIDEMIOL, V20, P74, DOI 10.1016/j.annepidem.2009.09.005
   de Oliveira A, 2013, FOOD CHEM TOXICOL, V52, P207, DOI 10.1016/j.fct.2012.11.006
   Deka A, 2011, PHARMACOL RES, V64, P136, DOI 10.1016/j.phrs.2011.03.009
   Dela Cruz CS, 2011, CLIN CHEST MED, V32, P605, DOI 10.1016/j.ccm.2011.09.001
   Dias PM, 2014, J AGR FOOD CHEM, V62, P6655, DOI 10.1021/jf501611w
   Djalalinia S, 2015, PAK J MED SCI, V31, P239, DOI 10.12669/pjms.311.7033
   Dominianni C, 2013, BRIT J CANCER, V109, P1352, DOI 10.1038/bjc.2013.434
   Donepudi MS, 2014, J CANCER RES THER, V10, P506, DOI 10.4103/0973-1482.137927
   Dragicevic N, 2011, J ALZHEIMERS DIS, V26, P507, DOI 10.3233/JAD-2011-101629
   Du GJ, 2012, NUTRIENTS, V4, P1679, DOI 10.3390/nu4111679
   Dutta D, 2015, NEUROCHEM INT, V89, P181, DOI 10.1016/j.neuint.2015.08.005
   Eilat-Adar S, 2013, NUTRIENTS, V5, P3646, DOI 10.3390/nu5093646
   Feng L, 2015, TEA COGNITIVE HLTH F, V0, P903
   Feng L, 2012, J NUTR HEALTH AGING, V0, P1
   Feng WY, 2006, CURR DRUG METAB, V7, P755, DOI 10.2174/138920006778520552
   Figueroa TTH, 2004, ARCH LATINOAM NUTR, V54, P380
   Files JA, 2010, MAYO CLIN P, V0, P0
   Firoz CK, 2015, SAUDI J BIOL SCI, V22, P19, DOI 10.1016/j.sjbs.2014.09.003
   Fleming M, 2012, J GASTROINTEST ONCOL, V3, P153, DOI 10.3978/j.issn.2078-6891.2012.030
   Fu QY, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22050849
   Fuhrman BJ, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-25
   Fukazawa H, 2012, BIOL PHARM B, V35, P0
   Gao Jing, 2005, ZHONGHUA LIU XING BING XUE ZA ZHI, V26, P323
   Gao Y, 2016, ANTICANCER RES, V36, P643
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Goel AK, 2015, WORLD J CLIN CASES, V3, P20, DOI 10.12998/wjcc.v3.i1.20
   Gomez-Pinilla F, 2008, SURG NEUROL, V70, P333, DOI 10.1016/j.surneu.2008.05.023
   Gomez-Pinilla Fernando, 2011, NUTRITION AND HEALTH (BICESTER), V20, P165
   Gomez-Pinilla F, 2011, PM&R, V3, PS111, DOI 10.1016/j.pmrj.2011.03.001
   Gondoin A, 2010, FOOD RES INT, V43, P1537, DOI 10.1016/j.foodres.2010.04.029
   Green CJ, 2014, J EPIDEMIOL, V24, P146, DOI 10.2188/jea.JE20130063
   Hajiaghaalipour F, 2015, FOOD CHEM, V169, P401, DOI 10.1016/j.foodchem.2014.07.005
   Hanamura T, 2018, BREAST CANCER-TOKYO, V25, P379, DOI 10.1007/s12282-017-0772-1
   Hanson C, 2014, INT J CHRONIC OBSTR, V9, P723, DOI 10.2147/COPD.S50111
   He RR, 2009, CHIN J INTEGR MED, V15, P34, DOI 10.1007/s11655-009-0034-8
   Heber D, 2014, J NUTR, V144, P1385, DOI 10.3945/jn.114.191007
   Hintzpeter J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0084468
   Ho Y, 2013, TEA HLTH DIS PREVENT, V0, P0
   Ho YS, 2013, TEA IN HEALTH AND DISEASE PREVENTION, V0, PP691, DOI 10.1016/B978-0-12-384937-3.00058-6
   Hodgson JM, 2008, ASIA PAC J CLIN NUTR, V17, P288
   Hoshino T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0076306
   Hu G, 2007, MOVEMENT DISORD, V22, P2242, DOI 10.1002/mds.21706
   Huang J, 2014, EUR J CLIN NUTR, V68, P1075, DOI 10.1038/ejcn.2014.143
   Hunn J, 2012, CLIN OBSTET GYNECOL, V55, P3, DOI 10.1097/GRF.0b013e31824b4611
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Ide K, 2014, NUTRIENTS, V6, P4032, DOI 10.3390/nu6104032
   Inoue M, 2009, CANCER EPIDEM BIOMAR, V18, P1746, DOI 10.1158/1055-9965.EPI-08-0923
   Islam MS, 2011, PHYTOMEDICINE, V19, P25, DOI 10.1016/j.phymed.2011.06.025
   Iwasaki M, 2010, BREAST CANCER RES, V12, P1
   Je Y, 2015, NUTR CANCER, V67, P825, DOI 10.1080/01635581.2015.1040521
   Jing YL, 2009, J GEN INTERN MED, V24, P557, DOI 10.1007/s11606-009-0929-5
   Jochmann N, 2008, CURR OPIN CLIN NUTR, V11, P758, DOI 10.1097/MCO.0b013e328314b68b
   Johnson JJ, 2010, PHYTOMEDICINE, V17, P3, DOI 10.1016/j.phymed.2009.09.011
   Jowko E, 2014, ANTIOXIDANTS SPORT N, V123, P0
   Kanchan T, 2016, SUDDEN NATURAL DEATH, V0, P0
   Katiyar SK, 2011, ARCH BIOCHEM BIOPHYS, V508, P152, DOI 10.1016/j.abb.2010.11.015
   Katiyar S, 2007, J NUTR BIOCHEM, V18, P287, DOI 10.1016/j.jnutbio.2006.08.004
   Khan N, 2013, CURR PHARM DESIGN, V19, P6141, DOI 10.2174/1381612811319340008
   Khan N, 2010, CANCER LETT, V293, P133, DOI 10.1016/j.canlet.2009.12.013
   Khan SI, 2011, REPROD BIOL ENDOCRIN, V9, P0, DOI 10.1186/1477-7827-9-91
   Kharroubi AT, 2015, WORLD J DIABETES, V6, P850, DOI 10.4239/wjd.v6.i6.850
   Kim YC, 2015, J VET SCI, V16, P135, DOI 10.4142/jvs.2015.16.2.
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Kumar D, 2015, ARCH PHYSIOL BIOCHEM, V121, P109, DOI 10.3109/13813455.2015.1043308
   Kumar G, 2010, MINI-REV MED CHEM, V10, P492, DOI 10.2174/138955710791384063
   Kumar Y, 2014, POLYPHENOLS IN HUMAN HEALTH AND DISEASE, V0, PP643, DOI 10.1016/B978-0-12-398456-2.00049-9
   Kuriyama S, 2006, AM J CLIN NUTR, V83, P355
   Lambert JD, 2010, ARCH BIOCHEM BIOPHYS, V501, P65, DOI 10.1016/j.abb.2010.06.013
   Larsson SC, 2009, CANCER CAUSE CONTROL, V20, P2039, DOI 10.1007/s10552-009-9396-x
   Lee AH, 2013, CANCER EPIDEMIOL, V37, P54, DOI 10.1016/j.canep.2012.10.003
   Lee HJ, 2012, POULTRY SCI, V91, P66, DOI 10.3382/ps.2011-01645
   Leekha S, 2011, MAYO CLIN P, V0, P0
   Leong H, 2008, BREAST CANCER RES TR, V107, P359, DOI 10.1007/s10549-007-9568-x
   Leung ACY, 2016, CANCER EPIDEMIOL, V45, P119, DOI 10.1016/j.canep.2016.10.010
   Li Chia-Chun, 2016, HU LI ZA ZHI, V63, P5, DOI 10.6224/JN.63.5.5
   Li FJ, 2012, SCI WORLD J, V0, P0, DOI DOI 10.1100/2012/923464
   Li M, 2016, CANCER EPIDEMIOL, V40, P73, DOI 10.1016/j.canep.2015.11.013
   Li Shenwei, 2011, ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, V21, P239, DOI 10.3851/IMP1774
   Li X, 2016, ENCYCLOPEDIA OF FOOD AND HEALTH, V0, PP279, DOI 10.1016/B978-0-12-384947-2.00684-X
   Liang WB, 2007, EVID-BASED COMPL ALT, V4, P17, DOI 10.1093/ecam/nel066
   Liu H, 2013, J ZHEJIANG UNIV-SC B, V14, P47, DOI 10.1631/jzus.B1200218
   Lorenz M, 2013, AM J CLIN NUTR, V98, P1642S, DOI 10.3945/ajcn.113.058230
   Lu CW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0038332
   Lustosa BB, 2016, INT J CARDIOL, V225, P147, DOI 10.1016/j.ijcard.2016.09.092
   Ma QP, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0165861
   MacKenzie T, 2007, METABOLISM, V56, P1340, DOI 10.1016/j.metabol.2007.05.018
   Malongane F, 2017, J SCI FOOD AGR, V97, P4679, DOI 10.1002/jsfa.8472
   Mao JT, 2013, WHITE TEA PLANTS PRO, V0, P0
   Mao JT, 2010, CANCER PREV RES, V3, P1132, DOI 10.1158/1940-6207.CAPR-09-0264
   Mao YS, 2016, SURG ONCOL CLIN N AM, V25, P439, DOI 10.1016/j.soc.2016.02.001
   Massano J, 2012, CSH PERSPECT MED, V2, P0, DOI 10.1101/cshperspect.a008870
   Matsumoto K, 2011, BMC COMPLEM ALTERN M, V11, P0, DOI 10.1186/1472-6882-11-15
   Matthews CM, 2010, BAYL U MED CTR P, V0, P0
   McCann SE, 2009, INT J CANCER, V124, P1650, DOI 10.1002/ijc.24125
   Meeran SM, 2009, J INVEST DERMATOL, V129, P1258, DOI 10.1038/jid.2008.354
   Meeusen R, 2014, SPORTS MED, V44, P47, DOI 10.1007/s40279-014-0150-5
   Meydani M, 2010, NUTRIENTS, V2, P737, DOI 10.3390/nu2070737
   Miao M, 2015, FOOD CHEM, V186, P20, DOI 10.1016/j.foodchem.2015.02.049
   Miller PE, 2017, AM J MED, V130, P188, DOI 10.1016/j.amjmed.2016.08.038
   Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311
   Miura K, 2015, NUTR CANCER, V67, P1049, DOI 10.1080/01635581.2015.1073759
   Mo H, 2013, OXIDATIVE MED CELLUL, V2013, P0
   Moore RJ, 2009, BRIT J NUTR, V102, P1790, DOI 10.1017/S0007114509991218
   Moseley VR, 2013, ANTICANCER RES, V33, P5325
   Mousavi A, 2013, J RES MED SCI, V18, P1080
   Munday R, 2016, TEA HLTH EFFECTS ENC, V0, P273
   Nagini S, 2013, TEA IN HEALTH AND DISEASE PREVENTION, V0, PP737, DOI 10.1016/B978-0-12-384937-3.00062-8
   Naito Y, 2009, J CARDIOVASC PHARM, V54, P385, DOI 10.1097/FJC.0b013e3181b6e7a1
   Nandakumar V, 2011, CARCINOGENESIS, V32, P537, DOI 10.1093/carcin/bgq285
   Ng TP, 2008, AM J CLIN NUTR, V88, P224, DOI 10.1093/ajcn/88.1.224
   Noguchi-Shinohara M, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0096013
   Norval M, 2011, PHOTOCH PHOTOBIO SCI, V10, P199, DOI 10.1039/c0pp90044c
   Odegaard AO, 2008, AM J CLIN NUTR, V88, P979, DOI 10.1093/ajcn/88.4.979
   Oh H, 2017, BREAST CANCER RES, V19, P0, DOI 10.1186/s13058-017-0810-0
   Onakpoya I, 2014, NUTR METAB CARDIOVAS, V24, P823, DOI 10.1016/j.numecd.2014.01.016
   Oppeneer SJ, 2011, NUTR CANCER, V63, P817, DOI 10.1080/01635581.2011.594210
   Pan HB, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21121659
   Pan TH, 2003, DRUG AGING, V20, P711, DOI 10.2165/00002512-200320100-00001
   Pang HH, 2016, J CLIN ONCOL, V34, P3992, DOI 10.1200/JCO.2016.67.7088
   Pil L, 2016, PREV MED, V93, P177, DOI 10.1016/j.ypmed.2016.10.005
   Pillai SK, 2015, HEALTH SECUR, V13, P355, DOI 10.1089/hs.2015.0033
   Prediger RDS, 2010, J ALZHEIMERS DIS, V20, PS205, DOI 10.3233/JAD-2010-091459
   Qi GY, 2017, J FUNCT FOODS, V34, P168, DOI 10.1016/j.jff.2017.04.031
   Rafieian-Kopaei Mahmoud, 2017, ELECTRON PHYSICIAN, V9, P3838, DOI 10.19082/3838
   Rafieian-Kopaei Mahmoud, 2014, J NEPHROPHARMACOL, V3, P21
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rees JR, 2007, J AM ACAD DERMATOL, V56, P781, DOI 10.1016/j.jaad.2006.11.038
   Reygaert W, 2013, FRONT MICROBIOL, V4, P0, DOI 10.3389/fmicb.2013.00162
   Reygaert WC, 2014, FRONT MICROBIOL, V5, P0, DOI 10.3389/fmicb.2014.00434
   Roghani Mehrdad, 2010, PATHOPHYSIOLOGY, V17, P55, DOI 10.1016/j.pathophys.2009.07.004
   Saito E, 2015, ANN EPIDEMIOL, V25, P512, DOI 10.1016/j.annepidem.2015.03.007
   Samanta T, 2015, J FOOD SCI TECH MYS, V52, P2387, DOI 10.1007/s13197-013-1230-5
   Sampath C, 2017, BIOMED PHARMACOTHER, V87, P73, DOI 10.1016/j.biopha.2016.12.082
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Schmidt A, 2014, PSYCHOPHARMACOLOGY, V231, P3879, DOI 10.1007/s00213-014-3526-1
   Seebaluck-Sandoram R, 2017, MEDICINAL SPICES AND VEGETABLES FROM AFRICA: THERAPEUTIC POTENTIAL AGAINST METABOLIC, V0, P0
   Seib KL, 2016, EPIGENETICS INFECT D, V0, P0
   Seidl SE, 2014, FRONT AGING NEUROSCI, V6, P0, DOI 10.3389/fnagi.2014.00036
   Selena Ahmed JRS, 2012, GREEN TEA PLANTS PRO, V0, P0
   Serafini M, 2011, HLTH BENEFITS HERBAL, V0, P0
   Shah R, 2014, WORLD J CLIN ONCOL, V5, P283, DOI 10.5306/wjco.v5.i3.283
   Sharangi AB, 2009, FOOD RES INT, V42, P529, DOI 10.1016/j.foodres.2009.01.007
   Shen W, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0137781
   Shrubsole MJ, 2009, J NUTR, V139, P310, DOI 10.3945/jn.108.098699
   Shukla AP, 2015, J CARDIOPULM REHABIL, V35, P81, DOI 10.1097/HCR.0000000000000112
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220
   Sing MF, 2011, EUR J CANCER PREV, V20, P157, DOI 10.1097/CEJ.0b013e3283447497
   Singh NA, 2016, NUTR J, V15, P0, DOI 10.1186/s12937-016-0179-4
   Sinha D, 2017, SEM CANC BIOL, V0, P0
   Sinha R, 2012, AM J CLIN NUTR AJCN, V0, P0
   Sinreih M, 2017, DATA BRIEF, V12, P632, DOI 10.1016/j.dib.2017.04.050
   Sisti JS, 2015, CANCER EPIDEM BIOMAR, V24, P1174, DOI 10.1158/1055-9965.EPI-15-0246
   Smith P J, 2016, J PREV ALZHEIMERS DIS, V3, P53
   Song FJ, 2012, CANCER RES, V72, P3282, DOI 10.1158/0008-5472.CAN-11-3511
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   Striegel Lisa, 2015, FRONT NUTR, V2, P3, DOI 10.3389/fnut.2015.00003
   Su LJ, 2002, PUBLIC HEALTH NUTR, V5, P419, DOI 10.1079/PHN2001314
   Suzuki Y, 2005, J EPIDEMIOL, V15, P118, DOI 10.2188/jea.15.118
   Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88
   Suzuki-Sugihara N, 2016, NUTR RES, V36, P16, DOI 10.1016/j.nutres.2015.10.012
   Tam JHK, 2017, CEREBRAL CORTEX IN NEURODEGENERATIVE AND NEUROPSYCHIATRIC DISORDERS: EXPERIMENTAL APPROACHES TO CLINICAL ISSUES, V0, PP83, DOI 10.1016/B978-0-12-801942-9.00004-5
   Tang NP, 2009, AM J OBSTET GYNECOL, V201, P0, DOI 10.1016/j.ajog.2009.07.030
   Tang NP, 2009, LUNG CANCER, V65, P274, DOI 10.1016/j.lungcan.2008.12.002
   Tang WP, 2013, J FUNCT FOODS, V5, P1784, DOI 10.1016/j.jff.2013.08.007
   Tarride Jean-Eric, 2009, CAN J CARDIOL, V25, P0
   Taylor Peter W, 2005, FOOD SCI TECHNOL BULL, V2, P71, DOI 10.1616/1476-2137.14184
   Tenore GC, 2015, FOOD CHEM, V169, P320, DOI 10.1016/j.foodchem.2014.08.006
   Tenore GC, 2013, FOOD CHEM, V141, P2379, DOI 10.1016/j.foodchem.2013.04.128
   Thakur VS, 2012, CURR PHARM BIOTECHNO, V13, P191
   Tomata Y, 2016, AM J GERIAT PSYCHIAT, V24, P881, DOI 10.1016/j.jagp.2016.07.009
   Trudel D, 2012, GYNECOL ONCOL, V126, P491, DOI 10.1016/j.ygyno.2012.04.048
   Tucci SA, 2010, PHARMACEUTICALS-BASE, V3, P748, DOI 10.3390/ph3030748
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Uchiyama S, 2011, NUTRITION, V27, P287, DOI 10.1016/j.nut.2010.01.019
   Unno T, 2009, J NUTR SCI VITAMINOL, V55, P447, DOI 10.3177/jnsv.55.447
   Ustun C, 2013, MERSIN U TIP FAKULTE, V3, P8
   van Dieren S, 2009, DIABETOLOGIA, V52, P2561, DOI 10.1007/s00125-009-1516-3
   Velayutham P, 2008, CURR MED CHEM, V15, P1840
   Venkateswara Babu, 2011, J INDIAN SOC PERIODONTOL, V15, P18, DOI 10.4103/0972-124X.82258
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wang LF, 2014, NUTRITION, V30, P1122, DOI 10.1016/j.nut.2014.02.023
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang WC, 2014, ORAL ONCOL, V50, P276, DOI 10.1016/j.oraloncology.2013.12.014
   Wang Y, 2016, SCI REPORTS, V6, P0
   Wang YP, 2012, LUNG CANCER, V78, P169, DOI 10.1016/j.lungcan.2012.08.009
   Wang Y, 2009, J AGR FOOD CHEM, V57, P8109, DOI 10.1021/jf804025c
   Wang ZJ, 2013, WORLD J GASTROENTERO, V19, P2683, DOI 10.3748/wjg.v19.i17.2683
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
   White M, 2014, ROLE OXIDATIVE STRES, V0, P0
   Wile J, 2009, NUTR METAB, V6, P1
   Wu AH, 2003, INT J CANCER, V106, P574, DOI 10.1002/ijc.11259
   Wu Y, 2013, DATE BLACK TEA GREEN, V2, P1
   Xia EH, 2017, MOL PLANT, V10, P866, DOI 10.1016/j.molp.2017.04.002
   Xiang LP, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8080458
   Yajima H, 2014, PREVENTION DIET INDU, V12, P0
   Yang G, 2011, CARCINOGENESIS, V32, P1684, DOI 10.1093/carcin/bgr186
   Yang J, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2014-005632
   Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836
   Yang TT, 2017, BIOCHEM BIOPH RES CO, V489, P96, DOI 10.1016/j.bbrc.2017.05.095
   Yang XP, 2016, J SCI FOOD AGR, V96, P777, DOI 10.1002/jsfa.7147
   Yasui K, 2010, BIOMED RES-TOKYO, V31, P183, DOI 10.2220/biomedres.31.183
   Ye P, 2009, J HUAZHONG U SCI-MED, V29, P169, DOI 10.1007/s11596-009-0206-1
   Yu Y, 2014, APOPTOSIS, V19, P1, DOI 10.1007/s10495-013-0908-5
   Yuan JM, 2011, MOL NUTR FOOD RES, V55, P886, DOI 10.1002/mnfr.201000637
   Zhan X, 2017, TEA CONSUMPTION RISK, V0, P0
   Zhang M, 2002, CANCER EPIDEM BIOMAR, V11, P713
   Zhang XB, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0025822
   Zhang YW, 2013, WORLD J GASTROENTERO, V19, P5598, DOI 10.3748/wjg.v19.i34.5598
   Zhong W, 2015, EXP THER MED, V9, P405, DOI 10.3892/etm.2014.2135
   Zhou JY, 2016, BJOG-INT J OBSTET GY, V123, P90, DOI 10.1111/1471-0528.14007
   Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104
NR 248
TC 111
Z9 118
U1 7
U2 225
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0924-2244
EI 
J9 TRENDS FOOD SCI TECH
JI Trends Food Sci. Technol.
PD AUG 15
PY 2018
VL 78
IS 
BP 95
EP 106
DI 10.1016/j.tifs.2018.05.026
PG 12
WC Food Science & Technology
SC Food Science & Technology
GA GP6BC
UT WOS:000440960900008
DA 2025-04-28
ER

PT J
AU Acar-Tek, N
   Agagündüz, D
   Ayhan, B
AF Acar-Tek, Nilufer
   Agagunduz, Duygu
   Ayhan, Busra
TI Effect of Green Coffee Consumption on Resting Energy Expenditure, Blood Pressure, and Body Temperature in Healthy Women: A Pilot Study
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE Green coffee; caffeine; chlorogenic acids; resting energy expenditure; blood pressure; body temperature
ID induced insulin-resistance; chlorogenic acid; caffeine; obesity; pharmacokinetics; thermogenesis; metabolism; balance; humans; plasma
AB Objective: This study was conducted to determine the effects of green coffee consumption on resting energy expenditures (REEs), blood pressure, and body temperature of individuals. Method: The study was conducted with 24 women. The REE values of the individuals were measured with the COSMED Fitmate PRO. After the first REE measurements, individuals were given 1 cup of green coffee that was prepared to contain 6 mg caffeine per kg of lean body mass. After coffee consumption, REE measurements were made at 30, 60, 120, and 180 minutes. Blood pressure (mm Hg) and body temperature values (degrees C) were measured simultaneously with REE measurement. Results: There was a positive correlation between the caffeine amounts given with green coffee and 30-minute (p < 0.05), 60-minute (p = 0.06), and 120-minute (p < 0.05) REE (kcal/d) values. There was also a positive correlation between the total chlorogenic acid taken with green coffee and 30-minute (p < 0.05), 60-minute (p = 0.06), and 120-minute (p < 0.05) REE (kcal/d) values. The intracellular and extracellular fluid amounts liter(l) before and after consumption of green coffee by individuals were 18.7 +/- 1.57 versus 18.6 +/- 1.44 (p < 0.05) and 11.4 +/- 1.01 versus 11.2 +/- 0.97 (p < 0.05), respectively. The body temperature (degrees C) changes observed in the individuals whose usual dietary caffeine intake was less than or equal to the 50th percentile after green coffee consumption were statistically significant (p < 0.05). Similarly, the diastolic blood pressure changes observed in the individuals whose usual dietary caffeine intake was less than or equal to the 50th percentile after green coffee consumption was almost statistically significant (p = 0.06). Conclusions: The results of this study showed that 6 mg caffeine/kg (lean body mass) intake among women changed body temperature and blood pressure values and liquid balance depending on the usual dietary coffee intake. In addition, chlorogenic acid is also correlated with REE values besides green coffee caffeine.
C1 [Acar-Tek, Nilufer; Agagunduz, Duygu; Ayhan, Busra] Gazi Univ, Dept Nutr & Dietet, Fac Hlth Sci, Ankara, Turkey.
C3 Gazi University
RP Ayhan, B (corresponding author), Gazi Univ, Dept Nutr & Dietet, Fac Hlth Sci, Ankara, Turkey.
EM busraayhan989@gmail.com
CR Abdali D, 2015, MED PRIN PRACT, V24, P201, DOI 10.1159/000375305
   Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Armstrong LE, 2002, INT J SPORT NUTR EXE, V12, P189, DOI 10.1123/ijsnem.12.2.189
   Ballard TLP, 2006, CLIN EXP PHARMACOL P, V33, P310, DOI 10.1111/j.1440-1681.2006.04367.x
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bruckbauer A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0089166
   Cano-Marquina A, 2013, MATURITAS, V75, P7, DOI 10.1016/j.maturitas.2013.02.002
   COLLINS LC, 1994, INT J OBESITY, V18, P551
   Dulloo AG, 2011, OBES REV, V12, P866, DOI 10.1111/j.1467-789X.2011.00909.x
   DULLOO AG, 1992, METABOLISM, V41, P1233, DOI 10.1016/0026-0495(92)90015-3
   EFSA, 2016, EFSA J, V14, P0, DOI 10.2903/j.efsa.2016.4552
   Mesas AE, 2011, AM J CLIN NUTR, V94, P1113, DOI 10.3945/ajcn.111.016667
   Geleijnse JM, 2008, VASC HEALTH RISK MAN, V4, P963
   George SE, 2008, CRIT REV FOOD SCI, V48, P464, DOI 10.1080/10408390701522445
   Ghadieh HE, 2015, NUTR METAB, V12, P0, DOI 10.1186/s12986-015-0014-5
   Guessous I, 2014, CURR HYPERTENS REP, V16, P0, DOI 10.1007/s11906-014-0468-2
   Harland BF, 2000, NUTRITION, V16, P522, DOI 10.1016/S0899-9007(00)00369-5
   Higdon JV, 2006, CRIT REV FOOD SCI, V46, P101, DOI 10.1080/10408390500400009
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jellin J, 2012, PHARM LETT PRESCRIBE, V0, P0
   Killer SC, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0084154
   KOOT P, 1995, ANN NUTR METAB, V39, P135, DOI 10.1159/000177854
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Martínez-López S, 2014, FOOD RES INT, V64, P125, DOI 10.1016/j.foodres.2014.05.043
   Maughan RJ, 2003, J HUM NUTR DIET, V16, P411, DOI 10.1046/j.1365-277X.2003.00477.x
   McCarty MF, 2005, MED HYPOTHESES, V64, P848, DOI 10.1016/j.mehy.2004.03.037
   Nurminen ML, 1999, EUR J CLIN NUTR, V53, P831, DOI 10.1038/sj.ejcn.1600899
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Rakcolu N, 2014, YEMEK VE BESIN FOTORAF KATALOU, VVolume 132, P0
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/482704
   Riksen NP, 2009, PHARMACOL THERAPEUT, V121, P185, DOI 10.1016/j.pharmthera.2008.10.006
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Silva AM, 2013, APPL PHYSIOL NUTR ME, V38, P626, DOI 10.1139/apnm-2012-0253
   TARNOPOLSKY MA, 1994, SPORTS MED, V18, P109, DOI 10.2165/00007256-199418020-00004
   Westerterp-Plantenga MS, 2010, PHYSIOL BEHAV, V100, P42, DOI 10.1016/j.physbeh.2010.02.005
NR 41
TC 5
Z9 5
U1 1
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD NOV 17
PY 2018
VL 37
IS 8
BP 691
EP 700
DI 10.1080/07315724.2018.1461147
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HE1XU
UT WOS:000453068000006
PM 29723112
DA 2025-04-28
ER

PT J
AU Papadopoulou, E
   Botton, J
   Brantsæter, AL
   Haugen, M
   Alexander, J
   Meltzer, HM
   Bacelis, J
   Elfvin, A
   Jacobsson, B
   Engpiel, V
AF Papadopoulou, Eleni
   Botton, Jeremie
   Brantsaeter, Anne-Lise
   Haugen, Margaretha
   Alexander, Jan
   Meltzer, Helle Margrete
   Bacelis, Jonas
   Elfvin, Anders
   Jacobsson, Bo
   Engpiel, Verena
TI Maternal caffeine intake during pregnancy and childhood growth and overweight: results from a large Norwegian prospective observational cohort study
SO BMJ OPEN
LA English
DT Article
ID gestational weight-gain; body-mass index; birth-weight; rapid growth; developmental origins; pooled analysis; metabolic risk; disease; infancy; association
AB Objectives To study the association between maternal caffeine intake during pregnancy and the child's weight gain and overweight risk up to 8 years. Design Prospective nationwide pregnancy cohort. Setting The Norwegian Mother and Child Cohort Study. Participants A total of 50943 mothers recruited from 2002 to 2008 and their children, after singleton pregnancies, with information about average caffeine intake assessed at mid-pregnancy. Outcome measure Child's body size information at 11 age points from 6 weeks to 8 years. We defined excess growth in infancy as a WHO weight gain z-score of >0.67 from birth to age 1 year, and overweight according to the International Obesity Task Force. We used a growth model to assess individual growth trajectories. Results Compared with pregnant women with low caffeine intake (<50 mg/day, 46%), women with average (50-199 mg/day, 44 %), high (>= 200-299 mg/day, 7 %) and very high (>= 300 mg/day, 3%) caffeine intakes had an increased risk of their child experiencing excess growth in infancy, after adjustment for confounders (OR=1.15, 95% CI 1.09 to 1.22, OR=1.30, 95% CI 1.16 to 1.45, OR=1.66, 95%CI 1.42 to 1.93, respectively). In utero exposure to any caffeine was associated with higher risk of overweight at age 3 years and 5 years, while the association persisted at 8 years, only for very high exposures. Any caffeine intake was associated with increased body mass index from infancy to childhood. Children prenatally exposed to caffeine intake >200 mg/day had consistently higher weight. Very High caffeine exposures were associated with higher weight gain velocity from infancy to age 8 years. Conclusion Any caffeine consumption during pregnancy is associated with a higher risk of excess infant growth and of childhood overweight, mainly at preschool ages. Maternal caffeine intake may modify the overall weight growth trajectory of the child from birth to 8 years. This study adds supporting evidence for the current advice to reduce caffeine intake during pregnancy.
C1 [Papadopoulou, Eleni; Brantsaeter, Anne-Lise; Haugen, Margaretha] Norwegian Inst Publ Hlth, Dept Environm Exposure & Epidemiol, Div Infect Control & Environm Hlth, Oslo, Norway.
   [Botton, Jeremie] Epidemiol & Biostat Sorbonne Paris Cite Ctr CRESS, INSERM, Early Determinants Childs Hlth & Dev Team ORCHAD, UMR1 153, Paris, France.
   [Botton, Jeremie] Univ Paris Saclay, Univ Paris Sud, Fac Pharm, Chatenay Malabry, France.
   [Alexander, Jan; Meltzer, Helle Margrete] Norwegian Inst Publ Hlth, Div Infect Control & Environm Hlth, Oslo, Norway.
   [Bacelis, Jonas; Jacobsson, Bo] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Gothenburg, Sweden.
   [Elfvin, Anders] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Dept Pediat, Gothenburg, Sweden.
   [Jacobsson, Bo] Norwegian Inst Publ Hlth, Dept Genet & Bioinforrnat, Div Hlth Data & Digitalizat, Oslo, Norway.
   [Engpiel, Verena] Sahlgrens Univ Hosp, Dept Obstet & Gynecol, Gothenburg, Sweden.
C3 Norwegian Institute of Public Health (NIPH); Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Norwegian Institute of Public Health (NIPH); University of Gothenburg; University of Gothenburg; Norwegian Institute of Public Health (NIPH); Sahlgrenska University Hospital
RP Papadopoulou, E (corresponding author), Norwegian Inst Publ Hlth, Dept Environm Exposure & Epidemiol, Div Infect Control & Environm Hlth, Oslo, Norway.
EM eleni.papadopoulou@fhi.no
FU Norwegian Ministry of Health and Care Services; Ministry of Education and Research; NIH/NIEHS [N01-ES-75558]; NIH/NINDS [1 U01 NS 047537-01, 2 U01 NS 047537-06A1]; Stiftelsen Sigurd och Elsa Goljes Minnesfond [LA2013-0241]; Stiftelsen Fru Mary von Sydows, fodd Wijk, donationsfond; Wilhelm och Martina Lundgrens Vetenskapsfond [1 vet1-119/2014]
CR Agostoni C, 2015, EFSA J, V13, P0, DOI 10.2903/j.efsa.2015.4102
   Unknown -, 2006, WHO CHILD GROWTH STANDARDS: LENGTH/HEIGHT-FOR-AGE, V0, P0
   Unknown -, 2001, REGRESSION MODELING STRATEGIES: WITH APPLICATIONS TO LINEAR MODELS, V0, P0
   Unknown -, 2015, RISK ASS OTH SUBST C, V0, P0
   Baidal JAW, 2016, AM J PREV MED, V50, P761, DOI 10.1016/j.amepre.2015.11.012
   Baird J, 2005, BMJ-BRIT MED J, V331, P929, DOI 10.1136/bmj.38586.411273.E0
   Barker DJP, 2005, J AM SOC NEPHROL, V16, P2537, DOI 10.1681/ASN.2005020160
   BARKER DJP, 1995, BRIT MED J, V311, P171, DOI 10.1136/bmj.311.6998.171
   Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019
   BERKEY CS, 1982, BIOMETRICS, V38, P221, DOI 10.2307/2530305
   Botton J, 2008, AM J CLIN NUTR, V87, P1760, DOI 10.1093/ajcn/87.6.1760
   Boylan S, 2008, BMJ-BRIT MED J, V337, P0, DOI 10.1136/bmj.a2332
   Brantsæter AL, 2008, MATERN CHILD NUTR, V4, P28, DOI 10.1111/j.1740-8709.2007.00103.x
   Brantsæter AL, 2007, PUBLIC HEALTH NUTR, V10, P838, DOI 10.1017/S1368980007339037
   Brew BK, 2017, SCAND J PUBLIC HEALT, V45, P36, DOI 10.1177/1403494817702324
   Buscariollo DL, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087547
   Cole TJ, 2012, PEDIATR OBES, V7, P284, DOI 10.1111/j.2047-6310.2012.00064.x
   Comets E, 2014, SAEMIX: STOCHASTIC APPROXIMATION EXPECTATION MAXIMIZATION (SAEM) ALGORITHM, V0, P0
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   de Medeiros TS, 2017, MATERN CHILD HLTH J, V21, P1297, DOI 10.1007/s10995-016-2230-7
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071
   Gluckman PD, 2005, EARLY HUM DEV, V81, P51, DOI 10.1016/j.earlhumdev.2004.10.003
   Hanson M, 2011, AM J CLIN NUTR, V94, P1754S, DOI 10.3945/ajcn.110.001206
   HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503
   Hindmarsh PC, 2008, PEDIATR RES, V63, P99, DOI 10.1203/PDR.0b013e31815b8e8f
   JENSS RACHEL M, 1937, HUMAN BIOL, V9, P556
   Jones-Smith JC, 2013, NUTR DIABETES, V3, P0, DOI 10.1038/nutd.2012.32
   Karaolis-Danckert N, 2006, AM J CLIN NUTR, V84, P1449, DOI 10.1093/ajcn/84.6.1449
   Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356
   Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761
   Li DK, 2015, INT J OBESITY, V39, P658, DOI 10.1038/ijo.2014.196
   Li J, 2015, TOXICOL APPL PHARM, V284, P345, DOI 10.1016/j.taap.2015.03.002
   Liu JX, 2018, INT J OBESITY, V42, P8, DOI 10.1038/ijo.2017.183
   Magnus P, 2016, INT J EPIDEMIOL, V45, P382, DOI 10.1093/ije/dyw029
   Mihrshahi S, 2011, BMC PEDIATR, V11, P0, DOI 10.1186/1471-2431-11-99
   Monasta L, 2010, OBES REV, V11, P695, DOI 10.1111/j.1467-789X.2010.00735.x
   Monteiro POA, 2005, OBES REV, V6, P143, DOI 10.1111/j.1467-789X.2005.00183.x
   Morgen CS, 2018, INT J OBESITY, V42, P594, DOI 10.1038/ijo.2017.217
   Mort JR, 2008, ANN PHARMACOTHER, V42, P105, DOI 10.1345/aph.1K337
   Ong KK, 2006, ACTA PAEDIATR, V95, P904, DOI 10.1080/08035250600719754
   Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967
   Perng W, 2016, J PEDIATR-US, V173, P122, DOI 10.1016/j.jpeds.2016.02.053
   R Core team, 2016, R: A LANGUAGE AND ENVIRONMENTAL STATISTICAL COMPUTING, V0, P0, DOI DOI 10.1007/978-3-540-74686-7
   Rhee J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0132334
   Richmond RC, 2014, EARLY HUM DEV, V90, P769, DOI 10.1016/j.earlhumdev.2014.08.023
   Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf
   Sengpiel V, 2013, BMC MED, V11, P0, DOI 10.1186/1741-7015-11-42
   Skjærven R, 2000, ACTA OBSTET GYN SCAN, V79, P440, DOI 10.1034/j.1600-0412.2000.079006440.x
   Stratakis N, 2016, JAMA PEDIATR, V170, P381, DOI 10.1001/jamapediatrics.2015.4430
   Subhan FB, 2017, MATERN CHILD HLTH J, V21, P1396, DOI 10.1007/s10995-016-2246-z
   Tomimatsu T, 2007, REPROD SCI, V14, P588, DOI 10.1177/1933719107307717
   Voerman E, 2016, OBESITY, V24, P1170, DOI 10.1002/oby.21466
   Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Wu YM, 2015, TOXICOL APPL PHARM, V289, P109, DOI 10.1016/j.taap.2015.09.007
   Xn D, 2012, TOXICOL APPL PHARM, V264, P395, DOI 10.1016/j.taap.2012.08.016
   Xu D, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0044497
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yang S, 2016, ANN EPIDEMIOL, V26, P77, DOI 10.1016/j.annepidem.2015.10.002
NR 61
TC 43
Z9 45
U1 1
U2 18
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2044-6055
EI 
J9 BMJ OPEN
JI BMJ Open
PD MAR 15
PY 2018
VL 8
IS 3
BP 
EP 
DI 10.1136/bmjopen-2017-018895
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA GH7YZ
UT WOS:000433881200074
PM 29685923
DA 2025-04-28
ER

PT J
AU Beck, KL
   Jones, B
   Ullah, I
   McNaughton, SA
   Haslett, SJ
   Stonehouse, W
AF Beck, K. L.
   Jones, B.
   Ullah, I.
   McNaughton, S. A.
   Haslett, S. J.
   Stonehouse, W.
TI Associations between dietary patterns, socio-demographic factors and anthropometric measurements in adult New Zealanders: an analysis of data from the 2008/09 New Zealand Adult Nutrition Survey
SO EUROPEAN JOURNAL OF NUTRITION
LA English
DT Article
DE Dietary patterns; Factor analysis; Obesity; Socio-economic status
ID life-style factors; body-mass index; food security; energy-intake; health; prediction; age
AB Purpose To investigate associations between dietary patterns, socio-demographic factors and anthropometric measurements in adult New Zealanders. Methods Dietary patterns were identified using factor analysis in adults 15 years plus (n = 4657) using 24-h diet recall data from the 2008/09 New Zealand Adult Nutrition Survey. Multivariate regression was used to investigate associations between dietary patterns and age, gender and ethnicity. After controlling for demographic factors, associations between dietary patterns and food insecurity, deprivation, education, and smoking were investigated. Associations between dietary patterns and body mass index and waist circumference were examined adjusting for demographic factors, smoking and energy intake. Results Two dietary patterns were identified. 'Healthy' was characterised by breakfast cereal, low fat milk, soy and rice milk, soup and stock, yoghurt, bananas, apples, other fruit and tea, and low intakes of pies and pastries, potato chips, white bread, takeaway foods, soft drinks, beer and wine. 'Traditional' was characterised by beef, starchy vegetables, green vegetables, carrots, tomatoes, savoury sauces, regular milk, cream, sugar, tea and coffee, and was low in takeaway foods. The 'healthy' pattern was positively associated with age, female gender, New Zealand European or other ethnicity, and a secondary school qualification, and inversely associated with smoking, food insecurity, area deprivation, BMI and waist circumference. The 'traditional' pattern was positively associated with age, male gender, smoking, food insecurity and inversely associated with a secondary school qualification. Conclusions A 'Healthy' dietary pattern was associated with higher socio-economic status and reduced adiposity, while the 'traditional' pattern was associated with lower socio-economic status.
C1 [Beck, K. L.] Massey Univ Auckland, Coll Hlth, Sch Food & Nutr, Private Bag 102904, Auckland 0745, New Zealand.
   [Jones, B.; Ullah, I.] Massey Univ Auckland, Coll Sci, Inst Nat & Math Sci, Private Bag 102904, Auckland 0745, New Zealand.
   [Ullah, I.] Queensland Univ Technol, Sci & Engn Fac, GPO Box 2434, Brisbane, Qld 4001, Australia.
   [McNaughton, S. A.] Deakin Univ, Sch Exercise & Nutr Sci, Inst Phys Act & Nutr, 221 Burwood Highway, Burwood, Vic 3125, Australia.
   [Haslett, S. J.] Massey Univ, Coll Sci, Inst Fundamental Sci Stat, Private Bag 11222, Palmerston North 4442, New Zealand.
   [Haslett, S. J.] Australian Natl Univ, Stat Consulting Unit, Acton, ACT 2601, Australia.
   [Stonehouse, W.] CSIRO, Food & Nutr Business Unit, POB 11060, Adelaide, SA 5001, Australia.
C3 Massey University; Massey University; Queensland University of Technology (QUT); Deakin University; Massey University; Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)
RP Beck, KL (corresponding author), Massey Univ Auckland, Coll Hlth, Sch Food & Nutr, Private Bag 102904, Auckland 0745, New Zealand.
EM k.l.beck@massey.ac.nz
FU Higher Education Commission of Pakistan; NHMRC Career Development Fellowship Level 2 [1104636]; ARC Future Fellowship [FT100100581]; New Zealand Ministry of Health; National Health and Medical Research Council of Australia [1104636] Funding Source: NHMRC
CR Unknown -, 2012, FOC PAC NUTR FIND 20, V0, P0
   Unknown -, 2012, FOC MAOR NUTR FIND 2, V0, P0
   Unknown -, 2016, NATIONAL DIET AND NUTRITION SURVEY, V0, P0
   Australian Bureau of Statistics, 2014, 4364 0 55 007 AUSTR, V0, P0
   Ax E, 2016, BRIT J NUTR, V115, P95, DOI 10.1017/S0007114515004110
   Bailey RL, 2007, J AM DIET ASSOC, V107, P64, DOI 10.1016/j.jada.2006.10.009
   Beck KL, 2013, EUR J NUTR, V52, P467, DOI 10.1007/s00394-012-0348-y
   Bell LK, 2015, NUTRIENTS, V7, P6491, DOI 10.3390/nu7085295
   Carrera PM, 2007, J AM DIET ASSOC, V107, P1735, DOI 10.1016/j.jada.2007.07.016
   DiBello JR, 2009, J NUTR, V139, P1933, DOI 10.3945/jn.109.107888
   Gemming L, 2014, EUR J CLIN NUTR, V68, P259, DOI 10.1038/ejcn.2013.242
   Hefford M, 2005, HEALTH POLICY, V72, P9, DOI 10.1016/j.healthpol.2004.06.005
   Hellton KH, 2014, SCAND J STAT, V41, P1051, DOI 10.1111/sjos.12083
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Kim HS, 2008, NUTRITION, V24, P1065, DOI 10.1016/j.nut.2008.05.008
   Knudsen VK, 2014, EUR J CLIN NUTR, V68, P736, DOI 10.1038/ejcn.2014.38
   Lehtonen R, 2003, PRACTICAL METHODS FOR DESIGN AND ANALYSIS OF COMPLEX SURVEYS, V2nd, P0
   Lumley T, 2004, J STAT SOFTW, V9, P1, DOI 10.18637/JSS.V009.I08
   Lumley T, 2014, SURVEY: ANALYSIS OF COMPLEX SURVEY SAMPLES. R PACKAGE VERSION 3.30, V0, P0
   Macdiarmid J, 1998, NUTR RES REV, V11, P231, DOI 10.1079/NRR19980017
   Macdiarmid JI, 1997, EUR J CLIN NUTR, V51, P199, DOI 10.1038/sj.ejcn.1600380
   Martinez ME, 1998, AM J EPIDEMIOL, V148, P17, DOI 10.1093/oxfordjournals.aje.a009552
   Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068
   Mateo-Gallego R, 2012, NUTR RES, V32, P466, DOI 10.1016/j.nutres.2012.05.004
   McNaughton SA, 2005, EUR J CLIN NUTR, V59, P341, DOI 10.1038/sj.ejcn.1602079
   Ministry of health, 2015, UNDERSTANDING EXCESS BODY WEIGHT: NEW ZEALAND HEALTH SURVEY, V0, P0
   Mishra G, 2002, EUR J CLIN NUTR, V56, P687, DOI 10.1038/sj.ejcn.1601391
   Mishra GD, 2010, EUR J CLIN NUTR, V64, P1125, DOI 10.1038/ejcn.2010.121
   National Health and Nutrition Examinations Survey (NHANES), 2016, NHANES RESP RAT POP, V0, P0
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Park SY, 2005, J NUTR, V135, P843, DOI 10.1093/jn/135.4.843
   Parnell WR, 2001, NEW ZEAL MED J, V114, P141
   Prentice A M, 2001, OBES REV, V2, P141, DOI 10.1046/j.1467-789x.2001.00031.x
   Price GM, 1997, BRIT J NUTR, V77, P833, DOI 10.1079/BJN19970083
   Rankinen T, 1999, INT J OBESITY, V23, P801, DOI 10.1038/sj.ijo.0800929
   Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, P0
   Scagliusi FB, 2008, BRIT J NUTR, V100, P1060, DOI 10.1017/S0007114508971300
   Smith C, 2015, PUBLIC HEALTH NUTR, V18, P3249, DOI 10.1017/S1368980015000890
   Stanforth PR, 2004, INT J OBESITY, V28, P925, DOI 10.1038/sj.ijo.0802563
   Stefanogiannis N, 2005, PUBLIC HEALTH NUTR, V8, P395, DOI 10.1079/PHN2004694
   Thompson JMD, 2010, BRIT J NUTR, V103, P1665, DOI 10.1017/S0007114509993606
   Togo P, 2001, INT J OBESITY, V25, P1741, DOI 10.1038/sj.ijo.0801819
   Townsend MS, 2001, J NUTR, V131, P1738, DOI 10.1093/jn/131.6.1738
   Tucker KL, 2010, APPL PHYSIOL NUTR ME, V35, P211, DOI 10.1139/H10-010
   University of Otago and Ministry of Health, 2011, METH REP 2008 09 NZ, V0, P0
   Wall CR, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8050300
   Wilde PE, 2006, J NUTR, V136, P1395, DOI 10.1093/jn/136.5.1395
NR 49
TC 57
Z9 60
U1 0
U2 26
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1436-6207
EI 1436-6215
J9 EUR J NUTR
JI Eur. J. Nutr.
PD JUN 15
PY 2018
VL 57
IS 4
BP 1421
EP 1433
DI 10.1007/s00394-017-1421-3
PG 13
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GG4YU
UT WOS:000432703000012
PM 28378296
DA 2025-04-28
ER

PT J
AU Golzarand, M
   Toolabi, K
   Aghasi, M
AF Golzarand, Mahdieh
   Toolabi, Karamollah
   Aghasi, Mohadeseh
TI Effect of green tea, caffeine and capsaicin supplements on the anthropometric indices: A meta-analysis of randomized clinical trials
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Green tea; Caffeine; Capsaicin; Weight; Body fat; Meta-analysis
ID body-weight; camellia-sinensis; oxidative stress; double-blind; obese; extract; consumption; maintenance; resistance; overweight
AB We conducted a meta-analysis to assess the effect of green tea, caffeine and capsaicin supplements on the anthropometric indices in adults. PubMed/Medline, Scopus, Cochran and Web of Science databases were searched up to March 2017. Green tea significantly reduced weight by -0.65 kg (-1.10 to -0.20, P = 0.005), body mass index (BMI) by -0.26 kg/m(2) (-0.43 to -0.10, P = 0.002) and waist circumference by -1.11 cm (-1.99 to -0.23, P = 0.01) but not percent of body fat (PBF) (-1.42%, 95% CI: -3.02 to 0.18, P = 0.08). Caffeine supplement had no effect on weight (-2.99 kg, 95% CI: - 7.83 to 1.41, P = 0.18). We observed a significant weight loss after capsaicin supplement (-0.50 kg; 95% CI: -0.90 to -0.11, P = 0.01) but PBF did not change significantly from baseline (0.11%, 95% CI: -0.22 to 0.43, P = 0.51). Green tea and capsaicin supplements have a significant mild weight-lowering effect. On the contrary, it seems caffeine had no effect on weight.
C1 [Golzarand, Mahdieh; Aghasi, Mohadeseh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Tehran, Iran.
   [Toolabi, Karamollah] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Surg, Tehran, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical Sciences
RP Toolabi, K (corresponding author), Imam Khomeini Hosp, Keshavarz Blvd,POB 13145-158, Tehran, Iran.
EM tolabika@tums.ac.ir
CR Al-Naggar RA, 2013, RES J PHARM BIOL CHE, V4, P1649
   Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Bajerska J, 2015, J MED FOOD, V18, P698, DOI 10.1089/jmf.2014.0032
   Baladia E, 2014, NUTR HOSP, V29, P479, DOI 10.3305/nh.2014.29.3.7118
   Basu A, 2010, J AM COLL NUTR, V29, P31, DOI 10.1080/07315724.2010.10719814
   Bogdanski P, 2012, NUTR RES, V32, P421, DOI 10.1016/j.nutres.2012.05.007
   Cardoso GA, 2013, J MED FOOD, V16, P120, DOI 10.1089/jmf.2012.0062
   Chan CCW, 2006, J SOC GYNECOL INVEST, V13, P63, DOI 10.1016/j.jsgi.2005.10.006
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Christensen PM, 2017, FRONT PHYSIOL, V8, P0, DOI 10.3389/fphys.2017.00240
   Conforti F, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21121750
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Fukino Y, 2008, EUR J CLIN NUTR, V62, P953, DOI 10.1038/sj.ejcn.1602806
   Gahreman D, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8080510
   Glaister M, 2018, INT J SPORT PHYSIOL, V13, P402, DOI 10.1123/ijspp.2017-0312
   Grgic J, 2018, J INT SOC SPORT NUTR, V15, P0, DOI 10.1186/s12970-018-0216-0
   Grgic J, 2018, EUR J SPORT SCI, V18, P219, DOI 10.1080/17461391.2017.1394371
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, MOL NUTR FOOD RES, V60, P223, DOI 10.1002/mnfr.201500620
   Hasani-Ranjbar S, 2013, J DIABETES METAB DIS, V12, P0, DOI 10.1186/2251-6581-12-28
   Hedayati, 2013, IRANIAN J ENDOCRINOL, V15, P253
   Hovanloo F, 2016, J MED PLANTS, V15, P17
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Hursel R, 2009, AM J CLIN NUTR, V89, P822, DOI 10.3945/ajcn.2008.27043
   Icken D, 2016, EUR J CLIN NUTR, V70, P532, DOI 10.1038/ejcn.2015.183
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   Janssens PLHR, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0153134
   Janssens PLHR, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0067786
   Joy JM, 2016, J INT SOC SPORT NUTR, V13, P0, DOI 10.1186/s12970-016-0136-9
   Jurgens TM, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD008650.pub2
   Kovacs EMR, 2004, BRIT J NUTR, V91, P431, DOI 10.1079/BJN20041061
   Lee TA, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-78
   Lejeune MPGM, 2003, BRIT J NUTR, V90, P651, DOI 10.1079/BJN2003938
   Low S, 2009, ANN ACAD MED SINGAP, V38, P57
   Luo XJ, 2011, EUR J PHARMACOL, V650, P1, DOI 10.1016/j.ejphar.2010.09.074
   Malek MH, 2006, J STRENGTH COND RES, V20, P751
   Mirzaei K, 2010, GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, V169, P137
   Mohammadi S, 2010, J ZANJAN UNIV MED SCI HEALTH SERVICES, V18, P44
   Mousavi A, 2013, J RES MED SCI, V18, P1080
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nieman DC, 2012, PLANT FOOD HUM NUTR, V67, P415, DOI 10.1007/s11130-012-0325-x
   Nirengi S, 2016, J BIOMED OPT, V21, P0, DOI 10.1117/1.JBO.21.9.091305
   Ohnaka K, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/207426
   Pezeshki A, 2015, INT J PREVENTIVE MED, V0, P1
   Roberts JD, 2015, J INT SOC SPORT NUTR, V12, P0, DOI 10.1186/s12970-014-0062-7
   Snitker S, 2009, AM J CLIN NUTR, V89, P45, DOI 10.3945/ajcn.2008.26561
   Suliburska J, 2012, BIOL TRACE ELEM RES, V149, P315, DOI 10.1007/s12011-012-9448-z
   Sun NN, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21101351
   Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1
   TOUBRO S, 1993, INT J OBESITY, V17, P0
   Tsai CH, 2009, INT J FOOD SCI NUTR, V60, P151, DOI 10.1080/09637480903136667
   Tundis R, 2011, PLANT FOOD HUM NUTR, V66, P261, DOI 10.1007/s11130-011-0248-y
   Senger AEV, 2012, J NUTR HEALTH AGING, V16, P738, DOI 10.1007/s12603-012-0081-5
   Zheng J, 2017, BIOSCIENCE REP, V37, P0, DOI 10.1042/BSR20170286
   Zsiborás C, 2018, CRIT REV FOOD SCI, V58, P1419, DOI 10.1080/10408398.2016.1262324
NR 57
TC 16
Z9 17
U1 5
U2 33
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUL 15
PY 2018
VL 46
IS 
BP 320
EP 328
DI 10.1016/j.jff.2018.04.002
PG 9
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA GS4PG
UT WOS:000443630000035
DA 2025-04-28
ER

PT J
AU Cornelis, MC
   Gustafsson, S
   Ärnlöv, J
   Elmståhl, S
   Söderberg, S
   Sundström, J
   Michaëlsson, K
   Lind, L
   Ingelsson, E
AF Cornelis, M. C.
   Gustafsson, S.
   Arnlov, J.
   Elmstahl, S.
   Soderberg, S.
   Sundstrom, J.
   Michaelsson, K.
   Lind, L.
   Ingelsson, E.
TI Targeted proteomic analysis of habitual coffee consumption
SO JOURNAL OF INTERNAL MEDICINE
LA English
DT Article
DE biomarkers; coffee; epidemiology; population; proteomics
ID dose-response metaanalysis; inflammatory markers; prospective cohort; caffeine intake; serum ykl-40; bound leptin; obese gene; risk; women; cancer
AB BackgroundCoffee drinking has been implicated in mortality and a variety of diseases but potential mechanisms underlying these associations are unclear. Large-scale systems epidemiological approaches may offer novel insights to mechanisms underlying associations of coffee with health. ObjectiveWe performed an analysis of known and novel protein markers linked to cardiovascular disease and their association with habitual coffee intake in the Prospective Study of the Vasculature in Uppsala Seniors (PIVUS, n = 816) and followed up top proteins in the Uppsala Longitudinal Study of Adult Men (ULSAM, n = 635) and EpiHealth (n = 2418). MethodsIn PIVUS and ULSAM, coffee intake was measured by 7-day dietary records whilst a computer-based food frequency questionnaire was used in EpiHealth. Levels of up to 80 proteins were assessed in plasma by a proximity extension assay. ResultsFour protein-coffee associations adjusted for age, sex, smoking and BMI, met statistical significance in PIVUS (FDR < 5%, P < 2.31 x 10(-3)): leptin (LEP), chitinase-3-like protein 1 (CHI3L), tumour necrosis factor (TNF) receptor 6 and TNF-related apoptosis-inducing ligand. The inverse association between coffee intake and LEP replicated in ULSAM (, -0.042 SD per cup of coffee, P = 0.028) and EpiHealth (, -0.025 SD per time of coffee, P = 0.004). The negative coffee-CHI3L association replicated in EpiHealth (, -0.07, P = 1.15 x 10(-7)), but not in ULSAM (, -0.034, P = 0.16). ConclusionsThe current study supports an inverse association between coffee intake and plasma LEP and CHI3L1 levels. The coffee-CHI3L1 association is novel and warrants further investigation given links between CHI3L1 and health conditions that are also potentially influenced by coffee.
C1 [Cornelis, M. C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   [Gustafsson, S.; Ingelsson, E.] Uppsala Univ, Mol Epidemiol & Sci Life Lab, Dept Med Sci, Uppsala, Sweden.
   [Arnlov, J.] Karolinska Inst, Care Sci & Soc, Dept Neurobiol, Div Family Med & Primary Care, Huddinge, Sweden.
   [Arnlov, J.] Dalarna Univ, Sch Hlth & Social Sci, Falun, Sweden.
   [Elmstahl, S.] Malmo Univ Hosp, Lund Univ, Div Geriatr Med, Dept Clin Sci, Malmo, Sweden.
   [Soderberg, S.] Umea Univ, Dept Publ Hlth & Clin Med Cardiol, Umea, Sweden.
   [Sundstrom, J.; Lind, L.] Uppsala Univ, Dept Med Sci Cardiovasc Epidemiol, Uppsala, Sweden.
   [Sundstrom, J.] Uppsala Univ, Uppsala Clin Res Ctr, Uppsala, Sweden.
   [Michaelsson, K.] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden.
   [Ingelsson, E.] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.
C3 Northwestern University; Feinberg School of Medicine; Uppsala University; Karolinska Institutet; Dalarna University; Lund University; Skane University Hospital; Umea University; Uppsala University; Uppsala University; Uppsala University; Stanford University
RP Cornelis, MC (corresponding author), 680 North Lake Shore Dr,Suite 1400, Chicago, IL 60611 USA.; Ingelsson, E (corresponding author), 300 Pasteur Dr,Mail Code 5773, Stanford, CA 94305 USA.
EM marilyn.cornelis@northwestern.edu; eriking@stanford.edu
CR Aleksandrova K, 2015, AM J CLIN NUTR, V102, P1498, DOI 10.3945/ajcn.115.116095
   Unknown -, 2010, R LANG ENV STAT COMP, V0, P0
   Assarsson E, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0095192
   Bakuradze T, 2014, FOOD RES INT, V63, P420, DOI 10.1016/j.foodres.2014.05.032
   Becker W, 1994, SWEDISH NATL FOOD AD, V0, P0
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhupathiraju SN, 2014, DIABETOLOGIA, V57, P1346, DOI 10.1007/s00125-014-3235-7
   Bilge U, 2017, BIOMED RES-TOKYO, V2017, P0
   Brabant G, 2000, DIABETOLOGIA, V43, P438, DOI 10.1007/s001250051326
   Cornelis MC, 2014, CURRENT NUTRITION REPORTS, V3, P178
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Craig-Schapiro R, 2010, BIOL PSYCHIAT, V68, P903, DOI 10.1016/j.biopsych.2010.08.025
   Daglia M, 2000, J AGR FOOD CHEM, V48, P1449, DOI 10.1021/jf990510g
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   European Coffee Federation, 2012, EUR COFF REP 2012 13, V0, P0
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Frost-Meyer NJ, 2012, J FUNCT FOODS, V4, P819, DOI 10.1016/j.jff.2012.05.010
   Fusetti F, 2003, J BIOL CHEM, V278, P37753, DOI 10.1074/jbc.M303137200
   Gilbert R M, 1984, PROG CLIN BIOL RES, V158, P185
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Guertin KA, 2015, AM J CLIN NUTR, V101, P1000, DOI 10.3945/ajcn.114.096099
   HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777
   He CH, 2013, CELL REP, V4, P830, DOI 10.1016/j.celrep.2013.07.032
   Imatoh T, 2015, EUR J CLIN NUTR, V69, P1023, DOI 10.1038/ejcn.2015.23
   Ingelsson E, 2005, JAMA-J AM MED ASSOC, V294, P334, DOI 10.1001/jama.294.3.334
   Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Laitala VS, 2008, ADDICTION, V103, P2054, DOI 10.1111/j.1360-0443.2008.02375.x
   LANDINWILHELMSEN K, 1994, CLIN ENDOCRINOL, V41, P351, DOI 10.1111/j.1365-2265.1994.tb02556.x
   Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da
   Lind L, 2013, EUR J EPIDEMIOL, V28, P189, DOI 10.1007/s10654-013-9787-x
   Loftfield E, 2015, CANCER EPIDEM BIOMAR, V24, P1052, DOI 10.1158/1055-9965.EPI-15-0038-T
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Lundberg M, 2011, NUCLEIC ACIDS RES, V39, P0, DOI 10.1093/nar/gkr424
   Magni P, 2005, CLIN ENDOCRINOL, V62, P189, DOI 10.1111/j.1365-2265.2005.02195.x
   Marques-Vidal P, 2010, CLIN ENDOCRINOL, V72, P38, DOI 10.1111/j.1365-2265.2009.03628.x
   Maruyama K, 2009, ASIAN PAC J CANCER P, V10, P6
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   Pham NM, 2015, EUR J NUTR, V54, P205, DOI 10.1007/s00394-014-0701-4
   Nielsen AR, 2008, DIABETES, V57, P3078, DOI 10.2337/db08-0182
   Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Rao FV, 2005, CHEM BIOL, V12, P973, DOI 10.1016/j.chembiol.2005.07.009
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Ross GW, 2001, DRUG AGING, V18, P797, DOI 10.2165/00002512-200118110-00001
   Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913
   Thomsen SB, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0133672
   Wedick NM, 2011, NUTR J, V10, P0, DOI 10.1186/1475-2891-10-93
   Willett WC, 1998, NUTR EPIDEMIOLOGY, V0, P0
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Xu Y, 2015, FOOD FUNCT, V6, P297, DOI 10.1039/c4fo00970c
   Yamashita K, 2012, NUTR DIABETES, V2, P0, DOI 10.1038/nutd.2012.6
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Zamora-Ros R, 2016, EUR J NUTR, V55, P1359, DOI 10.1007/s00394-015-0950-x
   Zampelas A, 2004, AM J CLIN NUTR, V80, P862, DOI 10.1093/ajcn/80.4.862
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zheng GD, 2014, BRIT J NUTR, V112, P1034, DOI 10.1017/S0007114514001652
NR 61
TC 8
Z9 8
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0954-6820
EI 1365-2796
J9 J INTERN MED
JI J. Intern. Med.
PD FEB 15
PY 2018
VL 283
IS 2
BP 200
EP 211
DI 10.1111/joim.12703
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA FX1RS
UT WOS:000425830100008
PM 29044854
DA 2025-04-28
ER

PT J
AU Juju, DB
   Sekiyama, M
   Saito, O
AF Juju, Denabo Billo
   Sekiyama, Makiko
   Saito, Osamu
TI Food Security of Adolescents in Selected Khat- and Coffee-Growing Areas in the Sidama Zone, Southern Ethiopia
SO NUTRIENTS
LA English
DT Article
DE adolescents; food security; stunting; thinness; khat; coffee; Ethiopia
ID nutritional-status; health; prevalence; expansion; thinness; impact; trade
AB Whilst pervasive food insecurity exists among adolescents in Ethiopia, the available information is scant and inconsistent. Therefore, the main objective of this cross-sectional study was to contribute to these gaps by assessing the food security of adolescents in the selected khat- and coffee-growing areas. We selected 234 (117 girls and 117 boys) adolescents aged 12-18 years via stratified random sampling. We measured the height and weight of the adolescents and asked about their food insecurity experiences. We assessed the prevalence of stunting and thinness using the WHO 2007 growth reference standards. Out of the total, 17 (7.3%) and 30 (12.8%) adolescents were stunted and thin, respectively. In addition, 89 (38.0%) adolescents reported food insecurity experiences and nine (3.8%) were overweight. A regression analyses showed that the stunting was associated with the age of the adolescents and maternal education. Thinness was associated with area, gender, and the number of meals. Food insecurity experiences were associated with health problems in the past 30 days. In general, adolescents from the khat-growing area have better food security than those from the coffee-growing area, and the same is true, gender-wise, for girls compared to boys. We recommend possible interventions primarily for adolescents in coffee-growing areas.
C1 [Juju, Denabo Billo; Saito, Osamu] United Nations Univ, Inst Adv Study Sustainabil, Tokyo 1508925, Japan.
   [Sekiyama, Makiko] Natl Inst Environm Studies, Tsukuba, Ibaraki 3050053, Japan.
C3 United Nations University; National Institute for Environmental Studies - Japan
RP Saito, O (corresponding author), United Nations Univ, Inst Adv Study Sustainabil, Tokyo 1508925, Japan.
EM juju@student.unu.edu; sekiyama.makiko@nies.go.jp; saito@unu.edu
FU Japan Foundation for United Nations University (jfUNU); Japan Science and Technology Agency (JST); Japan International Cooperation Agency (JICA)
CR Abaye Kebele Agricultural Extension Office, 2017, BAS INF AB KEB UNPUB, V0, P0
   Al-Shaikh MH, 2017, EGYPT J CHEST DIS TU, V66, P317, DOI 10.1016/j.ejcdt.2017.01.010
   Unknown -, 2011, THE STATE OF THE WORLDS CHILDREN 2011: ADOLESCENCE-AN AGE OF OPPORTUNITY, V0, P0
   Assefa E, 2007, ASSESSMENT PRODUCTIO, V0, P0
   Assefa H, 2013, INT SCH RES NOTICES, V0, P0
   Berridge V, 2008, SOC HIST MED, V21, P189, DOI 10.1093/shm/hkn011
   Bezu S, 2014, WORLD DEV, V64, P259, DOI 10.1016/j.worlddev.2014.06.013
   Bogin B, 1999, PATTERNS OF HUMAN GROWTH, V23, P0
   Central Statistical Agency (CSA) Ethiopia and ICF, 2016, ETHIOPIA DEMOGRAPHIC AND HEALTH SURVEY, V0, P0
   Chume Kebele Agricultural Extension Office, 2017, UNPUB, V0, P0
   Cochrane L, 2016, INT J DRUG POLICY, V30, P27, DOI 10.1016/j.drugpo.2016.02.009
   Coll-Black Sarah, 2012, FOOD AND AGRICULTURE IN ETHIOPIA: PROGRESS AND POLICY CHALLENGES, V0, P280
   Dasgupta Aparajita, 2010, INDIAN J COMMUNITY MED, V35, P276, DOI 10.4103/0970-0218.66892
   Demissie S, 2013, SCI J PUBL HEALTH, V1, P175, DOI 10.11648/J.SJPH.20130104.12
   deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650
   Dessie G, 2015, LAND WATER DRUGS CAS, V3, P0
   Dessie G, 2008, GEOGR ANN B, V90B, P187, DOI 10.1111/j.1468-0467.2008.00286.x
   Dick B, 2015, J ADOLESCENT HEALTH, V56, P3, DOI 10.1016/j.jadohealth.2014.10.260
   Evans EW, 2013, ENCYCLOPEDIA OF HUMAN NUTRITION, VThird, P14
   Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3
   Fan S, 2013, FROM SUBSISTENCE TO PROFIT TRANSFORMING SMALLHOLDER FARMS, V0, P0
   Feyisa TH, 2003, MT RES DEV, V23, P185, DOI 10.1659/0276-4741(2003)023[0185:KEITEH]2.0.CO;2
   Gat-Yablonski G, 2015, NUTRIENTS, V7, P517, DOI 10.3390/nu7010517
   Gebreyohannes Y, 2014, INT J NUTR FOOD SCI, V10, P11, DOI 10.11648/j.ijnfs.20140306.13
   Gezon LL, 2012, CULT AGRIC FOOD ENVI, V34, P124, DOI 10.1111/j.2153-9561.2012.01072.x
   Haboubi Ghalib J, 2009, INDIAN J COMMUNITY MED, V34, P108, DOI 10.4103/0970-0218.51230
   Haddad CNL, 1996, 19 FCND INT FOOD POL, V0, P0
   Hadley C, 2008, SOC SCI MED, V66, P427, DOI 10.1016/j.socscimed.2007.08.025
   Harris-Fry H, 2017, INT J EQUITY HEALTH, V16, P0, DOI 10.1186/s12939-017-0603-1
   LARGO RH, 1993, HORM RES, V39, P41, DOI 10.1159/000182783
   Leenstra T, 2005, EUR J CLIN NUTR, V59, P41, DOI 10.1038/sj.ejcn.1602031
   Mark S, 2012, CAN J PUBLIC HEALTH, V103, P94, DOI 10.1007/BF03404210
   Mbow C, 2014, CURR OPIN ENV SUST, V6, P162, DOI 10.1016/j.cosust.2013.11.030
   Melaku YA, 2015, ARCH PUBLIC HEALTH, V73, P0, DOI 10.1186/s13690-015-0093-9
   Mellisse BT, 2018, AGROFOREST SYST, V92, P1579, DOI 10.1007/s10457-017-0106-5
   Minten B, 2018, WORLD DEV, V101, P119, DOI 10.1016/j.worlddev.2017.08.010
   Mohammed AY, 2015, INT J NUTR FOOD SCI, V4, P445, DOI 10.11648/J.IJNFS.20150404.15
   Mramba L, 2017, BMJ-BRIT MED J, V358, P0, DOI 10.1136/bmj.j3423
   Mulugeta A, 2009, ETHIOP J HEALTH DEV, V23, P5
   Negash A, 2004, AGR HUM VALUES, V21, P61, DOI 10.1023/B:AHUM.0000014023.30611.ad
   Odenwald M, 2010, J ETHNOPHARMACOL, V132, P537, DOI 10.1016/j.jep.2010.11.012
   Pal Amitava, 2017, INT J PEDIATR ADOLESC MED, V4, P9, DOI 10.1016/j.ijpam.2016.08.009
   Patton GC, 2016, J ADOLESCENT HEALTH, V59, P375, DOI 10.1016/j.jadohealth.2016.08.002
   Perola M, 2011, HORM RES PAEDIAT, V76, P10, DOI 10.1159/000330139
   Pinhas-Hamiel O, 2017, J ADOLESCENT HEALTH, V61, P233, DOI 10.1016/j.jadohealth.2017.02.016
   Regassa N, 2011, ETHIOP J ENV STUD MA, V4, P39, DOI 10.4314/EJESM.V4I1.5
   Roba KT, 2016, JOURNAL OF NUTRITION AND FOOD SCIENCES, V6, P493
   Roy S, 2016, J NEPAL PAEDIAT SOC, V36, P147
   Sahle M, 2018, AGRON SUSTAIN DEV, V38, P0, DOI 10.1007/s13593-017-0484-0
   SANDIFORD P, 1995, POP STUD-J DEMOG, V49, P5, DOI 10.1080/0032472031000148216
   Sarkar SK, 2010, AUSTRALIAN JOURNAL OF BASIC APPLIED SCIENCES, V4, P5813
   Sidama Zone Culture and Tourism Bureau, 2011, UNPUB, V0, P0
   Sidama Zone Finance and Economic Development Bureau, 2017, UNPUB, V0, P0
   Tefera A, 2013, GAIN REPORT ET-1302, V0, P0
   Tessema M, 2013, PAN AFR MED J, V14, P0, DOI 10.11604/pamj.2013.14.75.1630
   United States Department of Agriculture (USDA), 2017, COFF WORLD MARK TRAD, V0, P0
   WHO, 2018, GUID IMPL EFF ACT IM, V0, P0
   WHO, 2006, ADOLESCENT NUTR REV, V0, P0
   WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA, V0, P0
   Wolde M, 2015, BMC PUBLIC HEALTH, V15, P0, DOI 10.1186/s12889-014-1337-2
   World Health Organisation, 2014, HLTH WORLDS AD 2 CHA, V0, P0
   Zenebe M, 2018, ITAL J PEDIATR, V44, P0, DOI 10.1186/s13052-018-0449-1
NR 63
TC 9
Z9 9
U1 1
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD AUG 15
PY 2018
VL 10
IS 8
BP 
EP 
DI 10.3390/nu10080980
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GU9PD
UT WOS:000445680200028
PM 30060510
DA 2025-04-28
ER

PT J
AU Engin, AB
   Tsatsakis, AM
   Tsoukalas, D
   Engin, A
AF Engin, Ayse Basak
   Tsatsakis, Aristidis M.
   Tsoukalas, Dimitris
   Engin, Atilla
TI Do flavanols-rich natural products relieve obesity-related insulin resistance?
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Review
DE Insulin resistance; Obesity; Polyphenols; Cocoa; Coffee; G protein-coupled estrogen receptor
ID nonalcoholic fatty liver; diet-induced obesity; protein-kinase-c; adipose-tissue; mitochondrial dysfunction; endothelial function; blood-pressure; metabolic syndrome; oxidative stress; dark chocolate
AB Growing evidence support that insulin resistance may occur as a severe problem due to chronic energetic overfeeding and subsequent obesity. When an abundance of glucose and saturated fat enter the cell, impaired blood flow, hypoxia, inflammation and macrophage infiltration in obese adipose tissue may induce oxidative stress and insulin resistance. Excessive circulating saturated fatty acids ectopically accumulate in insulin-sensitive tissues and impair insulin action. In this context, excessive hepatic lipid accumulation may play a central, pathogenic role in insulin resistance. It is thought that dietary polyphenols may ameliorate obesity-related insulin resistance by attenuating inflammatory responses and oxidative stress. The most often occurring natural polyphenolic compounds are flavonoids. In this review, the possible mechanistic effect of flavonoid-rich natural products on insulin resistance-related metabolic pathways is discussed. Polyphenol intake can prevent high-fat diet-induced insulin resistance via cell surface G protein-coupled estrogen receptors by upregulating the expression of related genes, and their pathways, which are responsible for the insulin sensitivity.
C1 [Engin, Ayse Basak] Gazi Univ, Fac Pharm, Dept Toxicol, TR-06330 Ankara, Turkey.
   [Tsatsakis, Aristidis M.] Univ Crete, Med Sch, Lab Toxicol & Forens, Iraklion, Crete, Greece.
   [Tsoukalas, Dimitris] Univ Crete, Med Sch, Lab Toxicol, Iraklion, Crete, Greece.
   [Engin, Atilla] Gazi Univ, Fac Med, Dept Gen Surg, Ankara, Turkey.
C3 Gazi University; University of Crete; University of Crete; Gazi University
RP Engin, AB (corresponding author), Gazi Univ, Fac Pharm, Dept Toxicol, TR-06330 Ankara, Turkey.
EM abengin@gmail.com
CR Adamson GE, 1999, J AGR FOOD CHEM, V47, P4184, DOI 10.1021/jf990317m
   Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200
   Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047
   Alam MA, 2014, ADV NUTR, V5, P404, DOI 10.3945/an.113.005603
   Ali MM, 2004, Z NATURFORSCH C, V59, P726
   Alunad F, 1997, J CLIN INVEST, V100, P449
   Baeza G, 2016, J AGR FOOD CHEM, V64, P9663, DOI 10.1021/acs.jafc.6b04022
   Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351
   Banks WA, 2008, CURR PHARM DESIGN, V14, P1606, DOI 10.2174/138161208784705496
   Beaudoin MS, 2013, APPL PHYSIOL NUTR ME, V38, P140, DOI 10.1139/apnm-2012-0201
   Bloch-Damti A, 2006, DIABETOLOGIA, V49, P2463, DOI 10.1007/s00125-006-0349-6
   Boura-Halfon S, 2009, AM J PHYSIOL-ENDOC M, V296, PE581, DOI 10.1152/ajpendo.90437.2008
   Buijsse B, 2006, ARCH INTERN MED, V166, P411, DOI 10.1001/.411
   Buijsse B, 2010, EUR HEART J, V31, P1616, DOI 10.1093/eurheartj/ehq068
   Calabrò P, 2009, INTERN EMERG MED, V4, P25, DOI 10.1007/s11739-008-0207-2
   Caprioli G, 2015, INT J FOOD SCI NUTR, V66, P505, DOI 10.3109/09637486.2015.1064871
   Caprioli G, 2014, INT J FOOD SCI NUTR, V65, P465, DOI 10.3109/09637486.2013.873890
   Capurso C, 2012, VASC PHARMACOL, V57, P91, DOI 10.1016/j.vph.2012.05.003
   Carr AC, 2000, ARTERIOSCL THROM VAS, V20, P1716, DOI 10.1161/01.ATV.20.7.1716
   Cavia-Saiz M, 2010, J SCI FOOD AGR, V90, P1238, DOI 10.1002/jsfa.3959
   Cersosimo E, 2006, DIABETES-METAB RES, V22, P423, DOI 10.1002/dmrr.634
   Chan CY, 2011, LIFE SCI, V89, P779, DOI 10.1016/j.lfs.2011.09.006
   Chin JM, 2008, J ANAL TOXICOL, V32, P702, DOI 10.1093/jat/32.8.702
   Chiva-Blanch G, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/5812401
   Conde SV, 2012, BRIT J NUTR, V107, P86, DOI 10.1017/S0007114511002406
   Cook NC, 1996, J NUTR BIOCHEM, V7, P66, DOI 10.1016/0955-2863(95)00168-9
   Costa C, 2017, FOOD CHEM TOXICOL, V110, P286, DOI 10.1016/j.fct.2017.10.023
   Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198
   Croft KD, 1998, ANN NY ACAD SCI, V854, P435, DOI 10.1111/j.1749-6632.1998.tb09922.x
   Curtis PJ, 2012, DIABETES CARE, V35, P226, DOI 10.2337/dc11-1443
   Davison K, 2008, INT J OBESITY, V32, P1289, DOI 10.1038/ijo.2008.66
   DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173
   Di Girolamo FG, 2016, NUTRITION, V32, P928, DOI 10.1016/j.nut.2016.02.001
   Dorenkott MR, 2014, J AGR FOOD CHEM, V62, P2216, DOI 10.1021/jf500333y
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Engin A, 2017, ADV EXP MED BIOL, V960, P1, DOI 10.1007/978-3-319-48382-5_1
   Engin AB, 2015, WORLD J GASTROENTERO, V21, P3636, DOI 10.3748/wjg.v21.i12.3636
   Engin AB, 2011, CURR DRUG METAB, V12, P891
   Exley MA, 2014, J ENDOCRINOL, V223, PR41, DOI 10.1530/JOE-13-0516
   Faridi Z, 2008, AM J CLIN NUTR, V88, P58, DOI 10.1093/ajcn/88.1.58
   Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42
   Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002
   Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016
   Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200
   Fukuchi Y, 2008, J CLIN BIOCHEM NUTR, V43, P201, DOI 10.3164/jcbn.2008066
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   García-Ruiz I, 2006, HEPATOLOGY, V44, P581, DOI 10.1002/hep.21313
   Goossens GH, 2008, PHYSIOL BEHAV, V94, P206, DOI 10.1016/j.physbeh.2007.10.010
   Gopinath K, 2012, NEUROSCIENCE, V227, P134, DOI 10.1016/j.neuroscience.2012.07.060
   Gorjanovic S, 2017, J FOOD SCI TECH MYS, V54, P2324, DOI 10.1007/s13197-017-2672-y
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671
   Grassi D, 2013, CURR OPIN CLIN NUTR, V16, P662, DOI 10.1097/MCO.0b013e3283659a51
   Guarino MP, 2013, AGE, V35, P1755, DOI 10.1007/s11357-012-9475-x
   Guasch-Ferré M, 2017, OXID MED CELL LONGEV, V2017, P0, DOI 10.1155/2017/6723931
   Guimaraes R, 2010, FOOD CHEM TOXICOL, V48, P99, DOI 10.1016/j.fct.2009.09.022
   Hajduch E, 2008, BIOCHEM J, V410, P369, DOI 10.1042/BJ20070936
   Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002
   Harpaz Eynav, 2017, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Hassan RH, 2014, WORLD J DIABETES, V5, P244, DOI 10.4239/wjd.v5.i3.244
   Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137
   Holt RR, 2002, AM J CLIN NUTR, V76, P798, DOI 10.1093/ajcn/76.4.798
   Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457
   HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936
   Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195
   Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005
   Jain M, 2011, INFLAMM RES, V60, P483, DOI 10.1007/s00011-010-0295-0
   Janszky I, 2009, J INTERN MED, V266, P248, DOI 10.1111/j.1365-2796.2009.02088.x
   Jennings A, 2014, J NUTR, V144, P202, DOI 10.3945/jn.113.184358
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255
   Karim M, 2000, J NUTR, V130, P2105S, DOI 10.1093/jn/130.8.2105S
   Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11
   Keaver L, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0079827
   Koliaki C, 2015, CELL METAB, V21, P739, DOI 10.1016/j.cmet.2015.04.004
   Kris-Etherton PM, 2002, CURR OPIN LIPIDOL, V13, P41, DOI 10.1097/00041433-200202000-00007
   Langley-Evans SC, 2000, INT J FOOD SCI NUTR, V51, P181, DOI 10.1080/09637480050029683
   Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213
   Lee JY, 2003, J LIPID RES, V44, P479, DOI 10.1194/jlr.M200361-JLR200
   Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200
   Lee Y, 2017, J MED FOOD, V20, P610, DOI 10.1089/jmf.2016.3911
   Li Y, 2011, DIABETES RES CLIN PR, V93, P205, DOI 10.1016/j.diabres.2011.03.036
   Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Lorenz M, 2007, EUR HEART J, V28, P219, DOI 10.1093/eurheartj/ehl442
   Lu NH, 2011, TOXICOL IN VITRO, V25, P833, DOI 10.1016/j.tiv.2011.02.003
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Ma LN, 2015, CLIN CHIM ACTA, V444, P18, DOI 10.1016/j.cca.2015.01.027
   Mack E, 2008, DIABETES-METAB RES, V24, P577, DOI 10.1002/dmrr.881
   Mackenzie GG, 2004, FASEB J, V18, P167, DOI 10.1096/fj.03-0402fje
   Malhi H, 2006, J BIOL CHEM, V281, P12093, DOI 10.1074/jbc.M510660200
   Manach C, 2005, AM J CLIN NUTR, V81, P230S, DOI 10.1093/ajcn/81.1.230S
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Mao T, 2000, JOURNAL OF MEDICINAL FOOD, V3, P107
   Mao T K, 2002, DEV IMMUNOL, V9, P135
   Mao TK, 2000, LIFE SCI, V66, P1377, DOI 10.1016/S0024-3205(00)00449-5
   Matsui N, 2005, NUTRITION, V21, P594, DOI 10.1016/j.nut.2004.10.008
   Moller DE, 2003, INT J OBESITY, V27, PS17, DOI 10.1038/sj.ijo.0802494
   Montagne CT, 2000, DIABETES, V49, P883, DOI 10.2337/diabetes.49.6.883
   Moreno-Ulloa A, 2015, PHARMACOL RES, V100, P309, DOI 10.1016/j.phrs.2015.08.014
   Moreno-Ulloa A, 2014, BIOORG MED CHEM LETT, V24, P2749, DOI 10.1016/j.bmcl.2014.04.038
   Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024
   Nakagami H, 2005, CURR DIABETES REV, V1, P59, DOI 10.2174/1573399052952550
   Nawrot P, 2003, FOOD ADDIT CONTAM A, V20, P1, DOI 10.1080/0265203021000007840
   Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200
   Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964
   Njike VY, 2011, INT J CARDIOL, V149, P83, DOI 10.1016/j.ijcard.2009.12.010
   Oberhauser F, 2012, HORM METAB RES, V44, P465, DOI 10.1055/s-0032-1306341
   Ogura K, 2016, J AGR FOOD CHEM, V64, P8857, DOI 10.1021/acs.jafc.6b03424
   Osakabe N, 1998, BIOSCI BIOTECH BIOCH, V62, P1535, DOI 10.1271/bbb.62.1535
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015
   Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027
   Pederson TM, 2001, DIABETES, V50, P24, DOI 10.2337/diabetes.50.1.24
   Peng YH, 2016, J NEUROCHEM, V137, P701, DOI 10.1111/jnc.13563
   Pérez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398
   Pérez-Jiménez J, 2010, EUR J CLIN NUTR, V64, PS112, DOI 10.1038/ejcn.2010.221
   Perseghin G, 2009, DIABETES CARE, V32, PS164, DOI 10.2337/dc09-S303
   Pessayre D, 2004, EUR J GASTROEN HEPAT, V16, P1095, DOI 10.1097/00042737-200411000-00003
   Potashnik R, 2003, DIABETOLOGIA, V46, P639, DOI 10.1007/s00125-003-1097-5
   Punithavathi VR, 2008, J APPL TOXICOL, V28, P806, DOI 10.1002/jat.1343
   Rabinovitch RC, 2017, CELL REP, V21, P1, DOI 10.1016/j.celrep.2017.09.026
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Rector RS, 2010, J HEPATOL, V52, P727, DOI 10.1016/j.jhep.2009.11.030
   Rimbach G, 2009, INT J MOL SCI, V10, P4290, DOI 10.3390/ijms10104290
   Roberts CK, 2013, COMPR PHYSIOL, V3, P1, DOI 10.1002/cphy.c110062
   Rowley TJ, 2017, J NUTR BIOCHEM, V49, P30, DOI 10.1016/j.jnutbio.2017.07.015
   Rui LY, 2001, J CLIN INVEST, V107, P181, DOI 10.1172/JCI10934
   Russo A, 2000, CELL BIOL TOXICOL, V16, P91, DOI 10.1023/A:1007685909018
   Sacramento JF, 2015, EUR J PHARM SCI, V70, P107, DOI 10.1016/j.ejps.2015.01.011
   Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400
   Sanbongi C, 1997, CELL IMMUNOL, V177, P129, DOI 10.1006/cimm.1997.1109
   Sano T, 2017, NUTR METAB CARDIOVAS, V27, P249, DOI 10.1016/j.numecd.2016.11.008
   Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263
   Schewe T, 2001, BIOL CHEM, V382, P1687, DOI 10.1515/BC.2001.204
   Shamseddeen H, 2011, SURG CLIN N AM, V91, P1163, DOI 10.1016/j.suc.2011.08.001
   Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898
   Shrime MG, 2011, J NUTR, V141, P1982, DOI 10.3945/jn.111.145482
   Silha JV, 2005, INT J OBESITY, V29, P1308, DOI 10.1038/sj.ijo.0802987
   Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011
   Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170
   Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Stull AJ, 2010, J NUTR, V140, P1764, DOI 10.3945/jn.110.125336
   Tajiri Y, 2005, OBES RES, V13, P1810, DOI 10.1038/oby.2005.220
   Takahashi K, 2017, AGING-US, V9, P1863, DOI 10.18632/aging.101287
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Tresserra-Rimbau A, 2016, J NUTR, V146, P767, DOI 10.3945/jn.115.223610
   Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054
   Tsuchida A, 2005, DIABETES, V54, P3358, DOI 10.2337/diabetes.54.12.3358
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Turban S, 2011, FEBS LETT, V585, P269, DOI 10.1016/j.febslet.2010.12.022
   Wang P, 2004, CELL MOL LIFE SCI, V61, P2405, DOI 10.1007/s00018-004-4256-z
   Wang P, 2008, J CELL PHYSIOL, V216, P3, DOI 10.1002/jcp.21386
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Wang Y, 2009, J ENDOCRINOL, V203, P65, DOI 10.1677/JOE-09-0026
   Watanabe S, 2017, METAB SYNDR RELAT D, V15, P170, DOI 10.1089/met.2016.0114
   Wautier MP, 2001, AM J PHYSIOL-ENDOC M, V280, PE685, DOI 10.1152/ajpendo.2001.280.5.E685
   Wedick NM, 2012, AM J CLIN NUTR, V95, P925, DOI 10.3945/ajcn.111.028894
   Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335
   West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912
   Wree A, 2011, DIGESTION, V83, P124, DOI 10.1159/000318741
   Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711
   Yeh TC, 2014, HYPERTENSION, V63, P535, DOI 10.1161/HYPERTENSIONAHA.113.02272
   Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104
   Zhang PW, 2015, MEDICINE, V94, P0, DOI 10.1097/MD.0000000000000758
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
NR 170
TC 20
Z9 23
U1 0
U2 47
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD FEB 15
PY 2018
VL 112
IS 
BP 157
EP 167
DI 10.1016/j.fct.2017.12.055
PG 11
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA FW8GN
UT WOS:000425568900018
PM 29288757
DA 2025-04-28
ER

PT J
AU Liu, LT
   Sayama, K
AF Liu, Litong
   Sayama, Kazutoshi
TI The combined administration of EGCG and caffeine induces not only suppression of fat accumulation but also anorexigenic action in mice
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE EGCG; Caffeine; Anorexigenic action; Anti-obesity
ID glucagon-like peptide-1; blood-brain-barrier; green tea; metabolic syndrome; lipid-metabolism; gut hormones; body-weight; obesity; leptin; (-)-epigallocatechin-3-gallate
AB To elucidate the anorexigenic action and inhibitory effect of fat accumulation by epigallocatechin gallate (EGCG) and caffeine, including the optimal combination ratio and mechanism, fifteen diets with several concentrations of EGCG and/or caffeine were administered to mice for eight weeks. The 0.1% EGCG + 0.1% caffeine group showed the strongest suppression of food intake and a remarkable reduction of body weight and fat accumulation; therefore, the ratio was determined to be the optimal combination ratio. Moreover, serum glucagon-like peptide-1 (GLP-1) level and hypothalamic gene expression of pro-opiomelanocortin (POMC) were promoted by 0.1% EGCG + 0.1% caffeine. In conclusion, the combined treatment of 0.1% EGCG + 0.1% caffeine induces not only suppression of fat accumulation but also strong anorexigenic action in mice. The anorexigenic effect may be brought about via inhibiting gastric motility by GLP-1 and upregulating POMC in the hypothalamus.
C1 [Liu, Litong; Sayama, Kazutoshi] Shizuoka Univ, Grad Sch Sci & Technol, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
   [Sayama, Kazutoshi] Shizuoka Univ, Acad Inst, Coll Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
C3 Shizuoka University; Shizuoka University
RP Sayama, K (corresponding author), Shizuoka Univ, Acad Inst, Coll Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.
EM sayama.kazutoshi@shizuoka.ac.jp
CR Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7
   Banks WA, 1997, PEPTIDES, V18, P1257, DOI 10.1016/S0196-9781(97)00198-8
   Chen YK, 2011, J AGR FOOD CHEM, V59, P11862, DOI 10.1021/jf2029016
   Clément K, 1998, NATURE, V392, P398, DOI 10.1038/32911
   de Lartigue G, 2014, MOL METAB, V3, P595, DOI 10.1016/j.molmet.2014.06.003
   De Silva A, 2012, GUT LIVER, V6, P10, DOI 10.5009/gnl.2012.6.1.10
   Druce M, 2006, ARCH DIS CHILD, V91, P183, DOI 10.1136/adc.2005.073759
   Duan J, 2007, OBESITY, V15, P2624, DOI 10.1038/oby.2007.314
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Eckel RH, 2010, LANCET, V375, P181, DOI 10.1016/S0140-6736(09)61794-3
   FLETCHER MJ, 1968, CLIN CHIM ACTA, V22, P393, DOI 10.1016/0009-8981(68)90041-7
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Gray SP, 2017, DIABETOLOGIA, V60, P927, DOI 10.1007/s00125-017-4215-5
   Hainerova IA, 2010, J PEDIATR GASTR NUTR, V51, PS123, DOI 10.1097/MPG.0b013e3181f84208
   Halim MA, 2017, J CLIN ENDOCRINOLOGY, V103, P575, DOI 10.1210/jc.2017-0206
   Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kavanagh KT, 2001, J CELL BIOCHEM, V82, P387, DOI 10.1002/jcb.1164
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kogure A, 2002, CLIN EXP PHARMACOL P, V29, P391, DOI 10.1046/j.1440-1681.2002.03675.x
   Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   MCCALL AL, 1982, LIFE SCI, V31, P2709, DOI 10.1016/0024-3205(82)90715-9
   Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185
   Nakagawa K, 1997, J NUTR SCI VITAMINOL, V43, P679, DOI 10.3177/jnsv.43.679
   Razzoli M, 2017, NEUROSCI BIOBEHAV R, V76, P154, DOI 10.1016/j.neubiorev.2017.01.026
   Sayama K, 2000, IN VIVO, V14, P481
   Song WY, 2015, J CLIN BIOCHEM NUTR, V57, P164, DOI 10.3164/jcbn.15-50
   Sueoka N, 2001, ANN NY ACAD SCI, V928, P274
   Weber JM, 2003, ANTIVIR RES, V58, P167, DOI 10.1016/S0166-3542(02)00212-7
   Weinreb O, 2004, J NUTR BIOCHEM, V15, P506, DOI 10.1016/j.jnutbio.2004.05.002
   Westerterp-Plantenga M, 2006, PHYSIOL BEHAV, V89, P85, DOI 10.1016/j.physbeh.2006.01.027
   Wettergren A, 1998, AM J PHYSIOL-GASTR L, V275, PG984, DOI 10.1152/ajpgi.1998.275.5.G984
   ZAK B, 1957, AM J CLIN PATHOL, V27, P583, DOI 10.1093/ajcp/27.5_ts.583
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   Zheng GD, 2004, IN VIVO, V18, P55
NR 36
TC 14
Z9 16
U1 2
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD AUG 15
PY 2018
VL 47
IS 
BP 156
EP 162
DI 10.1016/j.jff.2018.05.030
PG 7
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA GN4RH
UT WOS:000439019200018
DA 2025-04-28
ER

PT J
AU Al-Basher, GI
   Aljabal, H
   Almeer, RS
   Allam, AA
   Mahmoud, AM
AF Al-Basher, Gadh I.
   Aljabal, Hanan
   Almeer, Rafa S.
   Allam, Ahmed A.
   Mahmoud, Ayman M.
TI Perinatal exposure to energy drink induces oxidative damage in the liver, kidney and brain, and behavioral alterations in mice offspring
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Article
DE Energy drinks; Oxidative stress; Liver injury; Caffeine; Taurine
ID caffeine consumption; red-bull; stress; taurine; anxiety; health; performance; obese; risk
AB The worldwide consumption of energy drinks (EDs) has increased in recent years. EDs have several side effects and can be linked to liver injury, kidney damage and risk-seeking behavior. The impact of perinatal consumption of EDs on the newborns has not been previously investigated. In this study, we evaluated the effects of perinatal exposure to a caffeinated ED on the liver, kidney, brain, locomotor activity and anxiety in mice newborns. Pregnant mice received 2.5 or 5 ml ED by oral gavage from the first day of pregnancy until day 15 after birth. Perinatal exposure to the ED induced a significant increase in lipid peroxidation and declined antioxidant defenses in the liver, kidney, cerebrum, cerebellum and medulla oblongata of the newborns at days 21 and 35 after birth. ED induced several histological alterations, including vacuolations and lipid infiltration of hepatocytes, developing and degenerated glomeruli and dilated urinary spaces in the renal cortex, pyknosis and chromatolysis of the cerebral and medullary neurons, and degenerated and abnormal Purkinje cells in the cerebellum. In addition, ED increased the locomotion and induced anxiety-like behavior in mice newborns. In conclusion, perinatal exposure to EDs induces oxidative stress, tissue injury and behavioral alterations in the mice newborns. Therefore, the consumption of EDs during pregnancy and lactation has a negative impact on the newborns and should be treated as a significant health problem that warrants attention.
C1 [Al-Basher, Gadh I.; Aljabal, Hanan; Almeer, Rafa S.] King Saud Univ, Zool Dept, Coll Sci, Riyadh, Saudi Arabia.
   [Allam, Ahmed A.; Mahmoud, Ayman M.] Beni Suef Univ, Zool Dept, Fac Sci, Bani Suwayf, Egypt.
C3 King Saud University; Egyptian Knowledge Bank (EKB); Beni Suef University
RP Mahmoud, AM (corresponding author), Beni Suef Univ, Physiol Div, Zool Dept, Fac Sci, Salah Salim St, Bani Suwayf 62514, Egypt.
EM ayman.mahmoud@science.bsu.edu.eg
FU Deanship of Scientific Research at King Saud University, College of Science Research Center
CR a. N. I. o. D. a. D. a. K. D United States National Library of Medicine, 2017, LIVERTOX CLIN RES IN, V0, P0
   Abd El-Twab SM, 2016, CAN J PHYSIOL PHARM, V94, P651, DOI 10.1139/cjpp-2015-0503
   Abreu RV, 2011, PHARMACOL BIOCHEM BE, V99, P659, DOI 10.1016/j.pbb.2011.06.010
   Abu-Taweel GM, 2012, INDIAN J EXP BIOL, V50, P696
   Ajarem JS, 1998, PHARMACOL BIOCHEM BE, V59, P313, DOI 10.1016/S0091-3057(97)00408-5
   Al-Shaar L, 2017, FRONT PUBLIC HEALTH, V5, P0, DOI 10.3389/fpubh.2017.00225
   Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882
   Bichler A, 2006, AMINO ACIDS, V31, P471, DOI 10.1007/s00726-005-0302-x
   Bouayed J, 2009, OXID MED CELL LONGEV, V2, P63, DOI 10.4161/oxim.2.2.7944
   Buege J A, 1978, METHODS ENZYMOL, V52, P302
   Childs E, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12148
   COHEN G, 1970, ANAL BIOCHEM, V34, P30, DOI 10.1016/0003-2697(70)90083-7
   Díaz A, 2016, OXID MED CELL LONGEV, V2016, P0, DOI 10.1155/2016/8725354
   Grasser EK, 2014, EUR J NUTR, V53, P1561, DOI 10.1007/s00394-014-0661-8
   Greene E, 2014, ANN PHARMACOTHER, V48, P1366, DOI 10.1177/1060028014541997
   Harb Jennifer Nicole, 2016, BMJ CASE REP, V2016, P0, DOI 10.1136/bcr-2016-216612
   Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x
   Holubcikova J, 2017, EUR J PEDIATR, V176, P599, DOI 10.1007/s00431-017-2881-4
   Howard MA, 2010, EXP CLIN PSYCHOPHARM, V18, P553, DOI 10.1037/a0021740
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Khayyat L, 2014, LIFE SCI J, V11, P1131
   MARKLUND S, 1974, EUR J BIOCHEM, V47, P469
   Marshall TA, 2003, PEDIATRICS, V112, PE184, DOI 10.1542/peds.112.3.e184
   Noschang CG, 2009, NEUROCHEM RES, V34, P1568, DOI 10.1007/s11064-009-9945-4
   Oliveira MWS, 2010, PHARMACOL REP, V62, P185, DOI 10.1016/S1734-1140(10)70256-5
   Pennay Amy, 2012, BMC RES NOTES, V5, P369, DOI 10.1186/1756-0500-5-369
   Reis R, 2017, J FOOD SCI, V82, P1037, DOI 10.1111/1750-3841.13662
   Richards Gareth, 2016, JOURNAL OF CAFFEINE RESEARCH, V6, P49, DOI 10.1089/jcr.2015.0033
   Sanchez-Lozada LG, 2007, AM J PHYSIOL-RENAL, V292, PF423, DOI 10.1152/ajprenal.00124.2006
   Schöffl I, 2011, PEDIATRICS, V128, PE227, DOI 10.1542/peds.2010-2677
   Seifert SM, 2013, CLIN TOXICOL, V51, P566, DOI 10.3109/15563650.2013.820310
   Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592
   Souza DB, 2017, EUR J NUTR, V56, P13, DOI 10.1007/s00394-016-1331-9
   Tofovic SP, 2002, KIDNEY INT, V61, P1433, DOI 10.1046/j.1523-1755.2002.00278.x
   Tofovic SP, 2007, RENAL FAILURE, V29, P891, DOI 10.1080/08860220701569846
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Valle MTC, 2017, EUR J NUTR, V0, P0, DOI DOI 10.1007/s00394-00017-01522-z
   Vivekanandarajah Abhirami, 2011, J MED CASE REP, V5, P227, DOI 10.1186/1752-1947-5-227
   Wall PM, 2001, NEUROSCI BIOBEHAV R, V25, P275, DOI 10.1016/S0149-7634(01)00013-6
   Zeidán-Chuliá F, 2013, OXID MED CELL LONGEV, V2013, P0, DOI 10.1155/2013/791795
NR 41
TC 17
Z9 18
U1 4
U2 17
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JUN 15
PY 2018
VL 102
IS 
BP 798
EP 811
DI 10.1016/j.biopha.2018.03.139
PG 14
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA GG3HV
UT WOS:000432583800093
PM 29605768
DA 2025-04-28
ER

PT J
AU Roshan, H
   Nikpayam, O
   Sedaghat, M
   Sohrab, G
AF Roshan, Hanieh
   Nikpayam, Omid
   Sedaghat, Meghdad
   Sohrab, Golbon
TI Effects of green coffee extract supplementation on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome: a randomised clinical trial
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Green coffee bean extract; Chlorogenic acid; Blood pressure; Weight; Fasting blood glucose; Lipid profile; Insulin resistance
ID high-fat diet; chlorogenic acid; endothelial function; healthy-volunteers; bean extract; weight-loss; mice; metaanalysis; consumption; overweight
AB This study was conducted to elucidate the effects of decaffeinated green coffee bean extract (GCE) on anthropometric indices, glycaemic control, blood pressure, lipid profile, insulin resistance and appetite in patients with the metabolic syndrome (Mets). Subjects were randomly allocated to consume 400 mg GCE or placebo capsules twice per d for 8 weeks. Both groups were advised to follow an energy balanced diet. After GCE supplementation, systolic blood pressure (SBP) significantly reduced compared with the placebo group (-13.76 (SD 8.48) v. -6.56 (SD 9.58) mmHg, P = 0.01). Also, GCE treatment significantly reduced fasting blood glucose (FBS) (-5.15 (SD 60.22) v. 29.42 (SD 40.01) mg/dl (-0.28 (SD 3.34) v. 1.63 (SD 2.22) mmol/l); P = 0.03) and homoeostatic model of assessment of insulin resistance in comparison to placebo (-1.41 (SD 3.33) v. 1.23 (SD 3.84), P = 0.02). In addition, waist circumference (-2.40 (SD 2.54) v. -0.66 (SD 1.17) cm, P = 0.009) and appetite score (-1.44 (SD 1.72) v. -0.2 (SD 1.32), P = 0.01) of the individuals supplemented with GCE indicated a significant decline. Besides, weight and BMI reduction in the intervention group was almost twice as much as the placebo group; however, this discrepancy was marginally significant (weight: -2.08 (SD 2.11) v. -0.92 (SD 1.30) kg, P = 0.05). No difference was observed in terms of glycated Hb (HbA1c) percentage and lipid profile parameters between the two groups. To sum up, GCE administration had an ameliorating effect on some of the Mets components such as high SBP, high FBS and Mets main aetiological factors including insulin resistance and abdominal obesity. Furthermore, GCE supplementation could reduce appetite level.
C1 [Roshan, Hanieh; Nikpayam, Omid] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Clin Nutr & Dietet Dept, Tehran 1981619573, Iran.
   [Sedaghat, Meghdad] Shahid Beheshti Univ Med Sci, Imam Hossein Hosp, Tehran 1981619573, Iran.
   [Sohrab, Golbon] Shahid Beheshti Univ Med Sci, Internal Med Dept, Tehran 1985717443, Iran.
C3 Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences
RP Sohrab, G (corresponding author), Shahid Beheshti Univ Med Sci, Internal Med Dept, Tehran 1985717443, Iran.
EM golbonsohrab@yahoo.com
FU National Nutrition and Food Technology Research Institute of Shahid Beheshti University [655]
CR Ahmed GM, 2013, ADVANCE JOURNAL OF FOOD SCIENCE & TECHNOLOGY, V5, P619
   Ainsworth BE, 2000, MED SCI SPORT EXER, V32, PS498, DOI 10.1097/00005768-200009001-00009
   Unknown -, 2006, THE IDF CONSENSUS WORLDWIDE DEFINITION OF THE METABOLIC SYNDROME, V0, P0
   Blum J, 2007, NUTRAFOODS, V6, P13
   Cheong JDLK, 2014, ARCH BIOCHEM BIOPHYS, V559, P46, DOI 10.1016/j.abb.2014.02.005
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi BK, 2016, ASIAN PAC J TROP MED, V9, P616, DOI 10.1016/j.apjtm.2016.05.017
   Dellalibera O, 2006, PHYTOTHERAPIE (PARIS), V4, P194, DOI 10.1007/s10298-006-0181-7
   Ebrahimi M, 2009, ACTA CARDIOL, V64, P321, DOI 10.2143/AC.64.3.2038016
   Ghaffarpour M, 1999, TEHRAN NASHRE OLUME, V7, P42
   Henry-Vitrac C, 2010, J AGR FOOD CHEM, V58, P4141, DOI 10.1021/jf9044827
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Jin SS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0120842
   Kaur J, 2014, CARDIOL RES PRACT, V2014, P0, DOI 10.1155/2014/943162
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI 10.1039/C4FO00290C
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Mubarak A, 2012, J AGR FOOD CHEM, V60, P9130, DOI 10.1021/jf303440j
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Ong KW, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0032718
   Razavi BM, 2017, J SCI FOOD AGR, V97, P1679, DOI 10.1002/jsfa.8134
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/482704
   Santana-Gálvez J, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22030358
   Sarria B, 2016, EUR J NUTR, V0, P0
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shimoda Hiroshi, 2006, BMC COMPLEMENT ALTERN MED, V6, P9, DOI 10.1186/1472-6882-6-9
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   Takami H, 2013, J EPIDEMIOL, V23, P12, DOI 10.2188/jea.JE20120053
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Upadhyay R, 2013, CRIT REV FOOD SCI, V53, P968, DOI 10.1080/10408398.2011.576319
   Varghese M, 2014, TRANSL NEUROSCI, V5, P111, DOI 10.2478/s13380-014-0213-y
   Watanabe T, 2006, CLIN EXP HYPERTENS, V28, P439, DOI 10.1080/10641960600798655
   Wilson MMG, 2005, AM J CLIN NUTR, V82, P1074, DOI 10.1093/ajcn/82.5.1074
NR 36
TC 114
Z9 115
U1 1
U2 39
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD FEB 14
PY 2018
VL 119
IS 3
BP 250
EP 258
DI 10.1017/S0007114517003439
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FX2XG
UT WOS:000425928600002
PM 29307310
DA 2025-04-28
ER

PT J
AU Naveed, M
   Hejazi, V
   Abbas, M
   Kamboh, AA
   Khan, GJ
   Shumzaid, M
   Ahmad, F
   Babazadeh, D
   Xia, FF
   Modarresi-Ghazani, F
   Li, WH
   Zhou, XH
AF Naveed, Muhammad
   Hejazi, Veghar
   Abbas, Muhammad
   Kamboh, Asghar Ali
   Khan, Ghulam Jilany
   Shumzaid, Muhammad
   Ahmad, Fawwad
   Babazadeh, Daryoush
   Xia FangFang
   Modarresi-Ghazani, Faezeh
   Li WenHua
   Zhou XiaoHui
TI Chlorogenic acid (CGA): A pharmacological review and call for further research
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE Clinical pharmacology; Medicinal values; Anti-hypertension; Antioxidant; Food additive; Green coffee extract
ID coffee bean extract; glandular trichm; biological-activity; antiinflammatory activity; 5-caffeoylquinic acid; secondary metabolites; oxidative stress; in-silico; antioxidant; derivatives
AB Phenolic acids have recently gained substantial attention due to their various practical, biological and pharmacological effects. Chlorogenic Acid (CGA, 3-CQA) is a most abundant isomer among caffeoylquinic acid isomers (3-, 4-, and 5-CQA), that currently known as 5-CQA as per guidelines of IUPAC. It is one of the most available acids among phenolic acid compounds which can be naturally found in green coffee extracts and tea. CGA is an important and biologically active dietary polyphenol, playing several important and therapeutic roles such as antioxidant activity, antibacterial, hepatoprotective, cardioprotective, anti-inflammatory, antipyretic, neuroprotective, anti-obesity, antiviral, anti-microbial, anti-hypertension, free radicals scavenger and a central nervous system (CNS) stimulator. In addition, it has been found that CGA could modulate lipid metabolism and glucose in both genetically and healthy metabolic related disorders. It is speculated that CGA can perform crucial roles in lipid and glucose metabolism regulation and thus help to treat many disorders such as hepatic steatosis, cardiovascular disease, diabetes, and obesity as well. Furthermore, this phenolic acid (CGA) causes hepatoprotective effects by protecting animals from chemical or lipopolysaccharide-induced injuries. The hypocholesterolemic influence of CGA can result from the altered metabolism of nutrients, including amino acids, glucose and fatty acids (FA). The purpose of this review was to broaden the scope of knowledge of researchers to conduct more studies on this subject to both unveil and optimize its biological and pharmacological effects. As a result, CGA may be practically used as a natural safeguard food additive to replace the synthetic antibiotics and thereby reduce the medicinal cost.
C1 [Naveed, Muhammad; Abbas, Muhammad; Zhou XiaoHui] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Sch Pharm, Nanjing 211198, Jiangsu, Peoples R China.
   [Naveed, Muhammad; Li WenHua] Aviat Gen Hosp, Dept Urol Surg, Beijing 100012, Peoples R China.
   [Hejazi, Veghar] Tabriz Univ Med Sci, Tabriz, Iran.
   [Kamboh, Asghar Ali] Sindh Agr Univ, Fac Anim Husb & Vet Sci, Dept Vet Microbiol, Tandojam 70060, Pakistan.
   [Khan, Ghulam Jilany] China Pharmaceut Univ, Jiangsu Ctr Pharmacodynam Res & Evaluat, Dept Pharmacol, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China.
   [Shumzaid, Muhammad] Riphah Int Univ, Riphah Inst Pharmaceut Sci, Lahore 54770, Pakistan.
   [Ahmad, Fawwad] Univ Agr Faisalabad, Inst Anim & Dairy Sci, Dept Poultry Sci, Faisalabad 38040, Pakistan.
   [Babazadeh, Daryoush] Shiraz Univ, Avian Dis Res Ctr, Fac Vet Med, Shiraz, Iran.
   [Xia FangFang] Nanjing Xiaozhuang Univ, Coll Environm Sci, Dept Chem, Nanjing 211171, Jiangsu, Peoples R China.
   [Modarresi-Ghazani, Faezeh] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
   [Zhou XiaoHui] Nanjing Shuiximen Hosp, Dept Heart Surg, Nanjing 210017, Jiangsu, Peoples R China.
   [Zhou XiaoHui] Southeast Univ, Zhongda Hosp, Dept Cardiothorac Surg, Nanjing 210017, Jiangsu, Peoples R China.
C3 China Pharmaceutical University; Tabriz University of Medical Science; Sindh Agricultural University; China Pharmaceutical University; University of Agriculture Faisalabad; Shiraz University; Nanjing Xiaozhuang University; Tabriz University of Medical Science; Southeast University - China
RP Zhou, XH (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Dept Clin Pharm, Sch Pharm, Nanjing 211198, Jiangsu, Peoples R China.; Li, WH (corresponding author), Aviat Gen Hosp, Dept Urol Surg, Beijing 100012, Peoples R China.; Modarresi-Ghazani, F (corresponding author), Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran.
EM faezeh.modarres@gmail.com; liwenhua361@sina.com; zhxh@cpu.edu.cn
FU Chinese Scholarship Council (CSC) P.R China
CR Unknown -, 2009, ELECT J DIFFERENTIAL, V0, P0, DOI DOI 10.1371/J0URNAL.P0NE.0106787
   Attele AS, 2002, DIABETES, V51, P1851, DOI 10.2337/diabetes.51.6.1851
   Ayseli MT, 2016, TRENDS FOOD SCI TECH, V48, P69, DOI 10.1016/j.tifs.2015.11.005
   Bagdas D, 2014, N-S ARCH PHARMACOL, V387, P1101, DOI 10.1007/s00210-014-1034-9
   Bajko E, 2016, LWT-FOOD SCI TECHNOL, V65, P471, DOI 10.1016/j.lwt.2015.08.024
   Caprioli G, 2017, NAT PROD RES, V31, P515, DOI 10.1080/14786419.2016.1195383
   Chiang LC, 2002, ANTIVIR RES, V55, P53, DOI 10.1016/S0166-3542(02)00007-4
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 1999, J SCI FOOD AGR, V79, P362, DOI 10.1002/(SICI)1097-0010(19990301)79:3<362::AID-JSFA256>3.0.CO;2-D
   Clifford MN, 2000, J SCI FOOD AGR, V80, P1033, DOI 10.1002/(SICI)1097-0010(20000515)80:7<1033::AID-JSFA595>3.0.CO;2-T
   Esposito F, 2013, PATHOG DIS, V68, P116, DOI 10.1111/2049-632X.12051
   Farzaei MH, 2015, WORLD J GASTROENTERO, V21, P6499, DOI 10.3748/wjg.v21.i21.6499
   Fernández MA, 1998, J PHARM PHARMACOL, V50, P1183, DOI 10.1111/j.2042-7158.1998.tb03332.x
   Fiamegos YC, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0018127
   Francisco V, 2013, J ETHNOPHARMACOL, V148, P126, DOI 10.1016/j.jep.2013.03.077
   Fu L, 2016, BIOMED RES INT, V2016, P0
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Hakkou Z, 2017, BIOMED PHARMACOTHER, V93, P62, DOI 10.1016/j.biopha.2017.06.015
   Hemmerle H, 1997, J MED CHEM, V40, P137, DOI 10.1021/jm9607360
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Jin SS, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0120842
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   Jung HA, 1999, ARCH PHARM RES, V22, P213, DOI 10.1007/BF02976549
   Karunanidhi A, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/392058
   Khan MTH, 2005, ANTIVIR RES, V67, P107, DOI 10.1016/j.antiviral.2005.05.002
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Kozuma K, 2005, HYPERTENS RES, V28, P711, DOI 10.1291/hypres.28.711
   Kremr D, 2016, QUIM NOVA, V39, P530
   Lafay S, 2006, J NUTR, V136, P1192, DOI 10.1093/jn/136.5.1192
   Les F, 2017, IND CROP PROD, V108, P295, DOI 10.1016/j.indcrop.2017.06.043
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Mandrone M, 2015, IND CROP PROD, V76, P402, DOI 10.1016/j.indcrop.2015.07.012
   Meng S, 2013, EVIDENCE BASED COMPL, V2013, P0
   Mills CE, 2013, FOOD CHEM, V141, P3335, DOI 10.1016/j.foodchem.2013.06.014
   Monteiro R, 2010, MEDIAT INFLAMM, V2010, P0, DOI 10.1155/2010/289645
   Naso LG, 2014, J INORG BIOCHEM, V135, P86, DOI 10.1016/j.jinorgbio.2014.02.013
   Natella F, 1999, J AGR FOOD CHEM, V47, P1453, DOI 10.1021/jf980737w
   Nicasio P, 2005, PHYTOTHER RES, V19, P661, DOI 10.1002/ptr.1722
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Ornano L, 2016, NAT PROD RES, V30, P920, DOI 10.1080/14786419.2015.1079189
   Panche AN, 2016, J NUTR SCI, V5, P0, DOI 10.1017/jns.2016.41
   Panico R, 1994, IUPAC COMMISSION NOM, V0, P71
   Park HJ, 2010, ARCH PHARM RES, V33, P1703, DOI 10.1007/s12272-010-1101-9
   Plesko S, 2015, ACTA CHIM SLOV, V62, P555
   Puupponen-Pimiä R, 2001, J APPL MICROBIOL, V90, P494, DOI 10.1046/j.1365-2672.2001.01271.x
   Renouf M, 2010, MOL NUTR FOOD RES, V54, P760, DOI 10.1002/mnfr.200900056
   Santana-Gálvez J, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22030358
   Sasaki K, 2010, FOOD CHEM, V118, P830, DOI 10.1016/j.foodchem.2009.05.070
   Senol FS, 2011, PHYTOCHEM LETT, V4, P462, DOI 10.1016/j.phytol.2011.08.016
   Shi HT, 2013, TOXICOLOGY, V303, P107, DOI 10.1016/j.tox.2012.10.025
   Shin HS, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9020165
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Sousa R, 2014, CLIN INFECT DIS, V59, P41, DOI 10.1093/cid/ciu235
   Stalmach A, 2010, ARCH BIOCHEM BIOPHYS, V501, P98, DOI 10.1016/j.abb.2010.03.005
   Stalmach A, 2009, DRUG METAB DISPOS, V37, P1749, DOI 10.1124/dmd.109.028019
   Stauder M, 2010, J AGR FOOD CHEM, V58, P11662, DOI 10.1021/jf1031839
   Sung WS, 2010, PURE APPL CHEM, V82, P219, DOI 10.1351/PAC-CON-09-01-08
   Suzuki A, 2002, HYPERTENS RES, V25, P99, DOI 10.1291/hypres.25.99
   Tamura H, 2006, MOL NUTR FOOD RES, V50, P396, DOI 10.1002/mnfr.200500216
   Tom ENL, 2016, PHYTOMEDICINE, V23, P1037, DOI 10.1016/j.phymed.2016.06.012
   Venditti A, 2017, CHEM BIODIVERS, V14, P0
   Venditti A, 2016, CHEM BIODIVERS, V13, P1380, DOI 10.1002/cbdv.201600082
   Venditti A, 2015, IND CROP PROD, V77, P353, DOI 10.1016/j.indcrop.2015.09.002
   Venditti A, 2015, PHARM BIOL, V53, P1505, DOI 10.3109/13880209.2014.991833
   Venditti A, 2014, CHEM BIODIVERS, V11, P245, DOI 10.1002/cbdv.201300253
   Vieira O, 1998, BIOCHEM PHARMACOL, V55, P333, DOI 10.1016/S0006-2952(97)00470-X
   Wan CW, 2013, PHYTOTHER RES, V27, P545, DOI 10.1002/ptr.4751
   Yuan YL, 2017, INT IMMUNOPHARMACOL, V44, P97, DOI 10.1016/j.intimp.2017.01.017
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zhang LB, 2011, MAR ENVIRON RES, V72, P33, DOI 10.1016/j.marenvres.2011.04.002
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zhao ZH, 2008, J AGR FOOD CHEM, V56, P3863, DOI 10.1021/jf073168d
NR 74
TC 1065
Z9 1140
U1 48
U2 538
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD JAN 15
PY 2018
VL 97
IS 
BP 67
EP 74
DI 10.1016/j.biopha.2017.10.064
PG 8
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA FR4NC
UT WOS:000419041300009
PM 29080460
DA 2025-04-28
ER

PT J
AU Galbete, C
   Nicolaou, M
   Meeks, K
   Klipstein-Grobusch, K
   Aikins, AD
   Addo, J
   Amoah, SK
   Smeeth, L
   Owusu-Dabo, E
   Spranger, J
   Agyemang, C
   Mockenhaupt, FP
   Beune, E
   Stronks, K
   Schulze, MB
   Danquah, I
AF Galbete, Cecilia
   Nicolaou, Mary
   Meeks, Karlijn
   Klipstein-Grobusch, Kerstin
   Aikins, Ama de-Graft
   Addo, Juliet
   Amoah, Stephen K.
   Smeeth, Liam
   Owusu-Dabo, Ellis
   Spranger, Joachim
   Agyemang, Charles
   Mockenhaupt, Frank P.
   Beune, Erik
   Stronks, Karien
   Schulze, Matthias B.
   Danquah, Ina
TI Dietary patterns and type 2 diabetes among Ghanaian migrants in Europe and their compatriots in Ghana: the RODAM study
SO NUTRITION & DIABETES
LA English
DT Article
ID meat consumption; prevalence; metaanalysis; prevention; management; risk
AB Background/objectives We aimed to study the associations of dietary patterns (DPs) with type 2 diabetes (T2D) among Ghanaian adults. Subjects/methods In the multi-centre, cross-sectional RODAM (Research on Obesity and Diabetes among African Migrants) study (n = 4543), three overall DPs ("mixed", "rice, pasta, meat and fish," and "roots, tubers and plantain") and two site-specific DPs per study site (rural Ghana, urban Ghana and Europe) were identified by principal component analysis. The DPs-T2D associations were calculated by logistic regression models. Results Higher adherence to the "rice, pasta, meat and fish" DP (characterized by legumes, rice/pasta, meat, fish, cakes/sweets, condiments) was associated with decreased odds of T2D, adjusted for socio-demographic factors, total energy intake and adiposity measures (odds ratio (OR) per 1 SD = 0.80; 95% confidence interval (CI) = 0.70-0.92). Similar DPs and T2D associations were discernible in urban Ghana and Europe. In the total study population, neither the "mixed" DP (whole grain cereals, sweet spreads, dairy products, potatoes, vegetables, poultry, coffee/tea, sodas/juices, olive oil) nor the "roots, tubers and plantain" DP (refined cereals, fruits, nuts/seeds, roots/tubers/plantain, fermented maize products, legumes, palm oil, condiments) was associated with T2D. Yet, after the exclusion of individuals with self-reported T2D, the "roots, tubers and plantain" DP was inversely associated with T2D (ORper 1 SD = 0.88; 95% CI = 0.69-1.12). Conclusion In this Ghanaian population, DPs characterized by the intake of legumes, fish, meat and confectionery were inversely associated with T2D. The effect of a traditional-oriented diet (typical staples, vegetables and legumes) remains unclear.
C1 [Galbete, Cecilia; Schulze, Matthias B.; Danquah, Ina] German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Epidemiol, Nuthetal, Germany.
   [Nicolaou, Mary; Meeks, Karlijn; Agyemang, Charles; Beune, Erik; Stronks, Karien] Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.
   [Klipstein-Grobusch, Kerstin] Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Julius Global Hlth, Utrecht, Netherlands.
   [Klipstein-Grobusch, Kerstin] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Div Epidemiol & Biostat, Johannesburg, South Africa.
   [Aikins, Ama de-Graft] Univ Ghana, Reg Inst Populat Studies, Legon, Ghana.
   [Addo, Juliet; Smeeth, Liam] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Non Communicable Dis Epidemiol, London, England.
   [Amoah, Stephen K.; Mockenhaupt, Frank P.] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Inst Trop Med & Int Hlth, Berlin, Germany.
   [Amoah, Stephen K.; Spranger, Joachim; Mockenhaupt, Frank P.; Danquah, Ina] Berlin Inst Hlth, Berlin, Germany.
   [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Global & Int Hlth, Kumasi, Ghana.
   [Spranger, Joachim] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Dept Endocrinol & Metab Dis, Berlin, Germany.
   [Danquah, Ina] Humboldt Univ, Freie Univ Berlin, Charite Univ Med Berlin, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.
C3 Leibniz Association; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Witwatersrand; University of Ghana; University of London; London School of Hygiene & Tropical Medicine; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Kwame Nkrumah University Science & Technology; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin
RP Galbete, C (corresponding author), German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Mol Epidemiol, Nuthetal, Germany.; Galbete, C (corresponding author), Univ Amsterdam, Amsterdam Publ Hlth Res Inst, Acad Med Ctr, Dept Publ Hlth, Amsterdam, Netherlands.
EM cecilia.galbete@dife.de
FU European Commission under the 7th Framework Programme [278901]; NutriAct-Competence Cluster Nutrition Research Berlin-Potsdam - Federal Ministry of Education and Research [FKZ: 01EA1408A-G]
CR Agyemang C, 2016, BMC MED, V14, P0, DOI 10.1186/s12916-016-0709-0
   Agyemang C, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2014-004877
   Unknown -, 2015, WHO CALLS ON COUNTRIES TO REDUCE SUGARS INTAKE AMONG ADULTS AND CHILDREN, V0, P0
   Ballotari P, 2015, BMC PUBLIC HEALTH, V15, P0, DOI 10.1186/s12889-015-1403-4
   Basu S, 2013, PUBLIC HEALTH NUTR, V16, P179, DOI 10.1017/S1368980012002881
   Becerra-Tomás N, 2018, CLIN NUTR, V37, P906, DOI 10.1016/j.clnu.2017.03.015
   Boeing H, 2012, EUR J NUTR, V51, P637, DOI 10.1007/s00394-012-0380-y
   Danquah I, 2018, EUR J NUTR, V57, P2723, DOI 10.1007/s00394-017-1538-4
   FAOFAOSTATS, 2017, FOOD BAL SHEETS FOOD, V0, P0
   Federation ID, 2015, IDF DIAB ATL INT DIA, V0, P0
   Frank LK, 2014, BRIT J NUTR, V112, P89, DOI 10.1017/S000711451400052X
   Galbete C, 2017, FOOD NUTR RES, V61, P0, DOI 10.1080/16546628.2017.1341809
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Jannasch F, 2017, NUTR J, V16, P0, DOI 10.1186/s12937-017-0286-x
   Jannasch F, 2017, J NUTR, V147, P1174, DOI 10.3945/jn.116.242552
   Kristal AR, 2005, CANCER EPIDEM BIOMAR, V14, P2826, DOI 10.1158/1055-9965.EPI-12-ED1
   Kröger J, 2014, CURR OPIN LIPIDOL, V25, P0, DOI 10.1097/MOL.0000000000000078
   Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9
   Meeks KAC, 2016, INTERN EMERG MED, V11, P327, DOI 10.1007/s11739-015-1302-9
   Misra A, 2007, NUTRITION, V23, P696, DOI 10.1016/j.nut.2007.06.008
   Mlotha V, 2016, FOOD SCI NUTR, V4, P322, DOI 10.1002/fsn3.293
   Newby PK, 2004, NUTR REV, V62, P177, DOI 10.1301/rn.2004.may.177-203
   Osei-Kwasi HA, 2016, INT J BEHAV NUTR PHY, V13, P0, DOI 10.1186/s12966-016-0412-8
   Palli D, 2013, DIABETOLOGIA, V56, P47, DOI 10.1007/s00125-012-2718-7
   Ros E, 2015, BRIT J NUTR, V113, PS111, DOI 10.1017/S0007114514003924
   Schwingshackl L, 2017, EUR J EPIDEMIOL, V32, P363, DOI 10.1007/s10654-017-0246-y
   WHO, 2006, DEF DIAGN DIABT MELL, V0, P0
   WHO, 2005, REPORT NO.: 9241593830, V0, P0
   Wittenbecher C, 2015, AM J CLIN NUTR, V101, P1241, DOI 10.3945/ajcn.114.099150
NR 29
TC 25
Z9 27
U1 0
U2 11
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2044-4052
EI 
J9 NUTR DIABETES
JI Nutr. Diabetes
PD APR 25
PY 2018
VL 8
IS 
BP 
EP 
DI 10.1038/s41387-018-0029-x
PG 12
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA GF1VF
UT WOS:000431723000008
PM 29695705
DA 2025-04-28
ER

PT J
AU Bezerra, IN
   de Alencar, ES
AF Bezerra, Ilana Nogueira
   de Alencar, Eudoxia Sousa
TI Association between excess weight and beverage portion size consumed in Brazil
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Adult; Food Consumption; Beverages; Risk Factors; Overweight, epidemiology; Diet Surveys
ID sugar-sweetened beverages; milk intake; children; adults; risk; population; obesity; energy; trends; men
AB OBJECTIVE: To describe the beverage portion size consumed and to evaluate their association with excess weight in Brazil. METHODS: We used data from the National Dietary Survey, which included individuals with two days of food record aged over 20 years (n = 24,527 individuals). The beverages were categorized into six groups: soft drink, 100% fruit juice, fruit drink, alcoholic beverage, milk, and coffee or tea. We estimated the average portion consumed for each group and we evaluated, using linear regression, the association between portion size per group and the variables of age, sex, income, and nutritional status. We tested the association between portion size and excess weight using Poisson regression, adjusted for age, sex, income, and total energy intake. RESULTS: The most frequently consumed beverages in Brazil were coffee and tea, followed by 100% fruit juices, soft drinks, and milk. Alcoholic beverages presented the highest average in the portion size consumed, followed by soft drinks, 100% fruit juice, fruit drink, and milk. Portion size showed positive association with excess weight only in the soft drink (PR = 1.19, 95% CI 1.10-1.27) and alcoholic beverage groups (PR = 1.20, 95% CI, 1.11-1.29), regardless of age, sex, income, and total energy intake. CONCLUSIONS: Alcoholic beverages and soft drinks presented the highest averages in portion size and positive association with excess weight. Public health interventions should address the issue of portion sizes offered to consumers by discouraging the consumption of large portions, especially sweetened and low nutritional beverages.
C1 [Bezerra, Ilana Nogueira] Univ Estadual Ceara, Ctr Ciencias Saude, Programa Posgrad Nutr & Saude, Fortaleza, CE, Brazil.
   [de Alencar, Eudoxia Sousa] Univ Fortaleza, Ctr Ciencias Saude, Fortaleza, CE, Brazil.
C3 Universidade Estadual do Ceara; Universidade Fortaleza
RP Bezerra, IN (corresponding author), Univ Estadual Ceara, Ctr Ciencias Saude, Av Dr Silas Munguba 1700 Itaperi, BR-60714903 Fortaleza, CE, Brazil.
EM Ilana.bezerra@uece.br
CR Basu S, 2014, PLOS MED, V11, P0, DOI 10.1371/journal.pmed.1001582
   Benton D, 2015, CRIT REV FOOD SCI, V55, P988, DOI 10.1080/10408398.2012.679980
   Bleich SN, 2009, AM J CLIN NUTR, V89, P372, DOI 10.3945/ajcn.2008.26883
   English L, 2015, APPETITE, V88, P39, DOI 10.1016/j.appet.2014.11.004
   Faria YD, 2014, ACTA PAUL ENFERM, V27, P591, DOI 10.1590/1982-0194201400096
   Gombi-Vaca MF, 2016, APPETITE, V98, P67, DOI 10.1016/j.appet.2015.12.014
   Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088
   Ludwig DS, 2013, JAMA PEDIATR, V167, P788, DOI 10.1001/jamapediatrics.2013.2408
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Manyema M, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0143050
   Michaëlsson K, 2014, BMJ-BRIT MED J, V349, P0, DOI 10.1136/bmj.g6015
   Moreira LFP, 2010, ARQ BRAS CARDIOL, V95, P1, DOI 10.1590/S0066-782X2010001100001
   Nielsen Samara Joy, 2003, JAMA (JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION), V289, P450, DOI 10.1001/jama.289.4.450
   Pereira JL, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164127
   Piernas C, 2011, AM J CLIN NUTR, V94, P1324, DOI 10.3945/ajcn.110.008466
   Pomeranz JL, 2014, NEW ENGL J MED, V371, P1956, DOI 10.1056/NEJMp1410076
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Rolls BJ, 2014, INT J OBESITY, V38, PS1, DOI 10.1038/ijo.2014.82
   Sato Y, 2015, OSTEOPOROSIS INT, V26, P1585, DOI 10.1007/s00198-015-3032-2
   Steenhuis IHM, 2010, PUBLIC HEALTH NUTR, V13, P852, DOI 10.1017/S1368980009992011
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Thompson F, 2008, NUTR PREVENTION TREA, V0, P3
   Young LR, 2012, AM J PREV MED, V43, P565, DOI 10.1016/j.amepre.2012.07.024
   Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246
   Zorumski CF, 2014, ALCOHOL, V48, P1, DOI 10.1016/j.alcohol.2013.09.045
NR 25
TC 13
Z9 15
U1 0
U2 2
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO, BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD JUN 15
PY 2018
VL 52
IS 
BP 
EP 
DI 10.11606/S1518-8787.2018052000082
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FX5LV
UT WOS:000426121500008
PM 29489988
DA 2025-04-28
ER

PT J
AU Otton, R
   Bolin, AP
   Ferreira, LT
   Marinovic, MP
   Rocha, ALS
   Mori, MA
AF Otton, Rosemari
   Bolin, Anaysa Paola
   Ferreira, Leticia Torres
   Marinovic, Marcelo Paradiso
   Silva Rocha, Andrea Livia
   Mori, Marcelo Alves
TI Polyphenol-rich green tea extract improves adipose tissue metabolism by down-regulating miR-335 expression and mitigating insulin resistance and inflammation
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Obesity; miR-155; Epigenetic; Energy expenditure; Metabolism; Adipose tissue
ID energy-expenditure; fat oxidation; kappa-b; adiponectin; obesity; epigallocatechin-3-gallate; sensitivity; caffeine; leptin; alpha
AB Obesity leads to changes in miRNA expression in adipose tissue, and this modulation is linked to the pathophysiology of the disease. Green tea (GT) is a natural source of polyphenols that have been shown to confer health benefits, particularly preventing metabolic diseases. Here, we investigated if the beneficial effects of GT in obesity results from changes in the miRNA profile in white adipose tissue. GT treatment [500 mg/body weight (BW)/12 weeks] increased energy expenditure of high-fat diet-fed mice (16 weeks), leading to reduced weight gain, decreased adiposity, reduced inflammation and improved insulin sensitivity. These phenotypes were associated with a decrease in the expression of miR-335 in the adipose tissue. miR-335 was up-regulated by TNF-alpha in adipocytes and, in turn, down-regulated genes involved in insulin signaling and lipid metabolism. On the other hand, GT inhibited TNF-a effect. In conclusion, miR-335 serves as a link between inflammation and impaired metabolism in adipose tissue, providing an important mechanistic insight into the molecular basis underlying GT action during obesity. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Otton, Rosemari; Ferreira, Leticia Torres; Marinovic, Marcelo Paradiso] Univ Cruzeiro Sul, CBS, Interdisciplinary Postgrad Program Hlth Sci, BR-03342000 Sao Paulo, Brazil.
   [Bolin, Anaysa Paola] Univ Sao Paulo, Biomed Sci Inst, Dept Pharmacol, BR-05508000 Sao Paulo, Brazil.
   [Silva Rocha, Andrea Livia; Mori, Marcelo Alves] Univ Estadual Campinas, Dept Biochem & Tissue Biol, BR-13083862 Campinas, SP, Brazil.
C3 Universidade Cruzeiro do Sul; Universidade de Sao Paulo; Universidade Estadual de Campinas
RP Otton, R (corresponding author), Av Regente Feijo 1295, BR-03342000 Sao Paulo, SP, Brazil.
EM rosemariotton@hotmail.com
FU Sao Paulo Research Foundation (FAPESP) [2013/22293-0, 2015/01316-7]; National Council for Scientific and Technological Development (CNPq); Cruzeiro do Sul University; Formas [2015-01316] Funding Source: Formas; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/01316-7, 13/22293-0] Funding Source: FAPESP
CR Ahmad N, 2000, ARCH BIOCHEM BIOPHYS, V376, P338, DOI 10.1006/abbi.2000.1742
   Albuquerque KFFS, 2016, EUR J NUTR, V55, P1261, DOI 10.1007/s00394-015-0940-z
   Amri EZ, 2017, MOL CELL ENDOCRINOL, V456, P87, DOI 10.1016/j.mce.2017.04.009
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Brandao BB, 2017, REDOX BIOL, V12, P82, DOI 10.1016/j.redox.2017.01.020
   Cai X, 2012, J MOL CELL BIOL, V4, P341, DOI 10.1093/jmcb/mjs044
   Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051
   Chan PC, 2010, TOXICOL PATHOL, V38, P1070, DOI 10.1177/0192623310382437
   Deiuliis JA, 2016, INT J OBESITY, V40, P88, DOI 10.1038/ijo.2015.170
   Douglass JD, 2017, MOL METAB, V6, P366, DOI 10.1016/j.molmet.2017.01.010
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Fantuzzi G, 2000, J LEUKOCYTE BIOL, V68, P437
   Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013
   Ferreira MA, 2016, OBES REV, V17, P1316, DOI 10.1111/obr.12452
   Gaidhu MP, 2010, AM J PHYSIOL-CELL PH, V298, PC961, DOI 10.1152/ajpcell.00547.2009
   Gaudet AD, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep22862
   Gordon MW, 2015, MOL CARCINOGEN, V54, P1060, DOI 10.1002/mc.22175
   Halim U, 2013, NAT COMMUN, V4, P0, DOI 10.1038/ncomms3213
   Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986
   Hotamisligil GS, 1999, J INTERN MED, V245, P621, DOI 10.1046/j.1365-2796.1999.00490.x
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Hotta K, 2001, DIABETES, V50, P1126, DOI 10.2337/diabetes.50.5.1126
   Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004
   Jang JY, 2013, BMC CANCER, V13, P0, DOI 10.1186/1471-2407-13-421
   Kim ES, 2007, OBESITY, V15, P3023, DOI 10.1038/oby.2007.360
   Lambert JD, 2003, J NUTR, V133, P4172, DOI 10.1093/jn/133.12.4172
   Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142
   Nakanishi N, 2009, BIOCHEM BIOPH RES CO, V385, P492, DOI 10.1016/j.bbrc.2009.05.058
   Ohishi Tomokazu, 2016, ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, V15, P74, DOI 10.2174/1871523015666160915154443
   Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011
   Tsang WP, 2010, J NUTR BIOCHEM, V21, P140, DOI 10.1016/j.jnutbio.2008.12.003
   Türközü D, 2017, CRIT REV FOOD SCI, V57, P254, DOI 10.1080/10408398.2014.986672
   Yamauchi T, 2013, CELL METAB, V17, P185, DOI 10.1016/j.cmet.2013.01.001
   Yang ZH, 2015, ACTA PHARM SIN B, V5, P145, DOI 10.1016/j.apsb.2015.01.002
   Zhu L, 2014, CELL BIOCHEM BIOPHYS, V68, P283, DOI 10.1007/s12013-013-9708-3
NR 37
TC 71
Z9 75
U1 1
U2 43
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JUL 15
PY 2018
VL 57
IS 
BP 170
EP 179
DI 10.1016/j.jnutbio.2018.03.024
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA GM5MJ
UT WOS:000438181200019
PM 29734116
DA 2025-04-28
ER

PT J
AU Wang, H
   Jeong, H
   Kim, NH
   Kang, Y
   Hwang, K
   Lee, H
   Hong, JH
   Oh, KS
AF Wang, Hyewon
   Jeong, HaYoung
   Kim, Na-Hui
   Kang, YoonJung
   Hwang, Kyungmi
   Lee, HwaJung
   Hong, Jin-Hwan
   Oh, Keum-Soon
TI Association between beverage intake and obesity in children: The Korea National Health and Nutrition Examination Survey (KNHANES) 2013-2015
SO NUTRITION RESEARCH AND PRACTICE
LA English
DT Article
DE Obesity; child; sugars; beverages; carbonated beverages
ID sugar-sweetened beverages; childhood obesity; weight-gain; dietary patterns; united-states; consumption; adolescents; overweight; risk; consequences
AB BACKGROUND/OBJECTIVES: Numerous researches have studied the association between sugar intake and obesity of children in many countries. This study was undertaken to investigate the association between beverage intake and obesity of children by reviewing a database for total sugar contents established in all foods and presented in a nutrition survey by the Korea National Health and Nutrition Examination Survey (KNHANES). SUBJECTS/METHODS: Data of 1,520 children aged 6-11 years in the 6th KNHANES (2013-2015) were analyzed for this study. A database for total sugar intake comprises the total sugar contents of all foods included in the results of a nutrition survey using the 24-hour recall method of 6th KNHANES. Beverages were categorized into carbonated beverages, fruit & vegetable drinks, other drinks, tea, and coffee. RESULTS: The average daily beverage intake of all children was 131.75 g/day, and the average daily total sugar intake in beverages was 13.76 g/day. Carbonated beverages had the highest intake rate (58.85 g/day) and also ranked highest for sugar intake (6.36 g/day). After adjusting for confounding variables, the odds ratio for obesity in children with beverage intake of >= 200 mL/day significantly increased by 1.83 times (95% CI, 1.11-3.00) as compared to children with beverage intake of < 200 mL/day. Also, a significant increase was observed in the odds ratio for obesity in total children (2.41 times; 95% CI, 1.35-4.33) and boys (3.15 times; 95% CI, 1.53-6.49) with carbonated beverage intake of < 200 mL/day when compared with children who consumed >= 200 mL/day. CONCLUSION: A positive association is observed between beverage intake and obesity in Korean children. In particular, an intake of carbonated beverages has a positive correlation with childhood obesity in boys. This study can therefore be used as scientific evidence for reducing sugar, and for the continuous management and research on beverages.
C1 [Wang, Hyewon; Jeong, HaYoung; Kim, Na-Hui; Kang, YoonJung; Hwang, Kyungmi; Lee, HwaJung; Hong, Jin-Hwan; Oh, Keum-Soon] Natl Inst Food & Drug Safety Evaluat, Nutr & Funct Food Res Team, Cheongju 28159, Chungbuk, South Korea.
C3 Ministry of Food & Drug Safety (MFDS), Republic of Korea; National Institute of Food & Drug Safety Evaluation
RP Oh, KS (corresponding author), Natl Inst Food & Drug Safety Evaluat, Nutr & Funct Food Res Team, Cheongju 28159, Chungbuk, South Korea.
EM gs9705@korea.kr
FU Ministry of Food and Drug Safety [17161MFDS081]
CR Unknown -, 2015, DIET REF INT KOR, V0, P0
   Bishop J, 2005, ASPE RESEARCH BRIEF: CHILDHOOD OBESITY, V0, P0
   Bray GA, 2004, AM J CLIN NUTR, V79, P537
   Cassady BA, 2012, AM J CLIN NUTR, V95, P587, DOI 10.3945/ajcn.111.025437
   Charlotte MB, 2011, DIABETES CARE, V34, P1986
   Collison KS, 2010, BMC PUBLIC HEALTH, V10, P0, DOI 10.1186/1471-2458-10-234
   Committee of Clinical Practice Guidelines Korean Society for the Study of Obesity, 2014, CLIN PRACT GUID OV O, V0, P0
   Daniels SR, 2005, CIRCULATION, V111, P1999, DOI 10.1161/01.CIR.0000161369.71722.10
   Dietz WH, 1998, J NUTR, V128, P411S, DOI 10.1093/jn/128.2.411S
   Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911
   Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458
   Flodmark CE, 2004, INT J OBESITY, V28, P1189, DOI 10.1038/sj.ijo.0802787
   Gibson S, 2007, INT J FOOD SCI NUTR, V58, P445, DOI 10.1080/09637480701288363
   Ha K, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8010031
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968
   Hursti UK, 2014, NORDIC NUTR RECOMMEN, V0, P0
   Jackson-Leach R, 2006, INT J PEDIATR OBES, V1, P26, DOI 10.1080/17477160600586614
   James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE
   Keller A, 2015, CHILD OBES, V11, P338, DOI 10.1089/chi.2014.0117
   Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102
   Kim HM, 2006, AM J EPIDEMIOL, V164, P787, DOI 10.1093/aje/kwj251
   Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508
   Koplan JP, 1999, JAMA-J AM MED ASSOC, V282, P1579, DOI 10.1001/jama.282.16.1579
   Korea Health Industry Development Institute, 2013, FOOD IND AN REP, V0, P0
   Krebs NF, 2003, PEDIATRICS, V112, P424, DOI 10.1542/peds.112.2.424
   Langlois Kellie, 2011, HEALTH REP, V22, P23
   Lee Haeng-Shin, 2013, CLIN NUTR RES, V2, P135, DOI 10.7762/cnr.2013.2.2.135
   Lee HaengShin Lee HaengShin, 2014, JOURNAL OF NUTRITION AND HEALTH, V47, P268, DOI 10.4163/jnh.2014.47.4.268
   Lobstein T, 2004, OBES REV, V5, P4, DOI 10.1111/j.1467-789X.2004.00133.x
   Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   McCrindle BW, 2015, CAN J CARDIOL, V31, P0, DOI 10.1016/j.cjca.2014.08.017
   Mikkilä V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418
   Millar L, 2014, OBESITY, V22, PE96, DOI 10.1002/oby.20665
   Ministry of Food and Drug Safety, 2016, MON TOT SUG SOD CONT, V0, P0
   Ministry of Food and Drug Safety Korea Health Industry Development Institute, 2015, SUG DAT COMP COMM CO, V0, P0
   Ministry of Health and Welfare, 2016, KOR HLTH STAT 2015 K, V0, P0
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Newens KJ, 2016, J HUM NUTR DIET, V29, P225, DOI 10.1111/jhn.12338
   Olsen NJ, 2012, OBESITY FACTS, V5, P506, DOI 10.1159/000341631
   Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Sánchez-Cruz JJ, 2013, REV ESP CARDIOL, V66, P371, DOI 10.1016/j.recesp.2012.10.016
   Song Y, 2010, INT J OBESITY, V34, P48, DOI 10.1038/ijo.2009.203
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
   World Health Organization (WHO), 2015, GUIDELINE: SUGARS INTAKE FOR ADULTS AND CHILDREN, V0, P0
NR 51
TC 18
Z9 18
U1 0
U2 14
PU KOREAN NUTRITION SOC
PI SEOUL
PA 804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA
SN 1976-1457
EI 2005-6168
J9 NUTR RES PRACT
JI Nutr. Res. Pract.
PD AUG 15
PY 2018
VL 12
IS 4
BP 307
EP 314
DI 10.4162/nrp.2018.12.4.307
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GQ2JG
UT WOS:000441480700005
PM 30090168
DA 2025-04-28
ER

PT J
AU Ali, HS
   Mansour, AF
   Kamil, MM
   Hussein, AMS
AF Ali, Hatem S.
   Mansour, Amr Farouk
   Kamil, M. M.
   Hussein, Ahmed M. S.
TI Formulation of Nutraceutical Biscuits Based on Dried Spent Coffee Grounds
SO INTERNATIONAL JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE Spent coffee grounds; nutraceutical biscuits; rheological properties; volatile compounds; sensory properties
ID chemical-composition; soy protein; quality; volatiles; products; residues; starch; moisture; industry; isolate
AB Background and Objective: Spent coffee grounds (SCGs) are the most abundant residual material (45%) obtained during the instant coffee production. Therefore, around 6 million tons of SCGs generated per year. The purposes of the present study consisted in evaluating the use of SCGs as innovative functional food ingredient in bakery products and study the effect of SCGs and their chemical constituents on the sensory properties, volatile constituents and rheological properties of the final product. Materials and Methods: Effect of mixing wheat flour with 2, 4 and 6% SCGs on rheological properties of the obtained dough was evaluated, then chemical, texture profile and sensory properties of the final product were studied. Results: Rheological properties of mixed wheat flour with SCGs dough was affected slightly with the higher dietary fiber content. Moisture content of SCGs reached to 58.98%, therefore, was dried to reach 7.47% to control the microbial activity. Protein, ash, crude fiber and total carbohydrate of SCGs were 8.97, 2.77, 51.86 and 78.5%, respectively. Also, SCGs is good source of lipids (13.89%). Chemical composition of biscuit indicated that increasing mixing level of SCGs (2-6%) has shown good enhancement in fiber and ashes compared to control sample. Volatile sensory active compounds of biscuits and its supplemented mix with SCGs was evaluated. Thirty-eight volatile compounds was separated and identified in the biscuit samples by using SPME/GC-MS analysis. Hunter color parameter of produced biscuit indicated that whiteness (L*) of control sample reached to 71.17, while mixing SCGs with wheat flour at levels 2, 4 and 6% decreased L* to 66.31, 54.88 and 43.88, respectively. Also, redness degree (a*) was lower in wheat flour (0.45) than SCGs (3.57). Therefore, a* value of biscuit increased with increasing mixing level of SCGs. Sensory properties of biscuits showed that increasing SCGs level decreased significantly the color score but overall acceptability not affected significantly. Conclusion: Spent coffee grounds contains sufficient amounts from dietary insoluble fibers, protein, lipids, ashes and lower glycaemic sugars. Mixing wheat flour with SCGs affected slightly the rheological properties of dough and overall acceptability of the final product. Therefore, the obtained biscuit could be recommended to patients with obesity-related diseases and diabetes in addition to people looking for foods intake with reduced energy.
C1 [Ali, Hatem S.; Kamil, M. M.; Hussein, Ahmed M. S.] Natl Res Ctr, Dept Food Technol, Giza, Egypt.
   [Mansour, Amr Farouk] Natl Res Ctr, Dept Flavor & Aromat Chem, Giza, Egypt.
   [Ali, Hatem S.] King Saud Univ, Dept Food Sci & Nutr, Coll Food Sci & Agr, Riyadh, Saudi Arabia.
C3 Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); National Research Centre (NRC); King Saud University
RP Hussein, AMS (corresponding author), Natl Res Ctr, Dept Food Technol, Giza, Egypt.
CR AACC, 2009, APPROVED METHODS OF THE AMERICAN ASSOCIATION OF CEREAL CHEMISTRY, V0, P0
   Adams RP, 1995, IDENTIFICATION OF ESSENTIAL OIL COMPONENTS BY GAS CHROMATOGRAPHY/MASS SPECTROMETRY, V0, P469
   Annor GA, 2006, P 13 WORLD C FOOD SC, V0, P0
   Unknown -, 2009, FOOD CHEM, V0, P0
   Ballesteros LF, 2014, FOOD BIOPROCESS TECH, V7, P3493, DOI 10.1007/s11947-014-1349-z
   Batey IL, 2000, CEREAL CHEM, V77, P754, DOI 10.1094/CCHEM.2000.77.6.754
   Bredie WLP, 2002, J AGR FOOD CHEM, V50, P1118, DOI 10.1021/jf0111662
   Cruz R, 2012, J AGR FOOD CHEM, V60, P7777, DOI 10.1021/jf3018854
   El-Shebini SM, 2013, JOURNAL OF APPLIED SCIENCES RESEARCH, V9, P1940
   Esfahani A, 2011, IUBMB LIFE, V63, P7, DOI 10.1002/iub.418
   Farouk A, 2016, J ESSENT OIL BEAR PL, V19, P1119, DOI 10.1080/0972060X.2016.1149112
   Flament I, 1991, VOLATILE COMPOUNDS F, V0, P617
   Fortuna T, 2000, INT J FOOD SCI TECH, V35, P285, DOI 10.1046/j.1365-2621.2000.00368.x
   GIVENS DI, 1986, AGR WASTES, V18, P69, DOI 10.1016/0141-4607(86)90108-3
   Hussein AMS, 2006, MINUFIYA J. AGRIC. RES, V31, P877
   Hussein AS, 2010, CZECH J FOOD SCI, V28, P225, DOI 10.17221/97/2009-CJFS
   International Coffee Organization (ICO), 2017, COFF MARK REP, V0, P0
   JANE J, 1992, CEREAL CHEM, V69, P405
   Kim YS, 1997, KOREAN J. FOOD SCI. TECHNOL., V29, P502
   Kondamudi N, 2008, J AGR FOOD CHEM, V56, P11757, DOI 10.1021/jf802487s
   Lago R, 2001, P 2 S PESQ CAF BRAS, V0, P1473
   LEDL F, 1990, ANGEW CHEM INT EDIT, V29, P565, DOI 10.1002/anie.199005653
   Mansour AF, 2001, CZECH JOURNAL OF FOOD SCIENCES, V19, P24
   Martinez-Saez N, 2017, FOOD CHEM, V216, P114, DOI 10.1016/j.foodchem.2016.07.173
   McClave JT, 1991, STATISTICAL FOR BUSINESS AND ECONOMICS, V0, P272
   Menjivar JA, 1994, THE SCIENCE OF COOKIE AND CRACKER PRODUCTION, V0, P283
   Mohsen SM, 2009, INT J FOOD SCI TECH, V44, P1705, DOI 10.1111/j.1365-2621.2009.01978.x
   Murthy PS, 2012, RESOUR CONSERV RECY, V66, P45, DOI 10.1016/j.resconrec.2012.06.005
   Mussatto SI, 2011, FOOD BIOPROCESS TECH, V4, P661, DOI 10.1007/s11947-011-0565-z
   Mussatto SI, 2011, CARBOHYD POLYM, V83, P368, DOI 10.1016/j.carbpol.2010.07.063
   Nabais JMV, 2008, FUEL PROCESS TECHNOL, V89, P262, DOI 10.1016/j.fuproc.2007.11.030
   Oliveira LS, 2006, LWT-FOOD SCI TECHNOL, V39, P235, DOI 10.1016/j.lwt.2005.01.011
   Ötles S, 2014, ACTA SCI POLON-TECHN, V13, P191, DOI 10.17306/J.AFS.2014.2.8
   Pasqualone A, 2014, FOOD RES INT, V65, P385, DOI 10.1016/j.foodres.2014.07.014
   Pozo-Bayón MA, 2006, FOOD REV INT, V22, P335, DOI 10.1080/87559120600864829
   Ratti C, 2009, CONTEMP FOOD ENG, V0, P1
   Scully Damhan S, 2016, BIOENGINEERING-BASEL, V3, P33, DOI 10.3390/bioengineering3040033
   Sherwin CP, 2003, J FOOD SCI, V68, P588, DOI 10.1111/j.1365-2621.2003.tb05715.x
   Shibanuma Y, 1996, CARBOHYD POLYM, V29, P253, DOI 10.1016/0144-8617(96)00026-4
   Silva MA, 1998, BIOMASS BIOENERG, V14, P457, DOI 10.1016/S0961-9534(97)10034-4
   Solina M, 2005, FOOD CHEM, V90, P861, DOI 10.1016/j.foodchem.2004.06.005
   Sudha ML, 2007, J FOOD ENG, V80, P922, DOI 10.1016/j.jfoodeng.2006.08.006
   TESTER RF, 1990, CEREAL CHEM, V67, P558
   Urooj A, 1998, INT J FOOD SCI NUTR, V49, P265, DOI 10.3109/09637489809089397
   Vardon DR, 2013, ACS SUSTAIN CHEM ENG, V1, P1286, DOI 10.1021/sc400145w
   Whistler L, 1997, CARBOHYDRATES CHEM F, V0, P0
   WHITFIELD FB, 1992, CRIT REV FOOD SCI, V31, P1, DOI 10.1080/10408399209527560
   [William HorwitzW. AOAC International AOAC International], 2000, OFFICIAL METHODS OF ANALYSIS OF AOAC INTERNATIONAL, VI., P0
   Wong CW, 2015, FOOD ENG SER, V0, PP41, DOI 10.1007/978-1-4939-2578-0_4
NR 50
TC 14
Z9 15
U1 7
U2 32
PU ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINET
PI FAISALABAD
PA 308-LASANI TOWN, SARGODHA RD, FAISALABAD, 38090, PAKISTAN
SN 1811-7775
EI 1812-5700
J9 INT J PHARMACOL
JI Int. J. Pharmacol.
PD JUN 15
PY 2018
VL 14
IS 4
BP 584
EP 594
DI 10.3923/ijp.2018.584.594
PG 11
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GD0FT
UT WOS:000430176800017
DA 2025-04-28
ER

PT J
AU Hibi, M
   Takase, H
   Iwasaki, M
   Osaki, N
   Katsuragi, Y
AF Hibi, Masanobu
   Takase, Hideto
   Iwasaki, Masaki
   Osaki, Noriko
   Katsuragi, Yoshihisa
TI Efficacy of tea catechin-rich beverages to reduce abdominal adiposity and metabolic syndrome risks in obese and overweight subjects: a pooled analysis of 6 human trials
SO NUTRITION RESEARCH
LA English
DT Review
DE Metabolic syndrome; Visceral fat; Tea catechins; Cardiovascular disease; Pooled analysis
ID green tea; weight-loss; metaanalysis; fat; cholesterol; consumption; caffeine; prevent; adults; men
AB This post hoc pooled analysis assessed the effectiveness of green tea catechins (GTC) to reduce the risk of metabolic syndrome (MetS) associated with abdominal fat reduction, because previous findings are unclear. Data were pooled from six human trials (n=921, 505 men) comparing the effects of GTC-containing beverages (540-588 mg GTC/beverage) and a placebo beverage. Outcome measures were abdominal fat [total fat area (TFA), visceral fat area (VFA), subcutaneous fat area (SFA)], and MetS risk. We estimated mean changes from baseline and calculated confidence intervals (CI) to assess reductions in abdominal fat accumulation and MetS improvement. Subclass analyses were performed by classifying subjects as Pre-MetS or MetS at trial initiation. Additional subclass analyses were performed with Pre-MetS and MetS subjects further stratified according to whether GTC intake reduced TFA, VFA, or SFA. Consumption of GTC-containing beverages for 12 weeks significantly reduced TFA (-17.7cm(2), 95%CI: -20.9 to -14.4), VFA (-7.5cm(2), 95%CI: -9.3 to -5.7), SFA (-10.2cm(2), 95%CI: -12.5 to -7.8), body weight, body mass index, and waist circumference; and improved blood pressure. Subclass analyses of Pre-MetS and MetS subjects showed improved MetS in the GTC group [odds ratio (OR), 1.67; 95%CI: 1.08-2.57]. The ORs for improved MetS in the TFA- and VFA-reduced groups were 2.79 (95%CI: 1.28-6.09) and 4.36 (95%CI: 2.03-9.39), respectively. Continual consumption of GTC-containing beverages reduced abdominal fat and improved MetS, suggesting its potential to prevent diabetes and cardiovascular disease. Additional large-scale intervention trials are needed to evaluate the effects of GTC on the risk of MetS in high-risk populations. (C) 2018 The Authors. Published by Elsevier B.V.
C1 [Hibi, Masanobu; Iwasaki, Masaki; Osaki, Noriko; Katsuragi, Yoshihisa] Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
   [Takase, Hideto] Kao Corp, Biol Sci Labs, 2606 Akabane, Ichikai, Tochigi 3213497, Japan.
C3 KAO Corporation; KAO Corporation
RP Hibi, M (corresponding author), Kao Corp, Hlth Care Food Res Labs, Sumida Ku, 2-1-3 Bunka, Tokyo 1318501, Japan.
EM hibi.masanobu@kao.com; takase.hideto@kao.com; iwasaki.masaki1@kao.com; osaki.noriko@kao.com; katsuragi.yoshihisa@kao.com
FU Kao Corporation
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Anderson JW, 2000, AM J CLIN NUTR, V71, P472
   Unknown -, 2005, NIHON NAIKA GAKKAI ZASSHI, V94, P794
   Unknown -, 2008, JPN PHARMACOL THER, V0, P0
   Unknown -, 2016, JPN PHARMACOL THER, V0, P0
   Unknown -, 2008, JPN PHARMACOL THER, V0, P0
   Barraj LM, 2014, NUTR RES, V34, P174, DOI 10.1016/j.nutres.2013.11.002
   Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486
   Del Rio D, 2004, J AGR FOOD CHEM, V52, P2807, DOI 10.1021/jf0354848
   Engel SS, 2013, CARDIOVASC DIABETOL, V12, P0, DOI 10.1186/1475-2840-12-3
   FUJIOKA S, 1987, METABOLISM, V36, P54, DOI 10.1016/0026-0495(87)90063-1
   Han TS, 2002, OBES RES, V10, P923, DOI 10.1038/oby.2002.126
   Hiuge-Shimizu A, 2012, ANN MED, V44, P82, DOI 10.3109/07853890.2010.526138
   Hursel R, 2009, INT J OBESITY, V33, P956, DOI 10.1038/ijo.2009.135
   Iso H, 2006, ANN INTERN MED, V144, P554, DOI 10.7326/0003-4819-144-8-200604180-00005
   Kataoka K, 2004, PROGRESS IN MEDICINE, V24, P3358
   Khalesi S, 2014, EUR J NUTR, V53, P1299, DOI 10.1007/s00394-014-0720-1
   Kozuma K, 2005, PROG MED, V25, P1945
   Kuriyama S, 2006, JAMA-J AM MED ASSOC, V296, P1255, DOI 10.1001/jama.296.10.1255
   Legeay S, 2015, NUTRIENTS, V7, P5443, DOI 10.3390/nu7075230
   Lopes HF, 2016, DIABETOL METAB SYNDR, V8, P0, DOI 10.1186/s13098-016-0156-2
   Lovejoy JC, 1996, METABOLISM, V45, P1119, DOI 10.1016/S0026-0495(96)90011-6
   MATSUZAWA Y, 1995, OBES RES, V3, PS187, DOI 10.1002/j.1550-8528.1995.tb00462.x
   Matsuzawa Y, 2014, DIABETES MANAGE, V4, P391
   Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakao YM, 2012, P JPN ACAD B-PHYS, V88, P454, DOI 10.2183/pjab.88.454
   Okauchi Y, 2007, DIABETES CARE, V30, P2392, DOI 10.2337/dc07-0218
   RICEEVANS CA, 1995, FREE RADICAL RES, V22, P375, DOI 10.3109/10715769509145649
   Rolfe ED, 2015, BMC PUBLIC HEALTH, V15, P0, DOI 10.1186/s12889-015-2147-x
   Sabu MC, 2002, J ETHNOPHARMACOL, V83, P109
   Sahakyan KR, 2015, ANN INTERN MED, V163, P827, DOI 10.7326/M14-2525
   Seto R, 1997, BIOSCI BIOTECH BIOCH, V61, P1434, DOI 10.1271/bbb.61.1434
   tsuchida t, 2002, PROG MED, V9, P2189
   Vernarelli JA, 2013, EUR J NUTR, V52, P1039, DOI 10.1007/s00394-012-0410-9
   Wan CJ, 2010, J DIABETES INVEST, V1, P259, DOI 10.1111/j.2040-1124.2010.00055.x
   Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X
   Zheng XX, 2013, AM J CLIN NUTR, V97, P750, DOI 10.3945/ajcn.111.032573
   Zheng XX, 2011, AM J CLIN NUTR, V94, P601, DOI 10.3945/ajcn.110.010926
NR 41
TC 41
Z9 44
U1 1
U2 34
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0271-5317
EI 1879-0739
J9 NUTR RES
JI Nutr. Res.
PD JUL 15
PY 2018
VL 55
IS 
BP 1
EP 10
DI 10.1016/j.nutres.2018.03.012
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GM1EX
UT WOS:000437808000001
PM 29914623
DA 2025-04-28
ER

PT J
AU Asgary, S
   Rastqar, A
   Keshvari, M
AF Asgary, Sedigheh
   Rastqar, Ali
   Keshvari, Mahtab
TI Functional Food and Cardiovascular Disease Prevention and Treatment: A Review
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE Cardiovascular disease; functional foods; nutrition
ID coronary-heart-disease; pomegranate juice consumption; intima-media thickness; whole-grain intake; aged garlic extract; postprandial endothelial function; cardiometabolic risk-factors; randomized controlled-trial; diastolic blood-pressure; saffron crocus-sativus
AB Cardiovascular disease (CVD) is now the leading cause of death globally and is a growing health concern. Lifestyle factors, including nutrition, play an important role in the etiology and treatment of CVD. Functional foods based on their basic nutritional functions can decrease the risk of many chronic diseases and have some physiological benefits. They contain physiologically active components either from plant or animal sources, marketed with the claim of their ability to reduce heart disease risk, focusing primarily on established risk factors, which are hyperlipidemia, diabetes, metabolic syndrome, obesity/overweight, elevated lipoprotein A level, small dense low-density lipoprotein cholesterol (LDL-C), and elevated inflammatory marker levels. Functional foods are suspected to exert their cardioprotective effects mainly through blood lipid profile level and improve hypertension control, endothelial function, platelet aggregation, and antioxidant actions. Clinical and epidemiological observations indicate that vegetable and fruit fiber, nuts and seeds, sea foods, coffee, tea, and dark chocolate have cardioprotective potential in humans, as well whole-grain products containing intact grain kernels rich in fiber and trace nutrients. They are nutritionally more important because they contain phytoprotective substances that might work synergistically to reduce cardiovascular risk. This review will focus on the reciprocal interaction between functional foods and the potential link to cardiovascular health and the possible mechanisms of action.
C1 [Asgary, Sedigheh; Keshvari, Mahtab] Isfahan Univ Med Sci, Cardiovasc Res Inst, Isfahan Cardiovasc Res Ctr, Esfahan, Iran.
   [Rastqar, Ali] Univ Laval, Dept Psychiat & Neurosci, Quebec City, PQ, Canada.
   [Rastqar, Ali] Univ Quebec, Mental Hlth Inst, Res Ctr, Quebec City, PQ, Canada.
C3 Isfahan University of Medical Sciences; Laval University; University of Quebec
RP Keshvari, M (corresponding author), Isfahan Univ Med Sci, Isfahan Cardiovasc Res Ctr, Isfahan Cardiovasc Res Inst, Moshtagh Sevom St,POB 81465-1148, Esfahan, Iran.
EM Mahtabkeshvari87@yahoo.com
CR Abuajah CI, 2015, J FOOD SCI TECH MYS, V52, P2522, DOI 10.1007/s13197-014-1396-5
   Agh F, 2017, ARCH IRAN MED, V20, P28, DOI 0172001/AIM.007
   Ahmadi N, 2013, INT J CARDIOL, V168, P2310, DOI 10.1016/j.ijcard.2013.01.182
   Akram M, 2010, ROM J BIOL PLANT BIO, V55, P65
   Al-Khalaf MI, 2013, AUSTRALIAN JOURNAL OF BASIC AND APPLIED SCIENCES, V7, P505
   Albert CM, 2002, ARCH INTERN MED, V162, P1382, DOI 10.1001/archinte.162.12.1382
   Alissa EM, 2012, J NUTR METAB, V2012, P0, DOI 10.1155/2012/569486
   Alobaidi Amina Hamed Ahmad, 2014, ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, V13, P68
   Alvarez-Suarez JM, 2014, J NUTR BIOCHEM, V25, P289, DOI 10.1016/j.jnutbio.2013.11.002
   Unknown -, 2015, LIFESTYLE CHANGES EF, V0, P0
   Unknown -, 2011, PAKISTAN JOURNAL OF NUTRITION, V0, P0, DOI DOI 10.3923/PJN.2011.162.167
   Unknown -, 2010, J. ADV. MED. BIOMED. RES, V0, P0
   Unknown -, 2016, LIPIDS HEALTH DIS, V0, P0, DOI DOI 10.1186/s12944-016-0382-5
   Unknown -, 2014, J SHAHREKORD U MED, V0, P0
   Unknown -, 2009, EARLY LIFE NUTRITION AND LIFELONG HEALTH, V0, P0
   Unknown -, 2003, QUAL HLTH CLAIMS LET, V0, P0
   Unknown -, 1999, FED REGISTER, V64, P57699
   Anthony MS, 1996, J NUTR, V126, P43, DOI 10.1093/jn/126.1.43
   Asgary S, 2016, J HUM HYPERTENS, V30, P627, DOI 10.1038/jhh.2016.34
   Asgary S, 2015, J ENDOCRINOL INVEST, V38, P1039, DOI 10.1007/s40618-015-0337-0
   Asgary S, 2009, J MED PLANTS RES, V3, P785
   Asgary Sedigheh, 2014, ISRN NUTR, V2014, P405867, DOI 10.1155/2014/405867
   Asgary S, 2013, ARYA ATHEROSCLER, V9, P326
   Asgary S, 2014, PHYTOTHER RES, V28, P193, DOI 10.1002/ptr.4977
   Asgary S, 2013, ARYA ATHEROSCLER, V9, P98
   Assimopoulou AN, 2005, PHYTOTHER RES, V19, P997, DOI 10.1002/ptr.1749
   Aune D, 2016, BMJ-BRIT MED J, V353, P0, DOI 10.1136/bmj.i2716
   Aviram M, 2004, CLIN NUTR, V23, P423, DOI 10.1016/j.clnu.2003.10.002
   Aviram M, 2001, ATHEROSCLEROSIS, V158, P195, DOI 10.1016/S0021-9150(01)00412-9
   Baba S, 2007, J NUTR, V137, P1436, DOI 10.1093/jn/137.6.1436
   BAKHIT RM, 1994, J NUTR, V124, P213, DOI 10.1093/jn/124.2.213
   Barnuud NN, 2014, INT J BIOMETEOROL, V58, P1279, DOI 10.1007/s00484-013-0724-1
   Barona J, 2012, NUTRIENTS, V4, P1945, DOI 10.3390/nu4121945
   Barona J, 2012, J NUTR, V142, P1626, DOI 10.3945/jn.112.162743
   Basu A, 2014, J NUTR, V144, P830, DOI 10.3945/jn.113.188169
   Bathaie SZ, 2010, CRIT REV FOOD SCI, V50, P761, DOI 10.1080/10408390902773003
   Battino M, 2009, NUTR REV, V67, PS145, DOI 10.1111/j.1753-4887.2009.00178.x
   Baum JA, 1998, AM J CLIN NUTR, V68, P545, DOI 10.1093/ajcn/68.3.545
   Bhandari Prasan R, 2015, J TRADIT COMPLEMENT MED, V5, P81, DOI 10.1016/j.jtcme.2014.10.009
   Bhatti IU, 2009, WORLD APPLIED SCIENCES JOURNAL, V6, P1053
   Bjelakovic G, 2007, JNCI-J NATL CANCER I, V99, P742, DOI 10.1093/jnci/djk211
   Bloom DE, 2012, PROGRAM ON THE GLOBAL DEMOGRAPHY OF AGING, V0, P0
   Bolger AP, 2000, DRUGS, V60, P1245, DOI 10.2165/00003495-200060060-00002
   Bolling BW, 2011, NUTR RES REV, V24, P244, DOI 10.1017/S095442241100014X
   Bondonno CP, 2015, AM J CLIN NUTR, V102, P368, DOI 10.3945/ajcn.114.101188
   Bondonno CP, 2012, FREE RADICAL BIO MED, V52, P95, DOI 10.1016/j.freeradbiomed.2011.09.028
   Boscá AR, 2000, MECH AGEING DEV, V114, P207, DOI 10.1016/S0047-6374(00)00089-0
   Budoff M, 2006, J NUTR, V136, P741S, DOI 10.1093/jn/136.3.741S
   Burton-Freeman B, 2012, MOL NUTR FOOD RES, V56, P622, DOI 10.1002/mnfr.201100649
   Buscemi S, 2012, AM J CLIN NUTR, V95, P1089, DOI 10.3945/ajcn.111.031088
   Cao ZL, 2009, AM J PHYSIOL-HEART C, V297, PH1494, DOI 10.1152/ajpheart.01233.2008
   Casas-Agustench P, 2011, NUTR METAB CARDIOVAS, V21, PS21, DOI 10.1016/j.numecd.2011.01.009
   Cassidy A, 2013, CIRCULATION, V127, P188, DOI 10.1161/CIRCULATIONAHA.112.122408
   Chao LK, 2005, J AGR FOOD CHEM, V53, P7274, DOI 10.1021/jf051151u
   Chen JY, 2013, J MED FOOD, V16, P361, DOI 10.1089/jmf.2012.2682
   Chen LH, 2015, FRONT PHARMACOL, V6, P0, DOI 10.3389/fphar.2015.00071
   Cheng AL, 2001, ANTICANCER RES, V21, P2895
   Chiva-Blanch G, 2012, J BERRY RES, V2, P63, DOI 10.3233/JBR-2012-028
   Chun OK, 2007, J NUTR, V137, P1244, DOI 10.1093/jn/137.5.1244
   Ciccone MM, 2013, MEDIAT INFLAMM, V2013, P0, DOI 10.1155/2013/782137
   Ciftci M, 2010, ACTA VET BRNO, V79, P33, DOI 10.2754/avb201079010033
   Coggan AR, 2015, CIRC-HEART FAIL, V8, P914, DOI 10.1161/CIRCHEARTFAILURE.115.002141
   Conen D, 2010, AM J CLIN NUTR, V92, P509, DOI 10.3945/ajcn.2010.29627
   Cortés B, 2006, J AM COLL CARDIOL, V48, P1666, DOI 10.1016/j.jacc.2006.06.057
   Craig WJ, 1997, J AM DIET ASSOC, V97, PS199, DOI 10.1016/S0002-8223(97)00765-7
   Craig WJ, 1999, AM J CLIN NUTR, V70, P491S, DOI 10.1093/ajcn/70.3.491s
   Crouse JR, 1999, ARCH INTERN MED, V159, P2070, DOI 10.1001/archinte.159.17.2070
   Daosukho C, 2007, FREE RADICAL BIO MED, V42, P1818, DOI 10.1016/j.freeradbiomed.2007.03.007
   Darmadi-Blackberry I, 2004, ASIA PAC J CLIN NUTR, V13, P217
   Dauchet L, 2006, J NUTR, V136, P2588, DOI 10.1093/jn/136.10.2588
   Davidson MH, 1998, J NUTR, V128, P1927, DOI 10.1093/jn/128.11.1927
   Davidson MH, 2009, AM J CARDIOL, V104, P936, DOI 10.1016/j.amjcard.2009.05.037
   Romero-Prado MMD, 2015, BASIC CLIN PHARMACOL, V117, P57, DOI 10.1111/bcpt.12360
   de Oliveira MC, 2003, NUTRITION, V19, P253, DOI 10.1016/S0899-9007(02)00850-X
   Dehkordi FR, 2008, FUND CLIN PHARMACOL, V22, P447, DOI 10.1111/j.1472-8206.2008.00607.x
   Desch S, 2010, AM J HYPERTENS, V23, P694, DOI 10.1038/ajh.2010.29
   Diep QN, 2004, CAN J PHYSIOL PHARM, V82, P976, DOI 10.1139/Y04-094
   Ding EL, 2006, NUTR METAB, V3, P0, DOI 10.1186/1743-7075-3-2
   Dow CA, 2012, METABOLISM, V61, P1026, DOI 10.1016/j.metabol.2011.12.004
   Durrington PN, 2001, HEART, V85, P544, DOI 10.1136/heart.85.5.544
   Duvoix A, 2005, CANCER LETT, V223, P181, DOI 10.1016/j.canlet.2004.09.041
   Dyerberg J, 2004, EUR J CLIN NUTR, V58, P1062, DOI 10.1038/sj.ejcn.1601934
   El-Bassossy HM, 2011, FOOD CHEM TOXICOL, V49, P3007, DOI 10.1016/j.fct.2011.07.060
   Engelhard YN, 2006, AM HEART J, V151, P0, DOI 10.1016/j.ahj.2005.05.008
   Esmaillzadeh A, 2006, INT J VITAM NUTR RES, V76, P147, DOI 10.1024/0300-9831.76.3.147
   Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303
   Flammer AJ, 2012, EUR HEART J, V33, P2172, DOI 10.1093/eurheartj/ehr448
   Biondo PBF, 2014, FOOD SCI TECH-BRAZIL, V34, P94, DOI 10.1590/S0101-20612014005000007
   Fu CL, 2006, PLANT FOOD HUM NUTR, V61, P73, DOI 10.1007/s11130-006-0016-6
   Fuchs D, 2007, AM J CLIN NUTR, V86, P1369, DOI 10.1093/ajcn/86.5.1369
   Gajendragadkar PR, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0099070
   Galleano M, 2009, J CARDIOVASC PHARM, V54, P483, DOI 10.1097/FJC.0b013e3181b76787
   GANGOLLI SD, 1994, EUR J PHARM-ENVIRON, V292, P1, DOI 10.1016/0926-6917(94)90022-1
   Giacco R, 2014, NUTR METAB CARDIOVAS, V24, P837, DOI 10.1016/j.numecd.2014.01.007
   Giampieri F, 2013, NAT PROD RES, V27, P448, DOI 10.1080/14786419.2012.706294
   Gilchrist M, 2013, FREE RADICAL BIO MED, V60, P89, DOI 10.1016/j.freeradbiomed.2013.01.024
   Glew RH, 2006, PLANT FOOD HUM NUTR, V61, P51, DOI 10.1007/s11130-006-0010-z
   Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016
   Goetz ME, 2016, J NUTR, V146, P2233, DOI 10.3945/jn.116.230185
   Goldberg I, 2012, FUNCTIONAL FOODS: DESIGNER FOODS, V0, PPHARMAFOODS
   González CA, 2006, BRIT J NUTR, V96, PS87, DOI 10.1017/BJN20061868
   Gossell-Williams M, 2011, CLIMACTERIC, V14, P558, DOI 10.3109/13697137.2011.563882
   Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70
   Grassi D, 2005, AM J CLIN NUTR, V81, P611
   Greenberg JA, 2007, AM J CLIN NUTR, V85, P392, DOI 10.1093/ajcn/85.2.392
   Gross M, 2004, PHARM BIOL, V42, P21, DOI 10.3109/13880200490893483
   Grosso G, 2015, AM J CLIN NUTR, V101, P783, DOI 10.3945/ajcn.114.099515
   Hammer A, 2015, CLIN HEMORHEOL MICRO, V59, P145, DOI 10.3233/CH-141817
   He FJ, 2007, J HUM HYPERTENS, V21, P717, DOI 10.1038/sj.jhh.1002212
   He K, 2004, CIRCULATION, V109, P2705, DOI 10.1161/01.CIR.0000132503.19410.6B
   He SY, 2005, LIFE SCI, V77, P907, DOI 10.1016/j.lfs.2005.02.006
   Hirai DM, 2017, AM J PHYSIOL-REG I, V312, PR13, DOI 10.1152/ajpregu.00263.2016
   Hobbs DA, 2013, J NUTR, V143, P1399, DOI 10.3945/jn.113.175778
   Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457
   HUANG HC, 1992, EUR J PHARMACOL, V221, P381
   Huguenin GVB, 2015, NUTR J, V14, P0, DOI 10.1186/s12937-015-0043-y
   Huseini HF, 2013, PHYTOTHER RES, V27, P1849, DOI 10.1002/ptr.4944
   Hwa JS, 2012, J ETHNOPHARMACOL, V139, P605, DOI 10.1016/j.jep.2011.12.001
   Hyson D, 2000, J MED FOOD, V3, P159, DOI 10.1089/jmf.2000.3.159
   Imaeda N, 1999, J NUTR SCI VITAMINOL, V45, P519, DOI 10.3177/jnsv.45.519
   Jacobs DR, 2000, J AM COLL NUTR, V19, P326S, DOI 10.1080/07315724.2000.10718968
   Jacques PF, 2013, BRIT J NUTR, V110, P545, DOI 10.1017/S0007114512005417
   Jain NK, 2012, ACTA POL PHARM, V69, P945
   Jaskani MJ, 2005, EUPHYTICA, V145, P259, DOI 10.1007/s10681-005-1644-x
   Joris PJ, 2013, ATHEROSCLEROSIS, V231, P78, DOI 10.1016/j.atherosclerosis.2013.09.001
   Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233
   Joukar S, 2013, PHARM BIOL, V51, P836, DOI 10.3109/13880209.2013.767362
   Joukar S, 2010, CARDIOVASC TOXICOL, V10, P66, DOI 10.1007/s12012-010-9063-1
   Jurenka J, 2008, ALTERN MED REV, V13, P128
   Kahle K, 2005, MOL NUTR FOOD RES, V49, P1143, DOI 10.1002/mnfr.200500132
   Kapil V, 2010, HYPERTENSION, V56, P274, DOI 10.1161/HYPERTENSIONAHA.110.153536
   Kelly JH, 2006, BRIT J NUTR, V96, PS61, DOI 10.1017/BJN20061865
   Keshvari M, 2013, ARYA ATHEROSCLER, V9, P280
   Kianbakht S, 2014, PHYTOTHER RES, V28, P432, DOI 10.1002/ptr.5011
   Kim SH, 2006, J ETHNOPHARMACOL, V104, P119, DOI 10.1016/j.jep.2005.08.059
   Kirwan JP, 2016, J NUTR, V146, P2244, DOI 10.3945/jn.116.230508
   Knekt P, 2002, AM J CLIN NUTR, V76, P560, DOI 10.1093/ajcn/76.3.560
   KO FN, 1995, BRIT J PHARMACOL, V116, P1801, DOI 10.1111/j.1476-5381.1995.tb16666.x
   Kojuri J, 2007, LIPIDS HEALTH DIS, V6, P0, DOI 10.1186/1476-511X-6-5
   Koli R, 2015, NUTR J, V14, P0, DOI 10.1186/s12937-015-0075-3
   Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94
   Kulkarni AP, 2007, J AGR FOOD CHEM, V55, P1491, DOI 10.1021/jf0626720
   Kurowska EM, 1997, CLIN INVEST MED, V20, P162
   LANE JD, 1989, PSYCHOSOM MED, V51, P373, DOI 10.1097/00006842-198907000-00001
   Lansky EP, 2007, J ETHNOPHARMACOL, V109, P177, DOI 10.1016/j.jep.2006.09.006
   Larijani VN, 2013, NUTRITION, V29, P71, DOI 10.1016/j.nut.2012.03.016
   Lauritzen L, 2016, BRIT J NUTR, V116, P2082, DOI 10.1017/S0007114516004293
   Leal J, 2006, EUR HEART J, V27, P1610, DOI 10.1093/eurheartj/ehi733
   Lee YP, 2009, AM J CLIN NUTR, V89, P766, DOI 10.3945/ajcn.2008.26708
   Lee YS, 2005, J NUTR BIOCHEM, V16, P213, DOI 10.1016/j.jnutbio.2004.09.006
   Liu XR, 2017, J NUTR, V147, P835, DOI 10.3945/jn.116.246785
   Liu YQ, 2012, COMPR REV FOOD SCI F, V11, P530, DOI 10.1111/j.1541-4337.2012.00201.x
   Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, P156, DOI 10.1038/nrd2466
   Lutsey PL, 2007, BRIT J NUTR, V98, P397, DOI 10.1017/S0007114507700715
   Lynn A, 2012, PLANT FOOD HUM NUTR, V67, P309, DOI 10.1007/s11130-012-0295-z
   Ma YY, 2010, DIABETES CARE, V33, P227, DOI 10.2337/dc09-1156
   Mahdavi R, 2015, FOOD FUNCT, V6, P2041, DOI 10.1039/C5FO00316D
   Mansour EH, 1999, ACTA ALIMENT HUNG, V28, P59
   Markey O, 2011, CARDIOVASC DIABETOL, V10, P0, DOI 10.1186/1475-2840-10-78
   Markowski Jaroslaw, 2006, JOURNAL OF FRUIT AND ORNAMENTAL PLANT RESEARCH, V14, P133
   Martins JM, 2005, J LIPID RES, V46, P1539, DOI 10.1194/jlr.M500129-JLR200
   Mathew AS, 2012, PLANT FOOD HUM NUTR, V67, P351, DOI 10.1007/s11130-012-0318-9
   Matsui T, 1998, FETT-LIPID, V100, P51, DOI 10.1002/(SICI)1521-4133(199802)100:2<51::AID-LIPI51>3.0.CO;2-W
   McKeown NM, 2016, PUBLIC HEALTH NUTR, V19, P326, DOI 10.1017/S1368980015001123
   McKeown NM, 2002, AM J CLIN NUTR, V76, P390, DOI 10.1093/ajcn/76.2.390
   Mehdizadeh R, 2013, IRAN J BASIC MED SCI, V16, P56
   Meisel H, 1998, INT DAIRY J, V8, P363, DOI 10.1016/S0958-6946(98)00059-4
   Mellen PB, 2008, NUTR METAB CARDIOVAS, V18, P283, DOI 10.1016/j.numecd.2006.12.008
   Mellen PB, 2010, J AM COLL NUTR, V29, P469, DOI 10.1080/07315724.2010.10719883
   Melnyk JP, 2010, FOOD RES INT, V43, P1981, DOI 10.1016/j.foodres.2010.07.033
   Mink PJ, 2007, AM J CLIN NUTR, V85, P895, DOI 10.1093/ajcn/85.3.895
   MONCADA S, 1993, NEW ENGL J MED, V329, P2002
   MORRIS JN, 1977, BMJ-BRIT MED J, V2, P1307, DOI 10.1136/bmj.2.6098.1307
   Mozaffarian D, 2006, JAMA-J AM MED ASSOC, V296, P1885, DOI 10.1001/jama.296.15.1885
   Mozaffarian D, 2011, CIRCULATION, V123, P2870, DOI 10.1161/CIRCULATIONAHA.110.968735
   Mulero J, 2015, NUTR HOSP, V32, P1462, DOI 10.3305/nh.2015.32.4.9510
   Murkovic M, 2002, J FOOD COMPOS ANAL, V15, P633, DOI 10.1006/jfca.2002.1052
   Naderi GA, 2005, JOURNAL OF MEDICINAL PLANTS, V4, P29
   Nagasako-Akazome Yoko, 2007, J OLEO SCI, V56, P417
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   NAQVI S A H, 1991, FITOTERAPIA, V62, P221
   Naz A, 2014, EXCLI J, V13, P650
   NERGIZ C, 1993, FOOD CHEM, V48, P259, DOI 10.1016/0308-8146(93)90137-5
   Niki E, 2011, J BERRY RES, V1, P169, DOI 10.3233/BR-2011-018
   Noad Rebecca L, 2016, HEART, V102, P1371, DOI 10.1136/heartjnl-2015-309218
   Nwofia GE, 2012, PAKISTAN JOURNAL OF NUTRITION, V11, P848
   OKeefe JH, 2013, J AM COLL CARDIOL, V62, P1043, DOI 10.1016/j.jacc.2013.06.035
   Oben J, 2008, NUTR J, V7, P0, DOI 10.1186/1475-2891-7-16
   Ohira T, 2013, CIRC J, V77, P1646, DOI 10.1253/circj.CJ-13-0702
   Omoni AO, 2005, TRENDS FOOD SCI TECH, V16, P344, DOI 10.1016/j.tifs.2005.02.002
   Onakpoya I, 2017, CRIT REV FOOD SCI, V57, P602, DOI 10.1080/10408398.2014.901292
   Padhi EMT, 2015, J NUTR, V145, P2665, DOI 10.3945/jn.115.219873
   Palozza P, 2012, ANN NUTR METAB, V61, P126, DOI 10.1159/000342077
   Panagiotakos DB, 2003, J NUTR, V133, P3228, DOI 10.1093/jn/133.10.3228
   Panahi Y, 2015, CLIN NUTR, V34, P1101, DOI 10.1016/j.clnu.2014.12.019
   Panahi Y, 2014, COMPLEMENT THER MED, V22, P851, DOI 10.1016/j.ctim.2014.07.006
   Panth N, 2016, ADV MED, V2016, P1, DOI 10.1155/2016/9152732
   Park E, 2016, BRIT J NUTR, V115, P226, DOI 10.1017/S0007114515004328
   PARKER TG, 1990, J CLIN INVEST, V85, P507, DOI 10.1172/JCI114466
   Peters U, 2001, AM J EPIDEMIOL, V154, P495, DOI 10.1093/aje/154.6.495
   Pezzuto JM, 2008, J AGR FOOD CHEM, V56, P6777, DOI 10.1021/jf800898p
   Phrommintikul A, 2006, INT J CARDIOL, V112, P142, DOI 10.1016/j.ijcard.2005.11.106
   Qidwai W, 2009, J ALTERN COMPLEM MED, V15, P639, DOI 10.1089/acm.2008.0367
   Qin Y, 2009, AM J CLIN NUTR, V90, P485, DOI 10.3945/ajcn.2009.27814
   Rahbar AR, 2015, FOOD FUNCT, V6, P1992, DOI 10.1039/c5fo00100e
   Rahman S, 2013, J ENAM MED COLL, V3, P94
   Rahmani S, 2016, PHYTOTHER RES, V30, P1540, DOI 10.1002/ptr.5659
   Rakic V, 1996, CLIN EXP PHARMACOL P, V23, P559, DOI 10.1111/j.1440-1681.1996.tb02779.x
   Rao AV, 1999, NUTR RES, V19, P305, DOI 10.1016/S0271-5317(98)00193-6
   Rao PV, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/642942
   Razavi BM, 2013, CHEM-BIOL INTERACT, V203, P547, DOI 10.1016/j.cbi.2013.03.010
   Rebholz CM, 2013, EUR J CLIN NUTR, V67, P58, DOI 10.1038/ejcn.2012.186
   Reis JF, 2016, J TRANSL MED, V14, P0, DOI 10.1186/s12967-016-1076-5
   Rendeiro C, 2016, BRIT J NUTR, V116, P1999, DOI 10.1017/S0007114516004219
   Riccardi G, 2005, CURR OPIN CLIN NUTR, V8, P630, DOI 10.1097/01.mco.0000171126.98783.0c
   Riccioni G, 2009, EUR J CARDIOV PREV R, V16, P351, DOI 10.1097/HJR.0b013e328325d807
   Richter CK, 2017, BRIT J NUTR, V117, P1403, DOI 10.1017/S000711451700143X
   Ried K, 2010, MATURITAS, V67, P144, DOI 10.1016/j.maturitas.2010.06.001
   Ros E, 2004, CIRCULATION, V109, P1609, DOI 10.1161/01.CIR.0000124477.91474.FF
   Ross SA, 2000, FITOTERAPIA, V71, P154, DOI 10.1016/S0367-326X(99)00131-8
   Sabaté J, 2010, ARCH INTERN MED, V170, P821, DOI 10.1001/archinternmed.2010.79
   Sabaté J, 2009, AM J CLIN NUTR, V89, PS1643, DOI 10.3945/ajcn.2009.26736Q
   Safaei N, 2017, ANN CARD ANAESTH, V20, P45, DOI 10.4103/0971-9784.197834
   Samarghandian S, 2014, PHARMACOGN RES, V6, P99, DOI 10.4103/0974-8490.128963
   Samman S, 2003, J NUTR, V133, P2188, DOI 10.1093/jn/133.7.2188
   Sampson L, 2002, J AM DIET ASSOC, V102, P1414, DOI 10.1016/S0002-8223(02)90314-7
   Santulli G, 2013, J. CARDIOVASC. DIS. RES., V1, P0
   Saraf-Bank S, 2016, J AM COLL NUTR, V35, P31, DOI 10.1080/07315724.2014.931262
   Sasikumar B, 2005, PLANT GENETIC RESOURCES CHARACTERIZATION AND UTILIZATION, V3, P230, DOI 10.1079/PGR200574
   Sauder KA, 2015, METABOLISM, V64, P1521, DOI 10.1016/j.metabol.2015.07.021
   Saxena A, 2004, J ALTERN COMPLEM MED, V10, P369, DOI 10.1089/107555304323062365
   Schoonderwoerd BA, 2008, EUROPACE, V10, P668, DOI 10.1093/europace/eun124
   Sedigheh A, 2011, AFR J PHARM PHARMACO, V5, P2620, DOI 10.5897/AJPP11.635
   SENANAYAKE UM, 1978, J AGR FOOD CHEM, V26, P822, DOI 10.1021/jf60218a031
   Sener G, 2002, JOURNAL OF MEDICINAL FOOD, V5, P37, DOI 10.1089/109662002753723205
   Setorki M, 2010, QOM UNIVERSITY OF MEDICAL SCIENCES JOURNAL, V3, P0
   Setorki M, 2009, LIPIDS HEALTH DIS, V8, P0, DOI 10.1186/1476-511X-8-39
   Seymour EM, 2008, J GERONTOL A-BIOL, V63, P1034, DOI 10.1093/gerona/63.10.1034
   Seymour EM, 2010, HYPERTENSION, V55, P1179, DOI 10.1161/HYPERTENSIONAHA.109.149393
   Shemshian Maryam, 2014, J COMPLEMENT INTEGR MED, V11, P43, DOI 10.1515/jcim-2013-0047
   Siervo M, 2013, J NUTR, V143, P818, DOI 10.3945/jn.112.170233
   Singh G, 2007, FOOD CHEM TOXICOL, V45, P1650, DOI 10.1016/j.fct.2007.02.031
   Sobenin IA, 2010, LIPIDS HEALTH DIS, V9, P0, DOI 10.1186/1476-511X-9-119
   Sobenin IA, 2009, HYPERTENS RES, V32, P433, DOI 10.1038/hr.2009.36
   Song F, 2013, J ETHNOPHARMACOL, V150, P125, DOI 10.1016/j.jep.2013.08.019
   Soni KB, 1992, INDIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, V36, P273
   SRIVASTAVA R, 1985, THROMB RES, V40, P413, DOI 10.1016/0049-3848(85)90276-2
   Steiner M, 2001, J NUTR, V131, P980S, DOI 10.1093/jn/131.3.980S
   Steptoe A, 2007, ATHEROSCLEROSIS, V193, P277, DOI 10.1016/j.atherosclerosis.2006.08.054
   Storniolo CE, 2017, EUR J NUTR, V56, P89, DOI 10.1007/s00394-015-1060-5
   Sumner MD, 2005, AM J CARDIOL, V96, P810, DOI 10.1016/j.amjcard.2005.05.026
   Sumpio BE, 2006, J AM COLL SURGEONS, V202, P813, DOI 10.1016/j.jamcollsurg.2006.01.018
   Szewczuk LM, 2004, J BIOL CHEM, V279, P22727, DOI 10.1074/jbc.M314302200
   Terauchi M, 2014, MENOPAUSE, V21, P990, DOI 10.1097/GME.0000000000000200
   Testai L, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9050502
   Tey SL, 2017, EUR J NUTR, V56, P1025, DOI 10.1007/s00394-015-1150-4
   Threapleton DE, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f6879
   Tjelle TE, 2015, BRIT J NUTR, V114, P1054, DOI 10.1017/S0007114515000562
   Torres N, 2006, J NUTR BIOCHEM, V17, P365, DOI 10.1016/j.jnutbio.2005.11.005
   Tovar J, 2014, BRIT J NUTR, V111, P706, DOI 10.1017/S000711451300305X
   Tranche S, 2016, GYNECOL ENDOCRINOL, V32, P477, DOI 10.3109/09513590.2015.1132305
   Tricarico PM, 2014, INT J MOL SCI, V15, P6843, DOI 10.3390/ijms15046843
   Tripoli E, 2007, FOOD CHEM, V104, P466, DOI 10.1016/j.foodchem.2006.11.054
   Ueeda M, 2008, CIRC J, V72, P1836, DOI 10.1253/circj.CJ-08-0249
   Umemura T, 2006, AM J CARDIOL, V98, P1538, DOI 10.1016/j.amjcard.2006.06.058
   Vafa MR, 2011, INT J PREVENTIVE MED, V2, P94
   Vahidi AR, 2007, PLANTA MED, V73, P995
   Vaisman N, 2015, INT J FOOD SCI NUTR, V66, P342, DOI 10.3109/09637486.2014.1000840
   Valderas-Martinez P, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8030170
   Varshney R, 2016, J NUTR, V146, P416S, DOI 10.3945/jn.114.202333
   Vauzour D, 2010, NUTRIENTS, V2, P1106, DOI 10.3390/nu2111106
   Velmurugan S, 2016, AM J CLIN NUTR, V103, P25, DOI 10.3945/ajcn.115.116244
   Venkatesan N, 1998, BRIT J PHARMACOL, V124, P425, DOI 10.1038/sj.bjp.0701877
   Verma S K, 1998, INDIAN J MED SCI, V52, P205
   Vilahur G, 2015, TRANSL RES, V166, P44, DOI 10.1016/j.trsl.2014.11.004
   Vinson JA, 2001, J AGR FOOD CHEM, V49, P5315, DOI 10.1021/jf0009293
   Wainstein J, 2011, J MED FOOD, V14, P1505, DOI 10.1089/jmf.2010.0300
   Wang X, 2014, BRIT J NUTR, V111, P1, DOI 10.1017/S000711451300278X
   Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523
   Weisburger JH, 2002, EXP BIOL MED, V227, P924, DOI 10.1177/153537020222701014
   West SG, 2014, BRIT J NUTR, V111, P653, DOI 10.1017/S0007114513002912
   Wien MA, 2003, INT J OBESITY, V27, P1365, DOI 10.1038/sj.ijo.0802411
   Wolak T, 2013, VASC PHARMACOL, V59, P63, DOI 10.1016/j.vph.2013.07.006
   Wong MCY, 2008, INFLAMMOPHARMACOLOGY, V16, P235, DOI 10.1007/s10787-008-8023-x
   Xaplanteris P, 2012, NUTR RES, V32, P390, DOI 10.1016/j.nutres.2012.03.011
   Xia T, 2006, FITOTERAPIA, V77, P530, DOI 10.1016/j.fitote.2006.06.008
   Yadav M, 2010, NUTR RES REV, V23, P184, DOI 10.1017/S0954422410000107
   Yamada T, 2011, J EPIDEMIOL, V21, P169, DOI 10.2188/jea.JE20100084
   Yang L, 2015, INT J CLIN EXP PATHO, V8, P14345
   Yang Z, 2014, MOL MED REP, V9, P1941, DOI 10.3892/mmr.2014.2002
   Yoshimoto N, 2015, PLANT J, V83, P941, DOI 10.1111/tpj.12954
   YOUNG VR, 1991, J AM DIET ASSOC, V91, P828
   Zarfeshany Aida, 2014, ADV BIOMED RES, V3, P100, DOI 10.4103/2277-9175.129371
   Zeb Irfan, 2012, J CARDIOVASC DIS RES, V3, P185, DOI 10.4103/0975-3583.98883
   Zeng YW, 2017, EVID-BASED COMPL ALT, V2017, P0, DOI 10.1155/2017/9402849
   Zern TL, 2005, J NUTR, V135, P1911, DOI 10.1093/jn/135.8.1911
   Zhang XH, 2001, BLOOD COAGUL FIBRIN, V12, P67, DOI 10.1097/00001721-200101000-00010
   Zhang XH, 2001, J NUTR, V131, P1471, DOI 10.1093/jn/131.5.1471
   Zhang YZ, 2014, J MOL CELL CARDIOL, V72, P85, DOI 10.1016/j.yjmcc.2014.02.012
   Zhang ZY, 2010, LIPIDS, V45, P765, DOI 10.1007/s11745-010-3463-7
   Zhou DH, 2014, AM J CLIN NUTR, V100, P270, DOI 10.3945/ajcn.113.079152
   Zou J, 2013, J NUTR BIOCHEM, V24, P1117, DOI 10.1016/j.jnutbio.2012.08.011
   Zou ZY, 2014, BRIT J NUTR, V111, P474, DOI 10.1017/S0007114513002730
   Zunino SJ, 2014, BRIT J NUTR, V112, P369, DOI 10.1017/S0007114514000890
NR 320
TC 70
Z9 74
U1 4
U2 99
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN 15
PY 2018
VL 37
IS 5
BP 429
EP 455
DI 10.1080/07315724.2017.1410867
PG 27
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GK3XG
UT WOS:000436083200009
PM 29528772
DA 2025-04-28
ER

PT J
AU Arent, SM
   Walker, AJ
   Pellegrino, JK
   Sanders, DJ
   McFadden, BA
   Ziegenfuss, TN
   Lopez, HL
AF Arent, Shawn M.
   Walker, Alan J.
   Pellegrino, Joseph K.
   Sanders, David J.
   McFadden, Bridget A.
   Ziegenfuss, Tim N.
   Lopez, Hector L.
TI The Combined Effects of Exercise, Diet, and a Multi-Ingredient Dietary Supplement on Body Composition and Adipokine Changes in Overweight Adults
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Article
DE Dietary supplement; raspberry ketone; adipokine; body composition; fat loss; capsaicin
ID insulin-resistance; down-regulation; adipose-tissue; leptin levels; weight-loss; fat mass; obesity; adiponectin; protein; capsaicin
AB Background: Very few weight and fat loss supplements undergo finished-product research to examine efficacy. The purpose of this study was to determine the effects of an 8-week diet and exercise program on body composition, hip and waist girth, and adipokines and evaluate whether a dietary supplement containing raspberry ketone, capsaicin, caffeine, garlic, and Citrus aurantium enhanced outcomes. Methods: Overweight men and women completed this randomized, placebo-controlled, double-blind study. Participants consumed 4 capsules/d of supplement (EXP; n = 18) or placebo (PLA; n = 18). Participants underwent 8 weeks of daily supplementation, calorie restriction (500 kcal < RMR [resting metabolic rate] x 1.2), and supervised progressive exercise training 3 times a week. Body composition, girth, and adipokines were assessed at baseline and postintervention (T1 and T2). Results: Significant decreases in weight (-2.6 +/- 0.57 kg, p < 0.001), fat mass (-1.8 +/- 0.20 kg; p < 0.001), and percentage body fat (-3.7% +/- 0.29%, p < 0.001) and a significant increase in lean body mass (LBM; 1.5 +/- 0.26 kg; p < 0.001) were seen from T1 to T2 in both groups. For men, only those in the EXP group increased LBM from T1 to T2 (1.3 +/- 0.38 kg; p < 0.05). Hip girth was also reduced, with the women in the EXP group (-10.7 +/- 2.15 cm, p < 0.001) having a greater reduction. There was a time by group interaction, with significant decreases in leptin (p < 0.001) and significant increases in adiponectin (p < 0.05) in the EXP group. Conclusions: Significant improvements in adipokines and leptin support the utility of exercise, diet, and fat loss for impacting inflammatory biomarkers. The improvement in adiponectin with EXP may suggest a unique health mechanism.
C1 [Arent, Shawn M.; Walker, Alan J.; Pellegrino, Joseph K.; Sanders, David J.; McFadden, Bridget A.] Rutgers State Univ, Ctr Hlth & Human Performance, New Brunswick, NJ 08901 USA.
   [Ziegenfuss, Tim N.; Lopez, Hector L.] Ctr Appl Hlth Sci, Stow, OH USA.
C3 Rutgers University System; Rutgers University New Brunswick
RP Arent, SM (corresponding author), Rutgers State Univ, Ctr Hlth Human Performance, 61 Dudley Rd, New Brunswick, NJ 08901 USA.
EM shawn.arent@rutgers.edu
CR Arciero PJ, 2014, J APPL PHYSIOL, V117, P1, DOI 10.1152/japplphysiol.00152.2014
   Ban JO, 2012, PHYTOTHER RES, V26, P1265, DOI 10.1002/ptr.3729
   Belza A, 2009, EUR J CLIN NUTR, V63, P57, DOI 10.1038/sj.ejcn.1602901
   Bloomer RJ, 2010, LIPIDS HEALTH DIS, V9, P0, DOI 10.1186/1476-511X-9-72
   Coppola A, 2009, INT J CARDIOL, V134, P414, DOI 10.1016/j.ijcard.2007.12.087
   Davitt PM, 2014, J STRENGTH COND RES, V28, P1937, DOI 10.1519/JSC.0000000000000355
   Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   Díez JJ, 2003, EUR J ENDOCRINOL, V148, P293, DOI 10.1530/eje.0.1480293
   Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008
   Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0
   Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3
   Ernsberger P, 2007, AM J HYPERTENS, V20, P866, DOI 10.1016/j.amjhyper.2007.02.015
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Hawley JA, 2009, APPL PHYSIOL NUTR ME, V34, P355, DOI 10.1139/H09-023
   Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032
   Hunter GR, 2010, OBESITY, V18, P690, DOI 10.1038/oby.2009.316
   Hursel R, 2010, INT J OBESITY, V34, P659, DOI 10.1038/ijo.2009.299
   Isa Y, 2008, BIOCHEM BIOPH RES CO, V373, P429, DOI 10.1016/j.bbrc.2008.06.046
   Josse AR, 2010, NUTR METAB, V7, P0, DOI 10.1186/1743-7075-7-65
   Kazumi T, 2004, METABOLISM, V53, P589, DOI 10.1016/j.metabol.2003.12.008
   Keophiphath M, 2009, J NUTR, V139, P2055, DOI 10.3945/jn.109.105452
   Layman DK, 2005, J NUTR, V135, P1903, DOI 10.1093/jn/135.8.1903
   Lazar MA, 2007, HORM METAB RES, V39, P710, DOI 10.1055/s-2007-985897
   Longland TM, 2016, AM J CLIN NUTR, V103, P738, DOI 10.3945/ajcn.115.119339
   Lopez HL, 2013, J INT SOC SPORT NUTR, V10, P0, DOI 10.1186/1550-2783-10-22
   Margetic S, 2002, INT J OBESITY, V26, P1407, DOI 10.1038/sj.ijo.0802142
   Melone M, 2012, J AM COLL CARDIOL, V59, P1697, DOI 10.1016/j.jacc.2011.11.064
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   Morimoto C, 2005, LIFE SCI, V77, P194, DOI 10.1016/j.lfs.2004.12.029
   Nader GA, 2006, MED SCI SPORT EXER, V38, P1965, DOI 10.1249/01.mss.0000233795.39282.33
   ONeill J, 2012, PHARMACOL REV, V64, P939, DOI 10.1124/pr.112.006163
   Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732
   Park KS, 2010, PLANTA MED, V76, P1654, DOI 10.1055/s-0030-1249860
   Pasman WJ, 1998, AM J PHYSIOL-ENDOC M, V274, PE280, DOI 10.1152/ajpendo.1998.274.2.E280
   Perusse L, 1997, J APPL PHYSIOL, V83, P5, DOI 10.1152/jappl.1997.83.1.5
   Reseland JE, 2001, AM J CLIN NUTR, V73, P240
   Sahebkar A, 2011, WORLD J GASTROENTERO, V17, P271, DOI 10.3748/wjg.v17.i2.271
   Smith MM, 2012, J PHYSIOL-LONDON, V590, P1787, DOI 10.1113/jphysiol.2011.221036
   SNYDER SH, 1981, P NATL ACAD SCI-BIOL, V78, P3260, DOI 10.1073/pnas.78.5.3260
   Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000
   Stohs SJ, 2012, INT J MED SCI, V9, P527, DOI 10.7150/ijms.4446
   Stohs SJ, 2011, INT J MED SCI, V8, P295, DOI 10.7150/ijms.8.295
   Strychar I, 2009, J AM DIET ASSOC, V109, P718, DOI 10.1016/j.jada.2008.12.026
   Ukkola O, 2002, J MOL MED, V80, P696, DOI 10.1007/s00109-002-0378-7
   Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3
   Wankhade UD, 2016, BIOMED RES INT, V2016, P0, DOI 10.1155/2016/2365609
   Whiting S, 2012, APPETITE, V59, P341, DOI 10.1016/j.appet.2012.05.015
   Willis LH, 2012, J APPL PHYSIOL, V113, P1831, DOI 10.1152/japplphysiol.01370.2011
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Yoneshiro T, 2012, AM J CLIN NUTR, V95, P845, DOI 10.3945/ajcn.111.018606
   Yoshioka M, 1998, BRIT J NUTR, V80, P503, DOI 10.1017/S0007114598001597
NR 52
TC 22
Z9 25
U1 0
U2 9
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN 15
PY 2018
VL 37
IS 2
BP 111
EP 120
DI 10.1080/07315724.2017.1368039
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GA8LV
UT WOS:000428592600004
PM 29111889
DA 2025-04-28
ER

PT J
AU Kollia, N
   Panagiotakos, DB
   Chrysohoou, C
   Georgousopoulou, E
   Tousoulis, D
   Stefanadis, C
   Papageorgiou, C
   Pitsavos, C
AF Kollia, Natasa
   Panagiotakos, Demosthenes B.
   Chrysohoou, Christina
   Georgousopoulou, Ekavi
   Tousoulis, Dimitrios
   Stefanadis, Christodoulos
   Papageorgiou, Charalabos
   Pitsavos, Christos
TI DETERMINANTS OF HEALTHY AGEING AND ITS RELATION TO 10-YEAR CARDIOVASCULAR DISEASE INCIDENCE: THE ATTICA STUDY
SO CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
DE ageing; cardiovascular disease; risk factors; psychological
ID risk-factor; markers; inflammation; obesity; population; mortality; europe; score
AB Objectives: The aim of the study was to understand determinants of ageing in relation to future cardiovascular disease (CVD) events at population level, and to explore determinants of healthy ageing and its relation to 10-year CVD incidence among apparently healthy individuals. Methods: In the context of the ATTICA study 453 apparently healthy men (45 +/- 13 years) and 400 women (44 +/- 18 years) with complete psychological evaluation were studied and followed during 2002-2012. Healthy Ageing Index (HAI) (range 0-7) was calculated based on socioeconomical, bio-clinical, psychological, and lifestyle characteristics (i.e. dietary habits and physical activity) of the participants during the baseline examination. CVD incidence during the follow-up period was defined according to ICD-10 criteria. Results: Healthy Ageing Index was inversely associated with higher 10-year CVD risk (OR per 1/7 (95% CI): 0.47 (0.28, 0.80). Age and sex-adjusted determinants of healthy ageing were abnormal waist to hip ratio (p <0.001), increased coffee consumption (p = 0.04), reduced basic metabolic rhythm (p <0.001), increased triglycerides (p = 0.003), and C-reactive protein levels (p = 0.02), as aggravating factors, while moderate alcohol consumption (p =0.002) was identified as a positive influential parameter. Conclusions: Understanding healthy ageing, as a dominant factor of CVD development, provides a new direction for better prevention efforts focused on healthy ageing at both population and individual level.
C1 [Kollia, Natasa; Panagiotakos, Demosthenes B.; Georgousopoulou, Ekavi] Harokopio Univ, Sch Hlth Sci & Educ, Dept Nutr & Dietet, Athens, Greece.
   [Chrysohoou, Christina; Tousoulis, Dimitrios; Stefanadis, Christodoulos; Pitsavos, Christos] Univ Athens, Sch Med, Cardiol Clin 1, Athens, Greece.
   [Papageorgiou, Charalabos] Univ Athens, Sch Med, Dept Psychiat, Athens, Greece.
C3 Harokopio University Athens; National & Kapodistrian University of Athens; Athens Medical School; Athens Medical School; National & Kapodistrian University of Athens
RP Panagiotakos, DB (corresponding author), 46 Paleon Polemiston St, Attica 16674, Greece.
EM d.b.panagiotakos@usa.net
FU Coca-Cola Company; Hellenic Cardiology Society [HCS2002]; Hellenic Atherosclerosis Society [HAS2003]; Aging Trajectories of Health: Longitudinal Opportunities and Synergies (ATHLOS) project (European Union's Horizon research and innovation program) [635316]
CR Unknown -, 2006, COM/2006/0571, V0, P0
   Atzmon G, 2002, J GERONTOL A-BIOL, V57, PM712, DOI 10.1093/gerona/57.11.M712
   Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3
   Dokic B, 2015, CENT EUR J PUBL HEAL, V23, P195
   Fountoulakis KN, 2006, ANN GEN PSYCHIAT, V5, P0, DOI 10.1186/1744-859X-5-2
   Fountoulakis KN, 2001, BMC PSYCHIATRY, V1, P0, DOI 10.1186/1471-244X-1-6
   Genchev G D, 2001, CENT EUR J PUBLIC HEALTH, V9, P83
   Gorenoi V, 2015, CENT EUR J PUBL HEAL, V23, P91
   Jagust W, 2005, ARCH NEUROL-CHICAGO, V62, P1545, DOI 10.1001/archneur.62.10.1545
   Kamphuis Carlijn B M, 2012, BMC PUBLIC HEALTH, V12, P1045, DOI 10.1186/1471-2458-12-1045
   Katsouyanni Klea, 1997, INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, V26, PS118, DOI 10.1093/ije/26.suppl_1.S118
   Lagrand WK, 1999, CIRCULATION, V100, P96, DOI 10.1161/01.CIR.100.1.96
   Lira FS, 2014, CURR DIABETES REV, V10, P391, DOI 10.2174/1573399810666141122210135
   Panagiotakos Demosthenes B, 2007, HELLENIC J CARDIOL, V48, P55
   Panagiotakos DB, 2006, NUTR METAB CARDIOVAS, V16, P559, DOI 10.1016/j.numecd.2005.08.006
   Panagiotakos DB, 2015, INT J CARDIOL, V180, P178, DOI 10.1016/j.ijcard.2014.11.206
   Papathanasiou George, 2009, HELLENIC J CARDIOL, V50, P283
   Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5
   Pikhart Hynek, 2007, CENTRAL EUROPEAN JOURNAL OF PUBLIC HEALTH, V15, P140
   Pitsavos C, 2006, ATHEROSCLEROSIS, V185, P320, DOI 10.1016/j.atherosclerosis.2005.06.001
   Pitsavos C, 2003, BMC PUBLIC HEALTH, V3, P0, DOI 10.1186/1471-2458-3-32
   Raber J, 1998, MOL NEUROBIOL, V18, P1, DOI 10.1007/BF02741457
   Ruggiero C, 2008, J GERONTOL A-BIOL, V63, P698, DOI 10.1093/gerona/63.7.698
   Schofield W N, 1985, HUM NUTR CLIN NUTR, V39 Suppl 1, P5
   Teunissen CE, 2003, J NEUROIMMUNOL, V134, P142, DOI 10.1016/S0165-5728(02)00398-3
   Tyrovolas S, 2014, EXP GERONTOL, V60, P57, DOI 10.1016/j.exger.2014.09.010
   World Health Organization, 2018, WORLD REP AG HLTH, V0, P0, DOI DOI 10.1007/S13398-014-0173-7.2
   Zubko A, 1998, TREASURY SPIRITUAL W, V3rd, P0
NR 28
TC 5
Z9 6
U1 1
U2 9
PU NATL INST PUBLIC HEALTH
PI PRAGUE 10
PA DEPT SCIENTIFIC INFORMATION, SROBAROVA 48, PRAGUE 10, 100 42, CZECH REPUBLIC
SN 1210-7778
EI 1803-1048
J9 CENT EUR J PUBL HEAL
JI Cent. Eur. J. Public Health
PD MAR 15
PY 2018
VL 26
IS 1
BP 3
EP 9
DI 10.21101/cejph.a5165
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GG7AM
UT WOS:000432850200001
PM 29684290
DA 2025-04-28
ER

PT J
AU Han, YY
   Zhao, CH
   He, XY
   Sheng, Y
   Ma, TS
   Sun, ZF
   Liu, XY
   Liu, CJ
   Fan, SX
   Xu, WT
   Huang, KL
AF Han, Yingyan
   Zhao, Changhui
   He, Xiaoyun
   Sheng, Yao
   Ma, Tianshi
   Sun, Zhifan
   Liu, Xueying
   Liu, Chaojie
   Fan, Shuangxi
   Xu, Wentao
   Huang, Kunlun
TI Purple lettuce (Lactuca sativa L.) attenuates metabolic disorders in diet induced obesity
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Article
DE Energy expenditure; Glucose tolerance; Insulin sensitivity; Lipid profile; Diabetes; Microbiota
ID improves glucose-metabolism; herbal medicines; lipid-metabolism; chlorogenic acid; gut microbiota; lachnospiraceae; sequences; romaine; damage; red
AB Purple lettuce (Lactuca sativa L.) is a type of low caloric vegetable often consumed freshly, whereas its function in metabolic control has been little studied. To investigate the protective effect of a type of purple lettuce against metabolic risk factors, we treated the C57BL/6J DIO mice with or without purple lettuces for 8 weeks. Results showed that purple lettuce effectively attenuated many metabolic risk factors in DIO mice. Typically, purple lettuce prevented the body weight gain by reducing fat mass accumulation and increasing energy expenditure. Additionally, consumption of purple lettuces enhanced glucose homeostasis, increased insulin sensitivity and improved the lipid profile in the DIO mice. This was, at least partly, attributable to its abundance of bioactive molecules like esculin and chlorogenic acid. High intake of purple lettuces modulated the intestinal microbiota composition like decreased Lachnospiraceae. We conclude that purple lettuce has great potential as functional foods in prevention of metabolic disorders.
C1 [Han, Yingyan; Sun, Zhifan; Liu, Xueying; Liu, Chaojie; Fan, Shuangxi] Beijing Agr Univ, Natl Demonstrat Ctr Expt Plant Prod Educ, Beijing Key Lab New Technol Agr Applicat, Beinong Rd 7, Beijing 102206, Peoples R China.
   [He, Xiaoyun; Sheng, Yao; Ma, Tianshi; Xu, Wentao; Huang, Kunlun] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing 100083, Peoples R China.
   [Zhao, Changhui] Jilin Univ, Dept Food Qual & Safety, Coll Food Sci & Engn, Changchun 130062, Jilin, Peoples R China.
C3 Beijing University of Agriculture; China Agricultural University; Jilin University
RP Fan, SX (corresponding author), Beijing Agr Univ, Natl Demonstrat Ctr Expt Plant Prod Educ, Beijing Key Lab New Technol Agr Applicat, Beinong Rd 7, Beijing 102206, Peoples R China.; Huang, KL (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, 17 Tsinghua East Rd, Beijing 100083, Peoples R China.
EM fsx20@163.com; foodsafety66@cau.edu.cn
FU Beijing University of Agriculture [GZL2016001, YQ201604]; Beijing Innovation Consortium of Agriculture Research System [BAIC08]
CR Abdali D, 2015, MED PRIN PRACT, V24, P201, DOI 10.1159/000375305
   Unknown -, 2015, STAT WAT RES CONTR B, V0, P0
   Asadpour E, 2014, ACTA POL PHARM, V71, P409
   Biddle A, 2013, DIVERSITY-BASEL, V5, P627, DOI 10.3390/d5030627
   Bigliardi B, 2013, TRENDS FOOD SCI TECH, V31, P118, DOI 10.1016/j.tifs.2013.03.006
   Cani PD, 2014, DIABETES METAB, V40, P246, DOI 10.1016/j.diabet.2014.02.004
   Cheng DM, 2016, MOL NUTR FOOD RES, V60, P2367, DOI 10.1002/mnfr.201600290
   Cheng DM, 2014, NUTRITION, V30, PS52, DOI 10.1016/j.nut.2014.02.022
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI 10.1038/nmeth.2604
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Faisst M, 2010, J CRIT CARE, V25, P105, DOI 10.1016/j.jcrc.2009.02.002
   Ferreres F, 1997, J AGR FOOD CHEM, V45, P4249, DOI 10.1021/jf970399j
   Ghadieh HE, 2015, NUTR METAB, V12, P0, DOI 10.1186/s12986-015-0014-5
   Ghorbani A, 2015, NUTR NEUROSCI, V18, P103, DOI 10.1179/1476830513Y.0000000107
   Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002
   Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073
   Hernandez JB, 2015, NAT COMMUN, V6, P0, DOI 10.1038/ncomms8216
   Higdon JV, 2003, ARTERIOSCL THROM VAS, V23, P365, DOI 10.1161/01.ATV.0000063608.43095.E2
   Isken F, 2010, J NUTR BIOCHEM, V21, P278, DOI 10.1016/j.jnutbio.2008.12.012
   Islam MN, 2013, ARCH PHARM RES, V36, P542, DOI 10.1007/s12272-013-0069-7
   Jung HA, 2012, ARCH PHARM RES, V35, P1021, DOI 10.1007/s12272-012-0610-0
   Kameyama K, 2014, MICROBES ENVIRON, V29, P427, DOI 10.1264/jsme2.ME14054
   Kang KS, 2014, J AGR FOOD CHEM, V62, P2069, DOI 10.1021/jf403840c
   Kim HJ, 2008, J AGR FOOD CHEM, V56, P3772, DOI 10.1021/jf0733719
   Kohn RA, 2005, J ANIM SCI, V83, P879
   Lee JS, 2005, FOOD SCI BIOTECHNOL, V14, P99
   Liang N, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8010016
   [刘晓天 Liu Xiaotian], 2016, 中国给水排水 CHINA WATER & WASTEWATER, V32, P57
   López A, 2014, J FOOD COMPOS ANAL, V33, P39, DOI 10.1016/j.jfca.2013.10.001
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Meng TX, 2011, J WOOD SCI, V57, P452, DOI 10.1007/s10086-011-1192-z
   Mubarak A, 2015, J AGR FOOD CHEM, V63, P1882, DOI 10.1021/acs.jafc.5b00621
   Mulabagal V, 2010, FOOD CHEM, V118, P300, DOI 10.1016/j.foodchem.2009.04.119
   Park JP, 2011, BIOTECHNOL BIOPROC E, V16, P1065, DOI 10.1007/s12257-011-0215-3
   Rodriguez-Casado A, 2016, CRIT REV FOOD SCI, V56, P1097, DOI 10.1080/10408398.2012.755149
   Scalbert A, 2005, AM J CLIN NUTR, V81, P215S, DOI 10.1093/ajcn/81.1.215S
   Sheng Y, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-12245-2
   Shin HS, 2015, FOOD CHEM, V168, P167, DOI 10.1016/j.foodchem.2014.06.100
   Wang J, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/757540
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Yuan XX, 2017, FASEB J, V31, P333, DOI 10.1096/fj.201600459rr
NR 47
TC 18
Z9 19
U1 2
U2 38
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JUN 15
PY 2018
VL 45
IS 
BP 462
EP 470
DI 10.1016/j.jff.2018.04.027
PG 9
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA GI6QB
UT WOS:000434494300053
DA 2025-04-28
ER

PT J
AU Carrageta, DF
   Dias, TR
   Alves, MG
   Oliveira, PF
   Monteiro, MP
   Silva, BM
AF Carrageta, David F.
   Dias, Tania R.
   Alves, Marco G.
   Oliveira, Pedro F.
   Monteiro, Mariana P.
   Silva, Branca M.
TI Anti-obesity potential of natural methylxanthines
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Adipogenesis; Caffeine; Lipolysis; Methylzanthines; Obesity
ID tea camellia-sinensis; central-nervous-system; cyclic adenosine-monophosphate; adipose-tissue inflammation; adipocyte gene-expression; binding-protein-alpha; white tea; green tea; ppar-gamma; coffee consumption
AB Obesity is one of the most challenging health issue worldwide that has been steadily increasing in the last decades. Obesity arises from a positive energy balance in result of increased intake and decreased energy expenditure, usually due to inadequate dietary habits and a sedentary lifestyle, which results in the accumulation of excess body fat. There are few pharmacological tools to address obesity, thus calorie restriction and increased physical activity are still the cornerstone of obesity treatment. In recent years, natural products obtained from plants have been thoroughly studied to infer whether these have any potential to target obesity. Methylxanthines comprise one of those classes of compounds that are abundant in common food products consumed on a daily basis worldwide, such as coffee, chocolate, or tea. Despite caffeine is the most popular and well-studied methylxanthine, theobromine and theophylline are also abundant in humans' diet. Notably, methylxanthines proved to stimulate lipolysis and inhibit adipogenesis, which are interesting properties that could contribute for obesity management. This review aims to discuss the most recent information concerning the promising role of methylxanthines in the modulation of adipose tissue functions, highlighting the potential of these molecules in the development of novel therapeutic approaches for obesity treatment.
C1 [Carrageta, David F.; Dias, Tania R.; Silva, Branca M.] UBI, CICS, Rua Marques dAvila & Bolama, P-6201001 Covilha, Portugal.
   [Carrageta, David F.; Dias, Tania R.; Alves, Marco G.; Oliveira, Pedro F.] Univ Porto, Unit Multidisciplinary Res Biomed UMIB, Inst Biomed Sci Abel Salazar ICBAS, Dept Microscopy,Lab Cell Biol, Rua Jorge Viterbo, P-4050313 Porto, Portugal.
   [Oliveira, Pedro F.] Univ Porto, I3S, P-4200135 Porto, Portugal.
   [Monteiro, Mariana P.] Univ Porto, Dept Anat, Unit Multidisciplinary Res Biomed UMIB, Inst Biomed Sci Abel Salazar ICBAS, Rua Jorge Viterbo, P-4050313 Porto, Portugal.
C3 Universidade da Beira Interior; Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto
RP Silva, BM (corresponding author), Univ Beira Interior, Ctr Invest Ciencias Saude, Fac Ciencias Saude, Ave Infante D Henrique, P-6200506 Covilha, Portugal.
EM bmcms@ubi.pt
FU "Fundacao para a Ciencia e a Tecnologia" - FCT [SFRH/BD/109284/2015]; UMIB [PEst-OE/SAU/UI0215/2014]; FEDER through the COMPETE/QREN; FSE/POPH [PTDC/BIM-MET/4712/2014]; POCI - COMPETE [POCI-01-0145-FEDER007491];  [PTDC/BBB-BQB/1368/2014]; Fundação para a Ciência e a Tecnologia [PTDC/BBB-BQB/1368/2014] Funding Source: FCT
CR Acheson KJ, 2004, AM J CLIN NUTR, V79, P40
   Al-Hazzani AA, 2011, FOOD CHEM TOXICOL, V49, P3281, DOI 10.1016/j.fct.2011.09.023
   Alcazar A, 2007, J AGR FOOD CHEM, V55, P5960, DOI 10.1021/jf070601a
   Alves MG, 2015, J FUNCT FOODS, V14, P102, DOI 10.1016/j.jff.2015.01.019
   AMOROSO P, 1993, THORAX, V48, P882, DOI 10.1136/thx.48.9.882
   Aoyagi R, 2014, BIOL PHARM BULL, V37, P1820, DOI 10.1248/bpb.b14-00378
   Arnold R, 2002, BIOORG MED CHEM LETT, V12, P2587, DOI 10.1016/S0960-894X(02)00480-8
   Ashihara H, 2008, PHYTOCHEMISTRY, V69, P841, DOI 10.1016/j.phytochem.2007.10.029
   Atawodi SEO, 2007, J AGR FOOD CHEM, V55, P9824, DOI 10.1021/jf0721038
   Azam Sonish, 2003, MED SCI MONIT, V9, P0
   Bajko E, 2016, LWT-FOOD SCI TECHNOL, V65, P471, DOI 10.1016/j.lwt.2015.08.024
   Baker SP, 2000, BRIT J PHARMACOL, V130, P1156, DOI 10.1038/sj.bjp.0703405
   Barakat H, 2006, J CLIN ENDOCR METAB, V91, P1882, DOI 10.1210/jc.2005-2109
   Baraldi PG, 2007, EXPERT OPIN DRUG DIS, V2, P1161, DOI 10.1517/17460441.2.9.1161
   Barnes PJ, 2013, AM J RESP CRIT CARE, V188, P901, DOI 10.1164/rccm.201302-0388PP
   BAUMANN TW, 1995, PHYTOCHEMISTRY, V39, P1063, DOI 10.1016/0031-9422(94)00141-F
   Beale JM, 2011, WILSON AND GISVOLDS TEXTBOOK OF ORGANIC MEDICINAL AND PHARMACEUTICAL CHEMISTRY, V12th, P0
   BEAVO JA, 1970, MOL PHARMACOL, V6, P597
   Ben Lagha A, 2017, SCI REP-UK, V7, P0, DOI 10.1038/srep44815
   Borglum JD, 1996, MOL CELL ENDOCRINOL, V117, P17, DOI 10.1016/0303-7207(95)03728-4
   BOULENGER JP, 1982, NEUROSCI LETT, V30, P161, DOI 10.1016/0304-3940(82)90290-7
   Bray GA, 2008, J CLIN ENDOCR METAB, V93, PS81, DOI 10.1210/jc.2008-1294
   Bray GA, 2007, PHARMACOL REV, V59, P151, DOI 10.1124/pr.59.2.2
   Bray GA, 2016, LANCET, V387, P1947, DOI 10.1016/S0140-6736(16)00271-3
   BROKAW CJ, 1987, J CELL BIOCHEM, V35, P175, DOI 10.1002/jcb.240350302
   BUDOHOSKI L, 1984, FEBS LETT, V167, P1, DOI 10.1016/0014-5793(84)80820-0
   Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018
   BUTCHER RW, 1968, J BIOL CHEM, V243, P1705
   BUTCHER RW, 1962, J BIOL CHEM, V237, P1244
   Butt MS, 2011, CRIT REV FOOD SCI, V51, P363, DOI 10.1080/10408390903586412
   CARDINALI DP, 1980, TRENDS PHARMACOL SCI, V1, P405, DOI 10.1016/0165-6147(80)90064-4
   CARNEY JM, 1985, LIFE SCI, V36, P913, DOI 10.1016/0024-3205(85)90386-8
   Castro AVB, 2014, ARQ BRAS ENDOCRINOL, V58, P600, DOI 10.1590/0004-2730000003223
   Cedikova M, 2016, STEM CELLS INT, V2016, P0, DOI 10.1155/2016/6067349
   CHAVEY C, 2013, PHYSIOLOGY AND PHYSIOPATHOLOGY OF ADIPOSE TISSUE, V0, PP17, DOI 10.1007/978-2-8178-0343-2_2
   Chen Jiang-Fan, 2011, HANDB EXP PHARMACOL, V0, PP267, DOI 10.1007/978-3-642-13443-2_10
   Chen M D, 1994, ZHONGHUA YI XUE ZA ZHI (TAIPEI), V53, P257
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 2017, NAT PROD REP, V34, P1391, DOI 10.1039/c7np00030h
   Coelho M, 2013, ARCH MED SCI, V9, P191, DOI 10.5114/aoms.2013.33181
   Cotillard A, 2014, J CLIN ENDOCR METAB, V99, PE1466, DOI 10.1210/jc.2014-1074
   Csóka B, 2014, DIABETES, V63, P850, DOI 10.2337/db13-0573
   Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f
   Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780
   Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9
   DALY JW, 1983, CELL MOL NEUROBIOL, V3, P69, DOI 10.1007/BF00734999
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   de Mejia EG, 2009, BRAIN BEHAV IMMUN, V23, P721, DOI 10.1016/j.bbi.2009.02.013
   de Resende PE, 2015, J FUNCT FOODS, V15, P440, DOI 10.1016/j.jff.2015.03.040
   DENT G, 1994, AM J RESP CELL MOL, V10, P565, DOI 10.1165/ajrcmb.10.5.8179921
   DeOliveira CC, 2017, EUR J PHARMACOL, V799, P154, DOI 10.1016/j.ejphar.2017.02.017
   Dhalla Arvinder K, 2009, HANDB EXP PHARMACOL, V0, PP271, DOI 10.1007/978-3-540-89615-9_9
   Dias TR, 2017, CURR MED CHEM, V24, P334, DOI 10.2174/0929867323666160905150419
   Dias TR, 2016, J NUTR BIOCHEM, V37, P83, DOI 10.1016/j.jnutbio.2016.07.018
   Dias TR, 2015, TOXICOLOGY, V328, P12, DOI 10.1016/j.tox.2014.12.003
   Dias TR, 2014, J AGR FOOD CHEM, V62, P608, DOI 10.1021/jf4049462
   Dias TR, 2013, INTERNATIONAL JOURNAL OF FOOD SCIENCE, V0, P0
   Diepvens K, 2007, AM J PHYSIOL-REG I, V292, PR77, DOI 10.1152/ajpregu.00832.2005
   do Carmo I, 2008, OBES REV, V9, P11, DOI 10.1111/j.1467-789X.2007.00422.x
   Dong Q, 2001, DIABETES OBES METAB, V3, P360, DOI 10.1046/j.1463-1326.2001.00158.x
   DULLOO AG, 1986, INT J OBESITY, V10, P467
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   DULLOO AG, 1986, AM J CLIN NUTR, V43, P388, DOI 10.1093/ajcn/43.3.388
   Eisenstein A, 2014, J CELL PHYSIOL, V229, P414, DOI 10.1002/jcp.24473
   Esmaeilzadeh Seddigheh, 2014, GLOB J HEALTH SCI, V7, P101, DOI 10.5539/gjhs.v7n2p101
   Eteng MU, 2006, DISCOV INNOVAT, V18, P191
   FAIN JN, 1972, J BIOL CHEM, V247, P6866
   Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779
   Farmer SR, 2005, INT J OBESITY, V29, PS13, DOI 10.1038/sj.ijo.0802907
   Faulhaber-Walter R, 2011, DIABETES, V60, P2578, DOI 10.2337/db11-0058
   Fonseca-Alaniz MH, 2007, J PEDIAT-BRAZIL, V83, PS192, DOI 10.1590/S0021-75572007000700011
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Fredholm BB, 2001, BIOCHEM PHARMACOL, V61, P443, DOI 10.1016/S0006-2952(00)00570-0
   Fredholm BB, 2001, PHARMACOL REV, V53, P527
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654
   GELOEN A, 1989, AM J PHYSIOL, V257, PE547, DOI 10.1152/ajpendo.1989.257.4.E547
   Gharibi B, 2012, INT J OBESITY, V36, P397, DOI 10.1038/ijo.2011.129
   GILBERT RM, 1976, CAN MED ASSOC J, V114, P205
   Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816
   GOLDBERG R, 1975, POSTGRAD MED J, V51, P53, DOI 10.1136/pgmj.51.592.53
   Gramza-Michalowska A, 2014, J NUTR HEALTH AGING, V18, P143, DOI 10.1007/s12603-013-0404-1
   GREEN RD, 1977, BIOCHEM PHARMACOL, V26, P37, DOI 10.1016/0006-2952(77)90127-7
   Greenway F L, 2001, OBES REV, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x
   Grucka-Mamczar E, 2009, FLUORIDE, V42, P105
   Hajiaghaalipour F, 2015, FOOD CHEM, V169, P401, DOI 10.1016/j.foodchem.2014.07.005
   Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x
   Islam MS, 2011, PHYTOMEDICINE, V19, P25, DOI 10.1016/j.phymed.2011.06.025
   Jajoo S, 2006, J PHARMACOL EXP THER, V317, P1, DOI 10.1124/jpet.105.096255
   Jang YJ, 2015, FOOD FUNCT, V6, P2365, DOI 10.1039/c5fo00397k
   Johansson SM, 2007, ACTA PHYSIOL, V190, P87, DOI 10.1111/j.1365-201X.2007.01692.x
   Johnston-Cox H, 2012, PLOS ONE, V7, P0, DOI 10.1371/journal.pone.0040584
   Jungheim ES, 2013, NUTR REV, V71, PS3, DOI 10.1111/nure.12056
   KAARTINEN JM, 1991, BIOCHEM J, V279, P17, DOI 10.1042/bj2790017
   Kakuda T, 2002, BIOL PHARM BULL, V25, P1513, DOI 10.1248/bpb.25.1513
   Karunanidhi A, 2013, BIOMED RES INT, V2013, P0, DOI 10.1155/2013/392058
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Klotz K-N, 1997, N-S ARCH PHARMACOL, V357, P1, DOI 10.1007/PL00005131
   Kretschmar JA, 1999, PHYTOCHEMISTRY, V52, P19, DOI 10.1016/S0031-9422(99)00119-3
   Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5
   Landgraf K, 2015, DIABETES, V64, P1249, DOI 10.2337/db14-0744
   LANGIN D, 2013, PHYSIOLOGY AND PHYSIOPATHOLOGY OF ADIPOSE TISSUE, V0, P141
   Langin D, 2006, PHARMACOL RES, V53, P482, DOI 10.1016/j.phrs.2006.03.009
   Langin D, 2011, CELL METAB, V14, P569, DOI 10.1016/j.cmet.2011.10.003
   Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183
   Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004
   LEBLANC J, 1985, J APPL PHYSIOL, V59, P832, DOI 10.1152/jappl.1985.59.3.832
   Leff T, 2010, ADIPOSE TISSUE IN HEALTH AND DISEASE, V0, P21
   Leung LK, 2001, J NUTR, V131, P2248, DOI 10.1093/jn/131.9.2248
   Li HF, 2010, MOL CELL ENDOCRINOL, V323, P201, DOI 10.1016/j.mce.2010.03.021
   Liang HX, 2002, BRIT J PHARMACOL, V135, P1457, DOI 10.1038/sj.bjp.0704586
   LIN FT, 1994, P NATL ACAD SCI USA, V91, P8757, DOI 10.1073/pnas.91.19.8757
   LIN FT, 1992, GENE DEV, V6, P533, DOI 10.1101/gad.6.4.533
   Liu AG, 2015, OBESITY, V23, P1830, DOI 10.1002/oby.21163
   Liu AG, 2013, OBESITY, V21, P1991, DOI 10.1002/oby.20416
   Liu CC, 2017, MOL MED REP, V16, P1369, DOI 10.3892/mmr.2017.6698
   Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003
   Luna-Luna M, 2015, ARCH MED RES, V46, P392, DOI 10.1016/j.arcmed.2015.05.007
   Malongane F, 2017, J SCI FOOD AGR, V97, P4679, DOI 10.1002/jsfa.8472
   Martins AD, 2014, EUR J NUTR, V53, P1383, DOI 10.1007/s00394-013-0640-5
   MAURIEGE P, 1988, J LIPID RES, V29, P587
   MCCALL AL, 1982, LIFE SCI, V31, P2709, DOI 10.1016/0024-3205(82)90715-9
   McKeague M, 2016, METAB ENG, V38, P191, DOI 10.1016/j.ymben.2016.08.003
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Mission JF, 2015, OBSTET GYN CLIN N AM, V42, P335, DOI 10.1016/j.ogc.2015.01.008
   Moffat AC, 1986, CLARKES ISOLATION ID, V0, P0, DOI DOI 10.1002/JPS.2600760520
   Monteiro JP, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21080974
   Monteiro MP, 2014, HUM VACC IMMUNOTHER, V10, P887, DOI 10.4161/hv.27537
   Morigny P, 2016, BIOCHIMIE, V125, P259, DOI 10.1016/j.biochi.2015.10.024
   Moro S, 2006, MED RES REV, V26, P131, DOI 10.1002/med.20048
   Muir LA, 2016, OBESITY, V24, P597, DOI 10.1002/oby.21377
   Müller CE, 1998, SYNTHESIS-STUTTGART, V0, P1428
   Nanjundaiah S, 2016, APPL BIOCHEM BIOTECH, V178, P58, DOI 10.1007/s12010-015-1858-x
   NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   NICHOLSON CD, 1989, BRIT J PHARMACOL, V97, P889, DOI 10.1111/j.1476-5381.1989.tb12029.x
   Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749
   Noormandi Afsaneh, 2015, J TRADIT COMPLEMENT MED, V5, P15, DOI 10.1016/j.jtcme.2014.10.005
   Ofluoglu E, 2009, NEUROCHEM RES, V34, P395, DOI 10.1007/s11064-008-9790-x
   OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pa.35.040195.003053
   Onakpoya IJ, 2015, J HUM HYPERTENS, V29, P77, DOI 10.1038/jhh.2014.46
   Osswald Hartmut, 2011, HANDB EXP PHARMACOL, V0, PP391, DOI 10.1007/978-3-642-13443-2_15
   Palmer Nicole O, 2012, SPERMATOGENESIS, V2, P253
   PAVIA DL, 1973, J CHEM EDUC, V50, P791, DOI 10.1021/ed050p791
   Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008
   Peluso I, 2017, BRIT J PHARMACOL, V174, P1195, DOI 10.1111/bph.13649
   Pi-Sunyer FX, 2002, OBES RES, V10, P97S, DOI 10.1038/oby.2002.202
   Pissarnitski DA, 2004, BIOORG MED CHEM LETT, V14, P1291, DOI 10.1016/j.bmcl.2003.12.027
   León-Carmona JR, 2011, J PHYS CHEM B, V115, P4538, DOI 10.1021/jp201383y
   Ren JL, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-017-18888-5
   ROLBAND GC, 1990, J GERONTOL, V45, PB174, DOI 10.1093/geronj/45.5.B174
   ROLL T, 1980, PHARMACOLOGICAL BASIS OF THERAPEUTICS, V0, P592
   Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7
   Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066
   Rydén M, 2014, J CLIN ENDOCR METAB, V99, PE1870, DOI 10.1210/jc.2014-1526
   Saeed M, 2017, BIOMED PHARMACOTHER, V95, P1260, DOI 10.1016/j.biopha.2017.09.024
   Saely CH, 2012, GERONTOLOGY, V58, P15, DOI 10.1159/000321319
   SAGGERSON ED, 1990, BIOCHEM J, V269, P157, DOI 10.1042/bj2690157
   SALIHOVIC M, 2014, BULL. CHEM. TECHNOL. BOSNIA HERZEG, V42, P31
   Santana-Gálvez J, 2017, MOLECULES, V22, P0, DOI 10.3390/molecules22030358
   Santana-Rios G, 2001, MUTAT RES-GEN TOX EN, V495, P61, DOI 10.1016/S1383-5718(01)00200-5
   Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, P0, DOI 10.1101/cshperspect.a011148
   SATTIN A, 1970, MOL PHARMACOL, V6, P13
   Schubert MM, 2014, J APPL PHYSIOL, V117, P745, DOI 10.1152/japplphysiol.00570.2014
   SCHWABE U, 1985, N-S ARCH PHARMACOL, V330, P212, DOI 10.1007/BF00572436
   Shearer J, 2007, CAN J PHYSIOL PHARM, V85, P823, DOI 10.1139/Y07-070
   Shi D, 1999, CELL MOL NEUROBIOL, V19, P719, DOI 10.1023/A:1006901005925
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Snow V, 2005, ANN INTERN MED, V142, P525, DOI 10.7326/0003-4819-142-7-200504050-00011
   SPIEGELMAN BM, 1993, J BIOL CHEM, V268, P6823
   STAVRIC B, 1988, FOOD CHEM TOXICOL, V26, P541, DOI 10.1016/0278-6915(88)90007-5
   Stich V, 1999, AM J PHYSIOL-REG I, V277, PR1076, DOI 10.1152/ajpregu.1999.277.4.R1076
   Stoclet JC, 2004, EUR J PHARMACOL, V500, P299, DOI 10.1016/j.ejphar.2004.07.034
   Su SH, 2013, TOXICOL IN VITRO, V27, P1830, DOI 10.1016/j.tiv.2013.05.011
   Sun NN, 2016, MOLECULES, V21, P0, DOI 10.3390/molecules21101351
   Takasuga S, 1999, J BIOL CHEM, V274, P19545, DOI 10.1074/jbc.274.28.19545
   Talik P, 2012, SEP PURIF REV, V41, P1, DOI 10.1080/15422119.2011.569047
   Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432
   TARKA SM, 1982, CRC CR REV TOXICOL, V9, P275, DOI 10.3109/10408448209037495
   TASH JS, 1982, BIOL REPROD, V26, P745, DOI 10.1095/biolreprod26.4.745
   Tenore GC, 2013, FOOD CHEM, V141, P2379, DOI 10.1016/j.foodchem.2013.04.128
   TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351
   TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   TROST T, 1981, MOL PHARMACOL, V19, P228
   Tsiloulis T, 2015, PROG MOL BIOL TRANSL, V135, P175, DOI 10.1016/bs.pmbts.2015.06.016
   TVERDAL A, 1990, BMJ-BRIT MED J, V300, P566, DOI 10.1136/bmj.300.6724.566
   Van der Walt MM, 2015, BIOORGAN MED CHEM, V23, P6641, DOI 10.1016/j.bmc.2015.09.012
   VANNUCCI SJ, 1989, AM J PHYSIOL, V257, PE871, DOI 10.1152/ajpendo.1989.257.6.E871
   VASSAUX G, 1993, BIOCHEM BIOPH RES CO, V193, P1123, DOI 10.1006/bbrc.1993.1742
   Verhoef P, 2002, AM J CLIN NUTR, V76, P1244, DOI 10.1093/ajcn/76.6.1244
   Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237
   Wang HY, 1999, J BIOL CHEM, V274, P32159, DOI 10.1074/jbc.274.45.32159
   Wang HY, 1996, J BIOL CHEM, V271, P22022, DOI 10.1074/jbc.271.36.22022
   Weckerle CS, 2003, PHYTOCHEMISTRY, V64, P735, DOI 10.1016/S0031-9422(03)00372-8
   Wu C, 2016, OBES REV, V17, P429, DOI 10.1111/obr.12385
   Wu ZD, 1999, MOL CELL, V3, P151, DOI 10.1016/S1097-2765(00)80306-8
   Xu BY, 1998, AM J PHYSIOL-ENDOC M, V274, PE271, DOI 10.1152/ajpendo.1998.274.2.E271
   Yamaguchi S, 2009, J REPROD DEVELOP, V55, P645, DOI 10.1262/jrd.20238
   Yang N, 2018, INT J MOL MED, V41, P818, DOI 10.3892/ijmm.2017.3292
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
   Zajac MA, 2003, SYNTHETIC COMMUN, V33, P3291, DOI 10.1081/SCC-120023986
   Zhang WL, 2009, DIABETOLOGIA, V52, P810, DOI 10.1007/s00125-009-1311-1
   Zhao YY, 2012, HYPERTENS RES, V35, P370, DOI 10.1038/hr.2011.195
   Zheng GD, 2004, IN VIVO, V18, P55
   ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a
   Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421
NR 210
TC 36
Z9 39
U1 0
U2 36
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 2214-9414
J9 J FUNCT FOODS
JI J. Funct. Food.
PD APR 15
PY 2018
VL 43
IS 
BP 84
EP 94
DI 10.1016/j.jff.2018.02.001
PG 11
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA GC4MG
UT WOS:000429758000011
DA 2025-04-28
ER

PT J
AU Cornelis, MC
   Munafo, MR
AF Cornelis, Marilyn C.
   Munafo, Marcus R.
TI Mendelian Randomization Studies of Coffee and Caffeine Consumption
SO NUTRIENTS
LA English
DT Review
DE Mendelian Randomization; coffee; caffeine; behavior; causality; genetic epidemiology; epidemiological methods
ID genetic-variants; instrumental variables; causal role; risk; epidemiology; cholesterol; contribute; cannabis; alcohol; obesity
AB Habitual coffee and caffeine consumption has been reported to be associated with numerous health outcomes. This perspective focuses on Mendelian Randomization (MR) approaches for determining whether such associations are causal. Genetic instruments for coffee and caffeine consumption are described, along with key concepts of MR and particular challenges when applying this approach to studies of coffee and caffeine. To date, at least fifteen MR studies have investigated the causal role of coffee or caffeine use on risk of type 2 diabetes, cardiovascular disease, Alzheimer's disease, Parkinson's disease, gout, osteoarthritis, cancers, sleep disturbances and other substance use. Most studies provide no consistent support for a causal role of coffee or caffeine on these health outcomes. Common study limitations include low statistical power, potential pleiotropy, and risk of collider bias. As a result, in many cases a causal role cannot confidently be ruled out. Conceptual challenges also arise from the different aspects of coffee and caffeine use captured by current genetic instruments. Nevertheless, with continued genome-wide searches for coffee and caffeine related loci along with advanced statistical methods and MR designs, MR promises to be a valuable approach to understanding the causal impact that coffee and caffeine have in human health.
C1 [Cornelis, Marilyn C.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
   [Munafo, Marcus R.] Univ Bristol, Sch Psychol Sci, UK Ctr Tobacco & Alcohol Studies, MRC Integrat Epidemiol Unit IEU, Bristol BS8 1TU, Avon, England.
C3 Northwestern University; Feinberg School of Medicine; University of Bristol
RP Cornelis, MC (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.
EM marilyn.cornelis@northwestern.edu; marcus.munafo@bristol.ac.uk
FU National Institute on Aging [K01AG053477]; Benjamin Meaker Visiting Professorship; MRC [MC_UU_00011/7] Funding Source: UKRI
CR Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Andrzejewski D, 2004, J AGR FOOD CHEM, V52, P1996, DOI 10.1021/jf0349634
   Unknown -, 2018, BMJ BRIT MED J, V0, P0, DOI DOI 10.1136/BMJ.K601
   Bjorngaard JH, 2017, INT J EPIDEMIOL, V46, P1958, DOI 10.1093/ije/dyx147
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Burgess S, 2017, EPIDEMIOLOGY, V28, P30, DOI 10.1097/EDE.0000000000000559
   Burgess S, 2016, STAT MED, V35, P1880, DOI 10.1002/sim.6835
   Burgess S, 2015, INT J EPIDEMIOL, V44, P484, DOI 10.1093/ije/dyu176
   Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Carter MJ, 2014, THER RECREAT J, V48, P275
   Cho Y, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep18422
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Davey Smith G, 2014, HUM MOL GENET, V23, PR89, DOI 10.1093/hmg/ddu328
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Glymour MM, 2012, AM J EPIDEMIOL, V175, P332, DOI 10.1093/aje/kwr323
   Haycock PC, 2016, AM J CLIN NUTR, V103, P965, DOI 10.3945/ajcn.115.118216
   Hemani G, 2018, HUM MOL GENET, V27, PR195, DOI 10.1093/hmg/ddy163
   Holmes MV, 2017, NAT REV CARDIOL, V14, P0, DOI 10.1038/nrcardio.2017.78
   KATAN MB, 1986, LANCET, V1, P507
   Kendler KS, 2008, ARCH GEN PSYCHIAT, V65, P674, DOI 10.1001/archpsyc.65.6.674
   Kwok MK, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep36500
   Larsson SC, 2018, ANN RHEUM DIS, V77, P1544, DOI 10.1136/annrheumdis-2018-213055
   Larsson SC, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5375
   Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034
   Lee YH, 2018, CLIN RHEUMATOL, V37, P3133, DOI 10.1007/s10067-018-4252-6
   Leviton A, 1996, EPIDEMIOLOGY, V7, P110, DOI 10.1097/00001648-199601000-00022
   Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177
   Ludwig LA, 2014, FOOD FUNCT, V5, P1718, DOI 10.1039/C4FO00290C
   Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274
   MARKS V, 1973, LANCET, V1, P827
   Milder IEJ, 2005, BRIT J NUTR, V93, P393, DOI 10.1079/BJN20051371
   Minamisawa M, 2004, ANAL SCI, V20, P325, DOI 10.2116/analsci.20.325
   Munafò MR, 2018, INT J EPIDEMIOL, V47, P226, DOI 10.1093/ije/dyx206
   Nehlig A, 2018, PHARMACOL REV, V70, P384, DOI 10.1124/pr.117.014407
   Nordestgaard AT, 2016, INT J EPIDEMIOL, V45, P1938, DOI 10.1093/ije/dyw325
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Ong JS, 2018, INT J EPIDEMIOL, V47, P450, DOI 10.1093/ije/dyx236
   Paternoster L, 2017, PLOS GENET, V13, P0, DOI 10.1371/journal.pgen.1006944
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Relton CL, 2012, INT J EPIDEMIOL, V41, P161, DOI 10.1093/ije/dyr233
   Scalbert Augustin, 2000, JOURNAL OF NUTRITION, V130, P0
   Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070
   Soroko S, 1996, J AM COLL NUTR, V15, P97
   Spiller MA, 1998, CAFFEINE, V0, P97
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Swanson SA, 2017, EPIDEMIOLOGY, V28, P653, DOI 10.1097/EDE.0000000000000699
   Taylor AE, 2018, ADDICTION, V113, P148, DOI 10.1111/add.13975
   Taylor AE, 2017, INT J CANCER, V140, P322, DOI 10.1002/ijc.30462
   Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270
   Treur JL, 2018, J SLEEP RES, V27, P0, DOI 10.1111/jsr.12695
   Treur JL, 2017, ADDICT BIOL, V22, P1090, DOI 10.1111/adb.12391
   URGERT R, 1995, J AGR FOOD CHEM, V43, P2167, DOI 10.1021/jf00056a039
   van Dam RM, 2018, J INTERN MED, V283, P588, DOI 10.1111/joim.12754
   Vanyukov MM, 2012, DRUG ALCOHOL DEPEN, V123, PS3, DOI 10.1016/j.drugalcdep.2011.12.018
   Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7
   Verweij KJH, 2013, ADDICT BIOL, V18, P846, DOI 10.1111/j.1369-1600.2012.00478.x
   Wald A, 1940, ANN MATH STAT, V11, P284, DOI 10.1214/aoms/1177731868
   Ward ME, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0100248
   Ware JJ, 2017, ADDICTION, V112, P1842, DOI 10.1111/add.13888
   White JR, 2016, CLIN TOXICOL, V54, P308, DOI 10.3109/15563650.2016.1146740
   Wikoff D, 2017, FOOD CHEM TOXICOL, V109, P585, DOI 10.1016/j.fct.2017.04.002
   Yanagimoto K, 2004, J AGR FOOD CHEM, V52, P592, DOI 10.1021/jf030317t
   Zheng Jie, 2017, CURR EPIDEMIOL REP, V4, P330, DOI 10.1007/s40471-017-0128-6
   Zhou A, 2018, SCI REP-UK, V8, P0, DOI 10.1038/s41598-018-25919-2
   Zhu ZH, 2018, NAT COMMUN, V9, P0, DOI 10.1038/s41467-017-02317-2
NR 75
TC 64
Z9 65
U1 1
U2 23
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT 15
PY 2018
VL 10
IS 10
BP 
EP 
DI 10.3390/nu10101343
PG 19
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GY7UM
UT WOS:000448821300009
PM 30241358
DA 2025-04-28
ER

PT J
AU Crocketta, RA
   King, SE
   Marteau, TM
   Prevost, AT
   Bignardi, G
   Roberts, NW
   Stubbs, B
   Hollands, GJ
   Jebb, SA
AF Crocketta, Rachel A.
   King, Sarah E.
   Marteau, Theresa M.
   Prevost, A. T.
   Bignardi, Giacomo
   Roberts, Nia W.
   Stubbs, Brendon
   Hollands, Gareth J.
   Jebb, Susan A.
TI Nutritional labelling for healthier food or non-alcoholic drink purchasing and consumption
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID school vending machines; caloric information; portion sizes; energy-intake; impact; menu; consumer; choices; interventions; behaviors
AB Background Nutritional labelling is advocated as a means to promote healthier food purchasing and consumption, including lower energy intake. Internationally, many different nutritional labelling schemes have been introduced. There is no consensus on whether such labelling is effective in promoting healthier behaviour. Objectives To assess the impact of nutritional labelling for food and non-alcoholic drinks on purchasing and consumption of healthier items. Our secondary objective was to explore possible effect moderators of nutritional labelling on purchasing and consumption. Search methods We searched 13 electronic databases including CENTRAL, MEDLINE and Embase to 26 April 2017. We also handsearched references and citations and sought unpublished studies through websites and trials registries. Selection criteria Eligible studies: were randomised or quasi-randomised controlled trials (RCTs/Q-RCTs), controlled before-and-after studies, or interrupted time series (ITS) studies; compared a labelled product (with information on nutrients or energy) with the same product without a nutritional label; assessed objectively measured purchasing or consumption of foods or non-alcoholic drinks in real-world or laboratory settings. Data collection and analysis Two authors independently selected studies for inclusion and extracted study data. We applied the Cochrane 'Risk of bias' tool and GRADE to assess the quality of evidence. We pooled studies that evaluated similar interventions and outcomes using a random-effects meta-analysis, and we synthesised data from other studies in a narrative summary. Main results We included 28 studies, comprising 17 RCTs, 5 Q-RCTs and 6 ITS studies. Most (21/28) took place in the USA, and 19 took place in university settings, 14 of which mainly involved university students or staff. Most (20/28) studies assessed the impact of labelling on menus or menu boards, or nutritional labelling placed on, or adjacent to, a range of foods or drinks from which participants could choose. Eight studies provided participants with only one labelled food or drink option (in which labelling was present on a container or packaging, adjacent to the food or on a display board) and measured the amount consumed. The most frequently assessed labelling type was energy (i.e. calorie) information (12/28). Eleven studies assessed the impact of nutritional labelling on purchasing food or drink options in real-world settings, including purchases from vending machines (one cluster-RCT), grocery stores (one ITS), or restaurants, cafeterias or coffee shops (three RCTs, one QRCT and five ITS). Findings on vending machines and grocery stores were not interpretable, and were rated as very low quality. A meta-analysis of the three RCTs, all of which assessed energy labelling on menus in restaurants, demonstrated a statistically significant reduction of 47 kcal in energy purchased (MD 46.72 kcal, 95% CI 78.35, 15.10, N = 1877). Assuming an average meal of 600 kcal, energy labelling on menus would reduce energy purchased per meal by 7.8% (95% CI 2.5% to 13.1%). The quality of the evidence for these three studies was rated as low, so our confidence in the effect estimate is limited and may change with further studies. Of the remaining six studies, only two (both ITS studies involving energy labels on menus or menus boards in a coffee shop or cafeteria) were at low risk of bias, and their results support the meta-analysis. The results of the other four studies which were conducted in a restaurant, cafeterias (2 studies) or a coffee shop, were not clearly reported and were at high risk of bias. Seventeen studies assessed the impact of nutritional labels on consumption in artificial settings or scenarios (henceforth referred to as laboratory studies or settings). Of these, eight (all RCTs) assessed the effect of labels on menus or placed on a range of food options. A meta-analysis of these studies did not conclusively demonstrate a reduction in energy consumed during a meal (MD 50 kcal, 95% CI 104.41, 3.88, N = 1705). We rated the quality of the evidence as low, so our confidence in the effect estimate is limited and may change with further studies. Six laboratory studies (four RCTs and two Q-RCTs) assessed the impact of labelling a single food or drink option (such as chocolate, pasta or soft drinks) on energy consumed during a snack or meal. A meta-analysis of these studies did not demonstrate a statistically significant difference in energy (kcal) consumed (SMD 0.05, 95% CI 0.17 to 0.27, N = 732). However, the confidence intervals were wide, suggesting uncertainty in the true effect size. We rated the quality of the evidence as low, so our confidence in the effect estimate is limited and may change with further studies. There was no evidence that nutritional labelling had the unintended harm of increasing energy purchased or consumed. Indirect evidence came from five laboratory studies that involved mislabelling single nutrient content (i.e. placing low energy or low fat labels on high-energy foods) during a snack or meal. A meta-analysis of these studies did not demonstrate a statistically significant increase in energy (kcal) consumed (SMD 0.19, 95% CI 0.14to 0.51, N = 718). The effect was small and the confidence intervals wide, suggesting uncertainty in the true effect size. We rated the quality of the evidence from these studies as very low, providing very little confidence in the effect estimate. Authors' conclusions Findings from a small body of low-quality evidence suggest that nutritional labelling comprising energy information on menus may reduce energy purchased in restaurants. The evidence assessing the impact on consumption of energy information on menus or on a range of food options in laboratory settings suggests a similar effect to that observed for purchasing, although the evidence is less definite and also of low quality. Accordingly, and in the absence of observed harms, we tentatively suggest that nutritional labelling on menus in restaurants could be used as part of a wider set of measures to tackle obesity. Additional high-quality research in real-world settings is needed to enable more certain conclusions. Further high-quality research is also needed to address the dearth of evidence from grocery stores and vending machines and to assess potential moderators of the intervention effect, including socioeconomic status.
C1 [Crocketta, Rachel A.] Univ Stirling, Div Psychol, Stirling, Scotland.
   [King, Sarah E.; Marteau, Theresa M.; Bignardi, Giacomo; Hollands, Gareth J.] Univ Cambridge, Behav & Hlth Res Unit, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.
   [Prevost, A. T.] Imperial Coll London, Sch Publ Hlth, London, England.
   [Roberts, Nia W.] Univ Oxford, Bodleian Hlth Care Lib, Oxford, England.
   [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England.
   [Jebb, Susan A.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England.
C3 University of Stirling; University of Cambridge; Imperial College London; University of Oxford; University of London; King's College London; University of Oxford
RP Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Forvie Site,Robinson Way, Cambridge CB2 0SR, England.
EM theresa.marteau@medschl.cam.ac.uk
FU King's College London, UK; University of Cambridge, UK; University of Stirling, UK; National Institutes for Health Research, UK; National Institute of Health Research Senior Investigator Award [NF-SI-0513-10101]; Postdoctoral Research Fellowship; National Institutes of Health Research (NIHR) [ICA-CL-2017-03-001] Funding Source: National Institutes of Health Research (NIHR); MRC [MC_UU_00005/2, MC_U105960389] Funding Source: UKRI
CR AARON JI, 1995, NUTR RES, V15, P1251, DOI 10.1016/0271-5317(95)02001-C
   ALBRIGHT CL, 1990, HEALTH EDUC QUART, V17, P157, DOI 10.1177/109019819001700203
   Allan JL, 2015, HEALTH PSYCHOL, V34, P750, DOI 10.1037/hea0000173
   Unknown -, 2007, TACKLING OBESITIES F, V0, P0
   Unknown -, 2011, NATIONAL DIET AND NUTRITION SURVEY HEADLINE RESULTS FROM YEARS 1, V0, P0
   Unknown -, 1900, DOI 10.1002/14651858.CD012573 DOI 10.1002/14651858.CD012573, V0, P0
   Unknown -, 2011, COCHRANE HANDBOOK FOR SYSTEMATIC REVIEWS OF INTERVENTION, V0, P0
   Unknown -, 2014, REVIEW MANAGER REVMA, V0, P0
   Unknown -, 2011, COCHRANE HDB SYSTEMA, V0, P0
   Babio N, 2014, PUBLIC HEALTH NUTR, V17, P1403, DOI 10.1017/S1368980013001274
   Balasubramanian SK, 2002, J MARKETING, V66, P112, DOI 10.1509/jmkg.66.3.112.18502
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Bergen D, 2006, J AM DIET ASSOC, V106, P1866, DOI 10.1016/j.jada.2006.08.002
   Berning JP, 2011, AM J AGR ECON, V93, P364, DOI 10.1093/ajae/aaq104
   Bleich SN, 2017, OBESITY, V25, P2018, DOI 10.1002/oby.21940
   Bleich SN, 2014, AM J PUBLIC HEALTH, V104, P2417, DOI 10.2105/AJPH.2014.302150
   Blewett N, 2011, LABELLING LOGIC REVI, V0, P0
   Brownell KD, 2006, GLOBALIZATION HEALTH, V2, P0, DOI 10.1186/1744-8603-2-11
   Bucher T, 2015, ANN NUTR METAB, V67, P147
   Callaghan C, 2010, CAN J DIET PRACT RES, V71, P186, DOI 10.3148/71.4.2010.186
   Campos S, 2011, PUBLIC HEALTH NUTR, V14, P1496, DOI 10.1017/S1368980010003290
   Cantor J, 2015, HEALTH AFFAIR, V34, P1893, DOI 10.1377/hlthaff.2015.0623
   Cantu-Jungles TM, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9101088
   Cavanagh KV, 2014, APPETITE, V82, P1, DOI 10.1016/j.appet.2014.06.100
   Cawley J, 2015, PUBLIC HEALTH NUTR, V18, P8, DOI 10.1017/S1368980014001529
   Cecchini M, 2016, OBES REV, V17, P201, DOI 10.1111/obr.12364
   Chu YH, 2014, JOURNAL OF FOODSERVICE BUSINESS RESEARCH, V17, P215, DOI 10.1080/15378020.2014.926739
   Chu YH, 2009, FASEB J, V23, P0
   Chu YH, 2012, FASEB JOURNAL SUPPLE, V26, P8
   Chu YH, 2009, AM J PUBLIC HEALTH, V99, P2001, DOI 10.2105/AJPH.2008.153205
   Cioffi CE, 2015, APPETITE, V92, P7, DOI 10.1016/j.appet.2015.04.053
   Cioffi CE, 2012, AN EXAMINATION OF TH, V0, P0
   Cohen Jacob, 1988, STATISTICAL POWER ANAYLSIS FOR THE BEHAVIOR SCIENCES, V2nd, P0, DOI 10.4324/9780203771587
   Cowburn G, 2005, PUBLIC HEALTH NUTR, V8, P21, DOI 10.1079/PHN2005666
   Crockett RA, 2014, APPETITE, V81, P12, DOI 10.1016/j.appet.2014.05.024
   Das P, 2012, LANCET, V380, P189, DOI 10.1016/S0140-6736(12)61024-1
   DeGroot MH, 2012, PROBABILITY STATISTI, V0, P0
   Department of Health and Aging (Australia), 2013, FINAL COMMUNIQUE LEG, V0, P0
   Department of Health (UK), 2013, TECHNICAL GUIDANCE O, V0, P0
   Dingman DA, 2015, J PUBLIC HEALTH POL, V36, P110, DOI 10.1057/jphp.2014.38
   Dobbs R, 2014, OVERCOMING OBESITY A, V0, P0
   Dubbert PM, 1984, J APPL B, V17, P0
   Ducrot P, 2016, AM J PREV MED, V50, P627, DOI 10.1016/j.amepre.2015.10.020
   Dumanovsky T, 2011, BRIT MED J, V343, P0, DOI 10.1136/bmj.d4464
   Ebneter DS, 2013, APPETITE, V68, P92, DOI 10.1016/j.appet.2013.04.023
   Effective Practice and Organisation of Care (EPOC), 2015, EPOC TAX, V0, P0
   Effective Public Health Practice Project, 2010, QUALITY ASSESSMENT T, V0, P0
   Elbel B, 2011, INT J OBESITY, V35, P493, DOI 10.1038/ijo.2011.4
   Elbel B, 2013, AM J PREV MED, V45, P49, DOI 10.1016/j.amepre.2013.02.023
   Elbel B, 2011, OBESITY, V19, P0
   Ellison B, 2014, JOURNAL OF AGRICULTURAL AND APPLIED ECONOMICS, V46, P173
   Ellison B, 2013, JOURNAL OF BEHAVIOUR, V10, P1
   Ellison B, 2014, ECON INQ, V52, P666, DOI 10.1111/ecin.12069
   Engbers LH, 2006, BMC PUBLIC HEALTH, V6, P0, DOI 10.1186/1471-2458-6-253
   European Commission, 2011, PROVISION OF FOOD IN, V0, P0
   European Commission, 1990, OFFICIAL JOURNAL OF, V0, P40
   European Food Information Council, 2013, GLOBAL UPDATE ON NUT, V0, P0
   European Union, 2011, OFFICIAL J EUROPEAN, V0, P0, DOI DOI 10.1075/TTWIA.27.04KER
   Finkelstein EA, 2011, AM J PREV MED, V40, P122, DOI 10.1016/j.amepre.2010.10.019
   FREEDMAN MR, 2009, OBESITY S2, V17, P0
   Giesen JCAH, 2011, AM J CLIN NUTR, V93, P689, DOI 10.3945/ajcn.110.008193
   Girz L, 2012, INT J OBESITY, V36, P1340, DOI 10.1038/ijo.2011.135
   Gittelsohn J, 2013, J NUTR, V143, P1494, DOI 10.3945/jn.112.165266
   Gomez P, 2015, MARKET LETT, V28, P15
   Graham DJ, 2017, PUBLIC HEALTH NUTR, V20, P774, DOI 10.1017/S1368980016002676
   Grech A, 2015, OBES REV, V16, P1030, DOI 10.1111/obr.12311
   Grunert KG, 2007, J PUBLIC HEALTH-HEID, V15, P385, DOI 10.1007/s10389-007-0101-9
   Hammond D, 2013, PREV MED, V57, P860, DOI 10.1016/j.ypmed.2013.09.020
   Harnack LJ, 2008, INT J BEHAV NUTR PHYS ACT, V5, P0
   Harnack LJ, 2008, INTERNATIONAL JOURNA, V5, P0
   Hassan LM, 2010, J CONSUM AFF, V44, P499, DOI 10.1111/j.1745-6606.2010.01180.x
   Helfer P, 2014, ANN NY ACAD SCI, V1331, P174, DOI 10.1111/nyas.12461
   Higgins J, 2011, COCHRANE HDB SYSTEMA, V5, P0
   Hobin E, 2015, CANADIAN JOURNAL OF DIABETES, V39, PS32, DOI 10.1016/j.jcjd.2015.01.128
   HOERR SM, 1993, J SCHOOL HEALTH, V63, P386, DOI 10.1111/j.1746-1561.1993.tb06167.x
   Hollands GJ, 2017, NAT HUM BEHAV, V1, P0, DOI 10.1038/s41562-017-0140
   Hollands GJ, 2016, HEALTH PSYCHOL REV, V10, P381, DOI 10.1080/17437199.2015.1138093
   Hollands GJ, 2015, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD009164.pub2
   Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, P0, DOI 10.1186/1471-2458-13-1218
   Hollands GJ, 2013, ALTERING CHOICE ARCH, V0, P1
   Holmes A, 2011, ANNUAL MEETING, V0, P0
   Holmes AS, 2013, APPETITE, V62, P198, DOI 10.1016/j.appet.2012.05.029
   Horgen KB, 2002, HEALTH PSYCHOL, V21, P505, DOI 10.1037/0278-6133.21.5.505
   Jackson N, 2010, SYSTEMATIC REVIEWS O, V0, P0
   James A, 2015, AM J HEALTH PROMOT, V29, P294, DOI 10.4278/ajhp.130522-QUAN-267
   Kiesel K, 2009, DISSERT ABSTR, V69, P3668
   Kiesel K, 2013, INTERANTIONAL JOURNA, V31, P115
   Kocken PL, 2012, J SCHOOL HEALTH, V82, P115, DOI 10.1111/j.1746-1561.2011.00674.x
   Koenigstorfer J, 2014, J PUBLIC POLICY MARK, V33, P65, DOI 10.1509/jppm.12.091
   Kral TVE, 2002, APPETITE, V39, P137, DOI 10.1006/appe.2002.0498
   Krieger JW, 2013, AM J PREV MED, V44, P595, DOI 10.1016/j.amepre.2013.01.031
   Lassen AD, 2014, APPETITE, V75, P128, DOI 10.1016/j.appet.2013.12.005
   Malam S, 2009, COMPREHENSION AND US, V0, P0
   Marteau TM, 2015, BMJ-BRIT MED J, V351, P0, DOI 10.1136/bmj.h5863
   Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918
   Mathios AD, 2000, J LAW ECON, V43, P651, DOI 10.1086/467468
   Mathios AD, 1996, J PUBLIC POLICY MARK, V15, P45, DOI 10.1177/074391569601500104
   McNeill R, 2014, INT J BEHAV MED, V21, P0
   Mhurchu CN, 2007, AUST NZ J PUBL HEAL, V31, P105, DOI 10.1111/j.1753-6405.2007.00026.x
   Newton JN, 2015, LANCET, V386, P2257, DOI 10.1016/S0140-6736(15)00195-6
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nikolaou C, 2014, OBES REV, V15, P184
   Nikolaou CK, 2016, EUR J CLIN NUTR, V70, P386, DOI 10.1038/ejcn.2015.175
   Nikolaou CK, 2014, PREV MED, V67, P160, DOI 10.1016/j.ypmed.2014.07.027
   Obesity Policy Coalition, 2014, POLICY BRIEF KILOJOU, V0, P0
   Ogden J, 2007, HEALTH EDUC RES, V22, P397, DOI 10.1093/her/cyl090
   Platkin Charles, 2014, BMC OBES, V1, P21, DOI 10.1186/s40608-014-0021-5
   Public Health England, 2015, SUG RED EV ACT, V0, P0
   Pulos E, 2010, AM J PUBLIC HEALTH, V100, P1035, DOI 10.2105/AJPH.2009.174839
   Rayner M, 2013, OBES REV, V14, P70, DOI 10.1111/obr.12077
   Reale Sophie, 2016, BMC OBES, V3, P17, DOI 10.1186/s40608-016-0095-3
   Reeves B, 2011, COCHRANE HDB SYSTEMA, V0, P391
   Roberto CA, 2012, APPETITE, V58, P651, DOI 10.1016/j.appet.2012.01.003
   Roberto CA, 2010, AM J PUBLIC HEALTH, V100, P312, DOI 10.2105/AJPH.2009.160226
   Sacks G, 2011, AUST NZ J PUBL HEAL, V35, P122, DOI 10.1111/j.1753-6405.2011.00684.x
   Sacks G, 2009, HEALTH PROMOT INT, V24, P344, DOI 10.1093/heapro/dap032
   Sato JN, 2013, JOURNAL OF FOODSERVICE BUSINESS RESEARCH, V16, P155, DOI 10.1080/15378020.2013.782235
   SCHMITZ MF, 1986, J NUTR EDUC, V18, P0
   SCHUCKER RE, 1992, J NUTR EDUC, V24, P75
   Schunemann HJ, 2011, COCHRANE HANDBOOK FO, V0, P259
   Schwartz J, 2012, HEALTH AFFAIR, V31, P399, DOI 10.1377/hlthaff.2011.0224
   Seward MW, 2016, AM J PUBLIC HEALTH, V106, P1808, DOI 10.2105/AJPH.2016.303301
   Sharma S, 2011, JOURNAL OF FOODSERVICE BUSINESS RESEARCH, V14, P146, DOI 10.1080/15378020.2011.574540
   Shemilt I, 2017, BMC PUBLIC HEALTH, V17, P0, DOI 10.1186/s12889-016-3956-2
   Sinclair SE, 2014, J ACAD NUTR DIET, V114, P1375, DOI 10.1016/j.jand.2014.05.014
   Stutts MA, 2011, J CONSUM AFF, V45, P52, DOI 10.1111/j.1745-6606.2010.01192.x
   Sutherland LA, 2010, AM J CLIN NUTR, V91, P1090S, DOI 10.3945/ajcn.2010.28450C
   Swartz JJ, 1900, V8, V0, P135
   Temple JL, 2011, APPETITE, V57, P184, DOI 10.1016/j.appet.2011.04.018
   Temple JL, 2010, J AM DIET ASSOC, V110, P1094, DOI 10.1016/j.jada.2010.04.006
   Thorndike A, 2015, CIRCULATION, V131, P0
   Thorndike AN, 2014, AM J PREV MED, V46, P143, DOI 10.1016/j.amepre.2013.10.002
   Trudel R, 2015, JOURNAL OF EXPERIMEN, V21, P0
   US Food Drug Administration, 2016, MENU AND VENDING MAC, V0, P0
   US Food Drug Administration, 1994, GUIDE TO NUTRITION L, V0, P0
   Vadiveloo MK, 2011, INTERNATIONAL JOURNA, V8, P0
   VanEpps EM, 2016, J PUBLIC POLICY MARK, V35, P26, DOI 10.1509/jppm.14.112
   Vermeer WM, 2011, BMC PUBLIC HEALTH, V11, P0, DOI 10.1186/1471-2458-11-438
   Volkova E, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-968
   Vyth EL, 2011, J AM DIET ASSOC, V111, P131, DOI 10.1016/j.jada.2010.10.003
   Wang EY, 2016, FOOD POLICY, V64, P63, DOI 10.1016/j.foodpol.2016.09.004
   Wansink B, 2004, J FOOD SCI, V69, PS340, DOI 10.1111/j.1365-2621.2004.tb09946.x
   Wansink B, 2006, J MARKETING RES, V43, P605, DOI 10.1509/jmkr.43.4.605
   WARDLE J, 1994, HEALTH PSYCHOL, V13, P180, DOI 10.1037/0278-6133.13.2.180
   Webb KL, 2011, J HUNGER ENVIRON NUT, V6, P166, DOI 10.1080/19320248.2011.576210
   WHITAKER RC, 1994, J PEDIATR-US, V125, P535, DOI 10.1016/S0022-3476(94)70004-4
   World Health Organisation, 2013, GLOBAL ACTION FOR TH, V0, P0
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
NR 154
TC 174
Z9 179
U1 5
U2 77
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PD JUN 15
PY 2018
VL 0
IS 2
BP 
EP 
DI 10.1002/14651858.CD009315.pub2
PG 127
WC Medicine, General & Internal
SC General & Internal Medicine
GA FY0CC
UT WOS:000426476500006
PM 29482264
DA 2025-04-28
ER

PT J
AU Lukic, M
   Guha, N
   Licaj, I
   van den Brandt, PA
   Stayner, LT
   Tavani, A
   Weiderpass, E
AF Lukic, Marko
   Guha, Neela
   Licaj, Idlir
   van den Brandt, Piet A.
   Stayner, Leslie Thomas
   Tavani, Alessandra
   Weiderpass, Elisabete
TI Coffee Drinking and the Risk of Endometrial Cancer: An Updated Meta-Analysis of Observational Studies
SO NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
LA English
DT Article
ID dietary factors; decaffeinated coffee; prospective cohort; caffeine intake; c-peptide; hormone concentrations; publication bias; trend estimation; consumption; women
AB Background: Several compounds contained in coffee have been found to suppress carcinogenesis in experimental studies. We conducted a dose-response meta-analysis to assess the impact of coffee consumption on the risk of endometrial cancer. Materials and methods: We searched MEDLINE and EMBASE databases for studies published up to August 2016. Using random effects models, we estimated summary relative risks (RR) for cohort studies and odds ratios (OR) for case-control studies with 95% confidence intervals (CI). Dose-response analyses were conducted by using generalized least square trend estimation. Results: We identified 12 cohort studies and 8 case-control studies eligible for inclusion, contributing with 11,663 and 2,746 endometrial cancer cases, respectively. The summary RR for highest compared with lowest coffee intake was 0.74 (95% CI: 0.68-0.81; p(heterogeneity) = 0.09, I-2 = 32%). The corresponding summary RR among cohort studies was 0.78 (95% CI: 0.71-0.85; p(heterogeneity) = 0.14, I-2 = 31.9%) and 0.63 (95% CI: 0.53-0.76; p(heterogeneity) = 0.57, I-2 = 0%) for case-control studies. One-cup increment per day was associated with 3% risk reduction (95% CI: 2-4%) in cohort studies and 12% (95% CI: 5-18%) in case-control studies. After pooling the results from 5 cohort studies, the association remained significant only in women with body mass index over 30 (RR = 0.71, 95% CI: 0.61-0.81). Conclusion: The results from our meta-analysis strengthen the evidence of a protective effect of coffee consumption on the risk of EC and further suggest that increased coffee intake might be particularly beneficial for women with obesity.
C1 [Lukic, Marko; Licaj, Idlir; Weiderpass, Elisabete] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
   [Guha, Neela] Int Agcy Res Canc, Lyon, France.
   [Licaj, Idlir] Normandie Univ, UNICAEN, INSERM, Clin Res Dept,Ctr Francois Bacles,U1086, Caen, France.
   [van den Brandt, Piet A.] MUMC, Sch Oncol & Dev Biol GROW, Dept Epidemiol, Maastricht, Netherlands.
   [Stayner, Leslie Thomas] Univ Illinois, Sch Publ Hlth, Div Epidemiol & Biostat, Chicago, IL USA.
   [Tavani, Alessandra] IRCCS, Ist Ric Farmacol Mario Negri, Dept Epidemiol, Milan, Italy.
   [Weiderpass, Elisabete] Canc Registry Norway, Inst Populat Based Canc Res, Dept Res, Oslo, Norway.
   [Weiderpass, Elisabete] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.
   [Weiderpass, Elisabete] Folkhalsan Res Ctr, Genet Epidemiol Grp, Helsinki, Finland.
C3 UiT The Arctic University of Tromso; World Health Organization; International Agency for Research on Cancer (IARC); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Caen Normandie; Maastricht University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oslo; Karolinska Institutet; Folkhalsan Research Center
RP Lukic, M (corresponding author), UiT Arctic Univ Norway, Fac Hlth Sci, Dept Community Med, Tromso, Norway.
EM marko.lukic@uit.no
FU United States NCI; NIEHS [5U01CA033193]; European Union [VS/2017/0287]
CR Allen NE, 2008, ENDOCR-RELAT CANCER, V15, P485, DOI 10.1677/ERC-07-0064
   Bandera EV, 2010, CANCER CAUSE CONTROL, V21, P1467, DOI 10.1007/s10552-010-9575-9
   Bohn SK, 2014, MOL NUTR FOOD RES, V58, P915, DOI 10.1002/mnfr.201300526
   Bravi F, 2009, AM J OBSTET GYNECOL, V200, P0, DOI 10.1016/j.ajog.2008.09.015
   Bravi F, 2009, AM J OBSTET GYNECOL, V200, P130, DOI 10.1016/j.ajog.2008.10.032
   Cárdenas C, 2014, BIOCHEM BIOPH RES CO, V447, P452, DOI 10.1016/j.bbrc.2014.04.026
   Cárdenas C, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0023407
   Cust AE, 2007, INT J CANCER, V120, P2656, DOI 10.1002/ijc.22578
   Dalamaga M, 2012, ENDOCR REV, V33, P547, DOI 10.1210/er.2011-1015
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Ferlay J, 2015, INT J CANCER, V136, PE359, DOI 10.1002/ijc.29210
   Ferrini RL, 1996, AM J EPIDEMIOL, V144, P642, DOI 10.1093/oxfordjournals.aje.a008975
   Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5
   Friberg E, 2009, INT J CANCER, V125, P2413, DOI 10.1002/ijc.24543
   Gavrilyuk O, 2014, BMC WOMENS HEALTH, V14, P0, DOI 10.1186/1472-6874-14-48
   Giri A, 2011, NUTRIENTS, V3, P937, DOI 10.3390/nu3110937
   Goodman MT, 1997, CANCER RES, V57, P5077
   GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237
   Gunter MJ, 2012, INT J CANCER, V131, PE530, DOI 10.1002/ijc.26482
   Hashibe M, 2015, BRIT J CANCER, V113, P809, DOI 10.1038/bjc.2015.276
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Higgins LG, 2008, TOXICOL APPL PHARM, V226, P328, DOI 10.1016/j.taap.2007.09.018
   Hirose K, 2007, CANCER SCI, V98, P411, DOI 10.1111/j.1349-7006.2007.00391.x
   JACOBSEN BK, 1986, JNCI-J NATL CANCER I, V76, P823
   Jain M G, 2000, CANCER CONTROL, V7, P288
   Je Y, 2012, INT J CANCER, V131, P1700, DOI 10.1002/ijc.27408
   Je YJ, 2011, CANCER EPIDEM BIOMAR, V20, P2487, DOI 10.1158/1055-9965.EPI-11-0766
   Kalandidi A, 1996, ONCOLOGY, V53, P354
   Koizumi T, 2008, EUR J CANCER PREV, V17, P358, DOI 10.1097/CEJ.0b013e3282f0c02c
   Kotsopoulos J, 2009, CANCER-AM CANCER SOC, V115, P2765, DOI 10.1002/cncr.24328
   Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
   Lee KA, 2012, J BIOMED SCI, V19, P0, DOI 10.1186/1423-0127-19-60
   LEVI F, 1993, CANCER, V71, P3575, DOI 10.1002/1097-0142(19930601)71:11<3575::AID-CNCR2820711119>3.0.CO;2-0
   Li ZJ, 2016, EXP THER MED, V11, P2305, DOI 10.3892/etm.2016.3251
   LONDON S, 1991, AM J CLIN NUTR, V53, P166, DOI 10.1093/ajcn/53.1.166
   Loomis D, 2016, LANCET ONCOL, V17, P877, DOI 10.1016/S1470-2045(16)30239-X
   Lukanova A, 2004, INT J CANCER, V108, P262, DOI 10.1002/ijc.11544
   Macdonald G, 2012, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD001930.pub3
   McCann SE, 2009, INT J CANCER, V124, P1650, DOI 10.1002/ijc.24125
   Merritt MA, 2015, CANCER EPIDEM BIOMAR, V24, P466, DOI 10.1158/1055-9965.EPI-14-0970
   Nagata C, 1998, NUTR CANCER, V30, P21, DOI 10.1080/01635589809514635
   Nilsson LM, 2010, CANCER CAUSE CONTROL, V21, P1533, DOI 10.1007/s10552-010-9582-x
   Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103
   Orsini N, 2012, AM J EPIDEMIOL, V175, P66, DOI 10.1093/aje/kwr265
   Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676
   Petridou E, 2002, NUTR CANCER, V44, P16, DOI 10.1207/S15327914NC441_3
   Petridou E, 2002, EUR J CANCER PREV, V11, P427, DOI 10.1097/00008469-200210000-00004
   Renehan Andrew G, 2008, ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, V114, P71, DOI 10.1080/13813450801954303
   Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203
   Shearer J, 2003, J NUTR, V133, P3529, DOI 10.1093/jn/133.11.3529
   Shimazu T, 2008, INT J CANCER, V123, P2406, DOI 10.1002/ijc.23760
   STENSVOLD I, 1994, CANCER CAUSE CONTROL, V5, P401, DOI 10.1007/BF01694753
   Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461
   Terry P, 2002, NUTR CANCER, V42, P25, DOI 10.1207/S15327914NC421_4
   Uccella S, 2013, BRIT J CANCER, V109, P1908, DOI 10.1038/bjc.2013.540
   Wang AQ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33711
   Weiderpass E, 2014, NUTR CANCER, V66, P1132, DOI 10.1080/01635581.2014.948214
   Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952
   Wu TY, 2005, DIABETES CARE, V28, P1390, DOI 10.2337/diacare.28.6.1390
   Yamashita K, 2012, NUTR DIABETES, V2, P0, DOI 10.1038/nutd.2012.6
   Yang TO, 2015, AM J CLIN NUTR, V101, P570, DOI 10.3945/ajcn.113.081836
   Yu XF, 2011, BMC CANCER, V11, P0, DOI 10.1186/1471-2407-11-96
   Zhou Q, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep13410
NR 66
TC 21
Z9 23
U1 3
U2 13
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0163-5581
EI 1532-7914
J9 NUTR CANCER
JI Nutr. Cancer
PD JUN 15
PY 2018
VL 70
IS 4
BP 513
EP 528
DI 10.1080/01635581.2018.1460681
PG 16
WC Oncology; Nutrition & Dietetics
SC Oncology; Nutrition & Dietetics
GA GF8IR
UT WOS:000432214600001
PM 29708405
DA 2025-04-28
ER

PT J
AU Tung, YC
   Hsieh, TH
   Yang, MJ
   Hung, WL
   Ho, CT
   Pan, MH
AF Tung, Yen-Chen
   Hsieh, Tsung-Hai
   Yang, Meei-Ju
   Hung, Wei-Lun
   Ho, Chi-Tang
   Pan, Min-Hsiung
TI The effects of the extract of oolong tea and its metabolites from Andraca theae in high fat diet induced obese Wistar rat
SO FOOD SCIENCE AND HUMAN WELLNESS
LA English
DT Article
DE Tea; Andraca theae; High fat diet; Obesity
ID green tea; (-)-epigallocatechin-3-gallate; microbiota; expression; adipocyte; disease; weight; black
AB Obesity is a critical health issue worldwide. For a long time, the concept of drinking tea for health and pleasure is widely accepted. The strain of Andraca theae lives on the tea leaf and the bioactivity of its metabolites in the feces is unknown yet. Thus, the objective of this study was to investigate whether the extract of tea (Taiwan Tea Experiment Station No.12 (TE)) and its metabolites from Andraca theae (TME) could prevent obesity in the high fat diet-induced obese rats. Our results showed that TE had higher concentrations of epigallocatechin gallate (EGCG) and caffeine than that from TME. TE significantly decreased abdominal adipose tissue, especially epididymal fat via increasing preadipocyte factor 1 (Pref-1), SRY (sex determining region Y)-box 9 (SOX-9) and decreasing peroxisome proliferator-activated receptor gamma (PPAR gamma), CCAAT/enhancer binding protein (C/EBP)beta, C/EBP alpha and C/EBP gamma protein expression. Taken together, these results suggest that the content of tea polyphenols in TE play an important role for alleviating abdominal fat. (C) 2018 "Society information". Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
C1 [Tung, Yen-Chen; Hsieh, Tsung-Hai; Pan, Min-Hsiung] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 106, Taiwan.
   [Yang, Meei-Ju] Tea Res & Extens Stn, Taoyuan 326, Taiwan.
   [Hung, Wei-Lun] Univ Florida, Dept Food Sci & Human Nutr, Citrus Res & Educ Ctr, Lake Alfred, FL 33850 USA.
   [Ho, Chi-Tang] Rutgers State Univ, Dept Food Sci, New Brunswick, NJ 08901 USA.
C3 National Taiwan University; State University System of Florida; University of Florida; Rutgers University System; Rutgers University New Brunswick
RP Pan, MH (corresponding author), Natl Taiwan Univ, Inst Food Sci & Technol, 1,Sect 4,Roosevelt Rd, Taipei 10617, Taiwan.
EM mhpan@ntu.edu.tw
CR Ali AT, 2013, EUR J CELL BIOL, V92, P229, DOI 10.1016/j.ejcb.2013.06.001
   Bonora E, 2012, NAT REV GASTRO HEPAT, V9, P372, DOI 10.1038/nrgastro.2012.79
   Bose M, 2008, J NUTR, V138, P1677, DOI 10.1093/jn/138.9.1677
   Bouchard DR, 2010, OBESITY FACTS, V3, P345, DOI 10.1159/000322915
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   Chou TY, 2018, J FOOD DRUG ANAL, V26, P41, DOI 10.1016/j.jfda.2016.11.011
   Hudak Carolyn S, 2013, FRONT ENDOCRINOL (LAUSANNE), V4, P79, DOI 10.3389/fendo.2013.00079
   Jéquier E, 2002, INT J OBESITY, V26, PS12, DOI 10.1038/sj.ijo.0802123
   Kim HJ, 2016, BMB REP, V49, P111, DOI 10.5483/BMBRep.2016.49.2.128
   Kuo KL, 2005, J AGR FOOD CHEM, V53, P480, DOI 10.1021/jf049375k
   Lee MS, 2009, ANN NUTR METAB, V54, P151, DOI 10.1159/000214834
   Mohamed GA, 2014, BULLETIN OF THE FACULTY OF PHARMACY, V0, P0
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Shah Meera, 2017, CURR GASTROENTEROL REP, V19, P55, DOI 10.1007/s11894-017-0598-1
   Shi MG, 2013, TRADIT CHIN DRUG RES, V4, P1
   SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L
   STALLONE DD, 1991, INT J OBESITY, V15, P775
   Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160
   Unno T, 2014, J NUTR SCI VITAMINOL, V60, P213, DOI 10.3177/jnsv.60.213
   vant Slot G, 2009, J AGR FOOD CHEM, V57, P8041, DOI 10.1021/jf900458e
   Yuan ED, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10020187
NR 22
TC 10
Z9 10
U1 1
U2 10
PU KEAI PUBLISHING LTD
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING, DONGHENG DISTRICT 100717, PEOPLES R CHINA
SN 
EI 2213-4530
J9 FOOD SCI HUM WELL
JI Food Sci. Human Wellness
PD JUN 15
PY 2018
VL 7
IS 2
BP 120
EP 124
DI 10.1016/j.fshw.2018.05.001
PG 5
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA JH4VT
UT WOS:000492769100002
DA 2025-04-28
ER

PT J
AU de Oliveira, E
   Lima, NS
   Conceiçao, EPS
   Peixoto-Silva, N
   Moura, EG
   Lisboa, PC
AF de Oliveira, E.
   Lima, N. S.
   Conceicao, E. P. S.
   Peixoto-Silva, N.
   Moura, E. G.
   Lisboa, P. C.
TI Treatment with llex paraguariensis (yerba mate) aqueous solution prevents hepatic redox imbalance, elevated triglycerides, and microsteatosis in overweight adult rats that were precociously weaned
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Early weaning; Programming; Oxidative stress; Steatosis; Liver
ID tea ilex-paraguariensis; oxidative stress; developmental origins; metabolic-disorders; chlorogenic acid; antioxidant; steatosis; mice
AB Early weaning (EW) leads to overweight, visceral obesity, hyperleptinemia, and insulin resistance in adulthood. Treatment with llex paraguariensis (yerba mate) improves obesity and insulin resistance in these animals. Here, we evaluated the effects of chronic treatment with yerba mate on the redox balance and liver morphology of overweight early-weaned rats. To induce EW, we wrapped the dams with bandages to interrupt milk access during the last 3 days of lactation. Control pups (C) had free access to maternal milk for the full 21 days of lactation. On postnatal day (PN) 150, EW offspring were subdivided into the EW +YM group, which received the aqueous extract of yerba mate (1 g/kg bw by gavage once a day for 30 days) and the EW group, which received water by gavage for the same period. All rats were euthanized on PN180. The EW group showed higher bound carbonyl (a marker of total protein oxidation), higher TBARS levels (a marker of lipid peroxidation), and lower superoxide dismutase (SOD) activity in liver tissue than the C group, as well as higher triglyceride content and microsteatosis. In plasma, the EW offspring showed higher TBARS levels. One month of yerba mate treatment normalized these parameters. Thus, we have shown evidence that yerba mate improved antioxidant defenses and mitigated liver dysfunction in overweight adult rats that were weaned prematurely.
C1 [de Oliveira, E.; Lima, N. S.; Conceicao, E. P. S.; Peixoto-Silva, N.; Moura, E. G.; Lisboa, P. C.] Univ Estado Rio de Janeiro, Inst Biol, Dept Ciencias Fisiol, Lab Fisiol Endocrina, Rio De Janeiro, RJ, Brazil.
C3 Universidade do Estado do Rio de Janeiro
RP Lisboa, PC (corresponding author), Univ Estado Rio de Janeiro, Inst Biol, Dept Ciencias Fisiol, Lab Fisiol Endocrina, Rio De Janeiro, RJ, Brazil.
EM pclisboa@uerj.br
FU "National Council for Scientific and Technological Development'' (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq); "Carlos Chagas Filho Research Foundation of the State of Rio de Janeiro'' (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, FAPERJ); Coordination for the Enhancement of Higher Education Personnel (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, CAPES)
CR AEBI H, 1984, METHOD ENZYMOL, V105, P121
   Arçari DP, 2009, OBESITY, V17, P2127, DOI 10.1038/oby.2009.158
   BANNISTER JV, 1987, METHOD BIOCHEM ANAL, V32, P279
   Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x
   BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9
   Bastos DHM, 2007, MED AROMAT PLANT SCI BIOTECHNOL, V1, P37
   Bracesco N, 2011, J ETHNOPHARMACOL, V136, P378, DOI 10.1016/j.jep.2010.06.032
   Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi MS, 2017, J MED FOOD, V20, P1168, DOI 10.1089/jmf.2017.3995
   Conceiçao EPS, 2017, J DEV ORIG HLTH DIS, V8, P123, DOI 10.1017/S2040174416000519
   Conceiçao EPS, 2013, J NUTR BIOCHEM, V24, P81, DOI 10.1016/j.jnutbio.2012.02.010
   de Andrade F, 2012, FOOD CHEM TOXICOL, V50, P328, DOI 10.1016/j.fct.2011.08.028
   de Moura EG, 2008, NEUROIMMUNOMODULAT, V15, P176, DOI 10.1159/000153422
   Dupas C, 2006, MOL NUTR FOOD RES, V50, P1053, DOI 10.1002/mnfr.200600034
   FLOHE L, 1984, METHOD ENZYMOL, V105, P114
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Franco JG, 2013, J NUTR BIOCHEM, V24, P960, DOI 10.1016/j.jnutbio.2012.06.019
   Gambero A, 2015, NUTRIENTS, V7, P730, DOI 10.3390/nu7020730
   Gao HL, 2013, EXP GERONTOL, V48, P572, DOI 10.1016/j.exger.2013.03.008
   Gluckman PD, 2007, J INTERN MED, V261, P461, DOI 10.1111/j.1365-2796.2007.01802.x
   Gluckman PD, 2004, TRENDS ENDOCRIN MET, V15, P183, DOI 10.1016/j.tem.2004.03.002
   Hussein GME, 2011, BIOL PHARM BULL, V34, P1849, DOI 10.1248/bpb.34.1849
   Kaezer AR, 2012, CYTA-J FOOD, V10, P144, DOI 10.1080/19476337.2011.601429
   Kang Young-Rye, 2012, LAB ANIM RES, V28, P23, DOI 10.5625/lar.2012.28.1.23
   Kathirvel E, 2009, EUR J GASTROEN HEPAT, V21, P973, DOI 10.1097/MEG.0b013e328328f461
   Li YZ, 2002, NEUROSCI LETT, V330, P33, DOI 10.1016/S0304-3940(02)00722-X
   Lima ND, 2014, EUR J NUTR, V53, P73, DOI 10.1007/s00394-013-0500-3
   Lima ND, 2011, BRIT J NUTR, V105, P1405, DOI 10.1017/S0007114510005064
   LUCAS A, 1994, ARCH DIS CHILD, V71, P288, DOI 10.1136/adc.71.4.288
   Matsumoto RLT, 2009, J AGR FOOD CHEM, V57, P1775, DOI 10.1021/jf803096g
   Merzouk AS, 2017, FREE RADICAL RES, V51, P294, DOI 10.1080/10715762.2017.1307979
   Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003
   Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075
   Younes-Rapozo V, 2012, BRIT J NUTR, V108, P2286, DOI 10.1017/S0007114512000487
   Yun N, 2012, J NUTR BIOCHEM, V23, P1249, DOI 10.1016/j.jnutbio.2011.06.018
NR 36
TC 7
Z9 7
U1 0
U2 4
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP 14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD JUN 15
PY 2018
VL 51
IS 6
BP 
EP 
DI 10.1590/1414-4331X20187342
PG 10
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental Medicine
GA GG8WE
UT WOS:000432978700001
PM 29791596
DA 2025-04-28
ER

PT J
AU Torres-Collado, L
   García-de la Hera, M
   Navarrete-Muñoz, EM
   Compañ-Gabucio, LM
   Gonzalez-Palacios, S
   Vioque, J
AF Torres-Collado, Laura
   Garcia-de la Hera, Manuela
   Maria Navarrete-Munoz, Eva
   Maria Compan-Gabucio, Laura
   Gonzalez-Palacios, Sandra
   Vioque, Jesus
TI Coffee Drinking and Associated Factors in an Elderly Population in Spain
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE coffee; caffeinated; decaffeinated; elderly; consumption; factors
ID dose-response metaanalysis; cardiovascular-disease; consumption; risk; caffeine; agreement; obesity
AB Coffee consumption is highly prevalent worldwide, and many studies have reported positive and inverse associations of coffee with many diseases. However, factors associated with coffee consumption remain poorly characterized in some populations, such as the elderly. This study aimed to assess the factors associated with total, caffeinated and decaffeinated coffee consumption in an elderly population in Spain. Data were analyzed from 903 participants, aged 65 years and above, from two population-based studies carried out in the Valencia region in Spain (Valencia Nutritional Survey (VNS) and European Eye Study (EUREYE-Study). Total, caffeinated and decaffeinated coffee consumption was assessed through two specific questions using a validated food frequency questionnaire. Information on personal characteristics, anthropometry and lifestyles was collected in personal interviews. Multinomial logistic regression analysis was used to estimate the adjusted relative risk ratios (RRR) and confidence intervals (95% CI). The prevalence of total, caffeinated and decaffeinated coffee consumption was 70%, 38% and 32%, respectively. The consumption of caffeinated coffee was positively associated with: Educational level, RRR = 1.63 (1.09-2.44); body mass index (30), RRR = 2.03 (1.05-3.95); tobacco smoking, RRR = 1.96 (1.13-3.39); alcohol intake [12 g/day category intake vs. no-alcohol intake, RRR = 6.25 (3.56-10.95)]; and energy intake (p < 0.05). Consumption of caffeinated coffee was negatively associated with: Age (75 years), RRR = 0.64 (0.43-0.94); and pre-existing hypertension, RRR = 0.67 (0.45-0.98). The consumption of decaffeinated coffee was positively associated with: Alcohol intake, RRR = 2.63 (1.19-4.64); pre-existing diabetes, RRR = 1.67 (1.06-2.62); and energy intake (p < 0.01). The consumption of coffee is high among elderly people in Spain. It is a novelty in this study with elderly population that tobacco smoking and alcohol drinking were the two main factors associated with higher coffee consumption. Self-reported hypertension was associated with a lower consumption of caffeinated coffee, and pre-existing diabetes was associated with a higher consumption of decaffeinated coffee. These associations should be taken into account when the health effects of coffee consumption are investigated.
C1 [Torres-Collado, Laura; Garcia-de la Hera, Manuela; Maria Navarrete-Munoz, Eva; Maria Compan-Gabucio, Laura; Gonzalez-Palacios, Sandra; Vioque, Jesus] Univ Miguel Hernandez, Dept Publ Hlth Hist Med & Gynecol, Alicante Inst Hlth & Biomed Res, ISABIAL FISABIO Fdn, Alicante 03550, Spain.
   [Garcia-de la Hera, Manuela; Maria Navarrete-Munoz, Eva; Gonzalez-Palacios, Sandra; Vioque, Jesus] Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid 28029, Spain.
C3 General University Hospital of Alicante; Universidad Miguel Hernandez de Elche; Universitat d'Alacant; Instituto de Investigacion Sanitaria y Biomedica de Alicante (ISABIAL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP
RP Vioque, J (corresponding author), Univ Miguel Hernandez, Dept Publ Hlth Hist Med & Gynecol, Alicante Inst Hlth & Biomed Res, ISABIAL FISABIO Fdn, Alicante 03550, Spain.; Vioque, J (corresponding author), Spanish Consortium Res Epidemiol & Publ Hlth CIBE, Madrid 28029, Spain.
EM l.torres@umh.es; manoli@umh.es; enavarrete@umh.es; lcompan@umh.es; sandra.gonzalezp@umh.es; vioque@umh.es
FU Direccion General de Salud Publica, Generalitat Valenciana; Fondo Investigacion Sanitaria [FIS 00/0985]; European Commission [QLK6-CT-1999-02 094]; Spanish Ministry of Health [FIS 01/1692E, RCESP C 03/09]; Spanish Ministry of Health (CIBERESP, CIBER de Epidemiologia y Salud Publica); Generalitat Valenciana [CTGCA/2002/06, G 03/136]; Instituto de Salud Carlos III; FEDER funds [FIS PI13/00654]; Ministry of Education in Spain [FPU14/00046]
CR Unknown -, 2013, USDA NAT NUTR DAT ST, V0, P0
   Augood C, 2004, OPHTHAL EPIDEMIOL, V11, P117, DOI 10.1076/opep.11.2.117.28160
   BUSH TL, 1989, AM J PUBLIC HEALTH, V79, P1554, DOI 10.2105/AJPH.79.11.1554
   Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046
   Grosso G, 2016, EUR J CLIN NUTR, V70, P109, DOI 10.1038/ejcn.2015.119
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   HARLOW SD, 1989, AM J EPIDEMIOL, V129, P233, DOI 10.1093/oxfordjournals.aje.a115129
   Hewlett P, 2006, APPETITE, V46, P97, DOI 10.1016/j.appet.2005.10.004
   Higgins JPT, 2003, BMJ-BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557
   Lieberman HR, 2012, J ACAD NUTR DIET, V112, P902, DOI 10.1016/j.jand.2012.02.001
   Mahoney CR, 2019, CLIN NUTR, V38, P668, DOI 10.1016/j.clnu.2018.04.004
   Navarro AM, 2019, CLIN NUTR, V38, P389, DOI 10.1016/j.clnu.2017.12.009
   Palma I, 2008, TABLAS DE COMPOSICIN DE ALIMENTOS POR MEDIDAS CASERAS DE CONSUMO HABITUAL EN ESPAA. CENTRE DENSENYAMENT SUPERIOR DE NUTRICI I DIETTICA (CESNID), V0, P0
   Penolazzi B, 2012, APPETITE, V58, P971, DOI 10.1016/j.appet.2012.02.001
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Sotos-Prieto M, 2010, NUTR HOSP, V25, P388, DOI 10.3305/nh.2010.25.3.4293
   Vioque J, 2000, INT J OBESITY, V24, P1683, DOI 10.1038/sj.ijo.0801434
   Vioque J, 1991, EUROPEAN JOURNAL OF CANCER PREVENTION, V1, P19
   Vioque J, 2003, ENCUESTA DE NUTRICION Y SALUD DE LA COMUNIDAD, V0, P0
   Vioque J, 2007, BRIT J NUTR, V97, P977, DOI 10.1017/S0007114507659017
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086
   Wu L, 2017, CLIN NUTR, V36, P730, DOI 10.1016/j.clnu.2016.05.015
   Zulli A, 2016, EUR J NUTR, V55, P1331, DOI 10.1007/s00394-016-1179-z
NR 29
TC 16
Z9 16
U1 0
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD AUG 15
PY 2018
VL 15
IS 8
BP 
EP 
DI 10.3390/ijerph15081661
PG 8
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational Health
GA GS0GQ
UT WOS:000443168200101
PM 30082581
DA 2025-04-28
ER

PT J
AU Wang, LC
   Pan, TM
   Tsai, TY
AF Wang, Li-Chun
   Pan, Tzu-Ming
   Tsai, Tsung-Yu
TI Lactic acid bacteria-fermented product of green tea and Houttuynia cordata leaves exerts anti-adipogenic and anti-obesity effects
SO JOURNAL OF FOOD AND DRUG ANALYSIS
LA English
DT Article
DE Lactic acid bacteria; Green tea; Houttuynia cordata leaf; Anti-adipogenesis; Anti-obesity
ID hormone-sensitive lipase; paracasei ntu 101; high-fat-diet; lipoprotein-lipase; adipose-tissue; milk-soymilk; ppar-gamma; in-vivo; (-)-epigallocatechin-3-gallate; obesity
AB Obesity is associated with higher risks of developing diabetes and cardiovascular disease. Green tea, rich in polyphenolic compounds such as epigallocatechin gallate (EGCG) and epigallocatechin (EGC), has been shown to display anti-obesity effects. Houttuynia cordata leaves have also been shown to exhibit anti-obesity effects due to their chlorogenic acid content. Lactic acid bacteria are able to increase the production of polyphenolic compounds. This study aims to develop a novel anti-obesity fermentation product by combining H. cordata leaf tea with green tea, using Lactobacillus paracasei subsp. paracasei NTU 101 (NTU 101) for fermentation due to the advantages of bioconverting the polyphenolic compounds. The regulation of adipogenesis factors and the anti-obesity effect of the NTU 101-fermented tea were evaluated in an in vitro 3T3-L1 pre-adipocyte model and an in vivo obese rat model, respectively. The results show that the NTU 101-fermented tea, which contained higher EGCG, EGC, and chlorogenic acid levels than unfermented tea, was able to inhibit the lipogenesis of mature 3T3-L1 adipocytes by the stimulation of lipolysis. Furthermore, the body weight gain, body fat pad, and feeding efficiency of obese rats, induced with a high fat diet, were decreased by the oral administration of NTU 101-fermented tea. The significant anti-obesity effect was probably due to lipolysis. However, NTU 101 bacteria cells and EGCG may also act as functional ingredients to contribute to the anti-obesity effects of NTU 101-fermented products. Copyright (C) 2017, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
C1 [Wang, Li-Chun; Tsai, Tsung-Yu] Fu Jen Catholic Univ, PhD Program Nutr & Food Sci, Taipei, Taiwan.
   [Wang, Li-Chun] Natl Taitung Jr Coll, Continuing Educ Sch, Taitung, Taiwan.
   [Pan, Tzu-Ming] Natl Taiwan Univ, Dept Biochem Sci & Technol, 1 Sec 4,Roosevelt Rd, Taipei, Taiwan.
   [Pan, Tzu-Ming] Sunway Biotech Co Ltd, R&D Div, Taipei, Taiwan.
   [Tsai, Tsung-Yu] Fu Jen Catholic Univ, Dept Food Sci, 510 Zhongzheng Rd, Taipei, Taiwan.
C3 Fu Jen Catholic University; National Taiwan University; Fu Jen Catholic University
RP Pan, TM (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, 1 Sec 4,Roosevelt Rd, Taipei, Taiwan.; Tsai, TY (corresponding author), Fu Jen Catholic Univ, Dept Food Sci, 510 Zhongzheng Rd, Taipei, Taiwan.
EM tmpan@ntu.edu.tw; tytsai@mail.fju.edu.tw
CR Balzan S, 2013, FITOTERAPIA, V86, P115, DOI 10.1016/j.fitote.2013.02.008
   Berger JJ, 1999, J APPL PHYSIOL, V87, P227, DOI 10.1152/jappl.1999.87.1.227
   Bhushan B, 2003, APPL ENVIRON MICROB, V69, P1347, DOI 10.1128/AEM.69.3.1347-1351.2003
   Chen HC, 2002, J LIPID RES, V43, P986
   Cheng MC, 2015, FOOD FUNCT, V6, P3522, DOI 10.1039/c5fo00531k
   Chiang SS, 2012, APPL MICROBIOL BIOT, V93, P903, DOI 10.1007/s00253-011-3753-x
   Chiu CH, 2006, APPL MICROBIOL BIOT, V71, P238, DOI 10.1007/s00253-005-0145-0
   Cooperstone JL, 2017, AM J CLIN NUTR, V106, P59, DOI 10.3945/ajcn.116.150821
   CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   FRAYN KN, 1995, ADV ENZYME REGUL, V35, P163, DOI 10.1016/0065-2571(94)00011-Q
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Kusunoki M, 2000, DIABETOLOGIA, V43, P875, DOI 10.1007/s001250051464
   Li GX, 2010, CARCINOGENESIS, V31, P902, DOI 10.1093/carcin/bgq039
   Lin FM, 2004, J IND MICROBIOL BIOT, V31, P559, DOI 10.1007/s10295-004-0184-z
   Manohar M, 2013, J NUTR BIOCHEM, V24, P940, DOI 10.1016/j.jnutbio.2012.06.013
   Marcus A, 2015, J NUTR SCI VITAMINOL, V61, PS211, DOI 10.3177/jnsv.61.S211
   Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309
   Morrison RF, 1999, J CELL BIOCHEM, V0, P59
   Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088
   Ntambi JM, 2000, J NUTR, V130, P3122S, DOI 10.1093/jn/130.12.3122S
   Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200
   Raimondi S, 2009, APPL MICROBIOL BIOT, V81, P943, DOI 10.1007/s00253-008-1719-4
   Rekha CR, 2010, J APPL MICROBIOL, V109, P1198, DOI 10.1111/j.1365-2672.2010.04745.x
   Roberts CK, 2002, ATHEROSCLEROSIS, V161, P133, DOI 10.1016/S0021-9150(01)00622-0
   Rosen ED, 2000, GENE DEV, V14, P1293
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Saravanan R, 2017, PREP BIOCHEM BIOTECH, V47, P245, DOI 10.1080/10826068.2016.1207082
   Steinberg GR, 2007, AM J PHYSIOL-ENDOC M, V293, PE958, DOI 10.1152/ajpendo.00235.2007
   Suh KS, 2010, CELL BIOL TOXICOL, V26, P189, DOI 10.1007/s10565-009-9137-7
   Tao L, 2014, MOL NUTR FOOD RES, V58, P665, DOI 10.1002/mnfr.201300427
   Tsai TY, 2009, J AGR FOOD CHEM, V57, P2065, DOI 10.1021/jf802936c
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Zhang HH, 2010, FREE RADICAL BIO MED, V49, P2010, DOI 10.1016/j.freeradbiomed.2010.09.031
NR 34
TC 50
Z9 53
U1 5
U2 70
PU FOOD & DRUG ADMINSTRATION
PI TAIPEI
PA 161-2 KUNYANG STREET, NANGANG, TAIPEI, 00000, TAIWAN
SN 1021-9498
EI 
J9 J FOOD DRUG ANAL
JI J. Food Drug Anal.
PD JUL 15
PY 2018
VL 26
IS 3
BP 973
EP 984
DI 10.1016/j.jfda.2017.11.009
PG 12
WC Food Science & Technology; Pharmacology & Pharmacy
SC Food Science & Technology; Pharmacology & Pharmacy
GA GM1FH
UT WOS:000437809200004
PM 29976415
DA 2025-04-28
ER

PT J
AU Pereira, JL
   Félix, PV
   Mattei, J
   Fisberg, RM
AF Pereira, Jaqueline Lopes
   Felix, Paula Victoria
   Mattei, Josiemer
   Fisberg, Regina Mara
TI Differences over 12 Years in Food Portion Size and Association with Excess Body Weight in the City of SAo Paulo, Brazil
SO NUTRIENTS
LA English
DT Article
DE portion size; eating frequency; food intake; energy contribution; diet; obesity; overweight
ID sugar-sweetened beverages; energy-intake; waist circumference; dietary patterns; white rice; obesity; consumption; gain; nutrition; adiposity
AB Although changes in Brazilian diet have occurred over the last decades, there is no evidence about differences in food portion sizes (FPS) over time. Therefore, we aimed to evaluate the association of FPS with excess body weight (EBW), and to monitor differences in the population from SAo Paulo, Brazil, from 2003 to 2015. Data came from three cross-sectional population-based studies with 5270 individuals aged 12 years in 2003, 2008, and 2015. Dietary data were obtained from 24-h recalls. Logistic regression models were used to evaluate the association between FPS and EBW. Over the years, there was a diverse variation in FPS, with an increase in some groups (white meat, salted snacks, coffee/tea, eggs) and decrease in others (rice, red meat, sweets, pasta, sandwiches, cold cuts). The percentage of people reporting the intake of six food groupings (rice, white meat, sweets, fruits, commercial juices, toasts/biscuits) increased in the period. In this population, EBW was associated with larger FPS of 11 of the 30 food groupings investigated (cold cuts, fried snacks, fruit and commercial juices, pizza, red meat, rice, salted snacks, soft drinks, soups, sugar). These findings could support future interventions and policies for optimal food intake in Brazil.
C1 [Pereira, Jaqueline Lopes; Felix, Paula Victoria; Fisberg, Regina Mara] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, SP, Brazil.
   [Mattei, Josiemer] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
C3 Universidade de Sao Paulo; Harvard University; Harvard T.H. Chan School of Public Health
RP Fisberg, RM (corresponding author), Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, BR-01246904 Sao Paulo, SP, Brazil.
EM jaque.lps@gmail.com; paula.victoria@gmail.com; jmattei@hsph.harvard.edu; rfisberg@usp.br
FU Sao Paulo Municipal Health Department [2013-0.235.936-0]; Research Support Foundation of the State of Sao Paulo [98/14099-7, 2007/51488-2, 2009/15831-0, 2012/22113-9, 2016/07711-8]; National Council for Scientific and Technological Development [502948/2003-5, 481176/2008-0, 472873/2012-1, 473100/2009-6, 402674/2016-2, 301597/2017-0]
CR Albar SA, 2014, BRIT J NUTR, V112, P841, DOI 10.1017/S0007114514001548
   Alves MCGP, 2003, ISA CAPITAL PLANO AM, V0, P0
   Alves MCGP, 2009, PLANO AMOSTRAGEM ISA, V0, P0
   Unknown -, 2019, MANUAL DE EQUIVALENTES ALIMENTARES, V0, P0
   Unknown -, 1998, OB PREV MAN GLOB EP, V0, P0
   Azadbakht L, 2016, J AM COLL NUTR, V35, P491, DOI 10.1080/07315724.2015.1113902
   Banna JC, 2017, FRONT NUTR, V4, P0, DOI 10.3389/fnut.2017.00045
   Bezerra IN, 2018, REV SAUDE PUBL, V52, P0, DOI 10.11606/S1518-8787.2018052000082
   BLOCK G, 1986, AM J EPIDEMIOL, V124, P453, DOI 10.1093/oxfordjournals.aje.a114416
   Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1
   Carvalho AM, 2014, REV BRAS EPIDEMIOL, V17, P735
   Castro MA, 2016, BRIT J NUTR, V115, P1586, DOI 10.1017/S0007114516000556
   Church S, 2008, TRENDS IN PORTION SIZES IN THE UK-A PRELIMINARY REVIEW OF PUBLISHED INFORMATION, V0, P0
   Collins K, 2014, BMC PUBLIC HEALTH, V14, P0, DOI 10.1186/1471-2458-14-517
   Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB
   Cruwys T, 2015, APPETITE, V86, P3, DOI 10.1016/j.appet.2014.08.035
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   de Onis M, 2006, WHO CHILD GROWTH STANDARDS LENGTH/HEIGHT-FOR-AGE, V0, P0
   Duffey KJ, 2011, PLOS MED, V8, P0, DOI 10.1371/journal.pmed.1001050
   Fisberg RM, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10020169
   Fisher JO, 2015, APPETITE, V88, P1, DOI 10.1016/j.appet.2014.11.025
   Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140
   Glanz K, 1998, J AM DIET ASSOC, V98, P1118, DOI 10.1016/S0002-8223(98)00260-0
   Imamura F, 2015, BMJ-BRIT MED J, V351, P0, DOI 10.1136/bmj.h3576
   Jeffery RW, 2007, INT J BEHAV NUTR PHY, V4, P0, DOI 10.1186/1479-5868-4-27
   Kelly MT, 2009, BRIT J NUTR, V101, P1413, DOI 10.1017/S0007114508060777
   Lafay L, 2000, INT J OBESITY, V24, P1500, DOI 10.1038/sj.ijo.0801392
   Lebrao ML, 2003, SABE: SAUDE, V0, P0
   Ledikwe JH, 2005, J NUTR, V135, P905, DOI 10.1093/jn/135.4.905
   Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003
   Lissner L, 2002, PUBLIC HEALTH NUTR, V5, P889, DOI 10.1079/PHN2002388
   Livingstone MBE, 2014, ADV NUTR, V5, P829, DOI 10.3945/an.114.007104
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Rodrigues AGM, 2012, APPETITE, V59, P305, DOI 10.1016/j.appet.2012.05.018
   Matsudo S, 2001, REV BRAS ATIV FIS SAUDE, V6, P5, DOI 10.12820/RBAFS.V.6N2P5-18
   Mattei J, 2011, AM J CLIN NUTR, V94, P869, DOI 10.3945/ajcn.111.013219
   Mattes R, 2014, PHYSIOL BEHAV, V134, P110, DOI 10.1016/j.physbeh.2013.11.012
   Matthiessen J, 2003, PUBLIC HEALTH NUTR, V6, P65, DOI 10.1079/PHN2002361
   McCarthy SN, 2006, INT J OBESITY, V30, P993, DOI 10.1038/sj.ijo.0803235
   Mendez MA, 2011, AM J EPIDEMIOL, V173, P448, DOI 10.1093/aje/kwq380
   Ministerio da Saude, 2017, SECR VIG SAUD DEP VI, V0, P0
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Mozaffarian D, 2011, NEW ENGL J MED, V364, P2392, DOI 10.1056/NEJMoa1014296
   Munt AE, 2017, OBES REV, V18, P1, DOI 10.1111/obr.12472
   NEPA, 2011, TAB BRAS COMP AL, V0, P0
   Nielsen Samara Joy, 2003, JAMA (JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION), V289, P450, DOI 10.1001/jama.289.4.450
   OBrien SA, 2015, BRIT J NUTR, V113, P1148, DOI 10.1017/S0007114515000276
   Papanikolaou Y, 2008, J AM COLL NUTR, V27, P569, DOI 10.1080/07315724.2008.10719740
   Pereira JL, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0164127
   Pereira RA, 2014, PUBLIC HEALTH NUTR, V17, P113, DOI 10.1017/S1368980012004892
   Pinheiro ABV, 2008, TABELA PARA AVALIACAO DE CONSUMO ALIMENTAR EM MEDIDAS CASEIRAS, V5a, P0
   Popkin BM, 2001, J NUTR, V131, P871S, DOI 10.1093/jn/131.3.871S
   Prentice A M, 2003, OBES REV, V4, P187, DOI 10.1046/j.1467-789X.2003.00117.x
   Raynor HA, 2007, OBESITY, V15, P2311, DOI 10.1038/oby.2007.274
   Rhee JJ, 2012, PUBLIC HEALTH NUTR, V15, P1347, DOI 10.1017/S1368980012001000
   Rolls BJ, 2007, OBESITY, V15, P1535, DOI 10.1038/oby.2007.182
   Rolls BJ, 2006, J AM DIET ASSOC, V106, P543, DOI 10.1016/j.jada.2006.01.014
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Sichieri R, 2007, AM J CLIN NUTR, V86, P707, DOI 10.1093/ajcn/86.3.707
   Singh GM, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0124845
   Smiciklas-Wright H, 2003, J AM DIET ASSOC, V103, P41, DOI 10.1053/jada.2003.50000
   Steenhuis IHM, 2010, PUBLIC HEALTH NUTR, V13, P852, DOI 10.1017/S1368980009992011
   Vergnaud AC, 2010, AM J CLIN NUTR, V92, P398, DOI 10.3945/ajcn.2009.28713
   Wang L, 2010, ARCH INTERN MED, V170, P453, DOI 10.1001/archinternmed.2009.527
   Wannamethee SG, 2004, OBES RES, V12, P1386, DOI 10.1038/oby.2004.175
   Wannamethee SG, 2003, AM J CLIN NUTR, V77, P1312, DOI 10.1093/ajcn/77.5.1312
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, V0, P1
   WRIEDEN W, 2008, PROC NUTR SOC, V67, P0, DOI 10.1017/S0029665100590582
   Young LR, 2002, AM J PUBLIC HEALTH, V92, P246, DOI 10.2105/AJPH.92.2.246
NR 72
TC 9
Z9 10
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUN 15
PY 2018
VL 10
IS 6
BP 
EP 
DI 10.3390/nu10060696
PG 20
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GK8VC
UT WOS:000436507200040
PM 29848971
DA 2025-04-28
ER

PT J
AU Nehlig, A
AF Nehlig, Astrid
TI Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
SO PHARMACOLOGICAL REVIEWS
LA English
DT Review
ID cytochrome-p450 1a2 activity; st-johns-wort; receptor gene polymorphisms; xanthine-oxidase activity; pregnancy-induced changes; genome-wide association; adenosine a2a receptor; herb-drug interaction; activity in-vivo; parkinsons-disease
AB Most individuals adjust their caffeine intake according to the objective and subjective effects induced by the methylxanthine. However, to reach the desired effects, the quantity of caffeine consumed varies largely among individuals. It has been known for decades that the metabolism, clearance, and pharmacokinetics of caffeine is affected by many factors such as age, sex and hormones, liver disease, obesity, smoking, and diet. Caffeine also interacts with many medications. All these factors will be reviewed in the present document and discussed in light of the most recent data concerning the genetic variability affecting caffeine levels and effects at the pharmacokinetic and pharmacodynamic levels that both critically drive the level of caffeine consumption. The pharmacokinetics of caffeine are highly variable among individuals due to a polymorphism at the level of the CYP1A2 isoform of cytochrome P450, which metabolizes 95% of the caffeine ingested. Moreover there is a polymorphism at the level of another critical enzyme, N-acetyltransferase 2. At the pharmacodynamic level, there are several polymorphisms at the main brain target of caffeine, the adenosine A2A receptor or ADORA2. Genetic studies, including genome-wide association studies, identified several loci critically involved in caffeine consumption and its consequences on sleep, anxiety, and potentially in neurodegenerative and psychiatric diseases. We start reaching a better picture on how a multiplicity of biologic mechanisms seems to drive the levels of caffeine consumption, although much more knowledge is still required to understand caffeine consumption and effects on body functions.
C1 [Nehlig, Astrid] Univ Paris 05, Necker Enfants Malad Hosp, INSERM, U 1129,Pediat Neurol, Paris, France.
C3 Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)
RP Nehlig, A (corresponding author), Univ Paris 05, Necker Enfants Malad Hosp, INSERM, U 1129,Pediat Neurol, Paris, France.
EM nehliga@unistra.fr
FU Institute for Scientific Information on Coffee (ISIC), La Tour-de-Peilz (Switzerland); ISIC
CR ABERNETHY DR, 1985, EUR J CLIN PHARMACOL, V28, P425, DOI 10.1007/BF00544361
   Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036
   Adehin Ayorinde, 2015, DRUG METABOLISM AND PERSONALIZED THERAPY, V30, P203, DOI 10.1515/dmpt-2015-0001
   Adehin A, 2015, EUR J CLIN PHARMACOL, V71, P687, DOI 10.1007/s00228-015-1852-9
   Ahmed I, 2014, PLOS GENET, V10, P0, DOI 10.1371/journal.pgen.1004788
   Alonso-Navarro H, 2014, CURR DRUG METAB, V15, P129, DOI 10.2174/138920021502140327175404
   Alsene K, 2003, NEUROPSYCHOPHARMACOL, V28, P1694, DOI 10.1038/sj.npp.1300232
   Alvarez E, 2002, J NEUROCHEM, V80, P45, DOI 10.1046/j.0022-3042.2001.00677.x
   Amchin J, 1999, J CLIN PHARMACOL, V39, P252
   Amin N, 2012, MOL PSYCHIATR, V17, P1116, DOI 10.1038/mp.2011.101
   Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005
   Arab L, 2011, J ALZHEIMERS DIS, V27, P553, DOI 10.3233/JAD-2011-110431
   Arnaud Maurice J, 2011, HANDB EXP PHARMACOL, V0, PP33, DOI 10.1007/978-3-642-13443-2_3
   ARNAUD MJ, 1976, BIOCHEM MED METAB B, V16, P67, DOI 10.1016/0006-2944(76)90010-7
   ARNAUD MJ, 1991, FOURTEENTH INTERNATIONAL CONFERENCE ON COFFEE SCIENCE, V0, P71
   Arnaud MJ, 1993, CAFFEINE COFFEE HLTH, V0, P43
   Arold G, 2005, PLANTA MED, V71, P331, DOI 10.1055/s-2005-864099
   Ascherio A, 2004, AM J EPIDEMIOL, V160, P977, DOI 10.1093/aje/kwh312
   Ascherio A, 2001, ANN NEUROL, V50, P56, DOI 10.1002/ana.1052
   AZCONA O, 1995, BRIT J CLIN PHARMACO, V40, P393, DOI 10.1111/j.1365-2125.1995.tb04562.x
   Backman JT, 2006, BRIT J CLIN PHARMACO, V62, P345, DOI 10.1111/j.1365-2125.2006.02653.x
   Barone JJ, 1996, FOOD CHEM TOXICOL, V34, P119, DOI 10.1016/0278-6915(95)00093-3
   Batalha VL, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep31493
   BATTISTUZZI G, 1981, ANN HUM GENET, V45, P15, DOI 10.1111/j.1469-1809.1981.tb00301.x
   BEACH CA, 1985, J PHARMACOL EXP THER, V233, P18
   Beaumont R, 2017, J SPORT SCI, V35, P1920, DOI 10.1080/02640414.2016.1241421
   Bell DG, 2002, J APPL PHYSIOL, V93, P1227, DOI 10.1152/japplphysiol.00187.2002
   Beste C, 2012, EUR NEUROPSYCHOPHARM, V22, P555, DOI 10.1016/j.euroneuro.2011.12.004
   BIRKETT DJ, 1991, BRIT J CLIN PHARMACO, V31, P405, DOI 10.1111/j.1365-2125.1991.tb05553.x
   Blake MJ, 2006, PEDIATR RES, V60, P717, DOI 10.1203/01.pdr.0000245909.74166.00
   BLANCHARD J, 1983, EUR J CLIN PHARMACOL, V24, P93, DOI 10.1007/BF00613933
   BLANCHARD J, 1984, DRUG-NUTRIENT INTERACTIONS, V2, P243
   BLANCHARD J, 1983, J PHARMACOKINET BIOP, V11, P109, DOI 10.1007/BF01061844
   Bodenmann S, 2012, BRIT J PHARMACOL, V165, P1904, DOI 10.1111/j.1476-5381.2011.01689.x
   BOLOGA M, 1991, J PHARMACOL EXP THER, V257, P735
   BONATI M, 1985, DRUG METAB REV, V15, P1355, DOI 10.3109/03602538409029964
   BONATI M, 1982, CLIN PHARMACOL THER, V32, P98, DOI 10.1038/clpt.1982.132
   BORY C, 1979, J PEDIATR-US, V94, P988, DOI 10.1016/S0022-3476(79)80246-2
   BRACHTEL D, 1988, Z GASTROENTEROL, V26, P245
   Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810
   BROWN CR, 1988, CLIN PHARMACOL THER, V43, P488, DOI 10.1038/clpt.1988.63
   BRUGUEROLLE B, 1990, EUR J CLIN PHARMACOL, V39, P59, DOI 10.1007/BF02657059
   BUTLER MA, 1992, PHARMACOGENETICS, V2, P116, DOI 10.1097/00008571-199206000-00003
   Byrne EM, 2012, SLEEP, V35, P967, DOI 10.5665/sleep.1962
   Caetano L, 2017, MOL PSYCHIATR, V22, P1035, DOI 10.1038/mp.2016.173
   Caldeira D, 2013, HEART, V99, P1383, DOI 10.1136/heartjnl-2013-303950
   CALLAHAN MM, 1982, DRUG METAB DISPOS, V10, P417
   CARACO Y, 1995, INT J OBESITY, V19, P234
   Carrillo JA, 2000, CLIN PHARMACOKINET, V39, P127, DOI 10.2165/00003088-200039020-00004
   Carrillo JA, 1996, BRIT J CLIN PHARMACO, V41, P605, DOI 10.1046/j.1365-2125.1996.35418.x
   Chen Y, 2009, XENOBIOTICA, V39, P508, DOI 10.1080/00498250902951763
   Chen Y, 2010, ANN PHARMACOTHER, V44, P1038, DOI 10.1345/aph.1M533
   Chen Y, 2009, CLIN EXP PHARMACOL P, V36, P828, DOI 10.1111/j.1440-1681.2009.05158.x
   CHENG WSC, 1990, CLIN PHARMACOL THER, V47, P516, DOI 10.1038/clpt.1990.66
   Chien CF, 2010, CHEM-BIOL INTERACT, V184, P458, DOI 10.1016/j.cbi.2010.01.017
   Childs E, 2008, NEUROPSYCHOPHARMACOL, V33, P2791, DOI 10.1038/npp.2008.17
   Chroscinska-Krawczyk M, 2016, PHARMACOL REP, V68, P680, DOI 10.1016/j.pharep.2016.03.011
   Chroscinska-Krawczyk M, 2009, PHARMACOL REP, V61, P819, DOI 10.1016/S1734-1140(09)70137-9
   Chuang YH, 2016, NEUROEPIDEMIOLOGY, V47, P192, DOI 10.1159/000450855
   CHVASTA TE, 1971, GASTROENTEROLOGY, V61, P838
   Cornelis MC, 2015, MOL PSYCHIATR, V20, P647, DOI 10.1038/mp.2014.107
   Cornelis MC, 2007, AM J CLIN NUTR, V86, P240, DOI 10.1093/ajcn/86.1.240
   Cornelis MC, 2016, HUM MOL GENET, V25, P5472, DOI 10.1093/hmg/ddw334
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Cornelis MC, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002033
   Cornelis MC, 2006, JAMA-J AM MED ASSOC, V295, P1135, DOI 10.1001/jama.295.10.1135
   Culm-Merdek KE, 2005, BRIT J CLIN PHARMACO, V60, P486, DOI 10.1111/j.1365-2125.2005.02467.x
   Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724
   Curtis Brian R, 2014, IMMUNOHEMATOLOGY, V30, P95
   Curtis Brian R, 2014, IMMUNOHEMATOLOGY, V30, P55
   Cysneiros RM, 2007, CLIN PHARMACOL THER, V82, P54, DOI 10.1038/sj.clpt.6100211
   CZUCZWAR SJ, 1990, EPILEPSIA, V31, P318, DOI 10.1111/j.1528-1157.1990.tb05382.x
   Darwish M, 2008, CLIN PHARMACOKINET, V47, P61, DOI 10.2165/00003088-200847010-00006
   Debry G, 1994, COFFEE AND HLTH, V0, P0
   Deckert J, 1998, MOL PSYCHIATR, V3, P81, DOI 10.1038/sj.mp.4000345
   DELBEKE FT, 1988, BIOPHARM DRUG DISPOS, V9, P137, DOI 10.1002/bod.2510090203
   DEMENDONCA A, 1995, NEUROREPORT, V6, P1097, DOI 10.1097/00001756-199505300-00006
   DENARO CP, 1990, CLIN PHARMACOL THER, V48, P277, DOI 10.1038/clpt.1990.150
   Denden S, 2016, GENET MOL RES, V15, P0, DOI 10.4238/gmr.15027487
   Derry CJ, 2014, COCHRANE DB SYST REV, V12, P0
   DESMOND PV, 1980, DIGEST DIS SCI, V25, P193, DOI 10.1007/BF01308138
   Dik VK, 2014, INT J CANCER, V135, P401, DOI 10.1002/ijc.28655
   Dinger J, 2016, TOXICOL LETT, V241, P82, DOI 10.1016/j.toxlet.2015.11.013
   Djordjevic N, 2008, EUR J CLIN PHARMACOL, V64, P381, DOI 10.1007/s00228-007-0438-6
   Djordjevic N, 2013, DRUG METAB PHARMACOK, V28, P93, DOI 10.2133/dmpk.DMPK-12-RG-029
   Djordjevic N, 2012, J CLIN PHARMACOL, V52, P1527, DOI 10.1177/0091270011420261
   Djordjevic N, 2011, J CLIN PHARMACOL, V51, P994, DOI 10.1177/0091270010377630
   Doepker C, 2016, ANNU REV FOOD SCI T, V7, P117, DOI 10.1146/annurev-food-041715-033243
   Domschke K, 2012, CURR PHARM DESIGN, V18, P5691, DOI 10.2174/138161212803530781
   Donovan J L, 2001, PSYCHOPHARMACOL BULL, V35, P30
   Dragicevic N, 2012, NEUROPHARMACOLOGY, V63, P1368, DOI 10.1016/j.neuropharm.2012.08.018
   EFSA, 2016, EFSA J, V14, P0, DOI 10.2903/j.efsa.2016.4404
   El Yacoubi M, 2005, EUR J PHARMACOL, V519, P290, DOI 10.1016/j.ejphar.2005.07.022
   EVANS SM, 1992, PSYCHOPHARMACOLOGY, V108, P51, DOI 10.1007/BF02245285
   Faber MS, 2004, CLIN PHARMACOL THER, V76, P178, DOI 10.1016/j.clpt.2004.04.003
   Facheris MF, 2008, MOVEMENT DISORD, V23, P2033, DOI 10.1002/mds.22247
   Ferré S, 2008, J NEUROCHEM, V105, P1067, DOI 10.1111/j.1471-4159.2007.05196.x
   Fillmore MT, 2002, J STUD ALCOHOL, V63, P745, DOI 10.15288/jsa.2002.63.745
   Frary CD, 2005, J AM DIET ASSOC, V105, P110, DOI 10.1016/j.jada.2004.10.027
   Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3
   Fredholm BB, 1999, PHARMACOL REV, V51, P83
   Freitag CM, 2010, EUR CHILD ADOLES PSY, V19, P67, DOI 10.1007/s00787-009-0043-6
   Fritz BM, 2014, ALCOHOL CLIN EXP RES, V38, P2269, DOI 10.1111/acer.12472
   FUHR U, 1995, INT J CLIN PHARM TH, V33, P311
   FUHR U, 1993, BRIT J CLIN PHARMACO, V35, P431, DOI 10.1111/j.1365-2125.1993.tb04162.x
   FUHR U, 1992, ANTIMICROB AGENTS CH, V36, P942, DOI 10.1128/AAC.36.5.942
   Gajewska A, 2013, PROG NEURO-PSYCHOPH, V40, P115, DOI 10.1016/j.pnpbp.2012.08.008
   Gasior M, 1996, PHARMACOL BIOCHEM BE, V54, P639, DOI 10.1016/0091-3057(95)02222-8
   Gasior M, 1998, EUR J PHARMACOL, V352, P207, DOI 10.1016/S0014-2999(98)00375-6
   Geiger MJ, 2016, EUR NEUROPSYCHOPHARM, V26, P1274, DOI 10.1016/j.euroneuro.2016.05.007
   GEORGE J, 1986, CLIN EXP PHARMACOL P, V13, P731, DOI 10.1111/j.1440-1681.1986.tb02414.x
   Gloria-Bottini F, 2011, HEALTH, V3, P77, DOI 10.4236/health.2011.32014
   Goldstein ER, 2010, J INT SOC SPORT NUTR, V7, P0, DOI 10.1186/1550-2783-7-5
   Gotoh L, 2002, MOL BRAIN RES, V100, P1, DOI 10.1016/S0169-328X(02)00136-5
   Gotoh L, 2009, PSYCHIAT GENET, V19, P328, DOI 10.1097/YPG.0b013e3283328e26
   Granfors MT, 2005, CLIN PHARMACOL THER, V78, P400, DOI 10.1016/j.clpt.2005.06.009
   Granfors MT, 2004, CLIN PHARMACOL THER, V76, P598, DOI 10.1016/j.clpt.2004.08.018
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso LM, 2008, ANN EPIDEMIOL, V18, P172, DOI 10.1016/j.annepidem.2007.11.005
   Grosso LM, 2005, ANN EPIDEMIOL, V15, P460, DOI 10.1016/j.annepidem.2004.12.011
   GU L, 1992, PHARMACOGENETICS, V2, P73, DOI 10.1097/00008571-199204000-00004
   Guo WC, 2004, ACTA PHARMACOL SIN, V25, P1112
   Gurley BJ, 2005, CLIN PHARMACOL THER, V77, P415, DOI 10.1016/j.clpt.2005.01.009
   Gurley BJ, 2004, CLIN PHARMACOL THER, V76, P428, DOI 10.1016/j.clpt.2004.07.007
   Gurley BJ, 2005, DRUG AGING, V22, P525, DOI 10.2165/00002512-200522060-00006
   Ha HR, 1996, EUR J CLIN PHARMACOL, V49, P309, DOI 10.1007/BF00226333
   Hamilton SP, 2004, NEUROPSYCHOPHARMACOL, V29, P558, DOI 10.1038/sj.npp.1300311
   Hamon-Vilcot B, 2004, THERAPIE, V59, P247, DOI 10.2515/therapie:2004048
   Hamza TH, 2011, PLOS GENET, V7, P0, DOI 10.1371/journal.pgen.1002237
   HASHIGUCHI M, 1992, J CLIN PHARMACOL, V32, P184, DOI 10.1002/j.1552-4604.1992.tb03824.x
   Hasko Gyorgy, 2011, HANDB EXP PHARMACOL, V0, PP457, DOI 10.1007/978-3-642-13443-2_18
   Heckman MA, 2010, J FOOD SCI, V75, PR77, DOI 10.1111/j.1750-3841.2010.01561.x
   Heinz AJ, 2013, EXP CLIN PSYCHOPHARM, V21, P222, DOI 10.1037/a0032337
   Hermann R, 2012, PLANTA MED, V78, P1458, DOI 10.1055/s-0032-1315117
   Hohoff C, 2009, J NEURAL TRANSM, V116, P659, DOI 10.1007/s00702-008-0089-5
   Hohoff C, 2010, J PSYCHIATR RES, V44, P930, DOI 10.1016/j.jpsychires.2010.02.006
   Howland J, 2011, ADDICTION, V106, P335, DOI 10.1111/j.1360-0443.2010.03219.x
   Huang ZL, 2005, NAT NEUROSCI, V8, P858, DOI 10.1038/nn1491
   Ishiguro H, 2006, NEUROPSYCHOPHARMACOL, V31, P572, DOI 10.1038/sj.npp.1300855
   Ishikawa T, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0102152
   Ito K, 2002, P NATL ACAD SCI USA, V99, P8921, DOI 10.1073/pnas.132556899
   Jan WC, 2005, J ETHNOPHARMACOL, V102, P440, DOI 10.1016/j.jep.2005.07.002
   Jankiewicz Katarzyna, 2007, PRZEGL LEK, V64, P965
   Jaquet M, 2009, INT J FOOD MICROBIOL, V130, P117, DOI 10.1016/j.ijfoodmicro.2009.01.011
   JARBOE CH, 1986, J TOXICOL-CLIN TOXIC, V24, P415, DOI 10.3109/15563658608992604
   Jeppesen U, 1996, PHARMACOGENETICS, V6, P213, DOI 10.1097/00008571-199606000-00003
   Jodynis-Liebert J, 2004, J CLIN PHARMACOL, V44, P338, DOI 10.1177/0091270004263468
   JOERES R, 1987, PHARMACOL THERAPEUT, V33, P163, DOI 10.1016/0163-7258(87)90046-5
   Johnson-Kozlow M, 2002, AM J EPIDEMIOL, V156, P842, DOI 10.1093/aje/kwf119
   Josse AR, 2012, AM J CLIN NUTR, V96, P665, DOI 10.3945/ajcn.112.038794
   Kalow W, 1986, PROG CLIN BIOL RES, V214, P331
   KALOW W, 1991, CLIN PHARMACOL THER, V50, P508, DOI 10.1038/clpt.1991.176
   KALOW W, 1991, CLIN PHARMACOL THER, V49, P44, DOI 10.1038/clpt.1991.8
   KAMIMIRO GH, 1987, EUR J CLIN PHARMACOL, V31, P595, DOI 10.1007/BF00606637
   Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521
   KHANNA NN, 1984, J TOXICOL-CLIN TOXIC, V22, P473, DOI 10.3109/15563658408992578
   Kinzig-Schippers M, 1999, CLIN PHARMACOL THER, V65, P262, DOI 10.1016/S0009-9236(99)70105-0
   Kobayashi H, 2010, BEHAV BRAIN FUNCT, V6, P0, DOI 10.1186/1744-9081-6-50
   LACHANCE MP, 1983, TOXICOL APPL PHARM, V71, P237, DOI 10.1016/0041-008X(83)90340-X
   Laitala VS, 2008, ADDICTION, V103, P2054, DOI 10.1111/j.1360-0443.2008.02375.x
   Lam P, 2005, NEUROSCI LETT, V378, P98, DOI 10.1016/j.neulet.2004.12.012
   Lampe JW, 2000, CARCINOGENESIS, V21, P1157, DOI 10.1093/carcin/21.6.1157
   Landi M T, 1999, IARC SCI PUBL, V0, P173
   LANE JD, 1992, EUR J CLIN PHARMACOL, V43, P543, DOI 10.1007/BF02285099
   Ledent C, 1997, NATURE, V388, P674, DOI 10.1038/41771
   LEE CA, 1991, DRUG METAB DISPOS, V19, P966
   LEE MA, 1988, AM J PSYCHIAT, V145, P632
   LELO A, 1986, BRIT J CLIN PHARMACO, V22, P183, DOI 10.1111/j.1365-2125.1986.tb05247.x
   LELO A, 1986, BRIT J CLIN PHARMACO, V22, P177, DOI 10.1111/j.1365-2125.1986.tb05246.x
   LeMarchand L, 1996, CANCER EPIDEM BIOMAR, V5, P449
   LeMarchand L, 1997, PHARMACOGENETICS, V7, P11, DOI 10.1097/00008571-199702000-00002
   Liang NJ, 2014, MOLECULES, V19, P19180, DOI 10.3390/molecules191119180
   Liguori A, 2001, DRUG ALCOHOL DEPEN, V63, P123, DOI 10.1016/S0376-8716(00)00196-4
   LOFT S, 1988, HUM TOXICOL, V7, P277, DOI 10.1177/096032718800700309
   Lovallo WR, 2005, PSYCHOSOM MED, V67, P734, DOI 10.1097/01.psy.0000181270.20036.06
   Lucas M, 2011, ARCH INTERN MED, V171, P1571, DOI 10.1001/archinternmed.2011.393
   Luciano M, 2005, ADDICTION, V100, P1510, DOI 10.1111/j.1360-0443.2005.01223.x
   Luszczki JJ, 2006, PHARMACOL REP, V58, P652
   MacKenzie T, 2007, METABOLISM, V56, P1694, DOI 10.1016/j.metabol.2007.07.013
   MARKS V, 1973, LANCET, V1, P827
   Matzke GR, 2000, PHARMACOTHERAPY, V20, P182, DOI 10.1592/phco.20.3.182.34775
   Mazzotti DR, 2011, SLEEP, V34, P399, DOI 10.1093/sleep/34.3.399
   McLean C, 2002, J APPL PHYSIOL, V93, P1471, DOI 10.1152/japplphysiol.00762.2000
   Molero Y, 2013, GENES BRAIN BEHAV, V12, P305, DOI 10.1111/gbb.12015
   Montesinos MC, 2000, ARTHRITIS RHEUM, V43, P656, DOI 10.1002/1529-0131(200003)43:3<656::AID-ANR23>3.0.CO;2-H
   MORAIDIS I, 1994, BRAIN RES, V640, P140, DOI 10.1016/0006-8993(94)91868-6
   MORISOT C, 1990, ARCH FR PEDIATR, V47, P221
   Mumford GK, 1996, EUR J CLIN PHARMACOL, V51, P319, DOI 10.1007/s002280050205
   Muscat JE, 2008, BIOCHEM PHARMACOL, V76, P929, DOI 10.1016/j.bcp.2008.07.024
   NADA AH, 1991, INT J PHARM, V70, P191, DOI 10.1016/0378-5173(91)90180-V
   NEHLIG A, 1986, EUR J PHARMACOL, V129, P93, DOI 10.1016/0014-2999(86)90340-7
   Nehlig A, 2004, NUTR BRAIN BEHAV, V0, P133
   Nehlig A, 2004, NUTR BRAIN BEHAV, V0, P165
   Nehlig A, 2010, J ALZHEIMERS DIS, V20, PS85, DOI 10.3233/JAD-2010-091315
   Nordestgaard AT, 2016, INT J EPIDEMIOL, V45, P1938, DOI 10.1093/ije/dyw325
   Nunes RA, 2017, SLEEP MED, V30, P210, DOI 10.1016/j.sleep.2016.06.038
   Palacios N, 2010, PARKINSONISM RELAT D, V16, P370, DOI 10.1016/j.parkreldis.2010.02.012
   Palacios N, 2012, MOVEMENT DISORD, V27, P1276, DOI 10.1002/mds.25076
   Panza F, 2015, J NUTR HEALTH AGING, V19, P313, DOI 10.1007/s12603-014-0563-8
   Park GJH, 2003, HEPATOLOGY, V38, P1227, DOI 10.1053/jhep.2003.50475
   PARSONS WD, 1978, CLIN PHARMACOL THER, V24, P40
   Persico AM, 2000, AM J MED GENET, V96, P784, DOI 10.1002/1096-8628(20001204)96:6<784::AID-AJMG18>3.3.CO;2-Z
   Perucca E, 2005, EPILEPSIA, V46, P31, DOI 10.1111/j.1528-1167.2005.463007.x
   Ping J, 2012, CHEM-BIOL INTERACT, V195, P68, DOI 10.1016/j.cbi.2011.11.001
   Pirastu N, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep31590
   Pollock BG, 1999, J CLIN PHARMACOL, V39, P936, DOI 10.1177/00912709922008560
   PONS G, 1988, PEDIATR RES, V23, P632, DOI 10.1203/00006450-198806000-00021
   Popat RA, 2011, EUR J NEUROL, V18, P756, DOI 10.1111/j.1468-1331.2011.03353.x
   Posadzki P, 2013, BRIT J CLIN PHARMACO, V75, P603, DOI 10.1111/j.1365-2125.2012.04350.x
   Qi H, 2014, GERIATR GERONTOL INT, V14, P430, DOI 10.1111/ggi.12123
   Qi LW, 2011, CURR DRUG METAB, V12, P818, DOI 10.2174/138920011797470128
   Raaska K, 2004, BASIC CLIN PHARMACOL, V94, P13, DOI 10.1111/j.1742-7843.2004.pto_940104.x
   Rasmussen BB, 2002, PHARMACOGENETICS, V12, P473, DOI 10.1097/00008571-200208000-00008
   Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023
   Rétey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102
   Rétey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102
   Rieth N, 2016, ENDOCRINE, V52, P391, DOI 10.1007/s12020-015-0780-x
   RIETVELD EC, 1984, EUR J CLIN PHARMACOL, V26, P371, DOI 10.1007/BF00548769
   Ritchie K, 2007, NEUROLOGY, V69, P536, DOI 10.1212/01.wnl.0000266670.35219.0c
   Rocha L, 1999, PHARMACOGENETICS, V9, P9
   Rogers PJ, 2010, NEUROPSYCHOPHARMACOL, V35, P1973, DOI 10.1038/npp.2010.71
   Roncucci R, 1982, WORLD REV NUTR DIET, V43, P140
   Rupp TL, 2013, J SLEEP RES, V22, P160, DOI 10.1111/j.1365-2869.2012.01062.x
   Sachse C, 1999, BRIT J CLIN PHARMACO, V47, P445, DOI 10.1046/j.1365-2125.1999.00898.x
   Salinero JJ, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9030269
   Santos C, 2010, J ALZHEIMERS DIS, V20, PS175, DOI 10.3233/JAD-2010-091303
   Santos RMM, 2016, P 26 ASIC C KUNM CHI, V0, P0
   Saruwatari J, 2002, CLIN PHARMACOL THER, V72, P200, DOI 10.1067/mcp.2002.126173
   Saruwatari J, 2014, BASIC CLIN PHARMACOL, V115, P360, DOI 10.1111/bcpt.12224
   Sasaki S, 2017, PEDIATR RES, V82, P19, DOI 10.1038/pr.2017.70
   Schmider J, 1999, PHARMACOGENETICS, V9, P725, DOI 10.1097/01213011-199912000-00007
   SCOTT NR, 1988, CLIN SCI, V74, P377, DOI 10.1042/cs0740377
   SCOTT NR, 1986, BRIT J CLIN PHARMACO, V22, P475, DOI 10.1111/j.1365-2125.1986.tb02920.x
   Sebastiao AM, 2011, BBA-BIOMEMBRANES, V1808, P1340, DOI 10.1016/j.bbamem.2010.06.028
   Shirley KL, 2003, NEUROPSYCHOPHARMACOL, V28, P961, DOI 10.1038/sj.npp.1300123
   Shulman LM, 2002, PARKINSONISM RELAT D, V8, P289, DOI 10.1016/S1353-8020(02)00014-7
   Signorello LB, 2001, OBSTET GYNECOL, V98, P1059, DOI 10.1016/S0029-7844(01)01575-7
   Silva CG, 2013, SCI TRANSL MED, V5, P0, DOI 10.1126/scitranslmed.3006258
   Simon DK, 2017, J NEUROL SCI, V375, P355, DOI 10.1016/j.jns.2017.02.032
   Smith A, 2002, FOOD CHEM TOXICOL, V40, P1243, DOI 10.1016/S0278-6915(02)00096-0
   Snel J, 1993, COFFEE CAFFEINE HLTH, V0, P255
   SOMANI SM, 1980, J PEDIATR-US, V96, P1091, DOI 10.1016/S0022-3476(80)80652-4
   SOTO J, 1994, THER DRUG MONIT, V16, P49, DOI 10.1097/00007691-199402000-00008
   Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086
   Svenningsson P, 1999, J NEUROSCI, V19, P4011
   Swan GE, 1996, J SUBST ABUSE, V8, P19, DOI 10.1016/S0899-3289(96)90055-3
   Swanson JA, 1997, ADDICT BEHAV, V22, P55, DOI 10.1016/S0306-4603(96)00023-8
   Tan EK, 2006, AM J MED GENET B, V141B, P634, DOI 10.1002/ajmg.b.30359
   TANAKA H, 1984, BRAIN DEV-JPN, V6, P355, DOI 10.1016/S0387-7604(84)80111-4
   Tang JL, 2007, FOOD CHEM TOXICOL, V45, P2441, DOI 10.1016/j.fct.2007.05.023
   Tang W, 2011, HANDBOOK OF CHINESE MEDICINAL PLANTS CHEMISTRY, V0, PPHARMACOLOGY
   TANGLIU DD, 1983, J PHARMACOL EXP THER, V224, P180
   Tantcheva-Poór I, 1999, PHARMACOGENETICS, V9, P131
   TRAGANOS F, 1991, CELL PROLIFERAT, V24, P305, DOI 10.1111/j.1365-2184.1991.tb01159.x
   TRANG JM, 1985, BIOPHARM DRUG DISPOS, V6, P51, DOI 10.1002/bdd.2510060107
   Tsai HH, 2012, INT J CLIN PRACT, V66, P1056, DOI 10.1111/j.1742-1241.2012.03008.x
   Tsai TH, 2005, PLANTA MED, V71, P640, DOI 10.1055/s-2005-871270
   Tsutsumi K, 2001, CLIN PHARMACOL THER, V70, P121, DOI 10.1067/mcp.2001.116495
   TURMEN T, 1979, J PEDIATR-US, V95, P644, DOI 10.1016/S0022-3476(79)80788-X
   Urry E, 2016, NUTR METAB, V13, P0, DOI 10.1186/s12986-016-0126-6
   Vanattou-Saïfoudine N, 2012, BRIT J PHARMACOL, V167, P946, DOI 10.1111/j.1476-5381.2012.02065.x
   Vaz Julius, 1998, INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, V36, P112
   VISTISEN K, 1991, ADV EXP MED BIOL, V283, P407
   VISTISEN K, 1992, CARCINOGENESIS, V13, P1561, DOI 10.1093/carcin/13.9.1561
   Walton K, 2001, FOOD CHEM TOXICOL, V39, P667, DOI 10.1016/S0278-6915(01)00006-0
   Walzer M, 2012, PHARMACOTHERAPY, V32, P340, DOI 10.1002/j.1875-9114.2012.01028.x
   Watson J, 2002, BRIT J CLIN PHARMACO, V54, P400, DOI 10.1046/j.1365-2125.2002.01681.x
   Wedick NM, 2012, NUTR J, V11, P0, DOI 10.1186/1475-2891-11-86
   Welfare MR, 2000, BRIT J CLIN PHARMACO, V49, P240, DOI 10.1046/j.1365-2125.2000.00130.x
   Whitfield K, 2009, COCHRANE DB SYST REV, V0, P0, DOI DOI 10.1002/14651858.CD007339.pub2
   Whitten DL, 2006, BRIT J CLIN PHARMACO, V62, P512, DOI 10.1111/j.1365-2125.2006.02755.x
   WLAZ P, 1992, J NEURAL TRANSM-GEN, V89, P41, DOI 10.1007/BF01245350
   Xu HB, 2005, BRIT J PHARMACOL, V146, P296, DOI 10.1038/sj.bjp.0706319
   Xu K, 2006, J NEUROSCI, V26, P535, DOI 10.1523/JNEUROSCI.3008-05.2006
   Yamada-Fowler Naomi, 2015, JOURNAL OF CAFFEINE RESEARCH, V5, P3, DOI 10.1089/jcr.2014.0028
   Yamada-Fowler N, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0099294
   Yamazaki T, 2017, CLIN PHARM DRUG DEV, V6, P54, DOI 10.1002/cpdd.281
   Yang A, 2010, PSYCHOPHARMACOLOGY, V211, P245, DOI 10.1007/s00213-010-1900-1
   Yu T, 2016, J CLIN PHARMACOL, V56, P590, DOI 10.1002/jcph.632
   Zandvliet AS, 2005, BASIC CLIN PHARMACOL, V96, P71, DOI 10.1111/j.1742-7843.2005.pto960111.x
   Zuchinali P, 2016, EUROPACE, V18, P257, DOI 10.1093/europace/euv261
   Zuchora B, 2005, EUR NEUROPSYCHOPHARM, V15, P85, DOI 10.1016/j.euroneuro.2004.05.006
NR 282
TC 338
Z9 360
U1 17
U2 158
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0031-6997
EI 1521-0081
J9 PHARMACOL REV
JI Pharmacol. Rev.
PD APR 15
PY 2018
VL 70
IS 2
BP 384
EP 411
DI 10.1124/pr.117.014407
PG 28
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GL2TS
UT WOS:000436978700001
PM 29514871
DA 2025-04-28
ER

PT J
AU Bustos, AS
   Håkansson, A
   Linares-Pastén, JA
   Penarrieta, JM
   Nilsson, L
AF Bustos, Atma-Sol
   Hakansson, Andreas
   Linares-Pasten, Javier A.
   Penarrieta, Jose M.
   Nilsson, Lars
TI Interaction Between Phenolic Compounds and Lipase: The Influence of Solubility and Presence of Particles in the IC50 Value
SO JOURNAL OF FOOD SCIENCE
LA English
DT Article
DE inhibition; lipase; particles; phenols; reproducibility
ID pancreatic lipase; tea polyphenols; in-vitro; inhibitory-activity; green tea; water; flavonoids; behavior; obesity
AB Obesity is one of the principal human health problems and one of the main treatments against it is the inhibition of pancreatic lipase, the main responsible enzyme of lipid digestion. For that purpose, previous studies have tested several phenolic compounds against lipase, without considering their aggregation behavior in aqueous solutions. Because of this, the present study focuses on understanding how the solubility and the presence of particles affect the IC50 value of the interaction between lipase and phenolic compounds present in beverages like fruit juices and teas. Therefore, the inhibitory capacity against pancreatic lipase and the aggregate formation of 9 phenolic compounds (quercetin, rutin, myricetin, catechin, epigallocatechin gallate, cyanidin, caffeic acid, chlorogenic acid, and vanillic acid) were analyzed. The results obtained together with the solubility data from literature were treated by principal component analysis and indicate that the IC50 value does not correlate with the solubility or aggregate formation of the phenolic compounds. However, the IC50 values of phenolic compounds which aggregate during the assay conditions have low reproducibility. This study shows that the aggregate formation of phenolic compounds plays an important role during in vitro assays for pancreatic lipase inhibition and should be considered in future experiments as it can lead to false positive results. In terms of particle formation, the flavonoids investigated in this study are more prone to aggregation compared to the phenolic acids.
C1 [Bustos, Atma-Sol; Hakansson, Andreas; Nilsson, Lars] Lund Univ, Fac Engn LTH, Food Technol, POB 124, S-22100 Lund, Sweden.
   [Bustos, Atma-Sol; Penarrieta, Jose M.] Univ Mayor San Andres, Fac Pure & Nat Sci, Sch Chem, POB 303, La Paz, Bolivia.
   [Hakansson, Andreas] Kristianstad Univ, Food & Meal Sci, POB 15, S-29181 Kristianstad, Sweden.
   [Linares-Pasten, Javier A.] Lund Univ, Fac Engn LTH, Biotechnol, POB 117, S-22100 Lund, Sweden.
C3 Lund University; Universidad Mayor de San Andres; Kristianstad University; Lund University
RP Bustos, AS (corresponding author), Lund Univ, Fac Engn LTH, Food Technol, POB 124, S-22100 Lund, Sweden.; Bustos, AS (corresponding author), Univ Mayor San Andres, Fac Pure & Nat Sci, Sch Chem, POB 303, La Paz, Bolivia.
EM atma-sol.bustos@food.lth.se
FU Swedish Int. Development Agency (SIDA)
CR Unknown -, 2014, OB OV, V0, P0
   Birari RB, 2007, DRUG DISCOV TODAY, V12, P879, DOI 10.1016/j.drudis.2007.07.024
   Buchholz T, 2015, PLANTA MED, V81, P771, DOI 10.1055/s-0035-1546173
   Cha KH, 2012, J AGR FOOD CHEM, V60, P7152, DOI 10.1021/jf301047f
   Guerciolini R, 1997, INT J OBESITY, V21, P0
   Haminiuk CharlesWI, 2012, FOOD SCIENCE AND TECHNOLOGY - 47, V0, P2023
   HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381
   Hong C, 2014, INT J PHARMACEUT, V477, P251, DOI 10.1016/j.ijpharm.2014.10.044
   Kfoury M, 2016, FOOD CHEM, V196, P518, DOI 10.1016/j.foodchem.2015.09.078
   Li YF, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep34387
   Lunagariya NA, 2014, EXCLI J, V13, P897
   McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Noubigh A, 2007, J CHEM THERMODYN, V39, P297, DOI 10.1016/j.jct.2006.06.014
   OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560
   Peng B, 2009, J CHEM ENG DATA, V54, P1378, DOI 10.1021/je800816f
   Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774
   Sergent T, 2012, FOOD CHEM, V135, P68, DOI 10.1016/j.foodchem.2012.04.074
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   SHIMURA S, 1994, J JPN SOC FOOD SCI, V41, P847
   Sigma Aldrich, 2017, EP GALL, V0, P0
   Srinivas K, 2010, J CHEM ENG DATA, V55, P3101, DOI 10.1021/je901097n
   Sugiyama H, 2007, J AGR FOOD CHEM, V55, P4604, DOI 10.1021/jf070569k
   Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z
   Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7
   You Q, 2011, J AGR FOOD CHEM, V59, P9506, DOI 10.1021/jf201452v
   Yuda N, 2012, J FOOD SCI, V77, PH254, DOI 10.1111/j.1750-3841.2012.02967.x
   Zhang CT, 2018, J FUNCT FOODS, V40, P729, DOI 10.1016/j.jff.2017.12.019
   Zhang KX, 2016, FITOTERAPIA, V113, P102, DOI 10.1016/j.fitote.2016.07.008
NR 29
TC 23
Z9 27
U1 2
U2 45
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-1147
EI 1750-3841
J9 J FOOD SCI
JI J. Food Sci.
PD AUG 15
PY 2018
VL 83
IS 8
BP 2071
EP 2076
DI 10.1111/1750-3841.14217
PG 6
WC Food Science & Technology
SC Food Science & Technology
GA GQ0EV
UT WOS:000441290500008
PM 30020550
DA 2025-04-28
ER

PT J
AU Vanderlee, L
   Reid, JL
   White, CM
   Hobin, EP
   Acton, RB
   Jones, AC
   O'Neill, M
   Kirkpatrick, SI
   Hammond, D
AF Vanderlee, Lana
   Reid, Jessica L.
   White, Christine M.
   Hobin, Erin P.
   Acton, Rachel B.
   Jones, Amanda C.
   O'Neill, Meghan
   Kirkpatrick, Sharon I.
   Hammond, David
TI Evaluation of the online Beverage Frequency Questionnaire (BFQ)
SO NUTRITION JOURNAL
LA English
DT Article
DE Relative validity; Sugary drinks; Sugar sweetened beverages; Dietary assessment; Food frequency screener
ID sugar-sweetened beverages; body-mass index; alcohol-consumption; weight-gain; food records; adults; risk; obesity; energy; biomarker
AB Background: The contribution of beverages to overall diet is of increasing interest to researchers and policymakers, particularly in terms of consumption of drinks high in added sugars; however, few tools to assess beverage intake have been developed and evaluated. This study aimed to evaluate the relative validity of a new online Beverage Frequency Questionnaire (BFQ) among young adults in Canada. Methods: A cross-sectional relative validation study was conducted among young adults aged 16-30 years (n = 50). Participants completed a 17-item BFQ, a 7-day food record (7dFR), and a single-item measure of sugary drink intake. Pearson correlations and paired t-tests were used to evaluate correlation and agreement between the measures for 17 individual beverage categories, total drink consumption, total alcoholic beverage consumption, and two definitions of drinks with excess sugars. Cognitive interviews were conducted to examine participant interpretation and comprehensiveness of the BFQ. Results: Estimates of beverage intake based on the BFQ and the 7dFR were highly correlated, specifically for the total number and volume of beverages consumed, total alcoholic beverage consumption, sugary drink intake, and each of the 17 beverage categories with 3 exceptions: coffee or tea with sugar or cream, specialty coffees, and hard alcohol with caloric mix. Paired t-tests between the BFQ and the 7dFR indicated that the average reported volume was significantly different only for sweetened fruit drinks. The single-item measure of sugary beverage intake was not significantly correlated with the 7dFR. Cognitive interviewing demonstrated high comprehension levels, and confirmed the appropriateness of the BFQ beverage categories and sizes. Conclusions: Overall, the results suggest that the BFQ performed well relative to a 7dFR and had high usability among this study population, indicating its promise for collecting population-level data on beverage intake, including sugar-sweetened beverages, which are known indicators of diet and health.
C1 [Vanderlee, Lana; Hobin, Erin P.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.
   [Vanderlee, Lana; Reid, Jessica L.; White, Christine M.; Acton, Rachel B.; Jones, Amanda C.; O'Neill, Meghan; Kirkpatrick, Sharon I.; Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave W, Waterloo, ON, Canada.
   [Hobin, Erin P.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Hobin, Erin P.; O'Neill, Meghan] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
C3 University of Toronto; University of Waterloo; Public Health Ontario; University of Toronto
RP Hammond, D (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave W, Waterloo, ON, Canada.
EM dhammond@uwaterloo.ca
FU Public Health Agency of Canada (PHAC); PHAC - Canadian Institutes of Health Research (CIHR) Chair in Applied Public Health
CR Auerbach BJ, 2017, PEDIATRICS, V139, P0, DOI 10.1542/peds.2016-2454
   Battista K, 2017, HEALTH PROMOT CHRON, V37, P194, DOI 10.24095/hpcdp.37.6.03
   Beasley JM, 2016, PUBLIC HEALTH NUTR, V19, P3256, DOI 10.1017/S1368980016001580
   Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1
   Falbe J, 2016, AM J PUBLIC HEALTH, V106, P1865, DOI 10.2105/AJPH.2016.303362
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Garriguet Didier, 2008, HEALTH REP, V19, P23
   Garriguet Didier, 2008, HEALTH REP, V19, P17
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hedrick VE, 2012, J ACAD NUTR DIET, V112, P840, DOI 10.1016/j.jand.2012.01.023
   Hedrick VE, 2010, J AM DIET ASSOC, V110, P1227, DOI 10.1016/j.jada.2010.05.005
   Kipnis V, 2003, AM J EPIDEMIOL, V158, P14, DOI 10.1093/aje/kwg091
   Kodama S, 2014, OBES REV, V15, P202, DOI 10.1111/obr.12129
   Langlois Kellie, 2011, HEALTH REP, V22, P23
   Lauby-Secretan B, 2016, NEW ENGL J MED, V375, P794, DOI 10.1056/NEJMsr1606602
   Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X
   Malik VS, 2006, AM J CLIN NUTR, V84, P274
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/BMJ.E7492
   Nelson MC, 2009, J AM DIET ASSOC, V109, P730, DOI 10.1016/j.jada.2008.12.027
   Nissensohn M, 2013, INT J FOOD SCI NUTR, V64, P801, DOI 10.3109/09637486.2013.801406
   OConnor TM, 2006, PEDIATRICS, V118, PE1010, DOI 10.1542/peds.2005-2348
   Park S, 2014, PREV CHRONIC DIS, V11, P0, DOI 10.5888/pcd11.130304
   Popkin BM, 2015, ADV NUTR, V6, P625, DOI 10.3945/an.115.008425
   Prentice RL, 2011, AM J EPIDEMIOL, V174, P591, DOI 10.1093/aje/kwr140
   Rebro SM, 1998, J AM DIET ASSOC, V98, P1163, DOI 10.1016/S0002-8223(98)00269-7
   Sayon-Orea C, 2011, NUTR REV, V69, P419, DOI 10.1111/j.1753-4887.2011.00403.x
   Singh GM, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0065174
   Subar AF, 2003, AM J EPIDEMIOL, V158, P1, DOI 10.1093/aje/kwg092
   Subar AF, 2012, J ACAD NUTR DIET, V112, P1134, DOI 10.1016/j.jand.2012.04.016
   Tasevska N, 2015, NUTRIENTS, V7, P5816, DOI 10.3390/nu7075255
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   Traversy G, 2015, CURR OBES REP, V4, P122, DOI 10.1007/s13679-014-0129-4
   Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4
   Xi B, 2015, BRIT J NUTR, V113, P709, DOI 10.1017/S0007114514004383
   Yeomans MR, 2010, PHYSIOL BEHAV, V100, P82, DOI 10.1016/j.physbeh.2010.01.012
NR 40
TC 21
Z9 21
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1475-2891
J9 NUTR J
JI Nutr. J.
PD AUG 1
PY 2018
VL 17
IS 
BP 
EP 
DI 10.1186/s12937-018-0380-8
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GO9TU
UT WOS:000440451300001
PM 30068342
DA 2025-04-28
ER

PT J
AU Stajic, D
   Popovic, B
   Cpajak, M
   Ribaric, S
   Djonovic, N
AF Stajic, Dalibor
   Popovic, Bojana
   Cpajak, Mijan
   Ribaric, Senka
   Djonovic, Nela
TI Is there an association between nutritional status an d intellectual capabilities of adolescents?
SO PROGRESS IN NUTRITION
LA English
DT Article
DE adolescents; eating habits; nutritional status; intellectual capabilities; academic achievement
ID body-mass index; physical-activity; life-style; metabolic syndrome; academic-achievement; sedentary behavior; dietary habits; eating habits; intelligence; weight
AB The aim of this study was to investigate the correlations among lifestyles, eating habits, nutritional status and intellectual capabilities of adolescents. A cross-sectional study was carried out using anthropometric measurements and standardized food questionnaire. The sample consisted of 151 adolescents attending a secondary school in central Serbia. Academic achievement was estimated through grade point average (GPA) in the previous academic year. Intellectual capabilities were expressed through intelligence quotient (IQ) determined by Cybernetic battery of intelligence (KOG 3). Totally, 14.5% of students were categorized as overweight or obese. No strong correlation was found between specific dietary habits and nutritional status of adolescents. The percentage of respondents with IQ>110 was higher in the group with increased body mass index (BMI percentile>85) compared to that in the group with normal body weight or underweight (38.5% vs. 15.7%). Besides, 16.7% of students with BMI percentile<85 and only 7.7% of students with BMI percentile>85 had IQ<90. However, Spearman con-elation coefficient indicated no strong correlation between IQ test results and students' BMI (rho=0.144). On the other hand, students with lower academic performance (GPA<3.5) were more prone to certain dietary habits such as frequent consumptions of coffee (p=0.002) and fast food (p=0.044). On the contrary, sedentary lifestyles were rather typical for adolescents with better academic achievements GPA>3.5 (p=0.009). A significant correlation was found between students' IQ and height (Spearman's p=0.352). Although there was no strong correlation between intellectual capabilities and nutritional status of adolescents, certain eating habits and lifestyles might be associated with intellectual performance.
C1 [Stajic, Dalibor] Univ Kragujevac, Fac Med Sci, Dept Hyg & Ecol, Svetozara Markovica 69, Kragujevac 34000, Serbia.
   [Popovic, Bojana] First Tech Sch, Kragujevac, Serbia.
   [Cpajak, Mijan] Inst Neonatol, Belgrade, Serbia.
   [Ribaric, Senka] Clin Ctr Kragujevac, Kragujevac, Serbia.
   [Djonovic, Nela] Inst Publ Hlth, Kragujevac, Serbia.
C3 University of Kragujevac
RP Stajic, D (corresponding author), Univ Kragujevac, Fac Med Sci, Dept Hyg & Ecol, Svetozara Markovica 69, Kragujevac 34000, Serbia.
EM stajicdalibor@yahoo.com
CR Adesina AF, 2012, ITAL J PEDIATR, V38, P0, DOI 10.1186/1824-7288-38-31
   Unknown -, 2007, GROWTH REFERENCE DATA FOR 5-19 YEARS, V0, P0
   Ayranci U, 2010, NUTRITION, V26, P772, DOI 10.1016/j.nut.2009.07.007
   Beauchamp JP, 2011, BEHAV GENET, V41, P242, DOI 10.1007/s10519-010-9376-7
   Burrows T, 2017, J HUM NUTR DIET, V30, P117, DOI 10.1111/jhn.12407
   Calderon LL, 2004, J AM DIET ASSOC, V104, P1369, DOI 10.1016/j.jada.2004.06.017
   Correa-Burrows P, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9050433
   Cournot M, 2006, NEUROLOGY, V67, P1208, DOI 10.1212/01.wnl.0000238082.13860.50
   Dehghan M, 2005, NUTR J, V4, P0, DOI 10.1186/1475-2891-4-24
   Dziemidok P, 2011, ANN AGR ENV MED, V18, P318
   Freidl EK, 2013, SURG OBES RELAT DIS, V9, P991, DOI 10.1016/j.soard.2013.04.018
   Gallagher D, 2000, AM J CLIN NUTR, V72, P694, DOI 10.1093/ajcn/72.3.694
   Garcia-Continente X, 2015, AN PEDIATR, V83, P3, DOI 10.1016/j.anpedi.2014.07.006
   Harris MA, 2016, BMC GERIATR, V16, P0, DOI 10.1186/s12877-016-0340-0
   Hung HC, 2004, JNCI-J NATL CANCER I, V96, P1577, DOI 10.1093/jnci/djh296
   Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488
   Janssen I, 2005, OBES REV, V6, P123, DOI 10.1111/j.1467-789X.2005.00176.x
   Janszky I, 2011, ANN AGR ENV MED, V18, P270
   Kanazawa S, 2014, CURR OPIN ENDOCRINOL, V21, P339, DOI 10.1097/MED.0000000000000091
   Kanazawa S, 2009, AM J PSYCHOL, V122, P527
   Kapka-Skrzypczak L, 2012, ANN AGR ENV MED, V19, P299
   Karmakar T, 2016, AM J ED RES, V4, P1145
   KARP R, 1992, CLIN PEDIATR, V31, P336, DOI 10.1177/000992289203100604
   Keski-Rahkonen A, 2003, EUR J CLIN NUTR, V57, P842, DOI 10.1038/sj.ejcn.1601618
   Krupp D, 2015, EUR J NUTR, V54, P1269, DOI 10.1007/s00394-014-0804-y
   Leitzmann M, 2015, CANCER EPIDEMIOL, V39, PS46, DOI 10.1016/j.canep.2015.03.009
   León-Latre M, 2014, REV ESP CARDIOL, V67, P449, DOI 10.1016/j.rec.2013.10.015
   LI X, 1995, INT J OBESITY, V19, P355
   Lobstein T, 2003, OBES REV, V4, P195, DOI 10.1046/j.1467-789X.2003.00116.x
   MacCann C, 2013, INT J OBESITY, V37, P40, DOI 10.1038/ijo.2012.47
   Marioni RE, 2014, BEHAV GENET, V44, P91, DOI 10.1007/s10519-014-9644-z
   Maruf Fatai A, 2013, TANZAN J HEALTH RES, V15, P247
   McCarthy HD, 2006, INT J OBESITY, V30, P598, DOI 10.1038/sj.ijo.0803232
   Monneuse MO, 1997, EUR J CLIN NUTR, V51, P46, DOI 10.1038/sj.ejcn.1600361
   Musaiger AO, 2014, ANN AGR ENV MED, V21, P416, DOI 10.5604/1232-1966.1108616
   Must A, 2005, INT J OBESITY, V29, PS84, DOI 10.1038/sj.ijo.0803064
   Nield L, 2016, J HUM NUTR DIET, V29, P669, DOI 10.1111/jhn.12392
   Nikolic M, 2015, BRIT J GEN PRACT, V65, P451, DOI 10.3399/bjgp15X686449
   Ogechi UP, 2007, PAKISTAN JOURNAL OF NUTRITION, V6, P641
   Phan TLT, 2013, SURG OBES RELAT DIS, V9, P574, DOI 10.1016/j.soard.2012.08.009
   Radjen SD, 2011, AVIAT SPACE ENVIR MD, V82, P622, DOI 10.3357/ASEM.2981.2011
   Rampersaud GC, 2005, J AM DIET ASSOC, V105, P743, DOI 10.1016/j.jada.2005.02.007
   Rogol AD, 2002, J ADOLESCENT HEALTH, V31, P192, DOI 10.1016/S1054-139X(02)00485-8
   Szajewska H, 2010, CRIT REV FOOD SCI, V50, P113, DOI 10.1080/10408390903467514
   Taki Y, 2008, OBESITY, V16, P119, DOI 10.1038/oby.2007.4
   Timlin MT, 2008, PEDIATRICS, V121, PE638, DOI 10.1542/peds.2007-1035
   Vereecken CA, 2005, BRIT J NUTR, V94, P423, DOI 10.1079/BJN20051513
   WILLIAMS CL, 1995, PEDIATRICS, V96, P985
   Wing RR, 1999, MED SCI SPORT EXER, V31, PS547, DOI 10.1097/00005768-199911001-00010
   Wolf B, 1992, KOG 3 - BATERIJA TESTOVA INTELIGENCIJE, V0, P0
   World Health Organization, 2015, FACT SHEET 5 CHILDH, V0, P0
   World Health Organization/ UNICEF, 1995, PICT HLTH REV ANN BI, V0, P0
   Yates KF, 2012, ARTERIOSCL THROM VAS, V32, P2060, DOI 10.1161/ATVBAHA.112.252759
   Yu ZB, 2010, OBES REV, V11, P656, DOI 10.1111/j.1467-789X.2009.00656.x
   Zametkin AJ, 2004, J AM ACAD CHILD PSY, V43, P134, DOI 10.1097/00004583-200402000-00008
   2012, 1900, V27, V0, PP647, DOI 10.1007/S10654-012-9713-7
NR 56
TC 0
Z9 0
U1 0
U2 3
PU MATTIOLI 1885
PI FIDENZA
PA VIA DELLA LODESANA 649-SX, FIDENZA, 43046 PR, ITALY
SN 1129-8723
EI 
J9 PROG NUTR
JI Prog. Nutr.
PD DEC 15
PY 2018
VL 20
IS 
BP 279
EP 289
DI 10.23751/pn.v20i2-S.6166
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HY0RW
UT WOS:000467821100033
DA 2025-04-28
ER

PT J
AU Godin, KM
   Hammond, D
   Chaurasia, A
   Leatherdale, ST
AF Godin, Katelyn M.
   Hammond, David
   Chaurasia, Ashok
   Leatherdale, Scott T.
TI Examining changes in school vending machine beverage availability and sugar-sweetened beverage intake among Canadian adolescents participating in the COMPASS study: a longitudinal assessment of provincial school nutrition policy compliance and effectiveness
SO INTERNATIONAL JOURNAL OF BEHAVIORAL NUTRITION AND PHYSICAL ACTIVITY
LA English
DT Article
DE School nutrition policy; Sugar-sweetened beverages; Canada; Adolescents; Schools; Vending machines; Longitudinal study; Dietary assessment
ID food environment; soft drink; consumption; children; associations; caffeine; obesity; risk; interventions; behaviors
AB BackgroundSchool nutrition policies can encourage restrictions in sugar-sweetened beverage (SSB) availability in school food outlets in order to discourage students' SSB intake. The main objective was to examine how beverage availability in school vending machines changes over three school years across schools in distinct school nutrition policy contexts. Secondary objectives were to examine how students' weekday SSB intake varies with time and identify longitudinal associations between beverage availability and SSB intake.MethodsThis longitudinal study used data from the COMPASS study (2013/14-2015/16), representing 7679 students from 78 Canadian secondary schools and three provincial school nutrition policy contexts (Alberta - voluntary guidelines, Ontario public - mandatory guidelines, and Ontario private schools - no guidelines). We assessed availability of 10 beverage categories in schools' vending machines via the COMPASS School Environment Application and participants' intake of three SSB varieties (soft drinks, sweetened coffees/teas, and energy drinks) via a questionnaire. Hierarchical regression models were used to examine whether: i) progression of time and policy group were associated with beverage availability; and, ii) beverage availability was associated with students' SSB intake.ResultsOntario public schools were significantly less likely than the other policy groups to serve SSBs in their vending machines, with the exception of flavoured milks. Vending machine beverage availability was consistent over time. Participants' overall SSB intake remained relatively stable; reductions in soft drink intake were partially offset by increased sweetened coffee/tea consumption. Relative to Ontario public schools, attending school in Alberta was associated with more frequent energy drink intake and overall SSB intake whereas attending an Ontario private school was associated with less frequent soft drink intake, with no differences in overall SSB intake. Few beverage availability variables were significantly associated with participants' SSB intake.ConclusionsMandatory provincial school nutrition policies were predictive of more limited SSB availability in school vending machines. SSB intake was significantly lower in Ontario public and private schools, although we did not detect a direct association between SSB consumption and availability. The findings provide support for mandatory school nutrition policies, as well as the need for comprehensive school- and broader population-level efforts to reduce SSB intake.
C1 [Godin, Katelyn M.; Hammond, David; Chaurasia, Ashok; Leatherdale, Scott T.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
C3 University of Waterloo
RP Godin, KM (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, 200 Univ Ave West, Waterloo, ON N2L 3G1, Canada.
EM kmgodin@uwaterloo.ca
FU Canadian Institutes of Health Research (CIHR) Institute of Nutrition, Metabolism and Diabetes [OOP-110788]; CIHR Institute of Population and Public Health (IPPH) [MOP-114875]; Public Health Agency of Canada; CIHR Institute of Neurosciences, Mental Health and Addiction; IPPH
CR Ambrosini GL, 2013, AM J CLIN NUTR, V98, P327, DOI 10.3945/ajcn.112.051383
   Unknown -, 2018, CANMAP ROUT ENH POIN, V0, P0
   Unknown -, 2006, GUID SUPP SUCC TRANS, V0, P0
   Apparicio P, 2007, INT J HEALTH GEOGR, V6, P0, DOI 10.1186/1476-072X-6-4
   Austin SB, 2005, AM J PUBLIC HEALTH, V95, P1575, DOI 10.2105/AJPH.2004.056341
   Berman ER, 2015, AM J PUBLIC HEALTH, V105, P1404, DOI 10.2105/AJPH.2015.302593
   Branum AM, 2014, PEDIATRICS, V133, P386, DOI 10.1542/peds.2013-2877
   Bremer AA, 2010, J NUTR METAB, V2010, P0, DOI 10.1155/2010/196476
   Brown RJ, 2010, INT J PEDIATR OBES, V5, P305, DOI 10.3109/17477160903497027
   Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005
   Driessen CE, 2014, OBES REV, V15, P968, DOI 10.1111/obr.12224
   Finkelstein E, 2004, AM J PREV MED, V27, P163, DOI 10.1016/j.amepre.2004.06.017
   Frary CD, 2004, J ADOLESCENT HEALTH, V34, P56, DOI 10.1016/S1054-139X(03)00248-9
   Fung C, 2013, PREV MED, V57, P934, DOI 10.1016/j.ypmed.2013.07.016
   Garriguet Didier, 2008, HEALTH REP, V19, P17
   Godin KM, 2019, PUBLIC HEALTH NUTR, V22, P1928, DOI 10.1017/S1368980018001246
   Godin KM, 2017, PUBLIC HEALTH NUTR, V20, P2980, DOI 10.1017/S1368980017001926
   Godin KM, 2017, CAN J DIET PRACT RES, V78, P92, DOI 10.3148/cjdpr-2016-037
   Han E, 2013, J ACAD NUTR DIET, V113, P43, DOI 10.1016/j.jand.2012.09.016
   Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036
   Huang C, 2009, PREV CHRONIC DIS, V6, P0
   Imamura F, 2016, BRIT J SPORT MED, V50, P496, DOI 10.1136/bjsports-2016-h3576rep
   Jones AC, 2017, HLTH EC IMPACTS TAX, V0, P0
   Jones NR, 2010, HEALTH PLACE, V16, P776, DOI 10.1016/j.healthplace.2010.04.002
   Leatherdale ST, 2014, RELIABILITY VALIDITY, V2, P0
   Leatherdale ST, 2014, MEASUREMENT, V50, P331, DOI 10.1016/j.measurement.2014.01.008
   Leatherdale ST, 2013, INT J BEHAV NUTR PHY, V10, P0, DOI 10.1186/1479-5868-10-42
   Lebel A, 2016, J ENVIRON PUBLIC HEA, V2016, P0, DOI 10.1155/2016/1416384
   Levy DT, 2011, ADV NUTR, V2, P182S, DOI 10.3945/an.111.000356
   Lien N, 2014, HEALTH PLACE, V30, P28, DOI 10.1016/j.healthplace.2014.07.013
   Lo E, 2008, NUTR RES, V28, P144, DOI 10.1016/j.nutres.2008.01.005
   Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Mâsse LC, 2014, INT J BEHAV NUTR PHY, V11, P0, DOI 10.1186/1479-5868-11-29
   Mâsse LC, 2013, INT J BEHAV NUTR PHY, V10, P0, DOI 10.1186/1479-5868-10-26
   McKenna ML, 2010, CAN J PUBLIC HEALTH, V101, PS14, DOI 10.1007/BF03405619
   Minaker LM, 2011, PUBLIC HEALTH NUTR, V14, P1350, DOI 10.1017/S1368980011000449
   Mitchell DC, 2014, FOOD CHEM TOXICOL, V63, P136, DOI 10.1016/j.fct.2013.10.042
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/BMJ.E7492
   Mullally ML, 2010, CAN J PUBLIC HEALTH, V101, P40, DOI 10.1007/BF03405560
   Nelson MC, 2009, J AM DIET ASSOC, V109, P308, DOI 10.1016/j.jada.2008.10.043
   Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465
   Orava T, 2016, CAN J PUBLIC HEALTH, V107, PE417, DOI 10.17269/cjph.107.5326
   Park S, 2012, J NUTR, V142, P306, DOI 10.3945/jn.111.148536
   Pikora TJ, 2002, AM J PREV MED, V23, P187, DOI 10.1016/S0749-3797(02)00498-1
   Qian W, 2015, COMPASS TECHNICAL RE, V3, P0
   Shankar P, 2013, NUTRITION, V29, P1293, DOI 10.1016/j.nut.2013.03.024
   Statistics Canada, 2013, SEM PROF FSA BAS 201, V0, P0
   Statistics Canada, 2015, URB AR POP CTR, V0, P0
   Story M, 2009, MILBANK Q, V87, P71, DOI 10.1111/j.1468-0009.2009.00548.x
   Taber DR, 2012, ARCH PEDIAT ADOL MED, V166, P256, DOI 10.1001/archpediatrics.2011.200
   Turner L, 2012, J ACAD NUTR DIET, V112, P1380, DOI 10.1016/j.jand.2012.04.017
   Turton P, 2016, J NUTR EDUC BEHAV, V48, P181, DOI 10.1016/j.jneb.2015.12.004
   Valaitis R, 2016, FASEB J, V30, P0
   van der Horst K, 2008, AM J PREV MED, V35, P217, DOI 10.1016/j.amepre.2008.05.022
   Vanderlee L, 2014, J SCHOOL HEALTH, V84, P168, DOI 10.1111/josh.12139
   Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782
   Vecchiarelli S, 2006, J SCHOOL HEALTH, V76, P525, DOI 10.1111/j.1746-1561.2006.00153.x
   Vézina-Im LA, 2017, PUBLIC HEALTH NUTR, V20, P2416, DOI 10.1017/S1368980017000076
   Vine MM, 2017, CAN J PUBLIC HEALTH, V108, PE43, DOI 10.17269/cjph.108.5701
   Vine MM, 2014, CAN J DIET PRACT RES, V75, P118, DOI 10.3148/cjdpr-2014-003
   Vine MM, 2014, PUBLIC HEALTH NUTR, V17, P1290, DOI 10.1017/S1368980013002516
   Watts AW, 2014, INT J BEHAV NUTR PHY, V11, P0, DOI 10.1186/1479-5868-11-50
NR 65
TC 16
Z9 17
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 
EI 1479-5868
J9 INT J BEHAV NUTR PHY
JI Int. J. Behav. Nutr. Phys. Act.
PD NOV 27
PY 2018
VL 15
IS 
BP 
EP 
DI 10.1186/s12966-018-0754-5
PG 17
WC Nutrition & Dietetics; Physiology
SC Nutrition & Dietetics; Physiology
GA HB9RE
UT WOS:000451428900001
PM 30482211
DA 2025-04-28
ER

PT J
AU Wiggers, D
   Vanderlee, L
   White, CM
   Reid, JL
   Minaker, L
   Hammond, D
AF Wiggers, Danielle
   Vanderlee, Lana
   White, Christine M.
   Reid, Jessica L.
   Minaker, Leia
   Hammond, David
TI Food sources among young people in five major Canadian cities
SO CANADIAN JOURNAL OF PUBLIC HEALTH-REVUE CANADIENNE DE SANTE PUBLIQUE
LA English
DT Article
DE Diet, food and nutrition; Fast foods; Cooking; Nutrition policy
ID ultra-processed foods; likely impact; consumption; weight; diet; associations; products; quality; cooking; energy
AB Objective To examine food sources among young people in five major Canadian cities. Methods As part of the 2016 Canada Food Study, respondents aged 16-30 were recruited from five Canadian cities (Toronto, Montreal, Halifax, Edmonton, and Vancouver) using in-person intercept sampling and completed an online survey (n = 2840 retained for analysis). Descriptive statistics were used to summarize food preparation and purchase locations. A linear regression model was fitted to examine correlates of the proportion of meals that were ready-to-eat or prepared outside the home. Results In total, 80% of meals were prepared at home and 20% were prepared outside the home. More than 25% of meals prepared at home were ready-to-eat/box food. Of all meals consumed, 42% were either ready-to-eat/box food prepared at home or prepared outside the home. Food for meals prepared at home was purchased predominantly at grocery stores/supercentres while meals prepared outside the home were purchased predominantly at fast food/quick service/coffee shop outlets. Respondents who were younger, identified as Aboriginal, had obesity, had no children, lived in residence at school, university, or college, and reported poorer cooking skills reported more meals that were ready-to-eat or prepared outside the home. Conclusions The current findings indicate that a substantial proportion of meals consumed by young people consist of meals either prepared outside the home or ready-to-eat/box food prepared at home. Dietary recommendations should highlight basic patterns of food preparation and eating, such as limiting ultra-processed food and food prepared outside the home.
C1 [Wiggers, Danielle; White, Christine M.; Reid, Jessica L.; Hammond, David] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.
   [Vanderlee, Lana] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada.
   [Minaker, Leia] Univ Waterloo, Sch Planning, Waterloo, ON, Canada.
C3 University of Waterloo; University of Toronto; University of Waterloo
RP Hammond, D (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.
EM dhammond@uwaterloo.ca
FU Public Health Agency of Canada; Public Health Agency of Canada - Canadian Institutes of Health Research Chair in Applied Public Health; Canadian Institutes of Health Research Banting Postdoctoral Fellowship; Canadian Cancer Society [704744]
CR An R, 2016, EUR J CLIN NUTR, V70, P97, DOI 10.1038/ejcn.2015.104
   Bauer KW, 2009, PREV MED, V48, P284, DOI 10.1016/j.ypmed.2008.12.021
   Binkley JK, 2008, REV AGR ECON, V30, P750, DOI 10.1111/j.1467-9353.2008.00444.x
   Canadian Restaurant and Foodservices Association, 2010, CAN REST IND PUTT JO, V0, P0
   Garriguet D, 2004, OVERVIEW CANADIANS E, V0, P0
   Government of Canada, 2017, CAN FOOD GUID CONS, V0, P0
   Guthrie JF, 2002, J NUTR EDUC BEHAV, V34, P140, DOI 10.1016/S1499-4046(06)60083-3
   Hammond D, 2017, 2016 CANADA FOOD STUDY: TECHNICAL REPORT - WAVE 2, V0, P0
   Kant AK, 2004, PREV MED, V38, P243, DOI 10.1016/j.ypmed.2003.10.004
   Larson NI, 2006, J AM DIET ASSOC, V106, P2001, DOI 10.1016/j.jada.2006.09.008
   Mills S, 2017, INT J BEHAV NUTR PHY, V14, P0, DOI 10.1186/s12966-017-0567-y
   Minaker LM, 2016, PUBLIC HEALTH NUTR, V19, P2268, DOI 10.1017/S1368980016000355
   Minaker LM, 2014, J HUNGER ENVIRON NUT, V9, P485, DOI 10.1080/19320248.2014.898175
   Ministry of Health of Brazil, 2015, DIET GUID BRAZ POP, V0, P0
   Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107
   Monteiro CA, 2011, PUBLIC HEALTH NUTR, V14, P5, DOI 10.1017/S1368980010003241
   Moubarac J-C, 2017, ULTRAPROCESSED FOODS, V0, P0
   Moubarac JC, 2017, APPETITE, V108, P512, DOI 10.1016/j.appet.2016.11.006
   Moubarac JC, 2014, CAN J DIET PRACT RES, V75, P15, DOI 10.3148/75.1.2014.15
   Moubarac JC, 2013, PUBLIC HEALTH NUTR, V16, P2240, DOI 10.1017/S1368980012005009
   Nelson MC, 2008, OBESITY, V16, P2205, DOI 10.1038/oby.2008.365
   ONeill M, 2017, INT SOC BEH NUTR PHY, V0, P0
   Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0
   Poti JM, 2011, J AM DIET ASSOC, V111, P1156, DOI 10.1016/j.jada.2011.05.007
   Public Health Agency of Canada, 2011, OB IN CAN, V0, P0
   Seguin RA, 2016, J ENVIRON PUBLIC HEA, V2016, P0, DOI 10.1155/2016/3074241
   Shields M, 2006, REGIONAL DIFFERENCES, V0, P0
   Smith LP, 2013, NUTR J, V12, P0, DOI 10.1186/1475-2891-12-45
   Steele EM, 2017, POPUL HEALTH METR, V15, P0, DOI 10.1186/s12963-017-0119-3
   Stern D, 2016, AM J PREV MED, V50, P180, DOI 10.1016/j.amepre.2015.07.025
   Tiwari A, 2017, AM J PREV MED, V52, P616, DOI 10.1016/j.amepre.2017.01.017
   van der Horst KD, 2011, PUBLIC HEALTH NUTR, V14, P239, DOI 10.1017/S1368980010002624
   WHO, 2017, GLOB DAT BOD MASS IN, V0, P0
NR 34
TC 12
Z9 14
U1 0
U2 36
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 0008-4263
EI 1920-7476
J9 CAN J PUBLIC HEALTH
JI Can. J. Public Health-Rev. Can. Sante Publ.
PD AUG 15
PY 2018
VL 109
IS 4
BP 506
EP 515
DI 10.17269/s41997-018-0083-0
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GW5LV
UT WOS:000446977300010
PM 29981100
DA 2025-04-28
ER

PT J
AU O'Connor, L
   Imamura, F
   Brage, S
   Griffin, SJ
   Wareham, NJ
   Forouhi, NG
AF O'Connor, Laura
   Imamura, Fumiaki
   Brage, Soren
   Griffin, Simon J.
   Wareham, Nicholas J.
   Forouhi, Nita G.
TI Intakes and sources of dietary sugars and their association with metabolic and inflammatory markers
SO CLINICAL NUTRITION
LA English
DT Article
DE Sugars; Free sugar; Metabolic; Inflammation; Glycaemia
ID sweetened beverage consumption; dairy product intake; physical-activity; risk; obesity; mortality; cancer; youth; young
AB Background & aims: Associations of dietary sugars with metabolic and inflammatory markers may vary according to the source of the sugars. The aim of this study was to examine the association of dietary sugars from different sources [beverages (liquids), foods (solids), extrinsic (free) or intrinsic (non-free)] with metabolic and inflammatory markers. Methods: Population-based cross-sectional study of adults in the East of England (n = 9678). Sugar intakes were estimated using food frequency questionnaires. Fasting glycated haemoglobin, glucose, insulin, and C-Reactive Protein (CRP) were measured and indices of metabolic risk were derived (homeostatic model of insulin resistance, HOMA-IR and metabolic risk z-score). Results: In multiple linear regression analyses adjusted for potential confounders including BMI and TEI, sugars from liquids were positively associated with In-CRP [b-coefficient (95%CI), 0.14 (0.05,0.22) per 10% TEI] and metabolic risk z-score [0.13 (0.07,0.18)]. Free sugars were positively associated with In-HOMA-IR [0.05 (0.03,0.08)] and metabolic risk z-score [0.09 (0.06,0.12)]. Sugars from solids were not associated with any outcome. Among major dietary contributors to intakes (g/d), sugars in fruit, vegetables, dairy products/egg dishes, cakes/biscuits/confectionary and squash/juice drinks were not associated, but sugar added to tea, coffee, cereal was significantly positively associated with all outcomes. Sugars in 100% juice [0.16 (0.06,0.25) per 10%TEI] and other non-alcoholic beverages [0.13 (0.03,0.23)] were positively associated with metabolic risk z-score. Conclusion: Higher intakes of sugars from non-alcoholic beverages and sugar added to tea, coffee, cereal were associated with glycaemia and inflammatory markers. Sugars from solids were not associated, irrespective of whether they were intrinsic or extrinsic. Positive associations of free sugars were largely explained by contribution of beverages to intake. (C) 2017 The Author(s). Published by Elsevier Ltd.
C1 [O'Connor, Laura; Imamura, Fumiaki; Brage, Soren; Griffin, Simon J.; Wareham, Nicholas J.; Forouhi, Nita G.] Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Cambridge Biomed Campus,POB 285, Cambridge CB2 0QQ, England.
   [O'Connor, Laura] Manchester Metropolitan Univ, Fac Hlth Psychol & Social Care, Dept Hlth Profess, Manchester, Lancs, England.
   [Griffin, Simon J.] Univ Cambridge, Primary Care Unit, Dept Publ Hlth & Primary Care, Sch Clin Med,Inst Publ Hlth, Cambridge Biomed Campus, Cambridge, England.
C3 University of Cambridge; Manchester Metropolitan University; University of Cambridge
RP O'Connor, L; Forouhi, NG (corresponding author), Univ Cambridge, MRC Epidemiol Unit, Sch Clin Med, Inst Metab Sci, Cambridge Biomed Campus,POB 285, Cambridge CB2 0QQ, England.
EM laura.oconnor@mmu.ac.uk; nita.forouhi@mrc-epid.cam.ac.uk
FU Wellcome Trust; Medical Research Council [MC_UU_12015/1, MC_UU_12015/5]; MRC [MC_U106179473, MC_UU_12015/5, MC_UU_12015/3, MC_UU_12015/1, MC_UU_12015/4, MC_PC_13046] Funding Source: UKRI
CR Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432
   Bingham SA, 1997, INT J EPIDEMIOL, V26, PS137, DOI 10.1093/ije/26.suppl_1.S137
   Bingham SA, 2001, PUBLIC HEALTH NUTR, V4, P847, DOI 10.1079/PHN2000102
   Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141
   Brage S, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0137206
   Chen M, 2014, BMC MED, V12, P0, DOI 10.1186/s12916-014-0215-1
   de Koning L, 2011, AM J CLIN NUTR, V93, P1321, DOI 10.3945/ajcn.110.007922
   Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997
   Franks PW, 2004, DIABETES CARE, V27, P1187, DOI 10.2337/diacare.27.5.1187
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Imamura F, 2015, BMJ-BRIT MED J, V351, P0, DOI 10.1136/bmj.h3576
   Johnson RK, 2009, CIRCULATION, V120, P1011, DOI 10.1161/CIRCULATIONAHA.109.192627
   Kelly SA, 2003, PLOS ONE, V16, P9
   Kelly SAM, 2003, J HUM NUTR DIET, V16, P27, DOI 10.1046/j.1365-277X.2003.00414.x
   Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3
   Ma JT, 2014, J NUTR, V144, P1283, DOI 10.3945/jn.113.188599
   Malik VS, 2012, CURR DIABETES REP, V12, P195, DOI 10.1007/s11892-012-0259-6
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   MORENGA LT, 2013, BMJ-BRIT MED J, V346, P0, DOI 10.1136/BMJ.E7492
   Mulligan AA, 2014, BMJ OPEN, V4, P0, DOI 10.1136/bmjopen-2013-004503
   Muraki I, 2013, BMJ-BRIT MED J, V347, P0, DOI 10.1136/bmj.f5001
   OConnor L, 2015, DIABETOLOGIA, V58, P1474, DOI 10.1007/s00125-015-3572-1
   OConnor LM, 2014, DIABETOLOGIA, V57, P909, DOI 10.1007/s00125-014-3176-1
   Pan A, 2012, AM J CLIN NUTR, V95, P1454, DOI 10.3945/ajcn.111.032698
   Richelsen B, 2013, CURR OPIN CLIN NUTR, V16, P478, DOI 10.1097/MCO.0b013e328361c53e
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927
   Sluijs I, 2012, AM J CLIN NUTR, V96, P382, DOI 10.3945/ajcn.111.021907
   Tasevska N, 2014, AM J CLIN NUTR, V99, P1077, DOI 10.3945/ajcn.113.069369
   Te Morenga LA, 2014, AM J CLIN NUTR, V100, P65, DOI 10.3945/ajcn.113.081521
   The Scientific Advisory Committee on Nutrition (SACN), 2016, SCI CONS DRAFT SACN, V0, P0
   van Buul VJ, 2014, NUTR RES REV, V27, P119, DOI 10.1017/S0954422414000067
   WALKER ARP, 1977, S AFR MED J, V51, P842
   Wang JW, 2014, J NUTR, V144, P81, DOI 10.3945/jn.113.182519
   Willet W, 2012, NUTRITIONAL EPIDEMIOLOGY, V3rd, P0
   Yang QH, 2014, JAMA INTERN MED, V174, P516, DOI 10.1001/jamainternmed.2013.13563
NR 36
TC 60
Z9 64
U1 0
U2 21
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD AUG 15
PY 2018
VL 37
IS 4
BP 1313
EP 1322
DI 10.1016/j.clnu.2017.05.030
PG 10
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GK5GZ
UT WOS:000436204200030
PM 28711418
DA 2025-04-28
ER

PT J
AU Elkahoui, S
   Bartley, GE
   Yokoyama, WH
   Friedman, M
AF Elkahoui, Salem
   Bartley, Glenn E.
   Yokoyama, Wallace H.
   Friedman, Mendel
TI Dietary Supplementation of Potato Peel Powders Prepared from Conventional and Organic Russet and Non-organic Gold and Red Potatoes Reduces Weight Gain in Mice on a High-Fat Diet
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE potato; potato peel powder; mice; high-fat diet; antiobesity
ID gene-expression; plasma-cholesterol; hepatic steatosis; flavonoid content; chlorogenic acid; induced obesity; gut microbiota; glycoalkaloids; extract; tomato
AB The present study investigated the potential of potato peel powders, high in bioactive phenolic compounds and glycoalkaloids, to reduce weight gain in mice consuming a high-fat diet. Potato peel powders were prepared from the following fresh commercial potato varieties by hand-peeling and then freeze-drying and grinding the peels into powder: non-organic (conventionally grown) gold, red, and Russet and organically grown Russet. Mice diets (25% fat by weight) were supplemented with either 10 or 20% potato peel powders for 3 weeks. In comparison to the control diet, the isocaloric and isonitrogenous peel containing diets induced a reduction in weight gain that ranged from 17-45% (10% peel diets) to 46-73% (20% peel diets), suggesting that differences in weight gain are associated with the potato peel source and peel concentration of the diet. Weight reductions were accompanied by reduced epididymal white adipose tissue ranging from 22 to 80% as well as changes in the microbiota analyzed using next-generation sequencing and in obesity-associated genetic biomarkers determined by the quantitative real-time polymerase chain reaction. Safety aspects and possible mechanisms of the antiobesity effects are discussed in terms of the composition of the bioactive potato peel compounds, which were determined using high-performance liquid chromatography. The results suggest that potato peels, a major peeling byproduct of potato processing used to prepare fries, chips, and potato flour, that showed exceptionally high antiobesity properties in fat mice, have the potential to serve as an antiobesity functional food.
C1 [Elkahoui, Salem] Ctr Biotechnol Borj Cedria, Lab Bioact Subst, BP 901, Hammam Lif 2050, Tunisia.
   [Bartley, Glenn E.; Yokoyama, Wallace H.; Friedman, Mendel] ARS, Hlth Proc Foods Res, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
C3 Centre de Biotechnologie de Borj Cedria; United States Department of Agriculture (USDA)
RP Friedman, M (corresponding author), ARS, Hlth Proc Foods Res, Western Reg Res Ctr, USDA, Albany, CA 94710 USA.
EM mendel.friedman@ars.usda.gov
CR Abdel-Hafeez HM, 2018, J ANIM PHYSIOL AN N, V102, P56, DOI 10.1111/jpn.12656
   Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389
   Bagarolli RA, 2017, J NUTR BIOCHEM, V50, P16, DOI 10.1016/j.jnutbio.2017.08.006
   Bartley GE, 2010, J NUTR, V140, P1255, DOI 10.3945/jn.109.118349
   Ben Jeddou K, 2017, FOOD CHEM, V217, P668, DOI 10.1016/j.foodchem.2016.08.081
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Choi KM, 2013, J NUTR BIOCHEM, V24, P335, DOI 10.1016/j.jnutbio.2012.06.018
   Choi SH, 2016, J FOOD COMPOS ANAL, V50, P77, DOI 10.1016/j.jfca.2016.05.011
   Dahiya DK, 2018, FUTURE MICROBIOL, V13, P1007, DOI 10.2217/fmb-2017-0280
   DAO L, 1994, J AGR FOOD CHEM, V42, P633, DOI 10.1021/jf00039a006
   Derrien M, 2017, MICROB PATHOGENESIS, V106, P171, DOI 10.1016/j.micpath.2016.02.005
   Eberlé D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Ferré P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x
   Friedman M, 2000, FOOD CHEM TOXICOL, V38, P549, DOI 10.1016/S0278-6915(00)00050-8
   Friedman M, 1996, J NUTR, V126, P989, DOI 10.1093/jn/126.4.989
   Friedman M, 2005, J AGR FOOD CHEM, V53, P6162, DOI 10.1021/jf050620p
   Friedman M, 2003, J AGR FOOD CHEM, V51, P2964, DOI 10.1021/jf021146f
   FRIEDMAN M, 1992, ACS SYM SER, V484, P429
   Friedman M, 2000, J FOOD SCI, V65, P897, DOI 10.1111/j.1365-2621.2000.tb13608.x
   Friedman M, 2006, J AGR FOOD CHEM, V54, P8655, DOI 10.1021/jf061471t
   Friedman M, 2017, J FOOD COMPOS ANAL, V62, P69, DOI 10.1016/j.jfca.2017.04.019
   Friedman M, 2016, FOODS, V5, P0, DOI 10.3390/foods5040080
   Friedman M, 2015, J AGR FOOD CHEM, V63, P3323, DOI 10.1021/acs.jafc.5b00818
   HEFTMANN E, 1973, PHYTOCHEMISTRY, V12, P2661, DOI 10.1016/0031-9422(73)85075-7
   Juneja VK, 2018, J FOOD PROCESS PRES, V42, P0, DOI 10.1111/jfpp.13558
   Kang MC, 2016, FOOD CHEM TOXICOL, V90, P36, DOI 10.1016/j.fct.2016.01.023
   Kim H, 2015, J AGR FOOD CHEM, V63, P1460, DOI 10.1021/jf5026373
   Kim H, 2014, J AGR FOOD CHEM, V62, P1919, DOI 10.1021/jf404832s
   Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411
   Kim SP, 2015, FOOD FUNCT, V6, P2939, DOI 10.1039/c5fo00469a
   Kowalska K, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0188583
   Kozukue N, 2008, J AGR FOOD CHEM, V56, P11920, DOI 10.1021/jf802631t
   Kubow S, 2014, MOL NUTR FOOD RES, V58, P2235, DOI 10.1002/mnfr.201400013
   Langkilde S, 2009, FOOD CHEM TOXICOL, V47, P1099, DOI 10.1016/j.fct.2009.01.045
   Lazarov K, 1996, MED SCI RES, V24, P581
   Li W, 2015, FOOD CHEM, V170, P336, DOI 10.1016/j.foodchem.2014.08.078
   Li Z, 2016, BIOCHEM BIOPH RES CO, V480, P222, DOI 10.1016/j.bbrc.2016.10.031
   Lim J, 2017, J AGR FOOD CHEM, V65, P10011, DOI 10.1021/acs.jafc.7b03764
   Lim WC, 2016, J MED FOOD, V19, P410, DOI 10.1089/jmf.2015.3590
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mathur R, 2015, EXPERT REV GASTROENT, V9, P1087, DOI 10.1586/17474124.2015.1051029
   Nihei N, 2018, BIOFACTORS, V44, P336, DOI 10.1002/biof.1429
   Parkar SG, 2013, ANAEROBE, V23, P12, DOI 10.1016/j.anaerobe.2013.07.009
   RODDICK JG, 1979, PHYTOCHEMISTRY, V18, P1467, DOI 10.1016/S0031-9422(00)98476-0
   Saito T, 2016, NUTR RES, V36, P1090, DOI 10.1016/j.nutres.2016.09.004
   Seo DB, 2015, J MED FOOD, V18, P549, DOI 10.1089/jmf.2014.3265
   Seo KH, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167680
   Sepelev I, 2015, RES RURAL DEV, V0, P130
   Singh N, 2005, CLIN CHIM ACTA, V353, P165, DOI 10.1016/j.cccn.2004.10.016
   SWINYARD CA, 1973, TERATOLOGY, V8, P349, DOI 10.1002/tera.1420080318
   Tice R, 1998, ALPHA CHACONINE ALPH, V0, P0
   Tomas-Barberan F, 2014, MOL NUTR FOOD RES, V58, P1122, DOI 10.1002/mnfr.201300441
   Tusnio A, 2013, J ANIM FEED SCI, V22, P130
   Wadhwa M, 2015, CAB REVIEWS, V10, P1, DOI 10.1079/PAVSNNR201510043
   Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, PE271, DOI 10.1152/ajpendo.90920.2008
   Wang L, 2017, J AGR FOOD CHEM, V65, P8374, DOI 10.1021/acs.jafc.7b03230
NR 56
TC 29
Z9 30
U1 0
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD JUN 20
PY 2018
VL 66
IS 24
BP 6064
EP 6072
DI 10.1021/acs.jafc.8b01987
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science & Technology
SC Agriculture; Chemistry; Food Science & Technology
GA GK5JS
UT WOS:000436212000013
PM 29877090
DA 2025-04-28
ER

PT J
AU Kim, Y
   Je, Y
AF Kim, Youngyo
   Je, Youjin
TI Moderate coffee consumption is inversely associated with the metabolic syndrome in the Korean adult population
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Coffee; Metabolic syndrome; Korean adults; Obesity
ID nutrition examination survey; nonalcoholic fatty liver; national-health; cardiovascular-disease; chlorogenic acid; risk; metaanalysis; prevalence; mortality; patterns
AB Results from studies investigating the association between coffee consumption and the metabolic syndrome in Koreans have been inconsistent and remain controversial. We examined coffee intake in relation to the metabolic syndrome using data from the. Korea National Health and Nutrition Examination Survey 2012-2015, with 8387 adults aged 19-64 years. Furthermore, we conducted a stratified analysis by obesity status (BMI <25 v. >= 25 kg/m(2)) to examine whether the association varied by obesity status. A 112-item FFQ was used to assess diet. Multivariable logistic regression models were used to determine the association of coffee consumption (<1, 1-2, 3-4 and >= 5 times/d) and the metabolic syndrome. Compared to people who consumed <1 time/d of coffee, the OR for the metabolic syndrome in those who consumed 3-4 times/d of coffee was 0.75 (95% CI 0.58, 0.97). However, >= 5 times/d of coffee consumption was not significantly associated with the metabolic syndrome. By obesity status, in non-obese people, those consuming more coffee had lower odds of the metabolic syndrome, showing a significant linear trend (P-trend =0.0248). In obese people, the OR for the metabolic syndrome in people with 3-4 times/d of coffee consumption v. <1 time/d was 0.68 (95% CI 0.50, 0.93), but >= 5 times/d of coffee consumption showed a non-significant positive association. Our findings suggest that moderate coffee consumption of 3-4 times/d is inversely associated with the metabolic syndrome in Korean adults. The association between heavy coffee consumption of >= 5 times/d and the metabolic syndrome varied by obesity status.
C1 [Kim, Youngyo; Je, Youjin] Kyung Hee Univ, Dept Food & Nutr, 26 Kyunghee Daero, Seoul 02447, South Korea.
C3 Kyung Hee University
RP Je, Y (corresponding author), Kyung Hee Univ, Dept Food & Nutr, 26 Kyunghee Daero, Seoul 02447, South Korea.
EM youjinje@khu.ac.kr
FU National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [NRF-2015R1A1A1A05001362]; Ministry of Education [NRF-2017R1A6A3A01075728]
CR Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Unknown -, 2017, KOR HLTH STAT 2016 K, V0, P0
   Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Baik I, 2013, NUTR RES PRACT, V7, P233, DOI 10.4162/nrp.2013.7.3.233
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336
   Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Grosso G, 2014, J EPIDEMIOL, V24, P327, DOI 10.2188/jea.JE20130166
   Je Y, 2014, ASIA PAC J CLIN NUTR, V23, P691, DOI 10.6133/apjcn.2014.23.4.11
   Je Y, 2014, BRIT J NUTR, V111, P1162, DOI 10.1017/S0007114513003814
   Kim DW, 2015, PUBLIC HEALTH NUTR, V18, P1369, DOI 10.1017/S1368980014001712
   Kim HJ, 2014, DIABETES RES CLIN PR, V106, P145, DOI 10.1016/j.diabres.2014.07.007
   Kim KY, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0168413
   Kim Y, 2016, DIABETIC MED, V33, P428, DOI 10.1111/dme.12970
   Kim Y, 2018, NUTRIENTS, V10, P0, DOI 10.3390/nu10040390
   Kolovou GD, 2007, AM J MED SCI, V333, P362, DOI 10.1097/MAJ.0b013e318065c3a1
   Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228
   Lee HH, 2013, EUR J CLIN NUTR, V67, P83, DOI 10.1038/ejcn.2012.181
   Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109
   Lin TK, 2018, GLOBALIZATION HEALTH, V14, P0, DOI 10.1186/s12992-018-0344-y
   Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159
   Mancini A, 2015, MOLECULES, V20, P17339, DOI 10.3390/molecules200917339
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Moreira ASP, 2012, FOOD FUNCT, V3, P903, DOI 10.1039/c2fo30048f
   Narain A, 2017, INT J CLIN PRACT, V71, P0, DOI 10.1111/ijcp.12927
   Ong KW, 2013, BIOCHEM PHARMACOL, V85, P1341, DOI 10.1016/j.bcp.2013.02.008
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shin H, 2017, KOREAN J FAM MED, V38, P346, DOI 10.4082/kjfm.2017.38.6.346
   Shin HJ, 2014, J NUTR, V144, P1247, DOI 10.3945/jn.113.188441
   Siervo M, 2014, PUBLIC HEALTH NUTR, V17, P587, DOI 10.1017/S1368980013000141
   Suzuki A, 2007, AM J HYPERTENS, V20, P508, DOI 10.1016/j.amjhyper.2006.11.008
   USDA Foreign Agricultural Service, 2015, COFF MARK BRIEF UPD, V0, P0
   Wang JW, 2013, PEDIATR OBES, V8, P284, DOI 10.1111/j.2047-6310.2012.00108.x
   Wang JW, 2014, J NUTR, V144, P81, DOI 10.3945/jn.113.182519
   Welsh JA, 2011, CIRCULATION, V123, P249, DOI 10.1161/CIRCULATIONAHA.110.972166
   Yesil A, 2013, ALIMENT PHARM THER, V38, P1038, DOI 10.1111/apt.12489
NR 40
TC 23
Z9 23
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD DEC 14
PY 2018
VL 120
IS 11
BP 1279
EP 1287
DI 10.1017/S0007114518002635
PG 9
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HC3JY
UT WOS:000451699500008
PM 30311595
DA 2025-04-28
ER

PT J
AU Bailey, RL
   Fulgoni, VL
   Cowan, AE
   Gaine, PC
AF Bailey, Regan L.
   Fulgoni, Victor L., III
   Cowan, Alexandra E.
   Gaine, P. Courtney
TI Sources of Added Sugars in Young Children, Adolescents, and Adults with Low and High Intakes of Added Sugars
SO NUTRIENTS
LA English
DT Article
DE NHANES; added sugars; obesity; sweetened beverages; Dietary Guidelines
ID sweetened beverage consumption; united-states; soft drinks; us children; solid fats; metaanalysis; prevalence; nutrients; health; trends
AB High intake of added sugars is associated with excess energy intake and poorer diet quality. The objective of this cross-sectional study (n = 16,806) was to estimate usual intakes and the primary food sources of added sugars across the range of intakes (i.e., deciles) among U.S. children (2-8 years), adolescents and teens (9-18 years), and adults (19 years) using the National Health and Nutrition Examination (NHANES) data from 2009-2012. The percent energy contributed by added sugars was 14.3 +/- 0.2% (2-8 years), 16.2 +/- 0.2% (9-18 years), and 13.1 +/- 0.2% (19 years), suggesting the highest intakes are among adolescents and teens. However, the primary foods/beverages that contribute to added sugars were remarkably consistent across the range of intakes, with the exception of the lowest decile, and include sweetened beverages and sweet bakery products. Interestingly across all age groups, even those in the lowest decile of added sugars exceed the 10% guidelines. Additional foods contributing to high intakes were candy and other desserts (e.g., ice cream) in children and adolescents, and coffee and teas in adults. Tailoring public health messaging to reduce intakes of these identified food groups may be of utility in designing effective strategies to reduce added sugar intake in the U.S.
C1 [Bailey, Regan L.] Purdue Univ, Dept Nutr Sci, Stone Hall,Room 143A,700 West State St, W Lafayette, IN 47906 USA.
   [Fulgoni, Victor L., III] Nutr Impact LLC, 9725 D Dr North, Battle Creek, MI 49014 USA.
   [Cowan, Alexandra E.] Purdue Univ, Dept Nutr Sci, Room 143,700 West State St, W Lafayette, IN 47906 USA.
   [Gaine, P. Courtney] Sugar Assoc Inc, 1300 L St NW,Suite 1001, Washington, DC 20005 USA.
C3 Purdue University System; Purdue University; Nutrition Impact, LLC; Purdue University System; Purdue University
RP Bailey, RL (corresponding author), Purdue Univ, Dept Nutr Sci, Stone Hall,Room 143A,700 West State St, W Lafayette, IN 47906 USA.
EM reganbailey@purdue.edu; vic3rd@aol.com; cowan9@purdue.edu; gaine@sugar.org
FU Sugar Association
CR Bailey RL, 2017, NUTRITION TODAY, V52, PS3, DOI 10.1097/NT.0000000000000210
   BINGHAM SA, 1994, BRIT J NUTR, V72, P619, DOI 10.1079/BJN19940064
   Clemens RA, 2016, COMPR REV FOOD SCI F, V15, P433, DOI 10.1111/1541-4337.12194
   Dietary Guidelines Advisory Committee, 1900, P421, V0, P0
   Ervin RB, 2013, NCHS DATA BRIEF, V0, P1
   Ervin RB, 2012, NCHS DATA BRIEF, V0, P1
   Freedman LS, 2015, AM J EPIDEMIOL, V181, P473, DOI 10.1093/aje/kwu325
   Greenwood DC, 2014, BRIT J NUTR, V112, P725, DOI 10.1017/S0007114514001329
   Hu FB, 2013, OBES REV, V14, P606, DOI 10.1111/obr.12040
   Kaartinen NE, 2017, J NUTR SCI, V6, P0, DOI 10.1017/jns.2017.3
   Khan TA, 2016, EUR J NUTR, V55, PS25, DOI 10.1007/s00394-016-1345-3
   Kit BK, 2013, AM J CLIN NUTR, V98, P180, DOI 10.3945/ajcn.112.057943
   Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362
   Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079
   Marriott BP, 2010, CRIT REV FOOD SCI, V50, P228, DOI 10.1080/10408391003626223
   Micha R, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0175149
   Miller G, 2017, MMWR-MORBID MORTAL W, V66, P112, DOI 10.15585/mmwr.mm6604a5
   Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324
   Narain A, 2016, INT J CLIN PRACT, V70, P791, DOI 10.1111/ijcp.12841
   Ogden CL, 2015, NCHS DATA BRIEF, V0, PP1, DOI 10.1017/S1368980017000088
   Park S, 2016, MMWR-MORBID MORTAL W, V65, P169, DOI 10.15585/mmwr.mm6507a1
   Reedy J, 2010, J AM DIET ASSOC, V110, P1477, DOI 10.1016/j.jada.2010.07.010
   Romaguera D, 2013, DIABETOLOGIA, V56, P1520, DOI 10.1007/s00125-013-2899-8
   Rosinger A, 2017, NCHS DATA BRIEF, V0, P1
   Sievenpiper JL, 2013, AM J CLIN NUTR, V98, P261, DOI 10.3945/ajcn.113.067215
   Sigman-Grant M, 2003, AM J CLIN NUTR, V78, P815S, DOI 10.1093/ajcn/78.4.815S
   Slining MM, 2013, PEDIATR OBES, V8, P307, DOI 10.1111/j.2047-6310.2013.00156.x
   Tasevska N, 2015, NUTRIENTS, V7, P5816, DOI 10.3390/nu7075255
   The National Academies of Sciences Engineering and Medicine, 2017, P WORKSH NAT AC SCI, V0, P0
   Tooze JA, 2010, STAT MED, V29, P2857, DOI 10.1002/sim.4063
   US Department of Health and Human Services, 1900, P122, V0, P0
   Wang YC, 2008, PEDIATRICS, V121, PE1604, DOI 10.1542/peds.2007-2834
   Welsh JA, 2017, NUTRITION TODAY, V52, PS60, DOI 10.1097/nt.0000000000000193
   Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366
   World Health Organization (WHO), 2015, GUIDELINE: SUGARS INTAKE FOR ADULTS AND CHILDREN, V0, P0
NR 39
TC 146
Z9 170
U1 0
U2 61
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2072-6643
EI 
J9 NUTRIENTS
JI Nutrients
PD JAN 15
PY 2018
VL 10
IS 1
BP 
EP 
DI 10.3390/nu10010102
PG 11
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FU8FF
UT WOS:000424088000101
PM 29342109
DA 2025-04-28
ER

PT J
AU Peron, G
   Santarossa, D
   Voinovich, D
   Dall'Acqua, S
   Sut, S
AF Peron, Gregorio
   Santarossa, Davide
   Voinovich, Dario
   Dall'Acqua, Stefano
   Sut, Stefania
TI Urine metabolomics shows an induction of fatty acids metabolism in healthy adult volunteers after supplementation with green coffee (Coffea robusta L.) bean extract
SO PHYTOMEDICINE
LA English
DT Article
DE Green coffee; Metabolomics; Urine; Caffeoyl quinic acid
ID activated receptor-alpha; chlorogenic acid; lc-msn; 5-caffeoylquinic acid; nutraceuticals; obesity; mass; tea; identification; consumption
AB Background and objective: Green coffee bean extract is used as herbal medicine or supplement for weight reduction and obesity. The active constituents are considered caffeine and chlorogenic acid (CGA) derivatives. The mode of action of CGA is still unclear and can be related to peroxisome proliferator-activated receptor a (PPAR-alpha) and liver X receptor R alpha (LXR-alpha). Metabolomics may be an innovative tool for the description and discovery of the multiple target nature of such phytocomplex. Methods: 24 h urine samples were collected once a week from ten healthy adult volunteers consuming daily 400 mg of dry Green coffee bean extract (GCBE, 4.9% of chlorogenic acid) each day for 30 days (5 harvesting days, considering also the first day of supplementation). Urine samples were analyzed by LC-QTOF using both untargeted and targeted approaches. The latter was used to monitor two urinary markers of oxidative stress (allantoin, 8-OHdG). Results: Metabolomics analysis (PLS-DA) revealed changes in urine composition before and during the treatment with GCBE. Markers related to treatment were metabolites related to polyphenol administration as hippuric acid, benzoic acid derivatives, dihydroferulic and dihydrosinapic acid sulphate, but also carnitine derivatives and dicarboxylic acids. On the other hand, no changes in the levels of allantoin and 8-OHdG were observed. Conclusion: This preliminary study showed the possible usefulness of metabolomics approach in the evaluation of GCBE consumption in healthy subjects. The observed changes in urinary composition can be related to the catabolism of GCBE constituents and to induced fatty acid metabolism, mainly related to carnitine derivatives. This latter result could be considered, at least in part, as a further proof of the mode of action of green coffee extract.
C1 [Peron, Gregorio; Dall'Acqua, Stefano; Sut, Stefania] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, I-35131 Padua, Italy.
   [Santarossa, Davide; Voinovich, Dario] Univ Trieste, Dept Chem & Pharmaceut Sci, Ple Europa 1, I-34127 Trieste, Italy.
C3 University of Padua; University of Trieste
RP Dall'Acqua, S (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Via Marzolo 5, I-35131 Padua, Italy.
EM stefano.dallacqua@unipd.it
CR Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874
   Babova O, 2016, PHYTOCHEMISTRY, V123, P33, DOI 10.1016/j.phytochem.2016.01.016
   Bajko E, 2016, LWT-FOOD SCI TECHNOL, V65, P471, DOI 10.1016/j.lwt.2015.08.024
   Booth FW, 2012, COMPR PHYSIOL, V2, P1143, DOI 10.1002/cphy.c110025
   Brower V, 1998, NAT BIOTECHNOL, V16, P728, DOI 10.1038/nbt0898-728
   Buchanan R, 2013, J EVID-BASED INTEGR, V18, P309, DOI 10.1177/2156587213496818
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Clifford MN, 2008, FOOD CHEM, V106, P379, DOI 10.1016/j.foodchem.2007.05.081
   Clifford MN, 2006, J AGR FOOD CHEM, V54, P4095, DOI 10.1021/jf060536p
   Clifford MN, 2005, J AGR FOOD CHEM, V53, P3821, DOI 10.1021/jf050046h
   Clifford MN, 2003, J AGR FOOD CHEM, V51, P2900, DOI 10.1021/jf026187q
   Cooke MS, 2002, FREE RADICAL BIO MED, V33, P1601, DOI 10.1016/S0891-5849(02)01146-2
   Deen D, 2004, AM FAM PHYSICIAN, V69, P2875
   Del Rio D, 2010, NUTRIENTS, V2, P820, DOI 10.3390/nu2080820
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Farah A, 2008, J NUTR, V138, P2309, DOI 10.3945/jn.108.095554
   Farah Adriana, 2006, BRAZ. J. PLANT PHYSIOL., V18, P23, DOI 10.1590/S1677-04202006000100003
   Gao K, 2006, J NUTR, V136, P52, DOI 10.1093/jn/136.1.52
   Gaullier JM, 2005, J NUTR, V135, P778
   Gervois P, 2000, CLIN CHEM LAB MED, V38, P3, DOI 10.1515/CCLM.2000.002
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Huang C, 2016, BMC COMPLEMENT ALTER, V16, P0
   Huang K, 2015, J SCI FOOD AGR, V95, P1903, DOI 10.1002/jsfa.6896
   Ilyasova D, 2012, CLIN CHIM ACTA, V413, P1446, DOI 10.1016/j.cca.2012.06.012
   Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223
   Konishi Y, 2004, J AGR FOOD CHEM, V52, P6418, DOI 10.1021/jf049560y
   Krupp D, 2012, J NUTR, V142, P1314, DOI 10.3945/jn.112.159319
   Kuzbicka Karolina, 2013, PEDIATR ENDOCRINOL DIABETES METAB, V19, P106
   Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9
   Liang N, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8010016
   Liu SL, 2015, FOOD FUNCT, V6, P2779, DOI 10.1039/c5fo00626k
   Maeda H, 2015, J OLEO SCI, V64, P125, DOI 10.5650/jos.ess14226
   Meng S, 2013, ALTERN MED, V2013, P0
   Miyashita K, 2014, NUTRITION IN THE PREVENTION AND TREATMENT OF ABDOMINAL OBESITY, V0, PP329, DOI 10.1016/B978-0-12-407869-7.00030-1
   Monteiro M, 2007, J NUTR, V137, P2196, DOI 10.1093/jn/137.10.2196
   Nakajima Hideto, 2012, OPEN NEUROL J, V6, P51, DOI 10.2174/1874205X01206010051
   Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014
   Olthof MR, 2003, J NUTR, V133, P1806, DOI 10.1093/jn/133.6.1806
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Peron G, 2017, J PHARMACEUT BIOMED, V140, P62, DOI 10.1016/j.jpba.2017.03.015
   Pittler MH, 2004, AM J CLIN NUTR, V79, P529
   Poddar K, 2011, NUTR CLIN PRACT, V26, P539, DOI 10.1177/0884533611419859
   Revuelta-Iniesta R, 2014, BIOMED RES INT, V2014, P0, DOI 10.1155/2014/482704
   Ríos-Hoyol A, 2014, INT J VITAM NUTR RES, V84, P113, DOI 10.1024/0300-9831/a000198
   Sharma S, 2009, DRUG DISCOVERY TODAY, V6, P0
   Shimoda H, 2006, BMC COMPLEMENT ALTER, V6, P0
   Sudeep HV, 2016, BMC COMPLEM ALTERN M, V16, P0, DOI 10.1186/s12906-016-1258-y
   Sut S, 2016, CURR MED CHEM, V23, P3198, DOI 10.2174/0929867323666160615104837
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   Tolun AA, 2010, ANAL BIOCHEM, V402, P191, DOI 10.1016/j.ab.2010.03.033
   TSERNG KY, 1991, BIOCHEMISTRY-US, V30, P2508, DOI 10.1021/bi00223a030
   VERHAEGHE BJ, 1992, BIOL MASS SPECTROM, V21, P27, DOI 10.1002/bms.1200210107
   Vorkas PA, 2015, ANAL CHEM, V87, P4184, DOI 10.1021/ac503775m
   Wolfender JL, 2013, CURR MED CHEM, V20, P1056
   Yang Y, 2017, EVID BASED COMPLEMEN, V2017, P0
NR 57
TC 9
Z9 9
U1 2
U2 24
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0944-7113
EI 
J9 PHYTOMEDICINE
JI Phytomedicine
PD JAN 1
PY 2018
VL 38
IS 
BP 74
EP 83
DI 10.1016/j.phymed.2017.11.002
PG 10
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary Medicine
GA FW2YY
UT WOS:000425172900008
PM 29425657
DA 2025-04-28
ER

PT J
AU Haselgrübler, R
   Stadlbauer, V
   Stübl, F
   Schwarzinger, B
   Rudzionyte, I
   Himmelsbach, M
   Iken, M
   Weghuber, J
AF Haselgruebler, Renate
   Stadlbauer, Verena
   Stuebl, Flora
   Schwarzinger, Bettina
   Rudzionyte, Ieva
   Himmelsbach, Markus
   Iken, Marcus
   Weghuber, Julian
TI Insulin Mimetic Properties of Extracts Prepared from Bellis perennis
SO MOLECULES
LA English
DT Article
DE Bellis perennis extract; insulin mimetic property; GLUT4 translocation; glucose uptake; hens egg test-chorioallantoic membrane (HET-CAM) assay; type 2 diabetes
ID glucose-uptake; triterpene saponins; glucose-transporter-4 translocation; glut4 translocation; flowers; differentiation; transport; obesity; caco-2; plasma
AB Diabetes mellitus (DM) and consequential cardiovascular diseases lead to millions of deaths worldwide each year; 90% of all people suffering from DM are classified as Type 2 DM (T2DM) patients. T2DM is linked to insulin resistance and a loss of insulin sensitivity. It leads to a reduced uptake of glucose mediated by glucose transporter 4 (GLUT4) in muscle and adipose tissue, and finally hyperglycemia. Using a fluorescence microscopy-based screening assay we searched for herbal extracts that induce GLUT4 translocation in the absence of insulin, and confirmed their activity in chick embryos. We found that extracts prepared from Bellis perennis (common daisy) are efficient inducers of GLUT4 translocation in the applied in vitro cell system. In addition, these extracts also led to reduced blood glucose levels in chicken embryos (in ovo), confirming their activity in a living organism. Using high-performance liquid chromtaography (HPLC) analysis, we identified and quantified numerous polyphenolic compounds including apigenin glycosides, quercitrin and chlorogenic acid, which potentially contribute to the induction of GLUT4 translocation. In conclusion, Bellis perennis extracts reduce blood glucose levels and are therefore suitable candidates for application in food supplements for the prevention and accompanying therapy of T2DM.
C1 [Haselgruebler, Renate; Stadlbauer, Verena; Stuebl, Flora; Schwarzinger, Bettina; Rudzionyte, Ieva; Weghuber, Julian] Univ Appl Sci Upper Austria, Sch Engn, Stelzhamerstr 23, A-4600 Wels, Austria.
   [Stadlbauer, Verena; Schwarzinger, Bettina; Weghuber, Julian] Austrian Competence Ctr Feed & Food Qual Safety &, A-4600 Wels, Austria.
   [Himmelsbach, Markus] Johannes Kepler Univ Linz, Inst Analyt Chem, A-4040 Linz, Austria.
   [Iken, Marcus] PM Int AG, L-5445 Schengen, Luxembourg.
C3 Johannes Kepler University Linz
RP Stadlbauer, V; Weghuber, J (corresponding author), Univ Appl Sci Upper Austria, Sch Engn, Stelzhamerstr 23, A-4600 Wels, Austria.; Stadlbauer, V; Weghuber, J (corresponding author), Austrian Competence Ctr Feed & Food Qual Safety &, A-4600 Wels, Austria.
EM renate.haselgruebler@fh-wels.at; verena.stadlbauer@fh-wels.at; flora.stuebl@fh-wels.at; bettina.schwarzinger@fh-wels.at; ieva.rudzionyte@fh-wels.at; markus.himmelsbach@jku.at; marcus.iken@pm-international.de; julian.weghuber@fh-wels.at
FU Austrian Research Promotion Agency (FFG) [850681]; University of Applied Sciences Upper Austria Basic Funding initiative
CR Alemán-González-Duhart D, 2016, PPAR RES, V2016, P0, DOI 10.1155/2016/7614270
   Arakaki RF, 2016, POSTGRAD MED, V128, P409, DOI 10.1080/00325481.2016.1167570
   Bommer C, 2018, DIABETES CARE, V41, P963, DOI 10.2337/dc17-1962
   Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140
   Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782
   Cakilcioglu U, 2010, J ETHNOPHARMACOL, V132, P165, DOI 10.1016/j.jep.2010.08.017
   Cohen FJ, 2003, DIABETES CARE, V26, P1847, DOI 10.2337/diacare.26.6.1847
   Marques THC, 2013, BIOL RES, V46, P231, DOI 10.4067/S0716-97602013000300002
   Dandona P, 2005, CIRCULATION, V111, P1448, DOI 10.1161/01.CIR.0000158483.13093.9D
   Desai NR, 2012, AM J MED, V125, P0, DOI 10.1016/j.amjmed.2011.07.033
   Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7
   Eid HM, 2017, PHARM BIOL, V55, P2026, DOI 10.1080/13880209.2017.1345952
   Filipova E, 2017, DIABETES THER, V8, P705, DOI 10.1007/s13300-017-0273-4
   Haselgrubler R, 2018, JOVE-J VIS EXP, V134, P57237
   Haselgrübler R, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0182788
   Huang D, 2017, BIOMED RES INT, V2017, P0, DOI 10.1155/2017/7839101
   Huang M, 2016, FRONT PHARMACOL, V7, P0, DOI 10.3389/fphar.2016.00288
   Iqbal Z, 2018, CLIN THER, V40, P828, DOI 10.1016/j.clinthera.2018.04.001
   Kadan S, 2018, EVID-BASED COMPL ALT, V2018, P0, DOI 10.1155/2018/8294320
   Karakas FP, 2016, AFR J TRADIT COMPLEM, V13, P34, DOI 10.21010/ajtcam.v13i4.6
   Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009
   Krishnamoorthy RM, 2017, CHEM-BIOL INTERACT, V275, P95, DOI 10.1016/j.cbi.2017.07.016
   Lanzerstorfer P, 2015, FEBS J, V282, P987, DOI 10.1111/febs.13213
   Lanzerstorfer P, 2014, BRIT J PHARMACOL, V171, P5237, DOI 10.1111/bph.12845
   Lanzerstorfer P, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0092151
   List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863
   Liu XQ, 2005, J NUTR, V135, P165, DOI 10.1093/jn/135.2.165
   Malematja RO, 2018, EVID-BASED COMPL ALT, V2018, P0, DOI 10.1155/2018/5101656
   Martel J, 2017, NAT REV ENDOCRINOL, V13, P149, DOI 10.1038/nrendo.2016.142
   MEUNIER V, 1995, CELL BIOL TOXICOL, V11, P187, DOI 10.1007/BF00756522
   Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017
   Mitich LW, 1997, WEED TECHNOL, V11, P626, DOI 10.1017/S0890037X00045541
   Morikawa T, 2008, J NAT PROD, V71, P828, DOI 10.1021/np8000333
   Morikawa T, 2015, PHYTOCHEMISTRY, V116, P203, DOI 10.1016/j.phytochem.2015.05.011
   Morikawa T, 2011, CHEM PHARM BULL, V59, P889, DOI 10.1248/cpb.59.889
   MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x
   Mueckler M, 2001, J CLIN INVEST, V107, P1211, DOI 10.1172/JCI13020
   Müller U, 2018, MOL NUTR FOOD RES, V62, P0, DOI 10.1002/mnfr.201701012
   Naowaboot J, 2012, AM J CHINESE MED, V40, P163, DOI 10.1142/S0192415X12500139
   Nazaruk J, 2001, ACTA POL PHARM, V58, P401
   Nazaruk J, 2000, L ACTA POL PHARM, V57, P129
   Onur S, 2013, JOURNAL OF FOOD RESEARCH, V2, P101
   Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582
   Prasad CNV, 2010, FEBS LETT, V584, P531, DOI 10.1016/j.febslet.2009.11.092
   Rózanska D, 2018, ADV CLIN EXP MED, V27, P135, DOI 10.17219/acem/64983
   Sayem AM, 2018, MOLECULES, V23, P0, DOI 10.3390/molecules23020258
   Scheen AJ, 2012, DIABETES RES CLIN PR, V98, P175, DOI 10.1016/j.diabres.2012.09.001
   SCHOPKE T, 1992, PHYTOCHEMISTRY, V31, P2555, DOI 10.1016/0031-9422(92)83328-V
   Siatka T, 2010, MOLECULES, V15, P9450, DOI 10.3390/molecules15129450
   Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75
   Spielmann H, 1995, METHODS MOL BIOL, V43, P199
   Stadlbauer V, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0148109
   Torabi S, 2016, EXP BIOL MED, V241, P1776, DOI 10.1177/1535370216645213
   Uysal I, 2010, BIOL DIVERS CONSERV, V3, P15
   Uzun E, 2004, J ETHNOPHARMACOL, V95, P287, DOI 10.1016/j.jep.2004.07.013
   Volpe DA, 2011, FUTURE MED CHEM, V3, P2063, DOI 10.4155/FMC.11.149
   Xu ML, 2014, MOL NUTR FOOD RES, V58, P931, DOI 10.1002/mnfr.201300510
   Yoshikawa M, 2008, CHEM PHARM BULL, V56, P559, DOI 10.1248/cpb.56.559
   Yoshitomi H, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0183988
   Yoshiyama Y, 2005, BIOL PHARM BULL, V28, P1986, DOI 10.1248/bpb.28.1986
   Zhou B, 2016, LANCET, V387, P1513, DOI 10.1016/S0140-6736(16)00618-8
   Ziegler D, 2015, J DIABETES COMPLICAT, V29, P146, DOI 10.1016/j.jdiacomp.2014.08.008
NR 63
TC 24
Z9 26
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD OCT 15
PY 2018
VL 23
IS 10
BP 
EP 
DI 10.3390/molecules23102605
PG 15
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA HB6SF
UT WOS:000451201400201
PM 30314325
DA 2025-04-28
ER

PT J
AU Larsen, SC
   Mikkelsen, MLK
   Frederiksen, P
   Heitmann, BL
AF Larsen, S. C.
   Mikkelsen, M-L K.
   Frederiksen, P.
   Heitmann, B. L.
TI Habitual coffee consumption and changes in measures of adiposity: a comprehensive study of longitudinal associations
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Article
ID chlorogenic acid; metabolic-rate; obese women; weight-loss; long-term; caffeine; risk; metaanalysis; volunteers; mortality
AB BACKGROUND: A relationship between change in coffee consumption and reduced long-term weight gain has been suggested, but current evidence is inconsistent. OBJECTIVE: To examine longitudinal associations between coffee consumption and changes in body mass index (BMI), fat mass index (FMI), fat-free mass index (FFMI), body fat percentage (BF %) and waist circumference (WC). DESIGN: The study consisted of 2128 participants from the Danish part of the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) cohort with repeated information on coffee consumption, adiposity measures and covariates during an 11 year period. Linear regression analyses were conducted to assess the associations between baseline coffee consumption and subsequent change in adiposity measures. The same analyses were conducted analyzing associations between change in coffee consumption and concurrent as well as subsequent changes in adiposity measures, RESULTS: We found no consistent evidence of associations between baseline coffee consumption and subsequent 6-year changes in adiposity measures. A statistically significant association between increased coffee consumption over a 6-year period and decreased concurrent gain in BMI, FMI, BF % and WC (-0.05 kg m(-2) (95% confidence interval (Cl): -0.07, -0.02), -0.04 kg m(-2) (95% CI: -0.06, -0.02), -0.08% (95% CI: -0.13, -0.04) and -0.23 cm (95% CI: -0.34, -0.12), respectively, per 1 cup day 1 increase in coffee consumption) was found. No association was seen between change in coffee consumption and concurrent change in FFMI. Moreover, an initial change in coffee consumption during the first 5-year period was not associated with change in adiposity during the subsequent 6-year period. CONCLUSIONS: Increased coffee consumption was associated with a decreased concurrent gain in body weight, fat mass and waist circumference, but the associations were weak. Moreover, a causal relationship could not be established, as we found no evidence of associations between an initial change in coffee consumption and subsequent change in adiposity.
C1 [Larsen, S. C.; Mikkelsen, M-L K.; Frederiksen, P.; Heitmann, B. L.] Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, Nordre Fasanvej 57,Entrance 5,Ground Floor, DK-2000 Frederiksberg, The Capital Reg, Denmark.
   [Heitmann, B. L.] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.
   [Heitmann, B. L.] Univ Sydney, Boden Inst Obes Nutr Exercise & Eating Disorders, Sydney, NSW, Australia.
   [Heitmann, B. L.] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark.
C3 University of Copenhagen; Bispebjerg Hospital; University of Southern Denmark; University of Sydney; University of Copenhagen
RP Larsen, SC (corresponding author), Bispebjerg & Frederiksberg Hosp, Parker Inst, Res Unit Dietary Studies, Nordre Fasanvej 57,Entrance 5,Ground Floor, DK-2000 Frederiksberg, The Capital Reg, Denmark.
EM sofus.larsen@regionh.dk
CR ACHESON KJ, 1980, AM J CLIN NUTR, V33, P989, DOI 10.1093/ajcn/33.5.989
   Allison DB, 2001, CRIT REV FOOD SCI, V41, P1, DOI 10.1080/20014091091661
   Berkey CS, 2008, J PEDIATR, V153, P635, DOI 10.1016/j.jpeds.2008.04.072
   BRACCO D, 1995, AM J PHYSIOL-ENDOC M, V269, PE671, DOI 10.1152/ajpendo.1995.269.4.E671
   Carter BE, 2012, APPETITE, V59, P755, DOI 10.1016/j.appet.2012.08.015
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   DULLOO AG, 1989, AM J CLIN NUTR, V49, P44, DOI 10.1093/ajcn/49.1.44
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Greenberg JA, 2012, J AM COLL NUTR, V31, P160, DOI 10.1080/07315724.2012.10720023
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2016, EUR J EPIDEMIOL, V31, P1191, DOI 10.1007/s10654-016-0202-2
   Gunter MJ, 2017, ANN INTERN MED, V167, P236, DOI 10.7326/M16-2945
   Harpaz Eynav, 2017, JOURNAL OF BASIC AND CLINICAL PHYSIOLOGY AND PHARMACOLOGY, V28, P1, DOI 10.1515/jbcpp-2016-0090
   Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x
   Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728
   JUNG RT, 1981, CLIN SCI, V60, P527, DOI 10.1042/cs0600527
   Larsen SC, 2014, NUTR J, V13, P0, DOI 10.1186/1475-2891-13-43
   Larsen SC, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0069689
   Lopez-Garcia E, 2006, AM J CLIN NUTR, V83, P674, DOI 10.1093/ajcn.83.3.674
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nuhu Abdulmumin A, 2014, ISRN NUTR, V2014, P384230, DOI 10.1155/2014/384230
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Shimoda Hiroshi, 2006, BMC COMPLEMENT ALTERN MED, V6, P9, DOI 10.1186/1472-6882-6-9
   Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   Wang AQ, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep33711
   Wang TG, 2017, BMC MED, V15, P0, DOI 10.1186/s12916-017-0862-0
   YOSHIDA T, 1994, INT J OBESITY, V18, P345
NR 29
TC 29
Z9 29
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
EI 1476-5497
J9 INT J OBESITY
JI Int. J. Obes.
PD APR 15
PY 2018
VL 42
IS 4
BP 880
EP 886
DI 10.1038/ijo.2017.310
PG 7
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA GG4QL
UT WOS:000432681200037
PM 29381147
DA 2025-04-28
ER

PT J
AU Sótoudeh, G
   Abshirini, M
   Bagheri, F
   Siassi, F
   Koohdani, F
   Aslany, Z
AF Sotoudeh, Gity
   Abshirini, Maryam
   Bagheri, Fariba
   Siassi, Fereydoun
   Koohdani, Fariba
   Aslany, Zahra
TI Higher dietary total antioxidant capacity is inversely related to prediabetes: A case-control study
SO NUTRITION
LA English
DT Article
DE Dietary total antioxidant capacity; Oxidative stress; Fasting blood sugar; Prediabetes
ID oxidative stress; metabolic syndrome; glucose; obesity; cohort; adults; adolescents; children; healthy; cancer
AB Objectives: Dietary total antioxidant capacity (DTAC) has been proposed as a tool for assessing the intake of antioxidants. The relationship between DTAC and blood glucose levels has been investigated mostly in healthy people. The aim of this study was to evaluate the association between DTAC and prediabetes morbidity in a case-control study. Methods: We examined 300 individuals with and without prediabetes (n = 150/group) who attended a Diabetes Screening Center in Shahreza, Iran. The anthropometric measures, physical activity, and blood glucose levels of all participants were measured. Food intake over the previous year was determined using a semiquantitative food frequency questionnaire, and sex-specific, energy-adjusted DTAC was calculated using the U.S. Department of Agriculture's database. Logistic reg/ression was used to model the relationship between DTAC and prediabetes morbidity. Results: The mean DTAC was significantly lower in individuals with prediabetes than in the control group (P < 0.001). Across increasing DTAC quartiles, the participants had lower fasting blood glucose and 2-h postchallenge plasma glucose (P-trend < 0.02). After adjustment for body mass index; physical activity; education; dietary intake of fiber, fat, energy, and coffee; participants in the fourth quartile of DTAC were less likely to experience prediabetes compared with those in the first quartile (odds ratio, 0.18; 95% confidence interval, 0.07-0.49). Conclusion: The DTAC score appears useful when assessing the antioxidant capacity of diet and to better understand the relationship between diet and prediabetes morbidity. Future studies are needed to confirm the findings from the present study in other populations. (C) 2017 Elsevier Inc. All rights reserved.
C1 [Sotoudeh, Gity; Abshirini, Maryam; Bagheri, Fariba; Siassi, Fereydoun; Aslany, Zahra] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
   [Koohdani, Fariba] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Cellular, Mol Nutr, Tehran, Iran.
C3 Tehran University of Medical Sciences; Tehran University of Medical Sciences
RP Sótoudeh, G (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.
EM Gsotodeh@tums.ac.ir
FU Tehran University of Medical Sciences
CR Agudo A, 2007, AM J CLIN NUTR, V85, P1634, DOI 10.1093/ajcn/85.6.1634
   Unknown -, 2010, US DEP AGR, V0, P0
   Avignon A, 2012, NUTRITION, V28, P715, DOI 10.1016/j.nut.2012.01.001
   Azadbakht L, 2009, J NUTR, V139, P335, DOI 10.3945/jn.108.096297
   Azizi F, 2015, IJEM, V17, P1
   Bagheri F, 2016, BRIT J NUTR, V116, P874, DOI 10.1017/S0007114516002634
   Bahadoran Z, 2012, NUTR METAB, V9, P0, DOI 10.1186/1743-7075-9-70
   Barnard ND, 2005, AM J MED, V118, P991, DOI 10.1016/j.amjmed.2005.03.039
   Bhagwat S, 2007, USDA DATABASE OXYGEN, V0, P1
   Coskun O, 2005, PHARMACOL RES, V51, P117, DOI 10.1016/j.phrs.2004.06.002
   Craig ME, 2009, PEDIATR DIABETES, V10, P3, DOI 10.1111/j.1399-5448.2009.00568.x
   Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X
   Derakhshan A, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0102563
   Ford ES, 2001, PREV MED, V32, P33, DOI 10.1006/pmed.2000.0772
   Franzini L, 2012, NUTR METAB CARDIOVAS, V22, P50, DOI 10.1016/j.numecd.2010.04.001
   Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI 10.1172/JCI20042162S
   Hadaegh F, 2008, BMC PUBLIC HEALTH, V8, P0, DOI 10.1186/1471-2458-8-176
   Hermsdorff HHM, 2011, NUTR METAB, V8, P0, DOI 10.1186/1743-7075-8-59
   Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398
   Kataja-Tuomola MK, 2011, EUR J CLIN NUTR, V65, P590, DOI 10.1038/ejcn.2010.283
   Kavanaugh CJ, 2007, JNCI-J NATL CANCER I, V99, P1074, DOI 10.1093/jnci/djm037
   Li CY, 2009, DIABETES CARE, V32, P342, DOI 10.2337/dc08-1128
   Maritim AC, 2003, J BIOCHEM MOL TOXIC, V17, P24, DOI 10.1002/jbt.10058
   Moghaddam MB, 2012, WORLD APPL SCI J, V18, P1073, DOI 10.5829/idosi.wasj.2012.18.08.754
   Morris DH, 2013, DIABETOLOGIA, V56, P1489, DOI 10.1007/s00125-013-2902-4
   Okubo H, 2014, NUTR METAB CARDIOVAS, V24, P301, DOI 10.1016/j.numecd.2013.08.001
   Pellegrini N, 2003, J NUTR, V133, P2812, DOI 10.1093/jn/133.9.2812
   Pham-Huy Lien Ai, 2008, INT J BIOMED SCI, V4, P89
   Psaltopoulou T, 2011, NUTR METAB CARDIOVAS, V21, P561, DOI 10.1016/j.numecd.2009.11.005
   Puchau B, 2010, INT J FOOD SCI NUTR, V61, P713, DOI 10.3109/09637481003757860
   Puchau B, 2009, J AM COLL NUTR, V28, P648, DOI 10.1080/07315724.2009.10719797
   Puchau B, 2010, NUTRITION, V26, P534, DOI 10.1016/j.nut.2009.06.017
   Shen XH, 2009, INT J VITAM NUTR RES, V79, P255, DOI 10.1024/0300-9831.79.4.255
   Tabák AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001
   Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S
   Wu XL, 2004, J FOOD COMPOS ANAL, V17, P407, DOI 10.1016/j.jfca.2004.03.001
   Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7
NR 38
TC 24
Z9 25
U1 1
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD FEB 15
PY 2018
VL 46
IS 
BP 20
EP 25
DI 10.1016/j.nut.2017.08.005
PG 6
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA FT2XT
UT WOS:000423010000004
PM 29290350
DA 2025-04-28
ER

PT J
AU Stutz, B
   Ahola, AJ
   Harjutsalo, V
   Forsblom, C
   Groop, PH
AF Stutz, B.
   Ahola, A. J.
   Harjutsalo, V.
   Forsblom, C.
   Groop, P. -H.
TI Association between habitual coffee consumption and metabolic syndrome in type 1 diabetes
SO NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
LA English
DT Article
DE Coffee consumption; Metabolic syndrome; Type 1 diabetes; Insulin resistance; Renal function
ID tea consumption; cardiovascular-disease; glycemic control; risk; nephropathy; metaanalysis; hypertension; progression; adults
AB Background and aims: In the general population, habitual coffee consumption is inversely associated with the metabolic syndrome, a syndrome that is rather common also in patients with type 1 diabetes. However, whether coffee intake is beneficially related to the metabolic syndrome also in type 1 diabetes, is not known. We, therefore, studied the potential association between coffee consumption and the metabolic syndrome in a large population of individuals with type 1 diabetes. Furthermore, we investigated whether coffee consumption is associated with insulin resistance (estimated glucose disposal rate, eGDR), kidney function (estimated glomerular filtration rate, eGFR), and low-grade chronic inflammation (high-sensitivity C-reactive protein, hsCRP). Methods and results: Data from 1040 participants in the Finnish Diabetic Nephropathy Study were included in these cross-sectional analyses. Metabolic syndrome was assumed if at least 3 of the following cardiovascular risk factors were present: central obesity, high blood pressure, low HDL-cholesterol concentration, high triglyceride concentration, and hyperglycaemia. Subjects were categorized based on self-reported daily coffee intake: non-consumers (<1 cup/d), low (>= 1 cups/d < 3), moderate (>= 3 cups/d < 5), and high coffee consumption (>= 5 cups/d). In multivariable logistic regression analysis, moderate and high coffee consumption was associated with increased odds of the metabolic syndrome. Moreover, any level of coffee consumption was associated with increased risk of the blood pressure-component. An increasing trend was observed in the eGFR with increasing coffee consumption. Conclusions: In type 1 diabetes, high coffee intake is associated with the metabolic syndrome, and especially its blood pressure-component. (C) 2018 Published by Elsevier B.V.
C1 [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Folkhalsan Res Ctr, Folkhalsan Inst Genet, Helsinki, Finland.
   [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Univ Helsinki, Abdominal Ctr Nephrol, Helsinki, Finland.
   [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Univ Helsinki, Cent Hosp, Helsinki, Finland.
   [Stutz, B.; Ahola, A. J.; Harjutsalo, V.; Forsblom, C.; Groop, P. -H.] Univ Helsinki, Res Programs Unit, Diabet & Obes, Helsinki, Finland.
   [Harjutsalo, V.] Natl Inst Hlth & Welf, Diabet Prevent Unit, Helsinki, Finland.
   [Groop, P. -H.] Monash Univ, Cent Clin Sch, Dept Diabet, Melbourne, Vic, Australia.
C3 Folkhalsan Research Center; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Finland National Institute for Health & Welfare; Monash University
RP Groop, PH (corresponding author), Univ Helsinki, Folkhalsan Res Ctr, Biomedicum Helsinki C318b,POB 63, FIN-00014 Helsinki, Finland.
EM per-henrik.groop@helsinki.fi
FU Eli Lilly; Roche; Astra Zeneca; Boehringer-Ingelheim; EloWater; Genzyme; MSD; Novartis; Novo Nordisk; Sanofi; Folkhalsan Research Foundation; Wilhelm and Else Stockmann Foundation; Academy of Finland; Novo Nordisk Foundation; Signe and Ane Gyllenberg Foundation; Helsinki University Central Hospital Research Funds; Paivikki and Sakari Sohlberg Foundation; Diabetes Wellness Finland
CR Agudelo-Ochoa GM, 2016, J NUTR, V146, P524, DOI 10.3945/jn.115.224774
   Ahola AJ, 2017, SCI REP-UK, V7, P0, DOI 10.1038/s41598-017-06885-7
   Ahola AJ, 2012, ANN MED, V44, P73, DOI 10.3109/07853890.2010.530682
   Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644
   Chillarón JJ, 2009, J CLIN ENDOCR METAB, V94, P3530, DOI 10.1210/jc.2009-0960
   Cornelis MC, 2015, CURR OPIN LIPIDOL, V26, P20, DOI 10.1097/MOL.0000000000000143
   Ding M, 2014, CIRCULATION, V129, P643, DOI 10.1161/CIRCULATIONAHA.113.005925
   Greenberg JA, 2006, AM J CLIN NUTR, V84, P682, DOI 10.1093/ajcn/84.4.682
   Grosso G, 2017, NUTRIENTS, V9, P0, DOI 10.3390/nu9080890
   Grosso G, 2017, ANNU REV NUTR, V37, P131, DOI 10.1146/annurev-nutr-071816-064941
   Grosso G, 2015, EUR J NUTR, V54, P1129, DOI 10.1007/s00394-014-0789-6
   Hansen TK, 2010, DIABETOLOGIA, V53, P1517, DOI 10.1007/s00125-010-1742-8
   Herber-Gast GCM, 2016, AM J CLIN NUTR, V103, P1370, DOI 10.3945/ajcn.115.112755
   Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Marventano S, 2016, CLIN NUTR, V35, P1269, DOI 10.1016/j.clnu.2016.03.012
   Matsuura H, 2012, J EPIDEMIOL, V22, P160, DOI 10.2188/jea.JE20110068
   Natella F, 2012, NUTR REV, V70, P207, DOI 10.1111/j.1753-4887.2012.00470.x
   Nordestgaard AT, 2015, INT J EPIDEMIOL, V44, P551, DOI 10.1093/ije/dyv083
   Nordic Council of Ministers, 2014, NORD NUTR REC 2012 I, V002, P2012
   ONeill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   Rebello SA, 2013, CURR CARDIOL REP, V15, P0, DOI 10.1007/s11886-013-0403-1
   Riksen NP, 2009, PHARMACOL THERAPEUT, V121, P185, DOI 10.1016/j.pharmthera.2008.10.006
   Saraheimo M, 2003, DIABETOLOGIA, V46, P1402, DOI 10.1007/s00125-003-1194-5
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shi XQ, 2016, NUTR J, V15, P0, DOI 10.1186/s12937-016-0220-7
   Thorn LM, 2009, DIABETES CARE, V32, P950, DOI 10.2337/dc08-2022
   Thorn LM, 2005, DIABETES CARE, V28, P2019, DOI 10.2337/diacare.28.8.2019
   Tunnicliffe JM, 2008, APPL PHYSIOL NUTR ME, V33, P1290, DOI 10.1139/H08-123
   Wadén J, 2005, DIABETES CARE, V28, P777, DOI 10.2337/diacare.28.4.777
   Wadwa RP, 2005, DIABETES CARE, V28, P1051, DOI 10.2337/diacare.28.5.1051
   Zhang ZZ, 2011, AM J CLIN NUTR, V93, P1212, DOI 10.3945/ajcn.110.004044
NR 32
TC 23
Z9 24
U1 0
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0939-4753
EI 1590-3729
J9 NUTR METAB CARDIOVAS
JI Nutr. Metab. Carbiovasc. Dis.
PD MAY 15
PY 2018
VL 28
IS 5
BP 470
EP 476
DI 10.1016/j.numecd.2018.01.011
PG 7
WC Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition & Dietetics
SC Cardiovascular System & Cardiology; Endocrinology & Metabolism; Nutrition & Dietetics
GA GG1IZ
UT WOS:000432442000006
PM 29501444
DA 2025-04-28
ER

PT J
AU Karusheva, Y
   Kunstein, L
   Bierwagen, A
   Nowotny, B
   Kabisch, S
   Groener, JB
   Fleitmann, AK
   Herder, C
   Pacini, G
   Strassburger, K
   Häring, HU
   Nawroth, PP
   Pfeiffer, AFH
   Burkart, V
   Müssig, K
   Roden, M
   Szendroedi, J
AF Karusheva, Yanislava
   Kunstein, Lejla
   Bierwagen, Alessandra
   Nowotny, Bettina
   Kabisch, Stefan
   Groener, Jan B.
   Fleitmann, Ann Kristin
   Herder, Christian
   Pacini, Giovanni
   Strassburger, Klaus
   Haering, Hans-Ulrich
   Nawroth, Peter P.
   Pfeiffer, Andreas F. H.
   Burkart, Volker
   Muessig, Karsten
   Roden, Michael
   Szendroedi, Julia
TI An 8-week diet high in cereal fiber and coffee but free of red meat does not improve beta-cell function in patients with type 2 diabetes mellitus: a randomized controlled trial
SO NUTRITION & METABOLISM
LA English
DT Article
DE Calorie restriction; Coffee; Dietary fiber; Red meat; Beta-cell function
ID insulin sensitivity; tea consumption; whole-grain; risk; resistance; secretion; fat; individuals; tolerance; disease
AB BackgroundHigher dietary intake of fibers and coffee, but lower red meat intake is associated with reduced risk for type 2 diabetes in epidemiological studies. We hypothesized that a calorie-restricted diet, which is high in fiber and coffee, but free of red meat, improves beta-cell function in patients with T2D.MethodsIn a randomized parallel-group pilot trial, obese type 2 diabetes patients were randomly allocated to consume either a diet high in cereal fiber and coffee, but free of red meat (n=17) (L-RISK) or a diet low in fiber, free of coffee but high in red meat (n=20) (H-RISK) for 8weeks. Insulin secretion was assessed from glucagon stimulation tests (GST) and mixed-meal tolerance tests (MMTT) before and after dietary intervention.ResultsBoth diets resulted in comparable reduction of fasting concentrations of insulin (H-RISK -28% vs. L-RISK -32%, bothp<0.01), C-peptide (H-RISK -26% vs. L-RISK -30%, bothp<0.01) and blood glucose (H-RISK -6.8%, p<0.05 vs. L-RISK -10%, p<0.01). Gastric inhibitory peptide (GIP) secretion increased by 24% after 8weeks in the L-RISK only (p<0.01). However, GST and MMTT showed no differences in insulin secretion after intervention.ConclusionsCalorie restriction independent of the intake of fiber, coffee or meat failed to improve beta-cell function, but improved GIP secretion in obese patients with type 2 diabetes.Trial registrationRegistration at Clinicaltrials.gov, Identifier number: NCT01409330, Registered 4 August 2011 - Retrospectively registered.
C1 [Karusheva, Yanislava; Kunstein, Lejla; Bierwagen, Alessandra; Nowotny, Bettina; Fleitmann, Ann Kristin; Herder, Christian; Burkart, Volker; Muessig, Karsten; Roden, Michael; Szendroedi, Julia] Heinrich Heine Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Karusheva, Yanislava; Kunstein, Lejla; Bierwagen, Alessandra; Nowotny, Bettina; Kabisch, Stefan; Herder, Christian; Strassburger, Klaus; Haering, Hans-Ulrich; Pfeiffer, Andreas F. H.; Burkart, Volker; Muessig, Karsten; Roden, Michael; Szendroedi, Julia] German Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   [Kunstein, Lejla; Muessig, Karsten; Roden, Michael; Szendroedi, Julia] Heinrich Heine Univ Dusseldorf, Med Fac, Div Endocrinol & Diabetol, Moorenstr 5, D-40225 Dusseldorf, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] German Inst Nutr Res DifE Potsdam, Dept Clin Nutr, Arthur Scheunert Allee 114-1, D-14558 Bergholz Rehbrucke, Germany.
   [Kabisch, Stefan; Pfeiffer, Andreas F. H.] Charite Univ Med Berlin, Dept Endocrinol Diabet & Nutr, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.
   [Groener, Jan B.; Nawroth, Peter P.] Univ Hosp Heidelberg, Dept Internal Med 1, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
   [Pacini, Giovanni] CNR, Inst Biomed Engn, Metab Unit, Corso Stati Uniti 4, I-35127 Padua, Italy.
   [Strassburger, Klaus] Heinrich Heine Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Haering, Hans-Ulrich] Univ Hosp Tubingen, Div Endocrinol Diabetol Vasc Med Nephrol & Clin C, Dept Internal Med, Otfried Muller Str 10, D-72076 Tubingen, Germany.
   [Haering, Hans-Ulrich] Univ Hosp Tubingen, Inst Diabet Res & Metab Dis, Otfried Muller Str 10, D-72076 Tubingen, Germany.
C3 Leibniz Association; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Association; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Ruprecht Karls University Heidelberg; Consiglio Nazionale delle Ricerche (CNR); Heinrich Heine University Dusseldorf; Leibniz Association; Deutsches Diabetes-Zentrum (DDZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital
RP Szendroedi, J (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.; Szendroedi, J (corresponding author), German Ctr Diabet Res DZD, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM julia.szendroedi@ddz.uni-duesseldorf.de
FU DDZ - German Diabetes Center - German Federal Ministry of Health (Berlin, Germany); Ministry of Culture and Science of the state North Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF); Helmholtz Alliance Imaging and Curing Environmental Metabolic Diseases (ICEMED)
CR Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI 10.1001/jama.291.10.1199-b
   Aune D, 2009, DIABETOLOGIA, V52, P2277, DOI 10.1007/s00125-009-1481-x
   Brun T, 2015, HUM MOL GENET, V24, P5270, DOI 10.1093/hmg/ddv247
   Carlessi R, 2017, EUR J CLIN NUTR, V71, P890, DOI 10.1038/ejcn.2017.49
   Cho SS, 2013, AM J CLIN NUTR, V98, P594, DOI 10.3945/ajcn.113.067629
   Dandona P, 2015, AM J PHYSIOL-ENDOC M, V308, PE185, DOI 10.1152/ajpendo.00275.2014
   de Mello VDF, 2006, AM J CLIN NUTR, V83, P1032, DOI 10.1093/ajcn/83.5.1032
   Dominguez LJ, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0141760
   Ghanim H, 2017, J CLIN ENDOCR METAB, V102, P858, DOI 10.1210/jc.2016-2669
   Greenbaum CJ, 2008, DIABETES CARE, V31, P1966, DOI 10.2337/dc07-2451
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jang Y, 2001, ARTERIOSCL THROM VAS, V21, P2065, DOI 10.1161/hq1201.100258
   Juntunen KS, 2003, AM J CLIN NUTR, V77, P385
   Keijzers GB, 2002, DIABETES CARE, V25, P364, DOI 10.2337/diacare.25.2.364
   Kempf K, 2010, AM J CLIN NUTR, V91, P950, DOI 10.3945/ajcn.2009.28548
   Kim EK, 2016, J KOREAN MED SCI, V31, P222, DOI 10.3346/jkms.2016.31.2.222
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Krebs M, 2003, DIABETOLOGIA, V46, P917, DOI 10.1007/s00125-003-1129-1
   Lajous M, 2012, DIABETES CARE, V35, P128, DOI 10.2337/dc11-1518
   Lean MEJ, 2018, LANCET, V391, P541, DOI 10.1016/S0140-6736(17)33102-1
   Maedler K, 2017, J CLIN INVEST, V127, P1589, DOI 10.1172/JCI92172
   Markova M, 2017, GASTROENTEROLOGY, V152, P571, DOI 10.1053/j.gastro.2016.10.007
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Nowotny B, 2015, DIABETOLOGIA, V58, P255, DOI 10.1007/s00125-014-3457-8
   Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179
   Pan A, 2011, AM J CLIN NUTR, V94, P1088, DOI 10.3945/ajcn.111.018978
   Post RE, 2012, J AM BOARD FAM MED, V25, P16, DOI 10.3122/jabfm.2012.01.110148
   Loureiro LMR, 2018, INT J SPORT NUTR EXE, V28, P284, DOI 10.1123/ijsnem.2017-0342
   Schulze MB, 2007, DIABETES CARE, V30, P510, DOI 10.2337/dc06-2089
   Sjöström L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988
   Szendroedi J, 2016, CARDIOVASC DIABETOL, V15, P0, DOI 10.1186/s12933-016-0374-9
   Tang C, 2012, DIABETOLOGIA, V55, P1366, DOI 10.1007/s00125-012-2474-8
   Tilg H, 2017, NAT REV GASTRO HEPAT, V14, P32, DOI 10.1038/nrgastro.2016.147
   Tura A, 2006, DIABETES RES CLIN PR, V72, P298, DOI 10.1016/j.diabres.2005.10.005
   van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97
   van Nielen M, 2014, J NUTR, V144, P1423, DOI 10.3945/jn.114.193706
   Weber KS, 2016, EXP CLIN ENDOCR DIAB, V124, P230, DOI 10.1055/s-0035-1569354
   Yamakado M, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep11918
   Ye EQ, 2012, J NUTR, V142, P1304, DOI 10.3945/jn.111.155325
   Ziegler D, 2015, DIABETES CARE, V38, P1750, DOI 10.2337/dc15-0466
NR 40
TC 4
Z9 4
U1 1
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-7075
EI 
J9 NUTR METAB
JI Nutr. Metab.
PD DEC 29
PY 2018
VL 15
IS 
BP 
EP 
DI 10.1186/s12986-018-0324-5
PG 8
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HF9GP
UT WOS:000454550800001
PM 30619502
DA 2025-04-28
ER

PT J
AU Quinhoneiro, DCG
   Nicoletti, CF
   Pinhel, MAS
   Noronha, NY
   Braga, CBM
   Oliveira, BAP
   Cortes-Oliveira, C
   Oliveira, WP
   Salgado, W
   Marchini, JS
   Nonino, CB
AF Gomes Quinhoneiro, Driele Cristina
   Nicoletti, Carolina Ferreira
   Souza Pinhel, Marcela Augusta
   Noronha, Natalia Yumi
   Moreno Braga, Camila Bitu
   Parenti Oliveira, Bruno Affonso
   Cortes-Oliveira, Cristiana
   Oliveira, Wanderley Pereira
   Salgado Junior, Wilson
   Marchini, Julio Sergio
   Nonino, Carla Barbosa
TI Green tea supplementation upregulates uncoupling protein 3 expression in severe obese women adipose tissue but does not promote weight loss
SO INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
LA English
DT Article
DE Catechin; green tea; UCP3; obesity; nutrigenomics
ID diet-induced obesity; fat oxidation; body-composition; catechin-polyphenols; energy-expenditure; gene-expression; messenger-rna; extract; caffeine; consumption
AB This study aims (i) to verify expression of the UCPs, PLIN1, PPARG2, and ADRB3 genes in the abdominal subcutaneous adipose tissue of obese women at baseline and after 8 weeks of supplementation with decaffeinated green tea extract, and (ii) to associate findings with clinical parameters. This is a longitudinal study during which 11 women with obesity grade III were submitted to supplementation with 450 mg of (-)-epigallocatechin gallate (EGCG) (intervention group); the control group consisted of 10 eutrophic women. Anthropometric parameters [weight, height, and body mass index (BMI)], resting metabolic rate (RMR, measured by indirect calorimetry), and gene expression (measured by real-time PCR, RT-qPCR) were determined before and after supplementation. After 8 weeks, clinical parameters and UCP1, PLIN1, PPARG2, and ADRB3 expression remained unaltered in the intervention group (p > .05). Genetic analysis also showed that the UCP3 gene was upregulated (p = .026), but its upregulation did not promote weight loss.
C1 [Gomes Quinhoneiro, Driele Cristina; Nicoletti, Carolina Ferreira; Souza Pinhel, Marcela Augusta; Noronha, Natalia Yumi; Moreno Braga, Camila Bitu; Parenti Oliveira, Bruno Affonso; Cortes-Oliveira, Cristiana; Marchini, Julio Sergio; Nonino, Carla Barbosa] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, SP, Brazil.
   [Oliveira, Wanderley Pereira] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, Brazil.
   [Salgado Junior, Wilson] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Surg & Anat, Ribeirao Preto, Brazil.
C3 Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo
RP Nonino, CB (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, Ribeirao Preto, SP, Brazil.; Nonino, CB (corresponding author), Ave Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM carla@fmrp.usp.br
FU Sao Paulo Research Foundation (FAPESP) [2014/00669-0, 2013/08916-4]; Vinnova [2014-00669] Funding Source: Vinnova; Swedish Research Council [2013-08916] Funding Source: Swedish Research Council; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [14/00669-0] Funding Source: FAPESP
CR Auvichayapat P, 2008, PHYSIOL BEHAV, V93, P486, DOI 10.1016/j.physbeh.2007.10.009
   Baladia E, 2014, NUTR HOSP, V29, P479, DOI 10.3305/nh.2014.29.3.7118
   Bérubé-Parent S, 2005, BRIT J NUTR, V94, P432, DOI 10.1079/BJN20051502
   Bouchard C, 1997, HUM MOL GENET, V6, P1887, DOI 10.1093/hmg/6.11.1887
   Brown JC, 2016, J CLIN ONCOL, V34, P4217, DOI 10.1200/JCO.2016.66.8699
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Cermak R, 2006, CURR DRUG METAB, V7, P729, DOI 10.2174/138920006778520570
   Chen IJ, 2016, CLIN NUTR, V35, P592, DOI 10.1016/j.clnu.2015.05.003
   Chen N, 2009, NUTR RES, V29, P784, DOI 10.1016/j.nutres.2009.10.003
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Clifford MN, 2001, CRC CR REV FOOD SCI, V41, P393
   Cooper R, 2005, J ALTERN COMPLEM MED, V11, P521, DOI 10.1089/acm.2005.11.521
   Diano S, 2012, TRENDS MOL MED, V18, P52, DOI 10.1016/j.molmed.2011.08.003
   Diepvens K, 2006, PHYSIOL BEHAV, V87, P185, DOI 10.1016/j.physbeh.2005.09.013
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Dulloo AG, 2001, BIOCHEM SOC T, V29, P785, DOI 10.1042/BST0290785
   Flatt JP, 1998, HDB OBESITY, V0, P513
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628
   Frood S, 2013, CURR OBES REP, V2, P320, DOI 10.1007/s13679-013-0072-9
   Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp
   Hase T, 2001, JOURNAL OF OLEO SCIENCE, V50, P599, DOI 10.5650/jos.50.599
   Hasler CM, 2002, J NUTR, V132, P3772, DOI 10.1093/jn/132.12.3772
   Hodgson AB, 2013, ADV NUTR, V4, P129, DOI 10.3945/an.112.003269
   Hosseini A, 2010, J ANIM PHYSIOL AN N, V94, Pe178, DOI 10.1111/j.1439-0396.2010.01002.x
   Hsu CH, 2008, CLIN NUTR, V27, P363, DOI 10.1016/j.clnu.2008.03.007
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Janssens PLHR, 2016, PHYSIOL BEHAV, V162, P83, DOI 10.1016/j.physbeh.2016.01.044
   Khan N, 2007, LIFE SCI, V81, P519, DOI 10.1016/j.lfs.2007.06.011
   Klaus S, 2005, INT J OBESITY, V29, P615, DOI 10.1038/sj.ijo.0802926
   Lee Mak-Soon, 2016, PREV NUTR FOOD SCI, V21, P62, DOI 10.3746/pnf.2016.21.1.62
   Mazon JN, 2017, LIFE SCI, V182, P22, DOI 10.1016/j.lfs.2017.06.002
   Millet L, 1997, J CLIN INVEST, V100, P2665, DOI 10.1172/JCI119811
   Murase T, 2002, INT J OBESITY, V26, P1459, DOI 10.1038/sj.ijo.0802141
   Pena SDJ, 2011, PLOS ONE, V6, P0, DOI 10.1371/journal.pone.0017063
   Rains TM, 2011, J NUTR BIOCHEM, V22, P1, DOI 10.1016/j.jnutbio.2010.06.006
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Schrauwen P, 2001, FASEB J, V15, P2497, DOI 10.1096/fj.01-0400hyp
   SCHUTZ Y, 1992, AM J CLIN NUTR, V55, P670, DOI 10.1093/ajcn/55.3.670
   Shrestha S, 2009, J NUTR, V139, P640, DOI 10.3945/jn.108.103341
   Sueoka N, 2001, ANN NY ACAD SCI, V928, P274
   Toda C, 2014, BEST PRACT RES CL EN, V28, P757, DOI 10.1016/j.beem.2014.02.006
   Walder K, 1998, HUM MOL GENET, V7, P1431, DOI 10.1093/hmg/7.9.1431
   Wang HQ, 2010, OBESITY, V18, P773, DOI 10.1038/oby.2009.256
   Wang S, 2014, J NUTR BIOCHEM, V25, P1, DOI 10.1016/j.jnutbio.2013.09.001
   Weijs PJM, 2010, CLIN NUTR, V29, P347, DOI 10.1016/j.clnu.2009.09.009
   Wolfram S, 2005, ANN NUTR METAB, V49, P54, DOI 10.1159/000084178
   Wulan SN, 2010, MATURITAS, V65, P315, DOI 10.1016/j.maturitas.2009.12.012
   Yan JQ, 2013, SCI CHINA LIFE SCI, V56, P804, DOI 10.1007/s11427-013-4512-2
   Zhang M, 2004, INT J CANCER, V112, P465, DOI 10.1002/ijc.20456
NR 52
TC 17
Z9 17
U1 0
U2 21
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0963-7486
EI 1465-3478
J9 INT J FOOD SCI NUTR
JI Int. J. Food Sci. Nutr.
PD NOV 17
PY 2018
VL 69
IS 8
BP 995
EP 1002
DI 10.1080/09637486.2018.1442819
PG 8
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA GW9JR
UT WOS:000447302200013
PM 29482377
DA 2025-04-28
ER

PT J
AU Cherniack, EP
   Buslach, N
   Lee, HF
AF Cherniack, E. Paul
   Buslach, Natalie
   Lee, Heather F.
TI The Potential Effects of Caffeinated Beverages on Insulin Sensitivity
SO JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION
LA English
DT Review
DE Insulin sensitivity; coffee; tea; caffeine
ID high-fat diet; cardiovascular risk-factors; green tea extract; impaired glucose-tolerance; dose-response metaanalysis; type-2 diabetes-mellitus; rich dark chocolate; decaffeinated coffee; blood-pressure; obese adults
AB Caffeinated beverages, most commonly tea and coffee, may have important effects on insulin regulation that may give their consumption an important role among nutritional factors in the development of diseases of glucose and insulin metabolism, such as diabetes and atherosclerotic vascular diseases. These beverages include compounds that may have contradictory effects on insulin and glucose: Caffeine impairs insulin sensitivity, but polyphenolic molecules within tea, coffee, and cocoa augment the effects of insulin. In addition, epidemiologic associations exist between greater consumption of such beverages and lower risk of diabetes. The beneficial effects of such beverages might be enhanced by changing the process of their preparation and substitution of other substances commonly added to caffeinated beverages that impair the effect of insulin, such as sugar or milk.
C1 [Cherniack, E. Paul] Univ Miami, Miller Sch Med, Div Geriatr & Palliat Med, Miami, FL 33136 USA.
   [Cherniack, E. Paul] Miami VA Med Ctr, Miami, FL USA.
   [Buslach, Natalie] Rosalind Franklin Univ Med & Sci, Chicago Med Sch, Chicago, IL USA.
   [Lee, Heather F.] Univ Miami, Miller Sch Med, Miami, FL 33136 USA.
C3 University of Miami; Chicago Medical School; Rosalind Franklin University of Medicine & Science; University of Miami
RP Cherniack, EP (corresponding author), Bruce Carter Miami VA Med Ctr, 1201 NW 16St,Room NH 445, Miami, FL 33162 USA.
EM evan.cherniack@va.gov
CR Agardh EE, 2004, J INTERN MED, V255, P645, DOI 10.1111/j.1365-2796.2004.01331.x
   Alkerwi A, 2016, BRIT J NUTR, V115, P1661, DOI 10.1017/S0007114516000702
   Almoosawi S, 2012, FOOD FUNCT, V3, P1035, DOI 10.1039/c2fo30060e
   Ärnlöv J, 2004, JAMA-J AM MED ASSOC, V291, P1199, DOI 10.1001/jama.291.10.1199-b
   Ashida H, 2004, BIOFACTORS, V22, P135, DOI 10.1002/biof.5520220126
   Basu A, 2015, J NUTR, V145, P2325, DOI 10.3945/jn.115.215772
   Beam JR, 2015, NUTRITION, V31, P292, DOI 10.1016/j.nut.2014.07.012
   Bruder-Nascimento T, 2013, ARQ BRAS ENDOCRINOL, V57, P642, DOI 10.1590/S0004-27302013000800010
   Cao ZH, 2011, PHYTOTHER RES, V25, P234, DOI 10.1002/ptr.3247
   Catalano D, 2008, CLIMACTERIC, V11, P373, DOI 10.1080/13697130802348728
   Cordero-Herrera I, 2014, FOOD CHEM TOXICOL, V64, P10, DOI 10.1016/j.fct.2013.11.014
   Dawling S, 2001, CANCER RES, V61, P6716
   Deng JN, 2015, EVID-BASED COMPL ALT, V2015, P0
   Di Girolamo FG, 2016, NUTRITION, V32, P928, DOI 10.1016/j.nut.2016.02.001
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Dorenkott MR, 2014, J AGR FOOD CHEM, V62, P2216, DOI 10.1021/jf500333y
   Dostal AM, 2017, J HUM NUTR DIET, V30, P166, DOI 10.1111/jhn.12408
   Dulloo AG, 2000, INT J OBESITY, V24, P252, DOI 10.1038/sj.ijo.0801101
   Ferreira MA, 2016, OBES REV, V17, P1316, DOI 10.1111/obr.12452
   Graham TE, 2001, CAN J PHYSIOL PHARM, V79, P559, DOI 10.1139/cjpp-79-7-559
   Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671
   Grassi D, 2012, HYPERTENSION, V60, P827, DOI 10.1161/HYPERTENSIONAHA.112.193995
   Greer F, 2001, DIABETES, V50, P2349, DOI 10.2337/diabetes.50.10.2349
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Ihm SH, 2012, ATHEROSCLEROSIS, V224, P377, DOI 10.1016/j.atherosclerosis.2012.07.006
   Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184
   Kao YH, 2000, ENDOCRINOLOGY, V141, P980, DOI 10.1210/en.141.3.980
   Kerr D, 2005, DIABETOLOGIA, V48, P1418, DOI 10.1007/s00125-005-1790-7
   Krebs JD, 2012, METABOLISM, V61, P1231, DOI 10.1016/j.metabol.2012.01.021
   Kubot K, 2011, NUTR RES, V31, P421, DOI 10.1016/j.nutres.2011.05.004
   Liu K, 2013, AM J CLIN NUTR, V98, P340, DOI 10.3945/ajcn.112.052746
   Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P320, DOI 10.1007/s00125-010-1957-8
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Mastroiacovo D, 2015, AM J CLIN NUTR, V101, P538, DOI 10.3945/ajcn.114.092189
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Morakinyo A O, 2013, NIGER J PHYSIOL SCI, V28, P179
   Mubarak A, 2013, J AGR FOOD CHEM, V61, P4371, DOI 10.1021/jf400920x
   Muley A, 2012, CURR DIABETES REV, V8, P162, DOI 10.2174/157339912800564016
   Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457
   Pham NM, 2014, METABOLISM, V63, P400, DOI 10.1016/j.metabol.2013.11.008
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Rakvaag E, 2016, EUR J NUTR, V55, P2221, DOI 10.1007/s00394-015-1032-9
   Richard D, 2009, PHARMACOL RES, V59, P351, DOI 10.1016/j.phrs.2009.01.015
   Robertson TM, 2015, BRIT J NUTR, V114, P1218, DOI 10.1017/S0007114515002640
   Santana A, 2015, J NUTR BIOCHEM, V26, P893, DOI 10.1016/j.jnutbio.2015.03.001
   Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260
   Shrime MG, 2011, J NUTR, V141, P1982, DOI 10.3945/jn.111.145482
   SONG SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   Stote KS, 2012, EUR J CLIN NUTR, V66, P1153, DOI 10.1038/ejcn.2012.101
   Wu LY, 2004, EUR J NUTR, V43, P116, DOI 10.1007/s00394-004-0450-x
   Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yang WS, 2014, BRIT J NUTR, V111, P1329, DOI 10.1017/S0007114513003887
   Yarmolinsky J, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0126469
NR 55
TC 3
Z9 3
U1 1
U2 18
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0731-5724
EI 1541-1087
J9 J AM COLL NUTR
JI J. Am. Coll. Nutr.
PD JUN 15
PY 2018
VL 37
IS 2
BP 161
EP 167
DI 10.1080/07315724.2017.1372822
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GA8LV
UT WOS:000428592600011
PM 29313749
DA 2025-04-28
ER

PT J
AU Khalifa, I
   Zhu, W
   Li, KK
   Li, CM
AF Khalifa, Ibrahim
   Zhu, Wei
   Li, Kai-kai
   Li, Chun-mei
TI Polyphenols of mulberry fruits as multifaceted compounds: Compositions, metabolism, health benefits, and stability-A structural review
SO JOURNAL OF FUNCTIONAL FOODS
LA English
DT Review
DE Health benefits; Metabolism; Mulberry fruit; Polyphenols; Stability
ID morus-alba-l.; high-pressure homogenization; radical-scavenging activity; high hydrostatic-pressure; antioxidant activity; in-vitro; nigra l.; chemical-composition; inhibitory-activity; phenolic-compounds
AB Mulberry (Moms sp.) fruits provide high levels of anthocyanins, quercetin glycoside, and chlorogenic acid. Recently, mulberry's polyphenols and their functionalities are spotlighted in different ex vivo and in vivo studies. Meanwhile, the deficiency of systematic knowledge on the health effects and polyphenols composition greatly hinders the development of mulberry as a sustainable fruit. This review briefly summarises the polyphenol compositions, metabolism, health benefits, and their stability in different mulberry production steps. These claimed health effects include anti-oxidative, anti-cancer, anti-diabetes, anti-obesity, and other related effects. However, although the current evidence is promising, further clinical studies are needed to evaluate the role of mulberries' polyphenols to support human health. Besides, the mechanisms by which they confer the health benefits, the bioavailability studies on mulberry's polyphenols are also scarce. We compile the research findings from the available literatures within the last two decades, and we also suggest some future perspectives in this review.
C1 [Khalifa, Ibrahim; Zhu, Wei; Li, Kai-kai; Li, Chun-mei] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Hubei, Peoples R China.
   [Li, Chun-mei] Huazhong Agr Univ, Minist Educ China, Key Lab Environm Correlat Food Sci, Wuhan, Hubei, Peoples R China.
   [Khalifa, Ibrahim] Benha Univ, Fac Agr, Food Technol Dept, Moshtohor 13736, Egypt.
C3 Huazhong Agricultural University; Huazhong Agricultural University; Egyptian Knowledge Bank (EKB); Benha University
RP Li, CM (corresponding author), Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan 430070, Hubei, Peoples R China.
EM lichmyl@mail.hzau.edu.cn
FU National Natural Science Foundation of China [31571839]; Chinese Scholarships Council Foundation [2016GXZ745]
CR Akin M, 2016, ACTA SCI POLONORUM H, V15, P0
   Unknown -, 2013, PLOS ONE, V0, P0
   Bae SH, 2007, LWT-FOOD SCI TECHNOL, V40, P955, DOI 10.1016/j.lwt.2006.06.007
   Bao T, 2016, J FUNCT FOODS, V25, P537, DOI 10.1016/j.jff.2016.07.001
   BARONE FC, 1991, J NEUROSCI RES, V29, P336, DOI 10.1002/jnr.490290309
   BOUTIN JA, 1993, DRUG METAB DISPOS, V21, P1157
   Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Buchanan CJ, 1996, J SCI FOOD AGR, V71, P459, DOI 10.1002/(SICI)1097-0010(199608)71:4<459::AID-JSFA602>3.0.CO;2-H
   Butkhup L, 2013, INT J FOOD SCI TECH, V48, P934, DOI 10.1111/ijfs.12044
   Calín-Sánchez A, 2013, PLANT FOOD HUM NUTR, V68, P370, DOI 10.1007/s11130-013-0382-9
   Cavalcanti RN, 2011, FOOD RES INT, V44, P499, DOI 10.1016/j.foodres.2010.12.007
   Chen CC, 2005, FOOD CHEM, V91, P601, DOI 10.1016/j.foodchem.2004.06.039
   Chen HJ, 2016, SCI HORTIC-AMSTERDAM, V213, P186, DOI 10.1016/j.scienta.2016.10.036
   Chen PN, 2006, CANCER LETT, V235, P248, DOI 10.1016/j.canlet.2005.04.033
   Chen QQ, 2017, LWT-FOOD SCI TECHNOL, V80, P178, DOI 10.1016/j.lwt.2017.02.017
   Cheng JR, 2016, FOOD CHEM, V213, P721, DOI 10.1016/j.foodchem.2016.07.032
   Choi KH, 2016, J MED FOOD, V19, P737, DOI 10.1089/jmf.2016.3665
   Chon SU, 2009, EUR FOOD RES TECHNOL, V230, P231, DOI 10.1007/s00217-009-1165-2
   Donno D, 2015, FOOD RES INT, V69, P179, DOI 10.1016/j.foodres.2014.12.020
   Du Q, 2008, J FOOD COMPOS ANAL, V21, P390, DOI 10.1016/j.jfca.2008.02.007
   Engmann FN, 2015, J FOOD PROCESS PRES, V39, P854, DOI 10.1111/jfpp.12296
   Engmann FN, 2014, J SCI FOOD AGR, V94, P2345, DOI 10.1002/jsfa.6612
   Ercisli S, 2010, FOOD TECHNOLOGY BIOT, V48, P0
   Ercisli S, 2008, SCI HORTIC-AMSTERDAM, V116, P41, DOI 10.1016/j.scienta.2007.10.021
   Ercisli S, 2007, FOOD CHEM, V103, P1380, DOI 10.1016/j.foodchem.2006.10.054
   Eyduran SP, 2015, FOOD TECHNOLOGY BIOT, V88, P0
   Fazaeli M, 2013, FOOD BIOPROCESS TECH, V6, P585, DOI 10.1007/s11947-011-0648-x
   Fazaeli M, 2012, INT J FOOD ENG, V8, P0, DOI 10.1515/1556-3758.2023
   Gerasopoulos D, 1997, J SCI FOOD AGR, V73, P261, DOI 10.1002/(SICI)1097-0010(199702)73:2<261::AID-JSFA724>3.3.CO;2-J
   Gu PS, 2017, J NUTR BIOCHEM, V39, P15, DOI 10.1016/j.jnutbio.2016.08.014
   Gundogdu M, 2011, SCI HORTIC-AMSTERDAM, V132, P37, DOI 10.1016/j.scienta.2011.09.035
   Halvorsen BL, 2002, J NUTR, V132, P461, DOI 10.1093/jn/132.3.461
   Hassimotto NMA, 2008, NUTR RES, V28, P198, DOI 10.1016/j.nutres.2007.12.012
   Hassimotto NMA, 2005, J AGR FOOD CHEM, V53, P2928, DOI 10.1021/jf047894h
   He H, 2013, J AGR FOOD CHEM, V61, P8110, DOI 10.1021/jf4019323
   Hojjatpanah G, 2011, INT J FOOD SCI TECH, V46, P956, DOI 10.1111/j.1365-2621.2011.02573.x
   HOLLMAN PCH, 1995, AM J CLIN NUTR, V62, P1276, DOI 10.1093/ajcn/62.6.1276
   Hsieh YS, 2007, J AGR FOOD CHEM, V55, P10437, DOI 10.1021/jf071868c
   Hsu LS, 2012, FOOD CHEM TOXICOL, V50, P3086, DOI 10.1016/j.fct.2012.05.055
   Huang HP, 2011, FOOD CHEM, V129, P1703, DOI 10.1016/j.foodchem.2011.06.035
   Huo Y, 2002, FAO ANIMAL PROD. HEALTH PAPER, V147, P11
   Imran M, 2010, J ZHEJIANG UNIV-SC B, V11, P973, DOI 10.1631/jzus.B1000173
   Isabelile M, 2008, J AGR FOOD CHEM, V56, P9410, DOI 10.1021/jf801527a
   Iturralde M, 2005, APOPTOSIS, V10, P1369, DOI 10.1007/s10495-005-1511-1
   Jeong JC, 2010, NUTR CANCER, V62, P402, DOI 10.1080/01635580903441287
   Jiang DQ, 2013, FOOD CHEM TOXICOL, V59, P1, DOI 10.1016/j.fct.2013.05.023
   Jiang Y, 2015, FOOD CHEM, V174, P460, DOI 10.1016/j.foodchem.2014.11.083
   Jin Q, 2015, J FOOD SCI, V80, PC2440, DOI 10.1111/1750-3841.13099
   Kang TH, 2006, NEUROSCI LETT, V391, P122, DOI 10.1016/j.neulet.2005.08.053
   Kang WY, 2011, MED CHEM RES, V20, P809, DOI 10.1007/s00044-010-9391-5
   Kawamori R, 2009, LANCET, V373, P1607, DOI 10.1016/S0140-6736(09)60222-1
   Kim AJ, 2006, J MED FOOD, V9, P431, DOI 10.1089/jmf.2006.9.431
   Kim HG, 2010, BRIT J NUTR, V104, P8, DOI 10.1017/S0007114510000218
   이정애, 2011, CULINARY SCIENCE & HOSPITALITY RESEARCH, V17, P285, DOI 10.20878/cshr.2011.17.4.020
   Lee JS, 2013, INT IMMUNOPHARMACOL, V17, P858, DOI 10.1016/j.intimp.2013.09.019
   Lee Joonhee, 2009, PREVENTIVE NUTRITION AND FOOD SCIENCE, V14, P188
   Lee JY, 2004, FOOD SCI BIOTECHNOL, V13, P176
   Lee KM, 2016, FOOD SCI BIOTECHNOL, V25, P1035, DOI 10.1007/s10068-016-0167-7
   Li FH, 2016, FOOD BIOPROCESS TECH, V9, P1233, DOI 10.1007/s11947-016-1715-0
   Li J, 2014, BIOL PLANTARUM, V58, P618, DOI 10.1007/s10535-014-0450-5
   Liang LH, 2012, PHARMACOGN MAG, V8, P215, DOI 10.4103/0973-1296.99287
   Liang LH, 2012, FOOD RES INT, V46, P76, DOI 10.1016/j.foodres.2011.11.024
   Lin JY, 2007, FOOD CHEM, V101, P140, DOI 10.1016/j.foodchem.2006.01.014
   Liu LK, 2008, J FOOD SCI, V73, PH113, DOI 10.1111/j.1750-3841.2008.00801.x
   Liu LK, 2009, J AGR FOOD CHEM, V57, P7605, DOI 10.1021/jf9014697
   Liu XM, 2004, J BIOMED BIOTECHNOL, V0, PP326, DOI 10.1155/S1110724304403052
   Lucia K, 2016, J BERRY RES, V6, P333, DOI 10.3233/JBR-160141
   Marinova EM, 2009, FOOD CHEM, V114, P1498, DOI 10.1016/j.foodchem.2008.11.045
   Medina-Torres L, 2013, LWT-FOOD SCI TECHNOL, V50, P642, DOI 10.1016/j.lwt.2012.07.038
   Memon AA, 2010, POLISH J. FOOD NUTR. SCI, V60, P0
   Mena P, 2016, FOOD RES, V0, P0
   Minhas MA, 2016, PAK J ZOOL, V48, P1381
   Moser P, 2017, FOOD CHEM, V214, P308, DOI 10.1016/j.foodchem.2016.07.081
   Natic MM, 2015, FOOD CHEM, V171, P128, DOI 10.1016/j.foodchem.2014.08.101
   Nikkhah E, 2007, JOURNAL OF BIOLOGICAL SCIENCES, V7, P1412
   Oki T, 2006, J FOOD SCI, V71, PC18, DOI 10.1111/j.1365-2621.2006.tb12382.x
   Özgen M, 2009, SCI HORTIC-AMSTERDAM, V119, P275, DOI 10.1016/j.scienta.2008.08.007
   Pawlowska AM, 2008, J AGR FOOD CHEM, V56, P3377, DOI 10.1021/jf703709r
   Peng CH, 2011, J AGR FOOD CHEM, V59, P2663, DOI 10.1021/jf1043508
   Pérez-Gregorio MR, 2011, LWT-FOOD SCI TECHNOL, V44, P1793, DOI 10.1016/j.lwt.2011.03.007
   Qian ZJ, 2015, SCI REP-UK, V5, P0, DOI 10.1038/srep17348
   Qin CG, 2010, CZECH J FOOD SCI, V28, P117, DOI 10.17221/228/2008-CJFS
   Radojkovic MM, 2012, HEM IND, V66, P545, DOI 10.2298/HEMIND111111002R
   Sakagami H, 2007, IN VIVO, V21, P499
   Sánchez-Salcedo EM, 2015, J FUNCT FOODS, V12, P399, DOI 10.1016/j.jff.2014.12.010
   Sarikaphuti A, 2013, EXP THER MED, V6, P689, DOI 10.3892/etm.2013.1203
   Sato D, 2014, BIOSCI BIOTECH BIOCH, V78, P1123, DOI 10.1080/09168451.2014.921551
   Sengül M, 2005, FOOD CONTROL, V16, P73, DOI 10.1016/j.foodcont.2003.11.010
   Shih PH, 2010, J NUTR BIOCHEM, V21, P598, DOI 10.1016/j.jnutbio.2009.03.008
   Singh KP, 1997, INDIAN DRUGS, V34, P488
   Singhal Brij Kishore, 2010, JOURNAL OF FRUIT AND ORNAMENTAL PLANT RESEARCH, V18, P83
   Song N, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/150617
   Song W, 2009, J AGR FOOD CHEM, V57, P9133, DOI 10.1021/jf9022228
   Spencer JPE, 2007, GENES NUTR, V2, P257, DOI 10.1007/s12263-007-0056-z
   Suh HJ, 2003, NAHRUNG, V47, P132, DOI 10.1002/food.200390024
   Tan J, 1999, BRAIN RES BULL, V50, P143, DOI 10.1016/S0361-9230(99)00122-7
   [唐翠明 TANG CuiMing], 2008, 蚕业科学 ACTA SERICOLOGICA SINICA, V34, P24
   Targhi RG, 2017, RADIAT PHYS CHEM, V130, P297, DOI 10.1016/j.radphyschem.2016.08.030
   Tomas M, 2016, J SCI FOOD AGR, V0, P0
   Tomas M, 2015, FOOD CHEM, V186, P277, DOI 10.1016/j.foodchem.2014.11.151
   Toydemir G, 2013, J FUNCT FOODS, V5, P1402, DOI 10.1016/j.jff.2013.05.008
   Trivellini A, 2016, IND CROP PROD, V83, P241, DOI 10.1016/j.indcrop.2015.12.039
   Tsujimoto Y, 2007, J BIOCH, V0, P0
   Valentino L, 1984, CLSU CENTRAL LUZON S, V0, P0
   Veberic R, 2015, LWT-FOOD SCI TECHNOL, V60, P509, DOI 10.1016/j.lwt.2014.08.033
   Wang F, 2016, FOOD SCI TECHNOLOGY, V0, P0
   Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t
   Wang RJ, 2011, INT J FOOD PROP, V14, P1, DOI 10.1080/10942910903580900
   Wu T, 2013, PLOS ONE, V8, P0, DOI 10.1371/journal.pone.0077585
   Wu T, 2013, FOOD CHEM, V141, P482, DOI 10.1016/j.foodchem.2013.03.046
   Wu XL, 2004, J AGR FOOD CHEM, V52, P4026, DOI 10.1021/jf049696w
   Yamamoto J, 2006, PLATELETS, V17, P555, DOI 10.1080/09537100600759295
   Yan FJ, 2016, FOOD FUNCT, V7, P425, DOI 10.1039/c5fo00841g
   Yan JJ, 2004, BIOL PHARM BULL, V27, P2024, DOI 10.1248/bpb.27.2024
   Yang XL, 2010, FOOD CHEM TOXICOL, V48, P2374, DOI 10.1016/j.fct.2010.05.074
   You YL, 2015, FOOD FUNCT, V6, P401, DOI 10.1039/c4fo00719k
   Yu YS, 2016, J FOOD SCI, V81, PM702, DOI 10.1111/1750-3841.13213
   Yu YS, 2014, FOOD CHEM, V153, P114, DOI 10.1016/j.foodchem.2013.12.038
   Zadernowski R, 2005, J AGR FOOD CHEM, V53, P2118, DOI 10.1021/jf040411p
   Zhang W, 2008, J FOOD SCI, V73, PC512, DOI 10.1111/j.1750-3841.2008.00854.x
   Zhao Y, 2007, BERRY FRUIT VALUE AD, V0, P0
   Zou H, 2016, FOOD BIOPROCESS TECH, V9, P217, DOI 10.1007/s11947-015-1606-9
NR 123
TC 108
Z9 119
U1 12
U2 220
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1756-4646
EI 
J9 J FUNCT FOODS
JI J. Funct. Food.
PD JAN 15
PY 2018
VL 40
IS 
BP 28
EP 43
DI 10.1016/j.jff.2017.10.041
PG 16
WC Food Science & Technology; Nutrition & Dietetics
SC Food Science & Technology; Nutrition & Dietetics
GA GA0LW
UT WOS:000428005500004
DA 2025-04-28
ER

PT J
AU Liu, CW
   Tsai, HC
   Huang, CC
   Tsai, CY
   Su, YB
   Lin, MW
   Lee, KC
   Hsieh, YC
   Li, TH
   Huang, SF
   Yang, YY
   Hou, MC
   Lin, HC
   Lee, FY
   Lee, SD
AF Liu, Chih-Wei
   Tsai, Hung-Cheng
   Huang, Chia-Chang
   Tsai, Chang-Youh
   Su, Yen-Bo
   Lin, Ming-Wei
   Lee, Kuei-Chuan
   Hsieh, Yun-Cheng
   Li, Tzu-Hao
   Huang, Shiang-Fen
   Yang, Ying-Ying
   Hou, Ming-Chih
   Lin, Han-Chieh
   Lee, Fa-Yauh
   Lee, Shou-Dong
TI Effects and mechanisms of caffeine to improve immunological and metabolic abnormalities in diet-induced obese rats
SO AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
LA English
DT Article
ID free fatty-acids; induced insulin-resistance; necrosis-factor-alpha; human adipose-tissue; hepatic steatosis; lipid-metabolism; peroxisome proliferator; skeletal-muscle; tnf-alpha; sensitivity
AB In obesity, there are no effective therapies for parallel immune and metabolic abnormalities, including systemic/tissue insulin-resistance/ inflammation, adiposity and hepatic steatosis. Caffeine has anti-inflammation, antihepatic steatosis, and anti-insulin resistance effects. In this study, we evaluated the effects and molecular mechanisms of 6 wk of caffeine treatment (HFD-caf) on immunological and metabolic abnormalities of high-fat diet (HFD)-induced obese rats. Compared with HFD vehicle (HFD-V) rats, in HFD-caf rats the suppressed circulating immune cell inflammatory [TNF alpha, MCP-1, IL-6, intercellular adhesion molecule 1 (ICAM-1), and nitrite] profiles were accompanied by decreased liver, white adipose tissue (WAT), and muscle macrophages and their intracellular cytokine levels. Metabolically, the increase in metabolic rates reduced lipid accumulation in various tissues, resulting in reduced adiposity, lower fat mass, decreased body weight, amelioration of hepatic steatosis, and improved systemic/muscle insulin resistance. Further mechanistic approaches revealed an upregulation of tissue lipogenic [(SREBPlc, fatty acid synthase. acetyl-CoA carboxylase)/insulin-sensitizing (GLUT4 and p-IRSl)] markers in HFD-caf rats. Significantly, ex vivo experiments revealed that the cytokine release by the cocultured peripheral blood mononuclear cell (monocyte) and WAT (adipocyte), which are known to stimulate macrophage migration and hepatocyte lipogenesis, were lower in HFD-V groups than HFD-caf groups. Caffeine treatment simultaneously ameliorates immune and metabolic pathogenic signals present in tissue to normalize immunolgical and metabolic abnormalities found in HFD-induced obese rats.
C1 [Liu, Chih-Wei; Tsai, Chang-Youh] Taipei Vet Gen Hosp, Div Allergy Immunol & Rheutnatol, Taipei, Taiwan.
   [Lee, Kuei-Chuan; Hsieh, Yun-Cheng; Yang, Ying-Ying; Hou, Ming-Chih; Lin, Han-Chieh; Lee, Fa-Yauh] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Taipei, Taiwan.
   [Huang, Shiang-Fen] Taipei Vet Gen Hosp, Div Infect, Taipei, Taiwan.
   [Tsai, Hung-Cheng; Huang, Chia-Chang; Su, Yen-Bo; Li, Tzu-Hao; Yang, Ying-Ying] Taipei Vet Gen Hosp, Div Gen Med, Taipei, Taiwan.
   [Lin, Ming-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Div Prevent Med, Taipei, Taiwan.
   [Huang, Chia-Chang; Yang, Ying-Ying] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan.
   [Liu, Chih-Wei; Tsai, Hung-Cheng; Huang, Chia-Chang; Tsai, Chang-Youh; Su, Yen-Bo; Lin, Ming-Wei; Lee, Kuei-Chuan; Hsieh, Yun-Cheng; Li, Tzu-Hao; Huang, Shiang-Fen; Yang, Ying-Ying; Hou, Ming-Chih; Lin, Han-Chieh; Lee, Fa-Yauh; Lee, Shou-Dong] Natl Yang Ming Univ Sch, Dept Med, Taipei, Taiwan.
   [Li, Tzu-Hao] Taichung Vet Gen Hosp, Chia Yi Branch, Chiayi, Taiwan.
   [Lee, Shou-Dong] Chen Hsin Gen Hosp, Taipei, Taiwan.
C3 Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; Cheng Hsin General Hospital
RP Yang, YY (corresponding author), Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, 201 Sec 2,Shih Pai Rd, Taipei 11217, Taiwan.
EM yangyy@vghtpe.gov.tw
FU National Science Council [MOST-105-2314-B-010-024-MY3]; Taipei Veterans General Hospital;  [V105C-010];  [V106C-007];  [VGHUST105-G1-2-2]
CR Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41
   Arias-Loste MT, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17111878
   Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, PC1232, DOI 10.1152/ajpcell.00008.2006
   BRASS EP, 1994, BIOCHEM J, V301, P193, DOI 10.1042/bj3010193
   Bruun JM, 2005, J CLIN ENDOCR METAB, V90, P2282, DOI 10.1210/jc.2004-1696
   Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166
   Chavez-Valdez R, 2009, PEDIATR RES, V65, P203, DOI 10.1203/PDR.0b013e31818d66b1
   Di Gregorio GB, 2005, DIABETES, V54, P2305, DOI 10.2337/diabetes.54.8.2305
   Dray C, 2007, J PHYSIOL BIOCHEM, V63, P329, DOI 10.1007/BF03165764
   Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001
   Durante-Mangoni E, 2006, ALIMENT PHARM THERAP, V24, P1349, DOI 10.1111/j.1365-2036.2006.03114.x
   Engfeldt P, 1988, HORM METAB RES SUPPL, V19, P26
   Ferré P, 2004, DIABETES, V53, PS43, DOI 10.2337/diabetes.53.2007.S43
   Galvez B, 2006, ARTERIOSCL THROM VAS, V26, P1297, DOI 10.1161/01.ATV.0000220381.40739.dd
   Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA
   Green TD, 2012, J LEUKOCYTE BIOL, V92, P633, DOI 10.1189/jlb.1211604
   Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270
   Guarino MP, 2013, AGE, V35, P1755, DOI 10.1007/s11357-012-9475-x
   Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638
   Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011
   Ito S, 2007, ALCOHOL CLIN EXP RES, V31, P83S, DOI 10.1111/j.1530-0277.2006.00292.x
   Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498
   Kilkenny C, 2010, PLOS BIOL, V8, P0, DOI 10.1371/journal.pbio.1000412
   Kim HY, 2015, MOLECULES, V20, P3107, DOI 10.3390/molecules20023107
   Kim JH, 2009, VITAM HORM, V80, P613, DOI 10.1016/S0083-6729(08)00621-3
   Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219
   Kopp HP, 2003, ARTERIOSCL THROM VAS, V23, P1042, DOI 10.1161/01.ATV.0000073313.16135.21
   Lee KC, 2016, SCI REP-UK, V6, P0, DOI 10.1038/srep18899
   Lv XW, 2010, INFLAMM RES, V59, P635, DOI 10.1007/s00011-010-0176-6
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Montana G, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0167420
   Muqaku B, 2016, MOL NUTR FOOD RES, V60, P2529, DOI 10.1002/mnfr.201600328
   NEWTON R, 1981, EUR J CLIN PHARMACOL, V21, P45, DOI 10.1007/BF00609587
   Ohira H, 2016, LIPIDS HEALTH DIS, V15, P0, DOI 10.1186/s12944-016-0387-0
   Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055
   Poniachik J, 2006, CYTOKINE, V33, P252, DOI 10.1016/j.cyto.2006.02.006
   Rudelle S, 2007, OBESITY, V15, P349, DOI 10.1038/oby.2007.529
   Sindhu S, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0133494
   Sinha RA, 2014, HEPATOLOGY, V59, P1366, DOI 10.1002/hep.26667
   Suganami T, 2005, ARTERIOSCL THROM VAS, V25, P2062, DOI 10.1161/01.ATV.0000183883.72263.13
   Tamura Y, 2008, ARTERIOSCL THROM VAS, V28, P2195, DOI 10.1161/ATVBAHA.108.168633
   Tremblay F, 2001, DIABETES, V50, P1901, DOI 10.2337/diabetes.50.8.1901
   Wang H, 2010, J CELL BIOCHEM, V110, P1447, DOI 10.1002/jcb.22696
   Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930
   Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yamauchi R, 2010, J AGR FOOD CHEM, V58, P5597, DOI 10.1021/jf904062c
   Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788
   Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984
   Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411
   Yeh TC, 2014, HYPERTENSION, V63, P535, DOI 10.1161/HYPERTENSIONAHA.113.02272
   Zhang SJ, 2015, FOOD FUNCT, V6, P2578, DOI 10.1039/c5fo00247h
NR 52
TC 24
Z9 24
U1 1
U2 24
PU AMER PHYSIOLOGICAL SOC
PI Rockville
PA 6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES
SN 0193-1849
EI 1522-1555
J9 AM J PHYSIOL-ENDOC M
JI Am. J. Physiol.-Endocrinol. Metab.
PD MAY 15
PY 2018
VL 314
IS 5
BP E433
EP E447
DI 10.1152/ajpendo.00094.2017
PG 15
WC Endocrinology & Metabolism; Physiology
SC Endocrinology & Metabolism; Physiology
GA GP8OJ
UT WOS:000441170700003
PM 29118012
DA 2025-04-28
ER

PT J
AU Rothenberg, DO
   Zhou, CB
   Zhang, LY
AF Rothenberg, Dylan O'Neill
   Zhou, Caibi
   Zhang, Lingyun
TI A Review on the Weight-Loss Effects of Oxidized Tea Polyphenols
SO MOLECULES
LA English
DT Review
DE Camellia sinensis; tea catechins; obesity; weight-loss; lipid metabolism
ID gut microbiota composition; pancreatic alpha-amylase; fermentation in-vitro; diet-induced obesity; green tea; oolong tea; black tea; high-fat; body-fat; intestinal microbiota
AB The mechanistic systems in the body through which tea causes weight loss are complex and multi-dimensional. Additionally, the bioactive components in tea such as catechins, caffeine, and products of tea polyphenol oxidation vary greatly from one major tea type to the next. Green tea has been the primary subject of consideration for investigation into the preventative health effects of tea because it contains the highest levels of phenolic compounds and retains the highest antioxidant capabilities of any major tea type. However, recent research suggests decreasing body fat accumulation has little to do with antioxidant activity and more to do with enzyme inhibition, and gut microbiota interactions. This paper reviews several different tea polyphenol-induced weight-loss mechanisms, and purposes a way in which these mechanisms may be interrelated. Our original short-chain fatty acid (SCFA) hypothesis' suggests that the weight-loss efficacy of a given tea is determined by a combination of carbohydrate digestive enzyme inhibition and subsequent reactions of undigested carbohydrates with gut microbiota. These reactions among residual carbohydrates, tea polyphenols, and gut microbiota within the colon produce short-chain fatty acids, which enhance lipid metabolism through AMP-activated protein kinase (AMPK) activation. Some evidence suggests the mechanisms involved in SCFA generation may be triggered more strongly by teas that have undergone fermentation (black, oolong, and dark) than by non-fermented (green) teas. We discussed the mechanistic differences among fermented and non-fermented teas in terms of enzyme inhibition, interactions with gut microbiota, SCFA generation, and lipid metabolism. The inconsistent results and possible causes behind them are also discussed.
C1 [Rothenberg, Dylan O'Neill; Zhang, Lingyun] South China Agr Univ, Coll Hort Sci, Guangzhou 510640, Guangdong, Peoples R China.
   [Zhou, Caibi] Qiannan Normal Univ Nationalities, Dept Tea Sci, Duyun 558000, Peoples R China.
C3 South China Agricultural University; Qiannan Normal University of Nationalities
RP Zhang, LY (corresponding author), South China Agr Univ, Coll Hort Sci, Guangzhou 510640, Guangdong, Peoples R China.
EM Dylan.Rothenberg@colorado.edu; teasky@foxmail.com; Zhanglingyun@scau.edu.cn
FU Research and innovation team Foundation of Guizhou Province Education Department
CR Bäckhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Balaji M, 2016, OBES RES CLIN PRACT, V10, P363, DOI 10.1016/j.orcp.2015.12.004
   Banerjee S, 2012, NUTR RES, V32, P985, DOI 10.1016/j.nutres.2012.10.005
   Bessesen DH, 2007, YB ENDOCRINOL, V2007, P163, DOI 10.1016/S0084-3741(08)70093-3
   Besten GD, 2014, PLOS ONE, V9, P0
   Bradlow HL, 2014, HORM MOL BIOL CLIN I, V17, P53, DOI 10.1515/hmbci-2013-0063
   Candela M, 2010, INT J FOOD MICROBIOL, V140, P93, DOI 10.1016/j.ijfoodmicro.2010.04.017
   Cao ZH, 2013, PHYTOTHER RES, V27, P1193, DOI 10.1002/ptr.4831
   Espín JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033
   Chaput JP, 2007, MINI-REV MED CHEM, V7, P3, DOI 10.2174/138955707779317849
   Cheng M, 2017, FOOD RES INT, V92, P9, DOI 10.1016/j.foodres.2016.12.008
   den Besten G, 2015, PLOS ONE, V10, P0, DOI 10.1371/journal.pone.0136364
   den Besten G, 2015, DIABETES, V64, P2398, DOI 10.2337/db14-1213
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Dostal AM, 2016, J NUTR, V146, P38, DOI 10.3945/jn.115.222414
   Dulloo AG, 1999, AM J CLIN NUTR, V70, P1040
   Glisan SL, 2017, FOOD CHEM, V216, P296, DOI 10.1016/j.foodchem.2016.08.052
   Grove KA, 2012, OBESITY, V20, P2311, DOI 10.1038/oby.2011.139
   Hamdaoui MH, 2016, JOURNAL OF NUTRITION & INTERMEDIARY METABOLISM, V6, P33, DOI 10.1016/j.jnim.2016.07.002
   Han ZX, 2016, FOOD CHEM, V212, P739, DOI 10.1016/j.foodchem.2016.06.049
   Hardie DG, 2015, CURR OPIN CELL BIOL, V33, P1, DOI 10.1016/j.ceb.2014.09.004
   Henning SM, 2018, EUR J NUTR, V57, P2759, DOI 10.1007/s00394-017-1542-8
   Hodgson JM, 2006, BRIT J NUTR, V95, P14, DOI 10.1079/BJN20051621
   Hsu TF, 2006, EUR J CLIN NUTR, V60, P1330, DOI 10.1038/sj.ejcn.1602464
   Hu CJ, 2016, FOOD CHEM, V194, P312, DOI 10.1016/j.foodchem.2015.08.029
   Hursel R, 2011, OBES REV, V12, PE573, DOI 10.1111/j.1467-789X.2011.00862.x
   Hursel R, 2009, APPETITE, V52, P838
   Janssens PLHR, 2016, PLOS ONE, V11, P0, DOI 10.1371/journal.pone.0153134
   Janssens PLHR, 2015, J NUTR, V145, P864, DOI 10.3945/jn.114.207829
   Jobu K, 2013, FOOD RES INT, V54, P324, DOI 10.1016/j.foodres.2013.07.037
   Katuna-Czaplinska J, 2017, TRENDS FOOD SCI TECH, V70, P105, DOI 10.1016/j.tifs.2017.10.010
   Karamadoukis L, 2009, CLIN NEPHROL, V71, P430
   Kayashima Yasunari, 2015, BIOCHEM BIOPHYS REP, V4, P417, DOI 10.1016/j.bbrep.2015.10.013
   Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g
   Koo SI, 2007, J NUTR BIOCHEM, V18, P179, DOI 10.1016/j.jnutbio.2006.12.005
   Korpela K, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0090702
   Kwon YI, 2008, J FOOD BIOCHEM, V32, P15, DOI 10.1111/j.1745-4514.2007.00165.x
   Lee LS, 2016, FOOD SCI BIOTECHNOL, V25, P1523, DOI 10.1007/s10068-016-0236-y
   Lee MS, 2017, FOOD NUTR RES, V61, P0, DOI 10.1080/16546628.2017.1325307
   Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005
   [李府 Li Fu], 2008, 中国组织工程研究与临床康复 JOURNAL OF CLINICAL REHABILITATIVE TISSUE ENGINEERING RESEARCH, V12, P3061
   Liu SY, 2016, BMC COMPLEM ALTERN M, V16, P0, DOI 10.1186/s12906-016-1361-0
   Long YC, 2006, J CLIN INVEST, V116, P1776, DOI 10.1172/JCI29044
   Lu SY, 2016, J FUNCT FOODS, V20, P506, DOI 10.1016/j.jff.2015.11.017
   Mahmood N, 2016, COMPARATIVE CLINICAL PATHOLOGY, V25, P1253, DOI 10.1007/s00580-014-1967-x
   Miao M, 2013, J FUNCT FOODS, V5, P2024, DOI 10.1016/j.jff.2013.09.021
   Mielgo-Ayuso J, 2014, BRIT J NUTR, V111, P1263, DOI 10.1017/S0007114513003784
   Million M, 2013, CLIN MICROBIOL INFEC, V19, P305, DOI 10.1111/1469-0691.12172
   Moreno-Indias I, 2015, J DIABETES RES, V2015, P0, DOI 10.1155/2015/970375
   Moseti D, 2016, INT J MOL SCI, V17, P0, DOI 10.3390/ijms17010124
   Nagao T, 2007, OBESITY, V15, P1473, DOI 10.1038/oby.2007.176
   Nakai M, 2005, J AGR FOOD CHEM, V53, P4593, DOI 10.1021/jf047814+
   Nam M, 2018, J NUTR BIOCHEM, V51, P1, DOI 10.1016/j.jnutbio.2017.09.002
   Nyambe-Silavwe H, 2016, BRIT J NUTR, V116, P443, DOI 10.1017/S0007114516002221
   Ozdal T, 2016, NUTRIENTS, V8, P0, DOI 10.3390/nu8020078
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007
   Phung OJ, 2010, AM J CLIN NUTR, V91, P73, DOI 10.3945/ajcn.2009.28157
   Raso RA, 2017, ACTA CIR BRAS, V32, P342, DOI 10.1590/s0102-865020170050000003
   Remely M, 2015, BENEF MICROBES, V6, P431, DOI 10.3920/BM2014.0104
   Rocha A, 2016, EUR J NUTR, V55, P2231, DOI 10.1007/s00394-015-1033-8
   Sae-tan S, 2011, FOOD FUNCT, V2, P111, DOI 10.1039/c0fo00155d
   Satoh T, 2015, J ETHNOPHARMACOL, V161, P147, DOI 10.1016/j.jep.2014.12.009
   Serrano JCE, 2013, MOL NUTR FOOD RES, V57, P459, DOI 10.1002/mnfr.201200513
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Spiegelman BM, 2010, RES PERSPECT END INT, V0, PP89, DOI 10.1007/978-3-642-13517-0_8
   Striegel Lisa, 2015, FRONT NUTR, V2, P3, DOI 10.3389/fnut.2015.00003
   Sun HY, 2018, J FOOD SCI TECH MYS, V55, P399, DOI 10.1007/s13197-017-2951-7
   Sun LJ, 2016, J FUNCT FOODS, V26, P144, DOI 10.1016/j.jff.2016.07.012
   Thurairajah PH, 2005, EUR J GASTROEN HEPAT, V17, P1437, DOI 10.1097/01.meg.0000187680.53389.88
   Tilg H, 2014, GUT, V63, P1513, DOI 10.1136/gutjnl-2014-306928
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Unno T, 2009, J NUTR SCI VITAMINOL, V55, P447, DOI 10.3177/jnsv.55.447
   Walle T, 2009, INT J MOL SCI, V10, P5002, DOI 10.3390/ijms10115002
   Wang SH, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0111143
   Wang SM, 2017, EUR J NUTR, V56, P2037, DOI 10.1007/s00394-016-1241-x
   Welker TL, 2017, AQUACULT INT, V25, P1073, DOI 10.1007/s10499-016-0099-5
   Wen X, 2006, DRUG METAB DISPOS, V34, P1786, DOI 10.1124/dmd.106.011122
   Wilson T, 2016, BEVERAGE IMPACTS ON HEALTH AND NUTRITION, V2, P0
   Yamashita Y, 2014, FOOD FUNCT, V5, P2420, DOI 10.1039/c4fo00095a
   Yamashita Y, 2012, J AGR FOOD CHEM, V60, P11366, DOI 10.1021/jf303597c
   Yang CS, 2016, MOL NUTR FOOD RES, V60, P160, DOI 10.1002/mnfr.201500428
   Yang CS, 2018, J FOOD DRUG ANAL, V26, P1, DOI 10.1016/j.jfda.2017.10.010
   Yang XP, 2016, LWT-FOOD SCI TECHNOL, V66, P232, DOI 10.1016/j.lwt.2015.10.035
   Yang Y, 2015, FITOTERAPIA, V104, P45, DOI 10.1016/j.fitote.2015.05.007
   Yi Juan Yi Juan, 2007, ACTA NUTRIMENTA SINICA, V29, P582
   Zhang X, 2016, J AGR FOOD CHEM, V64, P2582, DOI 10.1021/acs.jafc.6b00586
   Zhang X, 2014, J AGR FOOD CHEM, V62, P10046, DOI 10.1021/jf5016335
   Zhang X, 2013, FOOD RES INT, V54, P1589, DOI 10.1016/j.foodres.2013.10.005
   Zhong YD, 2015, MOL NUTR FOOD RES, V59, P2066, DOI 10.1002/mnfr.201500187
   Zhou H, 2017, FOOD CHEM, V235, P227, DOI 10.1016/j.foodchem.2017.05.034
   Zhou J, 2014, PLOS ONE, V9, P0, DOI 10.1371/journal.pone.0087161
   Zhou L, 2016, FOOD FUNCT, V7, P1959, DOI 10.1039/c6fo00032k
   Zhu XL, 2013, J AGR FOOD CHEM, V61, P1868, DOI 10.1021/jf304643k
NR 94
TC 70
Z9 74
U1 7
U2 122
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 1420-3049
J9 MOLECULES
JI Molecules
PD MAY 15
PY 2018
VL 23
IS 5
BP 
EP 
DI 10.3390/molecules23051176
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA GJ3NX
UT WOS:000435204000191
PM 29758009
DA 2025-04-28
ER

PT J
AU Baltar, VT
   Cunha, DB
   Santos, RD
   Marchioni, DM
   Sichieri, R
AF Baltar, Valeria Troncoso
   Cunha, Diana Barbosa
   Santos, Roberta de Oliveira
   Marchioni, Dirce Maria
   Sichieri, Rosely
TI Breakfast patterns and their association with body mass index in Brazilian adults
SO CADERNOS DE SAUDE PUBLICA
LA English
DT Article
DE Breakfast; Feeding Behavior; Body Mass Index; Statistical Factor Analysis
ID dietary patterns; waist circumference; national-health; metabolic syndrome; food patterns; energy-intake; obesity; quality; density; meals
AB The objective was to investigate the relationships between body mass index (BMI), skipping breakfast, and breakfast patterns in Brazilian adults. We analyzed data of 21,003 individuals aged between 20 to 59 from the Brazilian National Dietary Survey 2008-2009. Breakfast was defined as the eating occasion between 5 and 10a.m. with the highest usual food consumption (exceeding 50Kcal/209.2kJ). Dietary patterns were derived by the factor analysis of 18 food groups (usual intake). Controlling for confounders linear regressions of BMI were used to verify the associations considering the survey design. Skipping breakfast was not associated with BMI. Three breakfast patterns were observed (48% variability): Brazilian Northern (positive loading for meats, preparations with corn, eggs, tubers/roots/potatoes, dairy products, savory snacks/crackers, fruit juices/fruit drinks/soy-based drinks); Western (positive for fruit juices/fruit drinks/soy-based drinks, sandwiches/ pizza, baked/deep-fried snacks, chocolate/desserts, cakes/cookies) and Brazilian Southeastern (cold cut meat, milk, cheese, coffee/tea, bread). The Brazilian Southeastern pattern was inversely associated with BMI, while the Brazilian Northern pattern was directly associated with it. Therefore, the results suggest a role for breakfast quality in the association with BMI. Thus, a Brazilian Southeastern breakfast usual intake may be inversely associated with BMI.
C1 [Baltar, Valeria Troncoso] Univ Fed Fluminense, Dept Epidemiol & Bioestat, Travessa Marques Parana 303,32 Andar, BR-24030210 Niteroi, RJ, Brazil.
   [Cunha, Diana Barbosa; Sichieri, Rosely] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Santos, Roberta de Oliveira; Marchioni, Dirce Maria] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, Brazil.
C3 Universidade Federal Fluminense; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo
RP Baltar, VT (corresponding author), Univ Fed Fluminense, Dept Epidemiol & Bioestat, Travessa Marques Parana 303,32 Andar, BR-24030210 Niteroi, RJ, Brazil.
EM vtbaltar@id.uff.br
FU Carlos Chagas Filho Foundation for Research Support in the State of Rio de Janeiro (FAPERJ)
CR Andersson J, 2003, APPETITE, V41, P149, DOI 10.1016/S0195-6663(03)00052-7
   Unknown -, 2011, COORD TRAB REND PESQ, V0, P0
   Brown AW, 2013, AM J CLIN NUTR, V98, P1298, DOI 10.3945/ajcn.113.064410
   Casazza K, 2013, NEW ENGL J MED, V368, P2236, DOI 10.1056/NEJMsa1208051
   Cho S, 2003, J AM COLL NUTR, V22, P296, DOI 10.1080/07315724.2003.10719307
   Cunha DB, 2010, BRIT J NUTR, V104, P908, DOI 10.1017/S0007114510001479
   Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/s0140-6736(16)30054-x
   Dodd KW, 2006, J AM DIET ASSOC, V106, P1640, DOI 10.1016/j.jada.2006.07.011
   Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5
   Gosby AK, 2014, OBES REV, V15, P183, DOI 10.1111/obr.12131
   Hair JF, 2010, MULTIVARIATE DATA ANALYSIS WITH READINGS, V7th Edition, P0, DOI 10.1016/J.IJPHARM.2011.02.019
   Heidemann C, 2008, CIRCULATION, V118, P230, DOI 10.1161/CIRCULATIONAHA.108.771881
   Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002
   Huang CJ, 2010, INT J OBESITY, V34, P720, DOI 10.1038/ijo.2009.285
   Instituto Brasileiro de Geografia e Estatistica, 2011, PESQ ORC FAM 2008 20, V0, P0
   Johnson RA, 1992, APPLIED MULTIVARIATE STATISTICAL ANALYSIS, V3rd edn, P0
   Kant AK, 2008, AM J CLIN NUTR, V88, P1396, DOI 10.3945/ajcn.2008.26171
   LeCheminant GM, 2017, APPETITE, V112, P44, DOI 10.1016/j.appet.2016.12.041
   Lee JS, 2016, EAT BEHAV, V21, P84, DOI 10.1016/j.eatbeh.2016.01.009
   Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262
   Martínez-González MA, 2013, REV ENDOCR METAB DIS, V14, P265, DOI 10.1007/s11154-013-9264-6
   Maskarinec G, 2000, J NUTR, V130, P3068, DOI 10.1093/jn/130.12.3068
   Min C, 2012, NUTR RES PRACT, V6, P61, DOI 10.4162/nrp.2012.6.1.61
   Mu M, 2014, J AM COLL NUTR, V33, P120, DOI 10.1080/07315724.2013.874897
   Newby P, 2003, AM J CLIN NUTR, V77, P1417, DOI 10.1093/ajcn/77.6.1417
   Newby PK, 2004, AM J CLIN NUTR, V80, P504, DOI 10.1093/ajcn/80.2.504
   Ocké MC, 2013, P NUTR SOC, V72, P191, DOI 10.1017/S0029665113000013
   Olinto MTA, 2011, PUBLIC HEALTH NUTR, V14, P150, DOI 10.1017/S136898001000162X
   Pannu Poonam K, 2016, ADV FOOD NUTR RES, V77, P57, DOI 10.1016/bs.afnr.2015.11.001
   Pasiakos SM, 2015, J NUTR, V145, P605, DOI 10.3945/jn.114.205203
   Santos RD, 2017, BMC PUBLIC HEALTH, V18, P0, DOI 10.1186/s12889-017-4582-3
   Santos RD, 2015, BRIT J NUTR, V114, P822, DOI 10.1017/S0007114515002445
   SCHLUNDT DG, 1992, AM J CLIN NUTR, V55, P645, DOI 10.1093/ajcn/55.3.645
   Schulze MB, 2006, OBESITY, V14, P1444, DOI 10.1038/oby.2006.164
   Sichieri R, 2002, OBES RES, V10, P42, DOI 10.1038/oby.2002.6
   Siega-Riz AM, 2000, PREV MED, V30, P415, DOI 10.1006/pmed.2000.0651
   Song WO, 2005, J AM DIET ASSOC, V105, P1373, DOI 10.1016/j.jada.2005.06.002
   Souza AD, 2013, REV SAUDE PUBL, V47, PS190, DOI 10.1590/S0034-89102013000700005
   Timlin MT, 2007, NUTR REV, V65, P268, DOI 10.1301/nr.2007.jun.268-281
   Tooze JA, 2006, J AM DIET ASSOC, V106, P1575, DOI 10.1016/j.jada.2006.07.003
   Verly E, 2017, EUR J CLIN NUTR, V71, P1418, DOI 10.1038/ejcn.2017.120
   Verly E, 2017, CAD SAUDE PUBLICA, V33, P0, DOI 10.1590/0102-311X00173216
   WHO, 2003, WHO TECH REP SER, V916, P1
   Willett WC, 2008, ASIA PAC J CLIN NUTR, V17, P75
   Yoo KB, 2014, ASIA PAC J CLIN NUTR, V23, P128, DOI 10.6133/apjcn.2014.23.1.08
NR 45
TC 21
Z9 23
U1 0
U2 4
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD JUN 15
PY 2018
VL 34
IS 6
BP 
EP 
DI 10.1590/0102-311X00111917
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GL0JY
UT WOS:000436773800001
PM 29952402
DA 2025-04-28
ER

PT J
AU Shokouh, P
   Jeppesen, PB
   Hermansen, K
   Laustsen, C
   Stodkilde-Jorgensen, H
   Hamilton-Dutoit, SJ
   Schmedes, M
   Qi, HY
   Norlinger, T
   Gregersen, S
AF Shokouh, Pedram
   Jeppesen, Per Bendix
   Hermansen, Kjeld
   Laustsen, Christoffer
   Stodkilde-Jorgensen, Hans
   Hamilton-Dutoit, Stephen Jacques
   Schmedes, Mette Sondergaard
   Qi, Haiyun
   Norlinger, Thomas Stokholm
   Gregersen, Soren
TI Effects of Unfiltered Coffee and Bioactive Coffee Compounds on the Development of Metabolic Syndrome Components in a High-Fat-/High-Fructose-Fed Rat Model
SO NUTRIENTS
LA English
DT Article
DE coffee; chlorogenic acid; caffeic acid; trigonelline; insulin resistance; metabolic syndrome x; non-alcoholic fatty liver disease; carbon-13 magnetic resonance spectroscopy; phytotherapy
ID decaffeinated coffee; glucose-homeostasis; magnetic-resonance; insulin-resistance; hepatic steatosis; consumption; risk; obesity; green; tea
AB The literature is inconsistent as to how coffee affects metabolic syndrome (MetS), and which bioactive compounds are responsible for its metabolic effects. This study aimed to evaluate the effects of unfiltered coffee on diet-induced MetS and investigate whether or not phenolic acids and trigonelline are the main bioactive compounds in coffee. Twenty-four male SpragueDawley rats were fed a high-fat (35% W/W) diet plus 20% W/W fructose in drinking water for 14 weeks, and were randomized into three groups: control, coffee, or nutraceuticals (5-O-caffeoylquinic acid, caffeic acid, and trigonelline). Coffee or nutraceuticals were provided in drinking water at a dosage equal to 4 cups/day in a human. Compared to the controls, total food intake (p = 0.023) and mean body weight at endpoint (p = 0.016) and estimated average plasma glucose (p = 0.041) were lower only in the coffee group. Surrogate measures of insulin resistance including the overall fasting insulin (p = 0.010), endpoint HOMA-IR (p = 0.022), and oral glucose tolerance (p = 0.029) were improved in the coffee group. Circulating triglyceride levels were lower (p = 0.010), and histopathological and quantitative (p = 0.010) measurements indicated lower grades of liver steatosis compared to controls after long-term coffee consumption. In conclusion, a combination of phenolic acids and trigonelline was not as effective as coffee per se in improving the components of the MetS. This points to the role of other coffee chemicals and a potential synergism between compounds.
C1 [Shokouh, Pedram; Jeppesen, Per Bendix; Hermansen, Kjeld; Gregersen, Soren] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Palle Juul Jensens Blvd 165, DK-8200 Aarhus N, Denmark.
   [Shokouh, Pedram] Odense Univ Hosp, Danish Diabet Acad, Klovervaenget 10, DK-5000 Odense, Denmark.
   [Laustsen, Christoffer; Stodkilde-Jorgensen, Hans; Qi, Haiyun; Norlinger, Thomas Stokholm] Aarhus Univ, Hosp Skejby, MR Res Ctr, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.
   [Hamilton-Dutoit, Stephen Jacques] Aarhus Univ, Hosp Skejby, Inst Pathol, Palle Juul Jensens Blvd 99, DK-8200 Aarhus N, Denmark.
   [Schmedes, Mette Sondergaard] Aarhus Univ, Dept Food Sci, DK-5792 Arslev, Denmark.
C3 Aarhus University; University of Southern Denmark; Odense University Hospital; Aarhus University; Aarhus University; Aarhus University
RP Shokouh, P (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Palle Juul Jensens Blvd 165, DK-8200 Aarhus N, Denmark.; Shokouh, P (corresponding author), Odense Univ Hosp, Danish Diabet Acad, Klovervaenget 10, DK-5000 Odense, Denmark.
EM Shokouh.P@Gmail.com; per.bendix.jeppesen@clin.au.dk; kjeld.hermansen@aarhus.rm.dk; cl@clin.au.dk; hsj@clin.au.dk; stephami@rm.dk; mette.schmedes@food.au.dk; qi@clin.au.dk; thomasnorlinger@gmail.com; soeren.gregersen@aarhus.rm.dk
FU Aarhus University; Danish Diabetes Academy; Novo Nordisk Foundation; Innovation Fund Denmark [1308-00028B]; Riisfort Foundation
CR Agostoni C, 2015, EFSA J, V13, P0, DOI 10.2903/j.efsa.2015.4102
   Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x
   Beynen AC, 1996, BRIT J NUTR, V76, P755, DOI 10.1079/BJN19960081
   Buckley AJ, 2018, DIABETES RES CLIN PR, V144, P144, DOI 10.1016/j.diabres.2018.08.011
   Cai L, 2012, EUR J CLIN NUTR, V66, P872, DOI 10.1038/ejcn.2012.68
   Chen SH, 2014, J GASTROEN HEPATOL, V29, P435, DOI 10.1111/jgh.12422
   Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003
   Comment A, 2014, BIOCHEMISTRY-US, V53, P7333, DOI 10.1021/bi501225t
   Cowan TE, 2014, J NUTR BIOCHEM, V25, P489, DOI 10.1016/j.jnutbio.2013.12.009
   Crescenzo R, 2014, EXP PHYSIOL, V99, P1203, DOI 10.1113/expphysiol.2014.079632
   Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
   de Pascual-Teresa S, 2000, J AGR FOOD CHEM, V48, P5331, DOI 10.1021/jf000549h
   Després JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895
   Ding M, 2014, DIABETES CARE, V37, P569, DOI 10.2337/dc13-1203
   Farah A, 2005, J AGR FOOD CHEM, V53, P1505, DOI 10.1021/jf048701t
   HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5
   HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000
   Ho L, 2012, NUTR NEUROSCI, V15, P37, DOI 10.1179/1476830511Y.0000000027
   Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439
   Jaiswal R, 2010, J AGR FOOD CHEM, V58, P8722, DOI 10.1021/jf1014457
   Jia HJ, 2014, GENES NUTR, V9, P0, DOI 10.1007/s12263-014-0389-3
   Jouihan H, 2012, BIO-PROTOCOL, V2, Pe223, DOI 10.21769/BIOPROTOC.223
   Laustsen C, 2017, AM J PHYSIOL-RENAL, V312, PF192, DOI 10.1152/ajprenal.00148.2016
   Lewis AJM, 2016, DIABETES, V65, P3544, DOI 10.2337/db16-0804
   Li XD, 2011, PROTEIN CELL, V2, P189, DOI 10.1007/s13238-011-1016-3
   Ludwig IA, 2014, FOOD FUNCT, V5, P1695, DOI 10.1039/C4FO00042K
   Ma YJ, 2015, PHARM RES-DORDR, V32, P1200, DOI 10.1007/s11095-014-1526-9
   Maki C, 2017, PLOS ONE, V12, P0, DOI 10.1371/journal.pone.0173264
   Matsuda Y, 2011, BIOSCI BIOTECH BIOCH, V75, P2309, DOI 10.1271/bbb.110452
   Mazur WM, 1998, BRIT J NUTR, V79, P37, DOI 10.1079/BJN19980007
   Mellbye FB, 2017, J NAT PROD, V80, P2353, DOI 10.1021/acs.jnatprod.7b00395
   Mellbye FB, 2015, J NAT PROD, V78, P2447, DOI 10.1021/acs.jnatprod.5b00481
   Meng SX, 2013, EVID-BASED COMPL ALT, V2013, P0, DOI 10.1155/2013/801457
   Moon CM, 2017, BIOCHEM BIOPH RES CO, V482, P112, DOI 10.1016/j.bbrc.2016.08.118
   Murase T, 2011, AM J PHYSIOL-ENDOC M, V300, PE122, DOI 10.1152/ajpendo.00441.2010
   ONeill S, 2015, OBES REV, V16, P1, DOI 10.1111/obr.12229
   Onakpoya I, 2011, GASTROENT RES PRACT, V2011, P0, DOI 10.1155/2011/382852
   Pan MH, 2016, FOOD FUNCT, V7, P4481, DOI 10.1039/c6fo01168c
   Panchal SK, 2012, NUTRITION, V28, P1055, DOI 10.1016/j.nut.2012.02.013
   Panchal SK, 2012, J NUTR, V142, P690, DOI 10.3945/jn.111.153577
   Panchal SK, 2011, J CARDIOVASC PHARM, V57, P51, DOI 10.1097/FJC.0b013e3181feb90a
   Panchal SK, 2011, J BIOMED BIOTECHNOL, V0, P0, DOI DOI 10.1155/2011/351982
   Park S, 2007, METABOLISM, V56, P599, DOI 10.1016/j.metabol.2006.12.004
   Peng BJ, 2015, BIOMED ENVIRON SCI, V28, P894, DOI 10.3967/bes2015.123
   Poole R, 2017, BMJ-BRIT MED J, V359, P0, DOI 10.1136/bmj.j5024
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Rustenbeck I, 2014, NUTR DIABETES, V4, P0, DOI 10.1038/nutd.2014.19
   Salomone F, 2014, TRANSL RES, V163, P593, DOI 10.1016/j.trsl.2013.12.001
   Santos RMM, 2016, EUR J NUTR, V55, P1345, DOI 10.1007/s00394-016-1206-0
   Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359
   Shang F, 2016, DIABETES METAB, V42, P80, DOI 10.1016/j.diabet.2015.09.001
   Shi XQ, 2016, NUTR J, V15, P0, DOI 10.1186/s12937-016-0220-7
   Song SJ, 2014, EVID-BASED COMPL ALT, V2014, P0, DOI 10.1155/2014/718379
   STENNERT A, 1994, Z LEBENSM UNTERS FOR, V199, P198, DOI 10.1007/BF01193443
   van Dam RM, 2002, LANCET, V360, P1477, DOI 10.1016/S0140-6736(02)11436-X
   Vitaglione P, 2010, HEPATOLOGY, V52, P1652, DOI 10.1002/hep.23902
   Wang JJ, 2007, EUR HEART J, V28, P857, DOI 10.1093/eurheartj/ehl524
   Wishart DS, 2007, NUCLEIC ACIDS RES, V35, PD521, DOI 10.1093/nar/gkl923
   Xu ZH, 2014, J ETHNOPHARMACOL, V151, P548, DOI 10.1016/j.jep.2013.11.021
NR 60
TC 11
Z9 11
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD OCT 15
PY 2018
VL 10
IS 10
BP 
EP 
DI 10.3390/nu10101547
PG 15
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA GY7UM
UT WOS:000448821300213
PM 30347674
DA 2025-04-28
ER

PT J
AU Essman, M
   Popkin, BM
   Corvalán, C
   Reyes, M
   Taillie, LS
AF Essman, Michael
   Popkin, Barry M.
   Corvalan, Camila
   Reyes, Marcela
   Taillie, Lindsey Smith
TI Sugar-Sweetened Beverage Intake among Chilean Preschoolers and Adolescents in 2016: A Cross-Sectional Analysis
SO NUTRIENTS
LA English
DT Article
DE beverage intake; children; adolescents; sugar-sweetened beverages; juice; milk
ID front-of-pack; body-mass; children; obesity; adults; bmi
AB Background: Chile has the highest sugar-sweetened beverage (SSB) sales of any country and a growing burden of childhood obesity. This study examines SSB intake in Chilean children after a 5% SSB tax increase in 2014 but prior to marketing, labeling, and school policies implemented in 2016. Methods: 24-h recalls were collected in 2016 from two cohorts comprised of preschoolers 3-5 years of age (n = 961) and adolescents 12-14 years of age (n = 770) from low-moderate income neighborhoods. Beverages were categorized as regulated or unregulated according to whether they exceeded nutrient thresholds established by the 2016 policies. Results: Preschoolers consumed mainly beverage calories from regulated dairy beverages and substitutes (109 kcal, SD 30), unregulated dairy beverages (102 kcal, SD 24), and regulated fruit and vegetables drinks (44 kcal, SD 20). For adolescents, the greatest contributions came from regulated sodas (77 kcal, SD 47), regulated dairy beverages and substitutes (41 kcal, SD 16), and unregulated coffee and tea (41 kcal, SD 11). Overall, regulated beverages provided a greater proportion of calories than unregulated for preschoolers (15.0% vs. 11.8%) and for adolescents (9.1% vs. 5.0%). Conclusions: Before major policy implementation, regulated beverages accounted for a higher percentage of energy intake than unregulated beverages among both age groups. Future research will be needed to evaluate the impact of Chile's new policies on sugary beverage intake in children.
C1 [Essman, Michael; Popkin, Barry M.; Taillie, Lindsey Smith] Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.
   [Popkin, Barry M.; Taillie, Lindsey Smith] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.
   [Corvalan, Camila; Reyes, Marcela] Univ Chile, Inst Nutr & Food Technol INTA, Santiago 7830490, Chile.
C3 University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Universidad de Chile
RP Taillie, LS (corresponding author), Univ N Carolina, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.; Taillie, LS (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.
EM essmanm@live.unc.edu; popkin@unc.edu; ccorvalan@inta.uchile.cl; mreyes@inta.uchile.cl; taillie@unc.edu
FU Bloomberg Philanthropies; IDRC Grant [108180]; CONICYT Fondecyt [1161436]
CR Araneda J, 2015, SALUD PUBLICA MEXICO, V57, P128
   Caro JC, 2018, PLOS MED, V15, P0, DOI 10.1371/journal.pmed.1002597
   Cerda R, 2010, PHOTOGRAPHIC ATLAS OF CHILEAN FOOD AND TYPICAL PREPARATIONS: NATIONAL SURVEY OF FOOD CONSUMPTION, V1st, P0
   Corvalan C, 2017, OBES REV, V18, P7, DOI 10.1111/obr.12571
   FAO and PAHO, 2017, PAN FOOD NUTR SEC LA, V0, P0
   Feunekes GI, 2008, APPETITE, V50, P57, DOI 10.1016/j.appet.2007.05.009
   Garmendia ML, 2013, EUR J CLIN NUTR, V67, P513, DOI 10.1038/ejcn.2012.190
   Grunert KG, 2010, APPETITE, V55, P177, DOI 10.1016/j.appet.2010.05.045
   JUNAEB, 2015, SIT NUTR PREESC ESC, V0, P0
   Kain J, 2002, EUR J CLIN NUTR, V56, P200, DOI 10.1038/sj.ejcn.1601301
   Kain J, 2009, OBESITY, V17, P1603, DOI 10.1038/oby.2009.37
   Kelly B, 2009, HEALTH PROMOT INT, V24, P120, DOI 10.1093/heapro/dap012
   Luger M, 2017, OBESITY FACTS, V10, P674, DOI 10.1159/000484566
   Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nissinen K, 2009, PUBLIC HEALTH NUTR, V12, P2018, DOI 10.1017/S1368980009005849
   Popkin BM, 2016, LANCET DIABETES ENDO, V4, P174, DOI 10.1016/S2213-8587(15)00419-2
   Popkin BM, 2006, AM J CLIN NUTR, V83, P529, DOI 10.1093/ajcn.83.3.529
   Stern D, 2014, J NUTR, V144, P949, DOI 10.3945/jn.114.190652
   Viner RM, 2006, INT J OBESITY, V30, P1368, DOI 10.1038/sj.ijo.0803183
   Vyth EL, 2010, PUBLIC HEALTH NUTR, V13, P1882, DOI 10.1017/S1368980010000637
NR 24
TC 17
Z9 19
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD NOV 15
PY 2018
VL 10
IS 11
BP 
EP 
DI 10.3390/nu10111767
PG 15
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA HC1GH
UT WOS:000451547700205
PM 30445671
DA 2025-04-28
ER

